1	The	DT	O	the	det	3	SENT_1	[p1l493t186r598b247],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l645t173r954b249],
3	ENGLAND	NNP	LOCATION	ENGLAND	_	0	SENT_1	[p1l1001t172r1659b249],

1	JOURNAL	NN	O	journal	_	0	SENT_2	[p1l333t297r950b400],
2	of	IN	O	of	_	0	SENT_2	[p1l999t304r1078b392],
3	MEDICINE	NNP	O	MEDICINE	prep_of	1	SENT_2	[p1l1115t297r1818b374],

1	ESTABLISHED	VBN	O	establish	_	0	SENT_3	[p1l357t487r570b505],
2	IN	IN	O	in	_	0	SENT_3	[p1l584t487r620b505],
3	1812	CD	DATE	1812	prep_in	1	SENT_3	[p1l635t487r705b505],

1	MAY	NNP	DATE	MAY	_	0	SENT_4	[p1l945t481r1031b505],
2	20	CD	DATE	20	num	1	SENT_4	[p1l1043t481r1100b510],
3	,	,	DATE	,	_	0	SENT_4	[p1l1043t481r1100b510],
4	2004	CD	DATE	2004	num	1	SENT_4	[p1l1115t480r1213b505],
5	VOL	NNP	O	VOL	dep	1	SENT_4	[p1l1532t487r1600b505],
6	.	.	O	.	_	0	SENT_4	[p1l1532t487r1600b505],

1	350	CD	NUMBER	350	_	0	SENT_5	[p1l1610t487r1662b506],
2	NO.	NNP	O	NO.	dep	1	SENT_5	[p1l1703t487r1758b505],
3	21	CD	NUMBER	21	num	2	SENT_5	[p1l1769t487r1802b504],

1	Activating	VBG	O	activate	amod	2	SENT_6	[p1l296t596r597b665],
2	Mutations	NNS	O	mutation	_	0	SENT_6	[p1l610t596r912b650],
3	in	IN	O	in	_	0	SENT_6	[p1l931t596r987b649],
4	the	DT	O	the	det	7	SENT_6	[p1l1005t595r1095b649],
5	Epidermal	NNP	O	Epidermal	nn	7	SENT_6	[p1l1112t595r1418b665],
6	Growth	NN	O	growth	nn	7	SENT_6	[p1l1435t595r1662b650],
7	Factor	NN	O	factor	prep_in	2	SENT_6	[p1l1678t600r1865b650],
8	Receptor	NN	O	receptor	nn	10	SENT_6	[p1l250t682r516b747],
9	Underlying	VBG	O	underlie	amod	10	SENT_6	[p1l530t678r863b748],
10	Responsiveness	NN	O	responsiveness	dep	2	SENT_6	[p1l877t678r1343b747],
11	of	IN	O	of	_	0	SENT_6	[p1l1363t677r1433b732],
12	N	NN	O	n	prep_of	10	SENT_6	[p1l1436t683r1488b733],
13	on	IN	O	on	prep	10	SENT_6	[p1l1491t678r1911b732],
14	.	.	O	.	_	0	SENT_6	[p1l1491t678r1911b732],

1	—	NN	O	—	_	0	SENT_7	[p1l1491t678r1911b732],
2	.	.	O	.	_	0	SENT_7	[p1l1491t678r1911b732],

1	Small	JJ	O	small	_	0	SENT_8	[p1l1491t678r1911b732],
2	.	.	O	.	_	0	SENT_8	[p1l1491t678r1911b732],

1	—	NN	O	—	_	0	SENT_9	[p1l1491t678r1911b732],
2	.	.	O	.	_	0	SENT_9	[p1l1491t678r1911b732],

1	Cell	NN	O	cell	_	0	SENT_10	[p1l1491t678r1911b732],

1	Lung	NN	O	lung	nn	2	SENT_11	[p1l716t766r870b831],
2	Cancer	NN	O	cancer	_	0	SENT_11	[p1l885t765r1091b816],
3	to	TO	O	to	_	0	SENT_11	[p1l1107t772r1162b816],
4	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	2	SENT_11	[p1l1180t760r1443b816],

1	Thomas	NNP	PERSON	Thomas	nn	2	SENT_12	[p1l188t895r359b935],
2	]	NNP	O	]	_	0	SENT_12	[p1l188t895r359b935],
3	.	.	O	.	_	0	SENT_12	[p1l188t895r359b935],

1	Lynch	NNP	PERSON	Lynch	nn	7	SENT_13	[p1l375t895r478b936],
2	,	,	O	,	_	0	SENT_13	[p1l375t895r478b936],
3	M.D.	NNP	O	M.D.	appos	7	SENT_13	[p1l495t898r585b932],
4	,	,	O	,	_	0	SENT_13	[p1l495t898r585b932],
5	Daphne	NNP	PERSON	Daphne	appos	7	SENT_13	[p1l602t895r733b936],
6	W	NNP	PERSON	W	nn	7	SENT_13	[p1l745t898r783b926],
7	Bell	NNP	PERSON	Bell	_	0	SENT_13	[p1l800t895r867b932],
8	,	,	O	,	_	0	SENT_13	[p1l800t895r867b932],
9	Ph.D.	NNP	O	Ph.D.	dep	7	SENT_13	[p1l885t895r983b932],
10	,	,	O	,	_	0	SENT_13	[p1l885t895r983b932],
11	Raffaella	NNP	PERSON	Raffaella	nn	12	SENT_13	[p1l1001t895r1141b926],
12	Sordella	NNP	PERSON	Sordella	appos	9	SENT_13	[p1l1155t895r1300b932],
13	,	,	O	,	_	0	SENT_13	[p1l1155t895r1300b932],
14	Ph.D.	NNP	O	Ph.D.	appos	9	SENT_13	[p1l1318t895r1417b932],
15	,	,	O	,	_	0	SENT_13	[p1l1318t895r1417b932],
16	Sarada	NNP	PERSON	Sarada	nn	17	SENT_13	[p1l1432t895r1545b926],
17	Gurubhagavatula	NNP	PERSON	Gurubhagavatula	appos	9	SENT_13	[p1l1559t895r1862b936],
18	,	,	O	,	_	0	SENT_13	[p1l1559t895r1862b936],
19	M.D.	NNP	O	M.D.	appos	9	SENT_13	[p1l1879t898r1969b932],
20	,	,	O	,	_	0	SENT_13	[p1l1879t898r1969b932],

1	Ross	NNP	PERSON	Ross	nn	3	SENT_14	[p1l265t947r341b975],
2	A.	NNP	PERSON	A.	nn	3	SENT_14	[p1l354t946r386b975],
3	Okimoto	NNP	PERSON	Okimoto	_	0	SENT_14	[p1l401t944r560b981],
4	,	,	O	,	_	0	SENT_14	[p1l401t944r560b981],
5	B.S.	NNP	O	B.S.	dep	3	SENT_14	[p1l577t947r647b981],
6	,	,	O	,	_	0	SENT_14	[p1l577t947r647b981],
7	Brian	NNP	PERSON	Brian	nn	9	SENT_14	[p1l665t947r748b975],
8	W.	NNP	PERSON	W.	nn	9	SENT_14	[p1l762t947r800b975],
9	Brannigan	NNP	PERSON	Brannigan	appos	5	SENT_14	[p1l818t947r998b985],
10	,	,	O	,	_	0	SENT_14	[p1l818t947r998b985],
11	B.A.	NNP	O	B.A.	appos	5	SENT_14	[p1l1016t946r1089b981],
12	,	,	O	,	_	0	SENT_14	[p1l1016t946r1089b981],
13	Patricia	NNP	PERSON	Patricia	nn	15	SENT_14	[p1l1106t947r1228b975],
14	L.	NNP	PERSON	L.	nn	15	SENT_14	[p1l1245t947r1268b975],
15	Harris	NNP	PERSON	Harris	appos	5	SENT_14	[p1l1285t947r1397b981],
16	,	,	O	,	_	0	SENT_14	[p1l1285t947r1397b981],
17	M.S.	NNP	LOCATION	M.S.	appos	5	SENT_14	[p1l1415t947r1497b981],
18	,	,	O	,	_	0	SENT_14	[p1l1415t947r1497b981],
19	Sara	NNP	PERSON	Sara	nn	21	SENT_14	[p1l1512t947r1584b975],
20	M.	NNP	PERSON	M.	nn	21	SENT_14	[p1l1600t947r1640b975],
21	Haserlat	NNP	PERSON	Haserlat	appos	5	SENT_14	[p1l1657t944r1807b981],
22	,	,	O	,	_	0	SENT_14	[p1l1657t944r1807b981],
23	B.A.	NNP	O	B.A.	appos	5	SENT_14	[p1l1824t946r1897b981],
24	,	,	O	,	_	0	SENT_14	[p1l1824t946r1897b981],

1	Jeffrey	NNP	PERSON	Jeffrey	nn	3	SENT_15	[p1l189t993r299b1034],
2	G.	NNP	PERSON	G.	nn	3	SENT_15	[p1l311t996r346b1024],
3	Supko	NNP	PERSON	Supko	_	0	SENT_15	[p1l361t993r474b1034],
4	,	,	O	,	_	0	SENT_15	[p1l361t993r474b1034],
5	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_15	[p1l492t993r591b1030],
6	,	,	O	,	_	0	SENT_15	[p1l492t993r591b1030],
7	Frank	NNP	PERSON	Frank	nn	17	SENT_15	[p1l608t993r698b1024],
8	G.	NNP	PERSON	G.	nn	17	SENT_15	[p1l710t996r745b1024],
9	Haluska	NNP	PERSON	Haluska	nn	17	SENT_15	[p1l762t993r907b1030],
10	,	,	O	,	_	0	SENT_15	[p1l762t993r907b1030],
11	M.D.	NNP	O	M.D.	appos	17	SENT_15	[p1l924t996r1014b1030],
12	,	,	O	,	_	0	SENT_15	[p1l924t996r1014b1030],
13	Ph.D.	NNP	O	Ph.D.	appos	17	SENT_15	[p1l1031t993r1130b1030],
14	,	,	O	,	_	0	SENT_15	[p1l1031t993r1130b1030],
15	David	NNP	PERSON	David	appos	17	SENT_15	[p1l1148t993r1241b1024],
16	N.	NNP	PERSON	N.	nn	17	SENT_15	[p1l1258t996r1293b1024],
17	Louis	NNP	PERSON	Louis	appos	3	SENT_15	[p1l1310t996r1407b1030],
18	,	,	O	,	_	0	SENT_15	[p1l1310t996r1407b1030],
19	M.D.	NNP	O	M.D.	appos	17	SENT_15	[p1l1424t996r1514b1030],
20	,	,	O	,	_	0	SENT_15	[p1l1424t996r1514b1030],

1	David	NNP	PERSON	David	nn	3	SENT_16	[p1l1532t993r1625b1024],
2	C.	NNP	PERSON	C.	nn	3	SENT_16	[p1l1640t996r1671b1024],
3	Christiani	NNP	PERSON	Christiani	_	0	SENT_16	[p1l1685t993r1857b1030],
4	,	,	O	,	_	0	SENT_16	[p1l1685t993r1857b1030],
5	M.D.	NNP	O	M.D.	dep	3	SENT_16	[p1l1874t996r1964b1030],
6	,	,	O	,	_	0	SENT_16	[p1l1874t996r1964b1030],

1	Jeffsettleman	NNP	PERSON	Jeffsettleman	_	0	SENT_17	[p1l603t1042r855b1082],
2	,	,	O	,	_	0	SENT_17	[p1l603t1042r855b1082],
3	Ph.D.	NNP	O	Ph.D.	conj_and	1	SENT_17	[p1l872t1042r971b1079],
4	,	,	O	,	_	0	SENT_17	[p1l872t1042r971b1079],
5	and	CC	O	and	_	0	SENT_17	[p1l986t1042r1046b1073],
6	Daniel	NNP	PERSON	Daniel	nn	8	SENT_17	[p1l1063t1042r1167b1073],
7	A.	NNP	PERSON	A.	nn	8	SENT_17	[p1l1181t1044r1213b1073],
8	Haber	NNP	PERSON	Haber	conj_and	1	SENT_17	[p1l1230t1042r1337b1079],
9	,	,	O	,	_	0	SENT_17	[p1l1230t1042r1337b1079],
10	M.D.	NNP	O	M.D.	nn	12	SENT_17	[p1l1354t1045r1444b1079],
11	,	,	O	,	_	0	SENT_17	[p1l1354t1045r1444b1079],
12	Ph.D.	NNP	O	Ph.D.	appos	8	SENT_17	[p1l1461t1042r1550b1073],
13	.	.	O	.	_	0	SENT_17	[p1l1461t1042r1550b1073],

1	ABSTRACT	NN	O	abstract	_	0	SENT_18	[p1l969t1189r1187b1212],

1	BAC	NN	O	bac	nn	7	SENT_19	[p1l95t1289r153b1309],
2	K	NN	O	k	nn	7	SENT_19	[p1l159t1289r174b1309],
3	G	NN	O	g	nn	7	SENT_19	[p1l180t1289r198b1309],
4	R	NN	O	r	nn	7	SENT_19	[p1l206t1289r220b1309],
5	o	NN	O	o	nn	7	SENT_19	[p1l225t1289r246b1309],
6	u	NN	O	u	nn	7	SENT_19	[p1l253t1289r270b1309],
7	N	NN	O	n	nsubj	17	SENT_19	[p1l279t1289r296b1309],
8	D	NN	O	d	prep	7	SENT_19	[p1l305t1289r323b1309],
9	Most	JJS	O	most	amod	10	SENT_19	[p1l93t1332r178b1359],
10	patients	NNS	O	patient	dep	8	SENT_19	[p1l185t1329r314b1368],
11	with	IN	O	with	_	0	SENT_19	[p1l323t1329r396b1360],
12	non	JJ	O	non	amod	16	SENT_19	[p1l405t1329r651b1360],
13	—	JJ	O	—	amod	16	SENT_19	[p1l405t1329r651b1360],
14	small-cell	NN	O	small-cell	nn	16	SENT_19	[p1l405t1329r651b1360],
15	lung	NN	O	lung	nn	16	SENT_19	[p1l659t1329r735b1368],
16	cancer	NN	O	cancer	prep_with	7	SENT_19	[p1l743t1339r850b1359],
17	have	VBP	O	have	_	0	SENT_19	[p1l858t1329r931b1360],
18	no	DT	O	no	det	19	SENT_19	[p1l940t1339r981b1359],
19	response	NN	O	response	dobj	17	SENT_19	[p1l991t1339r1138b1368],
20	to	TO	O	to	_	0	SENT_19	[p1l1148t1335r1178b1359],
21	the	DT	O	the	det	25	SENT_19	[p1l1188t1329r1239b1359],
22	tyrosine	NN	O	tyrosine	nn	25	SENT_19	[p1l1248t1329r1378b1368],
23	kinase	NN	O	kinase	nn	25	SENT_19	[p1l1387t1329r1492b1360],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_19	[p1l93t1378r239b1409],
25	geﬁtinib	NN	O	geﬁtinib	prep_to	19	SENT_19	[p1l248t1378r396b1418],
26	,	,	O	,	_	0	SENT_19	[p1l248t1378r396b1418],
27	which	WDT	O	which	nsubj	28	SENT_19	[p1l407t1378r508b1409],
28	targets	VBZ	O	target	rcmod	25	SENT_19	[p1l519t1385r630b1418],
29	the	DT	O	the	det	33	SENT_19	[p1l641t1379r691b1409],
30	epidermal	JJ	O	epidermal	amod	33	SENT_19	[p1l702t1378r867b1418],
31	growth	NN	O	growth	nn	33	SENT_19	[p1l878t1378r995b1418],
32	factor	NN	O	factor	nn	33	SENT_19	[p1l1006t1378r1102b1409],
33	receptor	NN	O	receptor	nsubj	36	SENT_19	[p1l1111t1385r1247b1418],
34	(	CD	NUMBER	(	num	36	SENT_19	[p1l1259t1381r1388b1414],
35	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_19	[p1l1259t1381r1388b1414],
36	)	NN	O	)	xcomp	28	SENT_19	[p1l1259t1381r1388b1414],
37	.	.	O	.	_	0	SENT_19	[p1l1259t1381r1388b1414],

1	However	RB	O	however	advmod	8	SENT_20	[p1l1401t1381r1492b1409, p1l94t1439r165b1466],
2	,	,	O	,	_	0	SENT_20	[p1l1401t1381r1492b1409, p1l94t1439r165b1466],
3	about	IN	O	about	advmod	5	SENT_20	[p1l176t1429r270b1460],
4	10	CD	PERCENT	10	pobj	3	SENT_20	[p1l277t1431r315b1459],
5	percent	NN	PERCENT	percent	nsubj	8	SENT_20	[p1l323t1435r447b1468],
6	of	IN	O	of	_	0	SENT_20	[p1l453t1428r492b1459],
7	patients	NNS	O	patient	prep_of	5	SENT_20	[p1l493t1429r622b1468],
8	have	VBP	O	have	_	0	SENT_20	[p1l631t1429r703b1460],
9	a	DT	O	a	det	15	SENT_20	[p1l712t1439r729b1459],
10	rapid	JJ	O	rapid	amod	15	SENT_20	[p1l737t1429r821b1468],
11	and	CC	O	and	_	0	SENT_20	[p1l830t1429r890b1459],
12	often	RB	O	often	advmod	13	SENT_20	[p1l898t1428r982b1459],
13	dramatic	JJ	O	dramatic	amod	15	SENT_20	[p1l991t1429r1134b1459],
14	clinical	JJ	O	clinical	amod	15	SENT_20	[p1l1143t1429r1258b1459],
15	response	NN	O	response	dobj	8	SENT_20	[p1l1266t1439r1421b1468],
16	.	.	O	.	_	0	SENT_20	[p1l1266t1439r1421b1468],

1	The	DT	O	the	det	3	SENT_21	[p1l1430t1429r1493b1459],
2	molecular	JJ	O	molecular	amod	3	SENT_21	[p1l94t1479r259b1510],
3	mechanisms	NNS	O	mechanism	nsubj	9	SENT_21	[p1l267t1479r475b1509],
4	underlying	VBG	O	underlie	partmod	3	SENT_21	[p1l485t1479r663b1518],
5	sensitivity	NN	O	sensitivity	dobj	4	SENT_21	[p1l672t1479r835b1518],
6	to	TO	O	to	_	0	SENT_21	[p1l843t1485r873b1509],
7	geﬁtinib	NN	O	geﬁtinib	prep_to	4	SENT_21	[p1l883t1478r1021b1518],
8	are	VBP	O	be	cop	9	SENT_21	[p1l1031t1489r1080b1509],
9	unknown	JJ	O	unknown	_	0	SENT_21	[p1l1089t1479r1255b1510],
10	.	.	O	.	_	0	SENT_21	[p1l1089t1479r1255b1510],

1	M	NN	O	m	nn	3	SENT_22	[p1l97t1558r117b1577],
2	ET	NNP	O	ET	nn	3	SENT_22	[p1l126t1558r159b1577],
3	H	NNP	O	H	nsubj	6	SENT_22	[p1l165t1558r183b1577],
4	O	NN	O	o	nn	5	SENT_22	[p1l191t1558r212b1577],
5	D	NN	O	d	dep	3	SENT_22	[p1l218t1558r236b1577],
6	S	NN	O	s	_	0	SENT_22	[p1l242t1558r256b1577],
7	We	PRP	O	we	nsubj	8	SENT_22	[p1l92t1601r144b1628],
8	searched	VBD	O	search	ccomp	6	SENT_22	[p1l153t1598r296b1628],
9	for	IN	O	for	_	0	SENT_22	[p1l304t1597r352b1629],
10	mutations	NNS	O	mutation	prep_for	8	SENT_22	[p1l359t1598r524b1629],
11	in	IN	O	in	_	0	SENT_22	[p1l533t1598r565b1628],
12	the	DT	O	the	det	14	SENT_22	[p1l573t1598r623b1628],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_22	[p1l631t1600r713b1629],
14	gene	NN	O	gene	prep_in	10	SENT_22	[p1l719t1608r795b1637],
15	in	IN	O	in	_	0	SENT_22	[p1l803t1598r835b1628],
16	primary	JJ	O	primary	amod	17	SENT_22	[p1l843t1598r972b1637],
17	tumors	NNS	O	tumor	prep_in	14	SENT_22	[p1l979t1604r1095b1629],
18	from	IN	O	from	_	0	SENT_22	[p1l1104t1597r1184b1629],
19	patients	NNS	O	patient	prep_from	8	SENT_22	[p1l1192t1598r1320b1637],
20	with	IN	O	with	_	0	SENT_22	[p1l1328t1598r1400b1629],
21	nonsmall	JJ	O	nonsmall	amod	25	SENT_22	[p1l1409t1608r1494b1629, p1l94t1648r256b1679],
22	—	NN	O	—	nn	25	SENT_22	[p1l1409t1608r1494b1629, p1l94t1648r256b1679],
23	cell	NN	O	cell	nn	25	SENT_22	[p1l1409t1608r1494b1629, p1l94t1648r256b1679],
24	lung	NN	O	lung	nn	25	SENT_22	[p1l267t1648r343b1687],
25	cancer	NN	O	cancer	prep_with	8	SENT_22	[p1l353t1658r462b1679],
26	who	WP	O	who	nsubj	27	SENT_22	[p1l470t1648r542b1679],
27	had	VBD	O	have	rcmod	25	SENT_22	[p1l554t1648r615b1679],
28	a	DT	O	a	det	29	SENT_22	[p1l626t1658r643b1679],
29	response	NN	O	response	dobj	27	SENT_22	[p1l654t1658r804b1687],
30	to	TO	O	to	_	0	SENT_22	[p1l815t1654r846b1679],
31	geﬁtinib	NN	O	geﬁtinib	prep_to	29	SENT_22	[p1l858t1648r1009b1687],
32	,	,	O	,	_	0	SENT_22	[p1l858t1648r1009b1687],
33	those	DT	O	those	dobj	27	SENT_22	[p1l1022t1648r1112b1679],
34	who	WP	O	who	nsubj	37	SENT_22	[p1l1121t1648r1193b1679],
35	did	VBD	O	do	aux	37	SENT_22	[p1l1205t1648r1258b1679],
36	not	RB	O	not	neg	37	SENT_22	[p1l1269t1654r1325b1679],
37	have	VB	O	have	rcmod	33	SENT_22	[p1l1334t1648r1409b1679],
38	a	DT	O	a	det	39	SENT_22	[p1l1419t1658r1437b1679],
39	response	NN	O	response	dobj	37	SENT_22	[p1l1447t1658r1491b1679, p1l94t1708r219b1737],
40	,	,	O	,	_	0	SENT_22	[p1l1447t1658r1491b1679, p1l94t1708r219b1737],
41	and	CC	O	and	_	0	SENT_22	[p1l231t1698r291b1729],
42	those	DT	O	those	dobj	27	SENT_22	[p1l301t1698r389b1729],
43	who	WP	O	who	nsubjpass	47	SENT_22	[p1l396t1698r468b1729],
44	had	VBD	O	have	aux	47	SENT_22	[p1l477t1698r537b1729],
45	not	RB	O	not	neg	47	SENT_22	[p1l547t1705r602b1729],
46	been	VBN	O	be	auxpass	47	SENT_22	[p1l610t1698r687b1729],
47	exposed	VBN	O	expose	rcmod	42	SENT_22	[p1l697t1698r830b1737],
48	to	TO	O	to	_	0	SENT_22	[p1l839t1705r870b1729],
49	geﬁtinib	NN	O	geﬁtinib	prep_to	47	SENT_22	[p1l879t1698r1026b1738],
50	.	.	O	.	_	0	SENT_22	[p1l879t1698r1026b1738],

1	The	DT	O	the	det	3	SENT_23	[p1l1036t1698r1099b1729],
2	ﬁinctional	JJ	O	ﬁinctional	amod	3	SENT_23	[p1l1108t1698r1276b1729],
3	consequences	NNS	O	consequence	nsubjpass	8	SENT_23	[p1l1285t1708r1492b1737, p1l94t1758r126b1779],
4	of	IN	O	of	_	0	SENT_23	[p1l138t1747r177b1779],
5	identiﬁed	JJ	O	identiﬁed	amod	6	SENT_23	[p1l181t1747r337b1779],
6	mutations	NNS	O	mutation	prep_of	3	SENT_23	[p1l348t1748r515b1779],
7	were	VBD	O	be	auxpass	8	SENT_23	[p1l525t1758r604b1779],
8	evaluated	VBN	O	evaluate	_	0	SENT_23	[p1l615t1748r767b1779],
9	after	IN	O	after	mark	14	SENT_23	[p1l778t1747r853b1779],
10	the	DT	O	the	det	12	SENT_23	[p1l863t1748r913b1779],
11	mutant	JJ	O	mutant	amod	12	SENT_23	[p1l925t1754r1046b1779],
12	proteins	NNS	O	protein	nsubjpass	14	SENT_23	[p1l1054t1748r1189b1787],
13	were	VBD	O	be	auxpass	14	SENT_23	[p1l1199t1758r1278b1779],
14	expressed	VBN	O	express	advcl	8	SENT_23	[p1l1289t1748r1450b1787],
15	in	IN	O	in	_	0	SENT_23	[p1l1461t1748r1492b1778],
16	cultured	VBN	O	culture	prepc_in	14	SENT_23	[p1l94t1798r229b1829],
17	cells	NNS	O	cell	dobj	16	SENT_23	[p1l238t1798r319b1828],
18	.	.	O	.	_	0	SENT_23	[p1l238t1798r319b1828],

1	R	NN	O	r	nn	3	SENT_24	[p1l96t1909r110b1928],
2	E	NN	O	e	nn	3	SENT_24	[p1l117t1909r130b1928],
3	s	NNS	O	s	nsubj	4	SENT_24	[p1l135t1909r149b1928],
4	u	VBP	O	u	dep	9	SENT_24	[p1l156t1909r173b1928],
5	LTS	NNP	O	LTS	nn	7	SENT_24	[p1l181t1909r230b1928],
6	Somatic	JJ	O	somatic	amod	7	SENT_24	[p1l95t1949r226b1979],
7	mutations	NNS	O	mutation	dobj	4	SENT_24	[p1l237t1949r404b1979],
8	were	VBD	O	be	auxpass	9	SENT_24	[p1l415t1958r494b1979],
9	identiﬁed	VBN	O	identiﬁed	_	0	SENT_24	[p1l505t1948r662b1979],
10	in	IN	O	in	_	0	SENT_24	[p1l673t1949r705b1978],
11	the	DT	O	the	det	14	SENT_24	[p1l717t1948r767b1979],
12	tyrosine	NN	O	tyrosine	nn	14	SENT_24	[p1l779t1949r909b1987],
13	kinase	NN	O	kinase	nn	14	SENT_24	[p1l920t1948r1025b1979],
14	domain	NN	O	domain	prep_in	9	SENT_24	[p1l1038t1948r1163b1979],
15	of	IN	O	of	_	0	SENT_24	[p1l1175t1948r1214b1979],
16	the	DT	O	the	det	18	SENT_24	[p1l1219t1948r1269b1979],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_24	[p1l1280t1951r1363b1979],
18	gene	NN	O	gene	prep_of	14	SENT_24	[p1l1372t1958r1449b1987],
19	in	IN	O	in	_	0	SENT_24	[p1l1460t1949r1492b1978],
20	eight	CD	TIME	eight	prep_in	9	SENT_24	[p1l94t1998r178b2037],
21	of	IN	TIME	of	_	0	SENT_24	[p1l185t1997r225b2028],
22	nine	CD	TIME	nine	num	23	SENT_24	[p1l227t1998r298b2028],
23	patients	NNS	O	patient	prep_of	20	SENT_24	[p1l307t1998r437b2037],
24	with	IN	O	with	_	0	SENT_24	[p1l445t1998r518b2029],
25	geﬁtinib-responsive	JJ	O	geﬁtinib-responsive	amod	27	SENT_24	[p1l528t1997r855b2037],
26	lung	NN	O	lung	nn	27	SENT_24	[p1l864t1998r939b2037],
27	cancer	NN	O	cancer	prep_with	23	SENT_24	[p1l948t2008r1061b2035],
28	,	,	O	,	_	0	SENT_24	[p1l948t2008r1061b2035],
29	as	IN	O	as	_	0	SENT_24	[p1l1072t2008r1105b2028],
30	compared	VBN	O	compare	prepc_as	9	SENT_24	[p1l1115t1998r1279b2037],
31	with	IN	O	with	pcomp	30	SENT_24	[p1l1287t1998r1360b2028],
32	none	NN	O	none	pobj	31	SENT_24	[p1l1369t2008r1451b2028],
33	of	IN	O	of	_	0	SENT_24	[p1l1460t1997r1500b2028],
34	the	DT	O	the	det	36	SENT_24	[p1l94t2047r144b2078],
35	seven	CD	NUMBER	seven	num	36	SENT_24	[p1l155t2057r244b2078],
36	patients	NNS	O	patient	prep_of	32	SENT_24	[p1l254t2048r384b2086],
37	with	IN	O	with	_	0	SENT_24	[p1l393t2047r467b2078],
38	no	DT	O	no	det	39	SENT_24	[p1l477t2057r518b2078],
39	response	NN	O	response	prep_with	36	SENT_24	[p1l529t2057r676b2086],
40	(	CD	NUMBER	(	num	41	SENT_24	[p1l689t2049r858b2083],
41	P	NN	O	p	npadvmod	42	SENT_24	[p1l689t2049r858b2083],
42	<	JJR	O	<	amod	39	SENT_24	[p1l689t2049r858b2083],
43	0.001	CD	NUMBER	0.001	num	44	SENT_24	[p1l689t2049r858b2083],
44	)	NN	O	)	nsubjpass	9	SENT_24	[p1l689t2049r858b2083],
45	.	.	O	.	_	0	SENT_24	[p1l689t2049r858b2083],

1	Mutations	NNS	O	mutation	nsubj	4	SENT_25	[p1l870t2048r1038b2078],
2	were	VBD	O	be	cop	4	SENT_25	[p1l1047t2057r1126b2078],
3	either	RB	O	either	advmod	4	SENT_25	[p1l1137t2047r1231b2078],
4	small	JJ	O	small	_	0	SENT_25	[p1l1241t2047r1338b2085],
5	,	,	O	,	_	0	SENT_25	[p1l1241t2047r1338b2085],
6	in	IN	O	in	_	0	SENT_25	[p1l1350t2047r1492b2078],
7	—	NN	O	—	nn	9	SENT_25	[p1l1350t2047r1492b2078],
8	frame	NN	O	frame	nn	9	SENT_25	[p1l1350t2047r1492b2078],
9	deletions	NNS	O	deletion	prep_in	4	SENT_25	[p1l94t2097r242b2128],
10	or	CC	O	or	_	0	SENT_25	[p1l254t2107r288b2128],
11	amino	NN	O	amino	nn	13	SENT_25	[p1l297t2098r402b2128],
12	acid	NN	O	acid	nn	13	SENT_25	[p1l412t2097r479b2128],
13	substitutions	NNS	O	substitution	prep_in	4	SENT_25	[p1l490t2097r702b2129],
14	clustered	VBN	O	cluster	partmod	9	SENT_25	[p1l714t2097r862b2128],
15	around	IN	O	around	_	0	SENT_25	[p1l872t2097r989b2129],
16	the	DT	O	the	det	18	SENT_25	[p1l1000t2098r1050b2128],
17	ATP-binding	JJ	O	atp-binding	amod	18	SENT_25	[p1l1059t2097r1271b2137],
18	pocket	NN	O	pocket	prep_around	14	SENT_25	[p1l1279t2097r1391b2137],
19	of	IN	O	of	_	0	SENT_25	[p1l1400t2097r1439b2128],
20	the	DT	O	the	det	23	SENT_25	[p1l1442t2098r1492b2128],
21	tyrosine	NN	O	tyrosine	nn	23	SENT_25	[p1l94t2148r224b2186],
22	kinase	NN	O	kinase	nn	23	SENT_25	[p1l236t2147r341b2178],
23	domain	NN	O	domain	prep_of	18	SENT_25	[p1l353t2147r488b2178],
24	.	.	O	.	_	0	SENT_25	[p1l353t2147r488b2178],

1	Similar	JJ	O	similar	amod	2	SENT_26	[p1l503t2147r621b2178],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_26	[p1l632t2148r799b2178],
3	were	VBD	O	be	auxpass	4	SENT_26	[p1l810t2157r888b2178],
4	detected	VBN	O	detect	_	0	SENT_26	[p1l901t2147r1036b2178],
5	in	IN	O	in	_	0	SENT_26	[p1l1048t2148r1080b2177],
6	tumors	NNS	O	tumor	prep_in	4	SENT_26	[p1l1092t2154r1209b2178],
7	from	IN	O	from	_	0	SENT_26	[p1l1222t2147r1302b2178],
8	2	CD	NUMBER	2	prep_from	6	SENT_26	[p1l1314t2149r1333b2177],
9	of	IN	O	of	_	0	SENT_26	[p1l1345t2147r1385b2178],
10	25	CD	NUMBER	25	num	11	SENT_26	[p1l1390t2149r1427b2178],
11	patients	NNS	O	patient	prep_of	8	SENT_26	[p1l1440t2157r1492b2186, p1l94t2197r183b2227],
12	with	IN	O	with	_	0	SENT_26	[p1l192t2196r266b2227],
13	primary	JJ	O	primary	amod	15	SENT_26	[p1l275t2197r406b2236],
14	non	JJ	O	non	amod	15	SENT_26	[p1l414t2196r659b2227],
15	—	NN	O	—	prep_with	11	SENT_26	[p1l414t2196r659b2227],
16	small	JJ	O	small	amod	20	SENT_26	[p1l414t2196r659b2227],
17	—	NN	O	—	nn	20	SENT_26	[p1l414t2196r659b2227],
18	cell	NN	O	cell	nn	20	SENT_26	[p1l414t2196r659b2227],
19	lung	NN	O	lung	nn	20	SENT_26	[p1l668t2196r744b2236],
20	cancer	NN	O	cancer	dobj	4	SENT_26	[p1l753t2206r859b2227],
21	who	WP	O	who	nsubjpass	25	SENT_26	[p1l866t2196r938b2227],
22	had	VBD	O	have	aux	25	SENT_26	[p1l948t2196r1008b2227],
23	not	RB	O	not	neg	25	SENT_26	[p1l1018t2203r1074b2227],
24	been	VBN	O	be	auxpass	25	SENT_26	[p1l1082t2196r1160b2227],
25	exposed	VBN	O	expose	rcmod	20	SENT_26	[p1l1170t2196r1303b2236],
26	to	TO	O	to	aux	27	SENT_26	[p1l1313t2203r1344b2227],
27	geﬁtinib	VB	O	geﬁtinib	xcomp	25	SENT_26	[p1l1354t2196r1492b2236],
28	(	CD	PERCENT	(	number	29	SENT_26	[p1l96t2248r125b2281],
29	8	CD	PERCENT	8	num	31	SENT_26	[p1l96t2248r125b2281],
30	percent	NN	PERCENT	percent	nn	31	SENT_26	[p1l136t2248r281b2285],
31	)	NN	O	)	dobj	27	SENT_26	[p1l136t2248r281b2285],
32	.	.	O	.	_	0	SENT_26	[p1l136t2248r281b2285],

1	All	DT	O	all	det	2	SENT_27	[p1l293t2246r339b2276],
2	mutations	NNS	O	mutation	nsubj	4	SENT_27	[p1l350t2246r517b2277],
3	were	VBD	O	be	cop	4	SENT_27	[p1l527t2256r605b2277],
4	heterozygous	JJ	O	heterozygous	_	0	SENT_27	[p1l617t2246r845b2285],
5	,	,	O	,	_	0	SENT_27	[p1l617t2246r845b2285],
6	and	CC	O	and	_	0	SENT_27	[p1l858t2246r918b2276],
7	identical	JJ	O	identical	amod	8	SENT_27	[p1l929t2246r1069b2276],
8	mutations	NNS	O	mutation	nsubjpass	10	SENT_27	[p1l1080t2246r1247b2277],
9	were	VBD	O	be	auxpass	10	SENT_27	[p1l1257t2256r1336b2277],
10	observed	VBN	O	observe	conj_and	4	SENT_27	[p1l1347t2246r1492b2277],
11	in	IN	O	in	_	0	SENT_27	[p1l93t2296r125b2326],
12	multiple	JJ	O	multiple	amod	13	SENT_27	[p1l135t2295r268b2335],
13	patients	NNS	O	patient	prep_in	10	SENT_27	[p1l277t2296r413b2335],
14	,	,	O	,	_	0	SENT_27	[p1l277t2296r413b2335],
15	suggesting	VBG	O	suggest	xcomp	10	SENT_27	[p1l425t2296r600b2335],
16	an	DT	O	a	det	19	SENT_27	[p1l607t2305r646b2326],
17	additive	JJ	O	additive	amod	19	SENT_27	[p1l655t2295r779b2326],
18	speciﬁc	NN	O	speciﬁc	nn	19	SENT_27	[p1l789t2295r909b2335],
19	gain	NN	O	gain	dobj	15	SENT_27	[p1l917t2296r987b2335],
20	of	IN	O	of	_	0	SENT_27	[p1l996t2295r1034b2326],
21	function	NN	O	function	prep_of	19	SENT_27	[p1l1036t2295r1180b2326],
22	.	.	O	.	_	0	SENT_27	[p1l1036t2295r1180b2326],

1	In	FW	O	in	nn	2	SENT_28	[p1l1190t2298r1224b2326],
2	vitro	FW	O	vitro	nsubj	18	SENT_28	[p1l1231t2296r1313b2333],
3	,	,	O	,	_	0	SENT_28	[p1l1231t2296r1313b2333],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_28	[p1l1323t2297r1422b2328],
5	mutants	NNS	O	mutant	appos	2	SENT_28	[p1l1427t2305r1492b2326, p1l94t2351r172b2375],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_28	[p1l182t2345r406b2375],
7	enhanced	VBN	O	enhance	amod	10	SENT_28	[p1l416t2345r574b2375],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_28	[p1l584t2345r714b2384],
9	kinase	NN	O	kinase	nn	10	SENT_28	[p1l723t2345r828b2376],
10	activity	NN	O	activity	dobj	6	SENT_28	[p1l838t2345r953b2384],
11	in	IN	O	in	_	0	SENT_28	[p1l961t2345r992b2375],
12	response	NN	O	response	prep_in	10	SENT_28	[p1l1002t2355r1149b2384],
13	to	TO	O	to	_	0	SENT_28	[p1l1159t2351r1190b2375],
14	epidermal	JJ	O	epidermal	amod	16	SENT_28	[p1l1200t2345r1365b2384],
15	growth	NN	O	growth	nn	16	SENT_28	[p1l1375t2345r1492b2384],
16	factor	NN	O	factor	prep_to	6	SENT_28	[p1l94t2394r189b2425],
17	and	CC	O	and	_	0	SENT_28	[p1l197t2394r258b2425],
18	increased	VBD	O	increase	conj_and	6	SENT_28	[p1l267t2394r423b2425],
19	sensitivity	NN	O	sensitivity	dobj	18	SENT_28	[p1l433t2395r596b2434],
20	to	TO	O	to	_	0	SENT_28	[p1l604t2401r635b2425],
21	inhibition	NN	O	inhibition	prep_to	18	SENT_28	[p1l644t2394r808b2425],
22	by	IN	O	by	_	0	SENT_28	[p1l817t2394r855b2434],
23	geﬁtinib	NN	O	geﬁtinib	prep_by	18	SENT_28	[p1l863t2394r1010b2434],
24	.	.	O	.	_	0	SENT_28	[p1l863t2394r1010b2434],

1	CO	NN	O	co	nn	6	SENT_29	[p1l94t2478r136b2497],
2	N	NN	O	n	nn	6	SENT_29	[p1l144t2478r161b2497],
3	C	NN	O	c	nn	6	SENT_29	[p1l168t2478r185b2497],
4	L	NN	O	l	nn	6	SENT_29	[p1l191t2478r203b2497],
5	U	NNP	O	U	nn	6	SENT_29	[p1l209t2478r226b2497],
6	S	NNP	O	S	nsubj	8	SENT_29	[p1l233t2478r247b2497],
7	I	PRP	O	I	nsubj	8	SENT_29	[p1l254t2478r259b2497],
8	O	VBP	O	o	_	0	SENT_29	[p1l266t2478r287b2497],
9	N	NN	O	n	nn	12	SENT_29	[p1l294t2478r311b2497],
10	S	NN	O	s	nn	12	SENT_29	[p1l319t2478r333b2497],
11	A	NN	O	a	nn	12	SENT_29	[p1l92t2519r118b2546],
12	subgroup	NN	O	subgroup	nsubj	21	SENT_29	[p1l127t2516r283b2555],
13	of	IN	O	of	_	0	SENT_29	[p1l293t2516r332b2547],
14	patients	NNS	O	patient	prep_of	12	SENT_29	[p1l334t2517r464b2555],
15	with	IN	O	with	_	0	SENT_29	[p1l472t2516r546b2547],
16	non	JJ	O	non	amod	20	SENT_29	[p1l555t2516r801b2547],
17	—	JJ	O	—	amod	20	SENT_29	[p1l555t2516r801b2547],
18	small-cell	NN	O	small-cell	nn	20	SENT_29	[p1l555t2516r801b2547],
19	lung	NN	O	lung	nn	20	SENT_29	[p1l809t2516r885b2555],
20	cancer	NN	O	cancer	prep_with	14	SENT_29	[p1l893t2526r1000b2547],
21	have	VBP	O	have	ccomp	8	SENT_29	[p1l1008t2516r1081b2547],
22	speciﬁc	NN	O	speciﬁc	nn	23	SENT_29	[p1l1091t2516r1215b2555],
23	mutations	NNS	O	mutation	dobj	21	SENT_29	[p1l1224t2517r1391b2547],
24	in	IN	O	in	_	0	SENT_29	[p1l1401t2517r1433b2546],
25	the	DT	O	the	det	27	SENT_29	[p1l1442t2516r1492b2547],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_29	[p1l93t2568r176b2596],
27	gene	NN	O	gene	prep_in	23	SENT_29	[p1l181t2575r268b2604],
28	,	,	O	,	_	0	SENT_29	[p1l181t2575r268b2604],
29	which	WDT	O	which	nsubj	30	SENT_29	[p1l276t2565r378b2596],
30	correlate	VBP	O	correlate	rcmod	27	SENT_29	[p1l386t2565r528b2596],
31	with	IN	O	with	_	0	SENT_29	[p1l535t2565r608b2596],
32	clinical	JJ	O	clinical	amod	33	SENT_29	[p1l617t2565r734b2596],
33	responsiveness	NN	O	responsiveness	prep_with	30	SENT_29	[p1l741t2566r989b2604],
34	to	TO	O	to	_	0	SENT_29	[p1l998t2572r1029b2596],
35	the	DT	O	the	det	39	SENT_29	[p1l1038t2565r1088b2596],
36	tyrosine	NN	O	tyrosine	nn	39	SENT_29	[p1l1097t2566r1226b2604],
37	kinase	NN	O	kinase	nn	39	SENT_29	[p1l1235t2565r1340b2596],
38	inhibitor	NN	O	inhibitor	nn	39	SENT_29	[p1l1348t2565r1494b2596],
39	geﬁtinib	NN	O	geﬁtinib	prep_to	30	SENT_29	[p1l94t2614r239b2653],
40	.	.	O	.	_	0	SENT_29	[p1l94t2614r239b2653],

1	These	DT	O	these	det	2	SENT_30	[p1l248t2614r345b2645],
2	mutations	NNS	O	mutation	nsubj	10	SENT_30	[p1l353t2615r519b2645],
3	lead	VBP	O	lead	_	0	SENT_30	[p1l528t2614r594b2645],
4	to	TO	O	to	_	0	SENT_30	[p1l603t2620r633b2645],
5	increased	VBN	O	increase	amod	8	SENT_30	[p1l642t2614r796b2645],
6	growth	NN	O	growth	nn	8	SENT_30	[p1l804t2614r921b2653],
7	factor	NN	O	factor	nn	8	SENT_30	[p1l929t2614r1024b2645],
8	signaling	NN	O	signaling	prep_to	3	SENT_30	[p1l1032t2614r1183b2653],
9	and	CC	O	and	_	0	SENT_30	[p1l1190t2614r1250b2645],
10	confer	VB	O	confer	conj_and	3	SENT_30	[p1l1259t2614r1363b2645],
11	susceptibility	NN	O	susceptibility	dobj	10	SENT_30	[p1l1371t2624r1492b2653, p1l94t2663r200b2702],
12	to	TO	O	to	_	0	SENT_30	[p1l209t2670r240b2694],
13	the	DT	O	the	det	14	SENT_30	[p1l251t2663r301b2694],
14	inhibitor	NN	O	inhibitor	prep_to	10	SENT_30	[p1l311t2663r463b2694],
15	.	.	O	.	_	0	SENT_30	[p1l311t2663r463b2694],

1	Screening	VBG	O	screen	csubj	9	SENT_31	[p1l477t2664r640b2702],
2	for	IN	O	for	_	0	SENT_31	[p1l649t2663r697b2694],
3	such	JJ	O	such	amod	4	SENT_31	[p1l707t2663r782b2694],
4	mutations	NNS	O	mutation	prep_for	1	SENT_31	[p1l793t2664r960b2694],
5	in	IN	O	in	_	0	SENT_31	[p1l971t2664r1002b2693],
6	lung	NN	O	lung	nn	7	SENT_31	[p1l1012t2663r1088b2702],
7	cancers	NNS	O	cancer	prep_in	4	SENT_31	[p1l1097t2673r1219b2694],
8	may	MD	O	may	aux	9	SENT_31	[p1l1230t2673r1299b2702],
9	identify	VB	O	identify	_	0	SENT_31	[p1l1307t2663r1432b2702],
10	patients	NNS	O	patient	dobj	9	SENT_31	[p1l1440t2673r1492b2702, p1l94t2713r183b2743],
11	who	WP	O	who	nsubj	13	SENT_31	[p1l192t2712r263b2743],
12	will	MD	O	will	aux	13	SENT_31	[p1l272t2712r333b2743],
13	have	VB	O	have	rcmod	10	SENT_31	[p1l342t2712r415b2743],
14	a	DT	O	a	det	15	SENT_31	[p1l424t2722r442b2743],
15	response	NN	O	response	dobj	13	SENT_31	[p1l451t2722r598b2751],
16	to	TO	O	to	_	0	SENT_31	[p1l607t2719r638b2743],
17	geﬁtinib	NN	O	geﬁtinib	prep_to	15	SENT_31	[p1l648t2712r795b2751],
18	.	.	O	.	_	0	SENT_31	[p1l648t2712r795b2751],

1	N	NN	O	n	nn	2	SENT_32	[p1l422t2828r436b2843],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_32	[p1l451t2827r535b2849],
3	MED	VBD	O	med	_	0	SENT_32	[p1l550t2828r603b2843],
4	35o	CD	NUMBER	35o	dobj	3	SENT_32	[p1l615t2827r693b2849],
5	;	:	O	;	_	0	SENT_32	[p1l615t2827r693b2849],
6	21	CD	NUMBER	21	dep	4	SENT_32	[p1l615t2827r693b2849],

1	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	_	0	SENT_33	[p1l731t2827r942b2849],
2	MAY	NNP	DATE	MAY	dep	1	SENT_33	[p1l981t2827r1033b2843],
3	20	CD	DATE	20	num	2	SENT_33	[p1l1045t2827r1084b2847],
4	,	,	DATE	,	_	0	SENT_33	[p1l1045t2827r1084b2847],
5	2004	CD	DATE	2004	num	2	SENT_33	[p1l1097t2827r1165b2849],

1	The	DT	O	the	det	4	SENT_34	[p1l752t2924r803b2948],
2	New	NNP	O	New	nn	4	SENT_34	[p1l812t2925r874b2948],
3	England	NNP	O	England	nn	4	SENT_34	[p1l883t2924r994b2955],
4	Journal	NNP	O	Journal	_	0	SENT_34	[p1l1003t2924r1100b2948],
5	of	IN	O	of	_	0	SENT_34	[p1l1110t2924r1139b2948],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_34	[p1l1145t2924r1270b2948],

1	From	IN	O	from	_	0	SENT_35	[p1l1533t1339r1595b1360],
2	the	DT	O	the	det	4	SENT_35	[p1l1603t1336r1642b1360],
3	Cancer	NNP	MISC	Cancer	nn	4	SENT_35	[p1l1650t1338r1735b1360],
4	Center	NNP	MISC	Center	pobj	1	SENT_35	[p1l1743t1338r1824b1360],
5	(	CD	NUMBER	(	num	4	SENT_35	[p1l1833t1338r1905b1367],
6	|	NN	O	|	dep	4	SENT_35	[p1l1833t1338r1905b1367],
7	'	''	O	'	_	0	SENT_35	[p1l1833t1338r1905b1367],
8	.	.	O	.	_	0	SENT_35	[p1l1833t1338r1905b1367],

1	J.L.	NNP	PERSON	J.L.	_	0	SENT_36	[p1l1833t1338r1905b1367],
2	,	,	O	,	_	0	SENT_36	[p1l1833t1338r1905b1367],
3	D.	NNP	O	D.	nn	4	SENT_36	[p1l1916t1339r2004b1364],
4	VV	NNP	O	VV	appos	1	SENT_36	[p1l1916t1339r2004b1364],
5	.	.	O	.	_	0	SENT_36	[p1l1916t1339r2004b1364],

1	B.	NNP	O	B.	nn	25	SENT_37	[p1l1916t1339r2004b1364],
2	,	,	O	,	_	0	SENT_37	[p1l1916t1339r2004b1364],
3	R.S.	NNP	LOCATION	R.S.	appos	25	SENT_37	[p1l2015t1338r2066b1364],
4	,	,	O	,	_	0	SENT_37	[p1l2015t1338r2066b1364],
5	S.G.	NNP	LOCATION	S.G.	appos	25	SENT_37	[p1l1532t1375r1588b1401],
6	,	,	O	,	_	0	SENT_37	[p1l1532t1375r1588b1401],
7	R.A.O.	NNP	O	R.A.O.	appos	25	SENT_37	[p1l1602t1375r1686b1401],
8	,	,	O	,	_	0	SENT_37	[p1l1602t1375r1686b1401],
9	B.W.B.	NNP	O	B.W.B.	appos	25	SENT_37	[p1l1699t1376r1782b1401],
10	,	,	O	,	_	0	SENT_37	[p1l1699t1376r1782b1401],
11	P.L.H.	NNP	O	P.L.H.	appos	25	SENT_37	[p1l1796t1376r1876b1401],
12	,	,	O	,	_	0	SENT_37	[p1l1796t1376r1876b1401],
13	S.M.H.	NNP	O	S.M.H.	appos	25	SENT_37	[p1l1887t1375r2065b1404],
14	,	,	O	,	_	0	SENT_37	[p1l1887t1375r2065b1404],
15	J.G.S.	NNP	O	J.G.S.	appos	25	SENT_37	[p1l1887t1375r2065b1404],
16	,	,	O	,	_	0	SENT_37	[p1l1887t1375r2065b1404],
17	F.G.H.	NNP	O	F.G.H.	appos	25	SENT_37	[p1l1533t1413r1620b1439],
18	,	,	O	,	_	0	SENT_37	[p1l1533t1413r1620b1439],
19	D.N.L.	NNP	O	D.N.L.	appos	25	SENT_37	[p1l1631t1413r1715b1439],
20	,	,	O	,	_	0	SENT_37	[p1l1631t1413r1715b1439],
21	D.C.C.	NNP	O	D.C.C.	appos	25	SENT_37	[p1l1727t1413r1863b1441],
22	,	,	O	,	_	0	SENT_37	[p1l1727t1413r1863b1441],
23	j.S.	NNP	O	j.S.	appos	25	SENT_37	[p1l1727t1413r1863b1441],
24	,	,	O	,	_	0	SENT_37	[p1l1727t1413r1863b1441],
25	D.A.H.	NNP	O	D.A.H.	_	0	SENT_37	[p1l1875t1413r1965b1442],
26	)	CD	NUMBER	)	num	25	SENT_37	[p1l1875t1413r1965b1442],
27	and	CC	O	and	_	0	SENT_37	[p1l1976t1411r2020b1435],
28	the	DT	O	the	det	29	SENT_37	[p1l2029t1411r2068b1435],
29	Departments	NNP	MISC	Departments	conj_and	25	SENT_37	[p1l1533t1451r1699b1480],
30	of	IN	MISC	of	_	0	SENT_37	[p1l1713t1448r1741b1472],
31	Medicine	NNP	MISC	Medicine	prep_of	29	SENT_37	[p1l1752t1449r1868b1472],
32	(	CD	NUMBER	(	num	31	SENT_37	[p1l1884t1451r1959b1480],
33	T.j.L.	NNP	O	T.j.L.	dep	25	SENT_37	[p1l1884t1451r1959b1480],
34	,	,	O	,	_	0	SENT_37	[p1l1884t1451r1959b1480],
35	D.	NNP	O	D.	nn	36	SENT_37	[p1l1975t1451r2065b1477],
36	VV	NNP	O	VV	appos	33	SENT_37	[p1l1975t1451r2065b1477],
37	.	.	O	.	_	0	SENT_37	[p1l1975t1451r2065b1477],

1	B.	NNP	O	B.	nn	12	SENT_38	[p1l1975t1451r2065b1477],
2	,	,	O	,	_	0	SENT_38	[p1l1975t1451r2065b1477],
3	J.G.S.	NNP	O	J.G.S.	conj_and	12	SENT_38	[p1l1527t1488r1606b1517],
4	,	,	O	,	_	0	SENT_38	[p1l1527t1488r1606b1517],
5	F.G.H.	NNP	O	F.G.H.	conj_and	12	SENT_38	[p1l1620t1488r1705b1514],
6	,	,	O	,	_	0	SENT_38	[p1l1620t1488r1705b1514],
7	D.C.C.	NNP	O	D.C.C.	conj_and	12	SENT_38	[p1l1719t1488r1857b1517],
8	,	,	O	,	_	0	SENT_38	[p1l1719t1488r1857b1517],
9	J.S.	NNP	LOCATION	J.S.	conj_and	12	SENT_38	[p1l1719t1488r1857b1517],
10	,	,	O	,	_	0	SENT_38	[p1l1719t1488r1857b1517],
11	D.A.H.	NNP	O	D.A.H.	conj_and	12	SENT_38	[p1l1871t1488r1961b1517],
12	)	NNP	O	)	_	0	SENT_38	[p1l1871t1488r1961b1517],
13	and	CC	O	and	_	0	SENT_38	[p1l1974t1486r2018b1510],
14	Pathology	NNP	O	Pathology	conj_and	12	SENT_38	[p1l2032t1488r2067b1510, p1l1530t1524r1625b1555],
15	(	CD	NUMBER	(	num	16	SENT_38	[p1l1639t1526r1749b1555],
16	D.N.L.	NNP	O	D.N.L.	dep	12	SENT_38	[p1l1639t1526r1749b1555],
17	)	CD	NUMBER	)	num	16	SENT_38	[p1l1639t1526r1749b1555],
18	,	,	O	,	_	0	SENT_38	[p1l1639t1526r1749b1555],
19	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	21	SENT_38	[p1l1765t1524r1955b1548],
20	General	NNP	ORGANIZATION	General	nn	21	SENT_38	[p1l1968t1524r2066b1548],
21	Hospital	NNP	ORGANIZATION	Hospital	appos	12	SENT_38	[p1l1533t1557r1635b1588],
22	and	CC	O	and	_	0	SENT_38	[p1l1647t1557r1691b1581],
23	Harvard	NNP	ORGANIZATION	Harvard	nn	25	SENT_38	[p1l1705t1557r1802b1581],
24	Medical	NNP	ORGANIZATION	Medical	nn	25	SENT_38	[p1l1815t1557r1909b1581],
25	School	NNP	ORGANIZATION	School	appos	12	SENT_38	[p1l1922t1557r2011b1585],
26	;	:	O	;	_	0	SENT_38	[p1l1922t1557r2011b1585],
27	and	CC	O	and	_	0	SENT_38	[p1l2022t1557r2066b1581],
28	the	DT	O	the	det	30	SENT_38	[p1l1530t1595r1569b1619],
29	Harvard	NNP	ORGANIZATION	Harvard	nn	30	SENT_38	[p1l1578t1595r1679b1619],
30	School	NNP	ORGANIZATION	School	conj_and	12	SENT_38	[p1l1689t1595r1773b1619],
31	of	IN	ORGANIZATION	of	_	0	SENT_38	[p1l1783t1595r1811b1619],
32	Public	NNP	ORGANIZATION	Public	nn	37	SENT_38	[p1l1817t1595r1893b1619],
33	Health	NNP	ORGANIZATION	Health	nn	37	SENT_38	[p1l1903t1595r1986b1619],
34	(	CD	NUMBER	(	num	37	SENT_38	[p1l1998t1597r2066b1626],
35	S.G.	NNP	LOCATION	S.G.	nn	37	SENT_38	[p1l1998t1597r2066b1626],
36	,	,	O	,	_	0	SENT_38	[p1l1998t1597r2066b1626],
37	D.C.C.	NNP	O	D.C.C.	prep_of	30	SENT_38	[p1l1533t1634r1619b1664],
38	)	CD	NUMBER	)	number	39	SENT_38	[p1l1533t1634r1619b1664],
39	—	CD	NUMBER	—	dep	12	SENT_38	[p1l1629t1647r1660b1650],
40	all	DT	O	all	dep	39	SENT_38	[p1l1668t1633r1693b1656],
41	in	IN	O	in	_	0	SENT_38	[p1l1704t1635r1724b1656],
42	Boston	NNP	LOCATION	Boston	prep_in	39	SENT_38	[p1l1736t1635r1828b1656],
43	.	.	O	.	_	0	SENT_38	[p1l1736t1635r1828b1656],

1	Address	NN	O	address	nsubj	2	SENT_39	[p1l1837t1633r1937b1656],
2	reprint	VB	O	reprint	_	0	SENT_39	[p1l1948t1635r2029b1664],
3	requests	NNS	O	request	dobj	2	SENT_39	[p1l2038t1641r2067b1656, p1l1531t1675r1611b1701],
4	to	TO	O	to	_	0	SENT_39	[p1l1619t1675r1644b1694],
5	Dr.	NNP	O	Dr.	nn	6	SENT_39	[p1l1654t1672r1686b1694],
6	Haber	NNP	PERSON	Haber	prep_to	2	SENT_39	[p1l1698t1670r1773b1694],
7	at	IN	O	at	_	0	SENT_39	[p1l1781t1675r1803b1694],
8	MGH	NNP	ORGANIZATION	MGH	nn	10	SENT_39	[p1l1813t1672r1879b1694],
9	Cancer	NNP	ORGANIZATION	Cancer	nn	10	SENT_39	[p1l1890t1672r1975b1694],
10	Center	NNP	ORGANIZATION	Center	prep_at	6	SENT_39	[p1l1982t1672r2066b1698],
11	,	,	O	,	_	0	SENT_39	[p1l1982t1672r2066b1698],
12	Bldg	NNP	O	Bldg	appos	10	SENT_39	[p1l1533t1708r1592b1739],
13	.	.	O	.	_	0	SENT_39	[p1l1533t1708r1592b1739],

1	149	CD	NUMBER	149	_	0	SENT_40	[p1l1603t1710r1651b1736],
2	,	,	O	,	_	0	SENT_40	[p1l1603t1710r1651b1736],
3	13th	JJ	ORDINAL	13th	amod	4	SENT_40	[p1l1661t1708r1712b1732],
4	St.	NNP	O	St.	appos	1	SENT_40	[p1l1721t1710r1758b1736],
5	,	,	O	,	_	0	SENT_40	[p1l1721t1710r1758b1736],
6	Charlestown	NNP	LOCATION	Charlestown	nn	8	SENT_40	[p1l1767t1708r1927b1736],
7	,	,	O	,	_	0	SENT_40	[p1l1767t1708r1927b1736],
8	MA	NNP	LOCATION	MA	dep	4	SENT_40	[p1l1937t1709r1980b1731],
9	02129	CD	DATE	02129	dep	8	SENT_40	[p1l1986t1709r2066b1736],
10	,	,	O	,	_	0	SENT_40	[p1l1986t1709r2066b1736],
11	or	CC	O	or	cc	4	SENT_40	[p1l1531t1753r1557b1769],
12	at	IN	O	at	_	0	SENT_40	[p1l1566t1750r1589b1769],
13	haber@helix.mgh.harvard.eclu	NN	O	haber@helix.mgh.harvard.eclu	prep_at	4	SENT_40	[p1l1598t1745r1995b1777],
14	.	.	O	.	_	0	SENT_40	[p1l1598t1745r1995b1777],

1	Drs.	NNP	O	Drs.	nn	2	SENT_41	[p1l1533t1822r1583b1844],
2	Lynch	NNP	PERSON	Lynch	nsubj	8	SENT_41	[p1l1596t1820r1673b1851],
3	,	,	O	,	_	0	SENT_41	[p1l1596t1820r1673b1851],
4	Bell	NNP	ORGANIZATION	Bell	conj_and	2	SENT_41	[p1l1686t1820r1737b1848],
5	,	,	O	,	_	0	SENT_41	[p1l1686t1820r1737b1848],
6	and	CC	O	and	_	0	SENT_41	[p1l1749t1820r1794b1844],
7	Sordella	NNP	PERSON	Sordella	nsubj	8	SENT_41	[p1l1806t1820r1908b1844],
8	contributed	VBD	O	contribute	_	0	SENT_41	[p1l1919t1820r2066b1844],
9	equally	RB	O	equally	advmod	8	SENT_41	[p1l1531t1885r1620b1916],
10	to	TO	O	to	_	0	SENT_41	[p1l1628t1890r1653b1909],
11	the	DT	O	the	det	12	SENT_41	[p1l1661t1885r1701b1909],
12	article	NN	O	article	prep_to	8	SENT_41	[p1l1711t1885r1794b1909],
13	.	.	O	.	_	0	SENT_41	[p1l1711t1885r1794b1909],

1	This	DT	O	this	det	2	SENT_42	[p1l1530t1960r1582b1984],
2	article	NN	O	article	nsubjpass	4	SENT_42	[p1l1592t1960r1665b1984],
3	was	VBD	O	be	auxpass	4	SENT_42	[p1l1673t1968r1720b1984],
4	published	VBN	O	publish	_	0	SENT_42	[p1l1730t1960r1850b1991],
5	at	IN	O	at	_	0	SENT_42	[p1l1860t1965r1882b1984],
6	wvvw.nejm.org	NN	O	wvvw.nejm.org	prep_at	4	SENT_42	[p1l1889t1962r2068b1991],
7	on	IN	O	on	_	0	SENT_42	[p1l1531t2005r1561b2021],
8	April	NNP	DATE	April	prep_on	6	SENT_42	[p1l1571t1997r1630b2028],
9	29,2004	CD	DATE	29,2004	num	8	SENT_42	[p1l1641t1999r1754b2025],
10	.	.	O	.	_	0	SENT_42	[p1l1641t1999r1754b2025],

1	N	NN	MISC	n	nn	3	SENT_43	[p1l1533t2074r1551b2095],
2	Englj	NNP	MISC	Englj	nn	3	SENT_43	[p1l1564t2072r1632b2103],
3	Med	NNP	O	Med	_	0	SENT_43	[p1l1645t2072r1699b2095],
4	2004	CD	DATE	2004	num	3	SENT_43	[p1l1710t2073r1942b2100],
5	;	:	O	;	_	0	SENT_43	[p1l1710t2073r1942b2100],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_43	[p1l1710t2073r1942b2100],
7	—	CD	NUMBER	—	dep	3	SENT_43	[p1l1710t2073r1942b2100],
8	39	CD	NUMBER	39	dep	7	SENT_43	[p1l1710t2073r1942b2100],
9	.	.	O	.	_	0	SENT_43	[p1l1710t2073r1942b2100],

1	Copyright	NN	O	copyright	_	0	SENT_44	[p1l1532t2114r1624b2139],
2	©	CD	NUMBER	©	num	6	SENT_44	[p1l1632t2116r1653b2137],
3	2004	CD	DATE	2004	num	6	SENT_44	[p1l1662t2115r1711b2133],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_44	[p1l1719t2114r1859b2133],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_44	[p1l1867t2114r1944b2133],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_44	[p1l1951t2115r2022b2139],
7	.	.	O	.	_	0	SENT_44	[p1l1951t2115r2022b2139],

1	Downloaded	VBN	O	download	_	0	SENT_45	[p1l194t2965r364b2988],
2	from	IN	O	from	_	0	SENT_45	[p1l373t2965r437b2988],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_45	[p1l446t2965r564b2995],
4	at	IN	O	at	_	0	SENT_45	[p1l574t2969r598b2988],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_45	[p1l606t2965r789b2989],
6	on	IN	O	on	_	0	SENT_45	[p1l798t2972r830b2988],
7	January	NNP	DATE	January	prep_on	1	SENT_45	[p1l839t2965r942b2995],
8	5	CD	DATE	5	num	7	SENT_45	[p1l952t2965r974b2993],
9	,	,	DATE	,	_	0	SENT_45	[p1l952t2965r974b2993],
10	2014	CD	DATE	2014	num	7	SENT_45	[p1l985t2965r1057b2989],
11	.	.	O	.	_	0	SENT_45	[p1l985t2965r1057b2989],

1	For	IN	O	for	_	0	SENT_46	[p1l1068t2965r1114b2988],
2	personal	JJ	O	personal	amod	3	SENT_46	[p1l1122t2965r1235b2995],
3	use	NN	O	use	pobj	1	SENT_46	[p1l1244t2972r1287b2988],
4	only	RB	O	only	advmod	3	SENT_46	[p1l1297t2965r1362b2995],
5	.	.	O	.	_	0	SENT_46	[p1l1297t2965r1362b2995],

1	N	NN	O	n	nn	2	SENT_47	[p1l1372t2965r1396b2988],
2	o	NN	O	o	_	0	SENT_47	[p1l1397t2972r1412b2988],
3	other	JJ	O	other	amod	4	SENT_47	[p1l1422t2965r1490b2988],
4	uses	NNS	O	use	dep	2	SENT_47	[p1l1499t2972r1554b2988],
5	without	IN	O	without	_	0	SENT_47	[p1l1565t2965r1666b2988],
6	permission	NN	O	permission	prep_without	4	SENT_47	[p1l1674t2965r1827b2995],
7	.	.	O	.	_	0	SENT_47	[p1l1674t2965r1827b2995],

1	The	DT	O	the	det	4	SENT_48	[p1l715t3112r752b3133],
2	NEW	NNP	O	NEW	nn	4	SENT_48	[p1l764t3114r845b3133],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_48	[p1l859t3114r1034b3133],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_48	[p1l1048t3114r1214b3140],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_48	[p1l1228t3112r1444b3139],

1	ON-SMALL-CELL	NN	O	on-small-cell	nn	3	SENT_49	[p1l426t3344r1164b3401],
2	LUNG	NN	O	lung	nn	3	SENT_49	[p1l1185t3344r1446b3401],
3	CANCER	NNP	O	CANCER	nsubj	5	SENT_49	[p1l1466t3345r1836b3401],
4	IS	VBZ	O	be	cop	5	SENT_49	[p1l1853t3345r1930b3401],
5	THE	DT	O	the	_	0	SENT_49	[p1l1949t3345r2135b3400],

1	leading	VBG	O	lead	amod	2	SENT_50	[p1l424t3452r739b3552],
2	cause	NN	O	cause	_	0	SENT_50	[p1l759t3478r990b3531],
3	of	IN	O	of	_	0	SENT_50	[p1l1014t3451r1114b3530],
4	death	NN	O	death	prep_of	2	SENT_50	[p1l1120t3452r1352b3530],
5	from	IN	O	from	_	0	SENT_50	[p1l1375t3451r1582b3530],
6	cancer	NN	O	cancer	prep_from	4	SENT_50	[p1l1606t3477r1881b3530],
7	in	IN	O	in	_	0	SENT_50	[p1l1900t3453r1981b3529],
8	the	DT	O	the	det	10	SENT_50	[p1l2005t3452r2134b3530],
9	United	NNP	LOCATION	United	nn	10	SENT_50	[p1l424t3581r706b3659],
10	States	NNPS	LOCATION	States	prep_in	6	SENT_50	[p1l727t3587r990b3659],
11	.	.	O	.	_	0	SENT_50	[p1l727t3587r990b3659],

1	Chemotherapy	NN	MISC	chemotherapy	nsubj	3	SENT_51	[p1l1015t3581r1629b3681],
2	slightly	RB	O	slightly	advmod	3	SENT_51	[p1l1645t3581r1948b3681],
3	prolongs	VBZ	O	prolong	_	0	SENT_51	[p1l1961t3606r2135b3681, p1l9t3710r236b3810],
4	survival	NN	O	survival	dobj	3	SENT_51	[p1l275t3709r584b3789],
5	among	IN	O	among	_	0	SENT_51	[p1l619t3735r917b3810],
6	patients	NNS	O	patient	prep_among	3	SENT_51	[p1l950t3710r1285b3810],
7	with	IN	O	with	_	0	SENT_51	[p1l1321t3709r1510b3789],
8	advanced	JJ	O	advanced	amod	9	SENT_51	[p1l1548t3709r1940b3789],
9	disease	NN	O	disease	prep_with	6	SENT_51	[p1l1979t3709r2133b3788, p2l11t49r211b118],
10	,	,	O	,	_	0	SENT_51	[p1l1979t3709r2133b3788, p2l11t49r211b118],

1	but	CC	O	but	cc	31	SENT_52	[p2l242t22r383b102],
2	at	IN	O	at	prep	31	SENT_52	[p2l402t39r480b101],
3	the	DT	O	the	det	4	SENT_52	[p2l500t23r629b101],
4	cost	NN	O	cost	dep	12	SENT_52	[p2l655t39r828b101],
5	of	IN	O	of	_	0	SENT_52	[p2l848t22r948b101],
6	clinically	RB	O	clinically	advmod	7	SENT_52	[p2l955t23r1330b123],
7	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_52	[p2l1351t22r1803b123],
8	adverse	JJ	O	adverse	amod	9	SENT_52	[p2l1821t23r2135b102],
9	effects	NNS	O	effect	prep_of	4	SENT_52	[p2l11t145r355b229],
10	.1	CD	NUMBER	.1	dep	12	SENT_52	[p2l11t145r355b229],
11	The	DT	O	the	det	12	SENT_52	[p2l376t151r538b229],
12	success	NN	O	success	dep	19	SENT_52	[p2l564t177r877b230],
13	of	IN	O	of	_	0	SENT_52	[p2l905t150r1005b229],
14	the	DT	O	the	det	15	SENT_52	[p2l1012t151r1140b229],
15	ABL	NNP	ORGANIZATION	ABL	prep_of	12	SENT_52	[p2l1162t158r1341b229],
16	tyrosine	NN	O	tyrosine	nn	19	SENT_52	[p2l1364t152r1699b251],
17	kinase	NN	O	kinase	nn	19	SENT_52	[p2l1724t151r1994b230],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_52	[p2l2019t152r2133b228, p2l10t278r296b357],
19	imatinib	NN	O	imatinib	dep	2	SENT_52	[p2l313t279r665b357],
20	in	IN	O	in	_	0	SENT_52	[p2l687t279r767b356],
21	the	DT	O	the	det	22	SENT_52	[p2l788t278r916b357],
22	treatment	NN	O	treatment	prep_in	2	SENT_52	[p2l937t295r1348b357],
23	of	IN	O	of	_	0	SENT_52	[p2l1363t278r1464b357],
24	chronic	JJ	O	chronic	amod	26	SENT_52	[p2l1466t279r1783b357],
25	myeloid	JJ	O	myeloid	amod	26	SENT_52	[p2l1802t278r2136b379],
26	leukemia	NN	O	leukemia	prep_of	22	SENT_52	[p2l9t408r403b487],
27	(	CD	NUMBER	(	num	29	SENT_52	[p2l445t413r708b499],
28	CML	NN	ORGANIZATION	cml	nn	29	SENT_52	[p2l445t413r708b499],
29	)	NN	O	)	nsubj	31	SENT_52	[p2l445t413r708b499],
30	has	VBZ	O	have	aux	31	SENT_52	[p2l752t408r895b486],
31	demonstrated	VBN	O	demonstrate	_	0	SENT_52	[p2l936t408r1535b486],
32	the	DT	O	the	det	33	SENT_52	[p2l1573t407r1705b486],
33	effectiveness	NN	O	effectiveness	dobj	31	SENT_52	[p2l1744t407r2132b487, p2l10t561r191b614],
34	of	IN	O	of	_	0	SENT_52	[p2l219t535r318b614],
35	targeting	VBG	O	target	prepc_of	33	SENT_52	[p2l325t536r705b636],
36	the	DT	O	the	det	39	SENT_52	[p2l727t536r854b614],
37	critical	JJ	O	critical	amod	39	SENT_52	[p2l880t535r1158b614],
38	genetic	JJ	O	genetic	amod	39	SENT_52	[p2l1181t536r1480b636],
39	lesion	NN	O	lesion	dobj	35	SENT_52	[p2l1503t536r1752b614],
40	that	WDT	O	that	nsubj	41	SENT_52	[p2l1777t536r1941b614],
41	promotes	VBZ	O	promote	rcmod	39	SENT_52	[p2l1959t561r2134b636, p2l10t679r268b740],
42	proliferative	JJ	O	proliferative	amod	43	SENT_52	[p2l302t662r825b762],
43	signals	NNS	O	signal	dobj	41	SENT_52	[p2l861t662r1160b762],
44	in	IN	O	in	_	0	SENT_52	[p2l1195t663r1277b739],
45	cancer	NN	O	cancer	nn	46	SENT_52	[p2l1311t688r1592b740],
46	cells	NNS	O	cell	prep_in	43	SENT_52	[p2l1623t658r1883b740],
47	?	.	O	?	_	0	SENT_52	[p2l1623t658r1883b740],

1	Geﬁ	NN	O	geﬁ	nn	2	SENT_53	[p2l1916t662r2132b740],
2	tinib	NN	O	tinib	nsubj	3	SENT_53	[p2l11t791r202b869],
3	targets	VBZ	O	target	_	0	SENT_53	[p2l228t807r508b891],
4	the	DT	O	the	det	6	SENT_53	[p2l535t790r662b869],
5	ATP	NN	O	atp	nn	6	SENT_53	[p2l682t796r854b868],
6	cleft	NN	O	cleft	dobj	3	SENT_53	[p2l877t790r1056b869],
7	within	IN	O	within	_	0	SENT_53	[p2l1070t790r1340b870],
8	the	DT	O	the	det	10	SENT_53	[p2l1364t791r1492b869],
9	tyrosine	NN	O	tyrosine	nn	10	SENT_53	[p2l1517t791r1846b891],
10	kinase	NN	O	kinase	prep_within	3	SENT_53	[p2l1869t790r2135b870],
11	epidermal	JJ	O	epidermal	amod	17	SENT_53	[p2l11t918r435b1017],
12	growth	NN	O	growth	nn	17	SENT_53	[p2l467t918r770b1017],
13	factor	NN	O	factor	nn	17	SENT_53	[p2l803t917r1049b995],
14	receptor	NN	O	receptor	nn	17	SENT_53	[p2l1078t934r1430b1017],
15	(	CD	NUMBER	(	num	17	SENT_53	[p2l1465t913r1843b1012],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_53	[p2l1465t913r1843b1012],
17	)	NN	O	)	dep	10	SENT_53	[p2l1465t913r1843b1012],
18	,	,	O	,	_	0	SENT_53	[p2l1465t913r1843b1012],
19	-	:	O	-	_	0	SENT_53	[p2l1465t913r1843b1012],
20	°	CD	NUMBER	°	num	21	SENT_53	[p2l1465t913r1843b1012],
21	’	CD	NUMBER	’	conj_and	10	SENT_53	[p2l1465t913r1843b1012],
22	which	WDT	O	which	nsubjpass	24	SENT_53	[p2l1874t918r2134b997],
23	is	VBZ	O	be	auxpass	24	SENT_53	[p2l10t1046r75b1124],
24	overexpressed	VBN	O	overexpress	rcmod	21	SENT_53	[p2l104t1046r700b1146],
25	in	IN	O	in	_	0	SENT_53	[p2l727t1046r807b1123],
26	40	CD	NUMBER	40	number	28	SENT_53	[p2l833t1051r935b1124],
27	to	TO	O	to	dep	28	SENT_53	[p2l963t1062r1042b1124],
28	80	CD	PERCENT	80	num	29	SENT_53	[p2l1071t1051r1171b1124],
29	percent	NN	PERCENT	percent	prep_in	24	SENT_53	[p2l1198t1062r1518b1146],
30	of	IN	O	of	_	0	SENT_53	[p2l1541t1045r1641b1124],
31	non	JJ	O	non	amod	37	SENT_53	[p2l1650t1045r2133b1124],
32	—	JJ	O	—	amod	37	SENT_53	[p2l1650t1045r2133b1124],
33	small	JJ	O	small	amod	37	SENT_53	[p2l1650t1045r2133b1124],
34	—	NN	O	—	nn	37	SENT_53	[p2l1650t1045r2133b1124],
35	cell	NN	O	cell	nn	37	SENT_53	[p2l11t1173r152b1252],
36	lung	NN	O	lung	nn	37	SENT_53	[p2l194t1173r388b1274],
37	cancers	NNS	O	cancer	prep_of	29	SENT_53	[p2l428t1199r742b1252],
38	and	CC	O	and	_	0	SENT_53	[p2l786t1173r942b1252],
39	many	JJ	O	many	amod	41	SENT_53	[p2l985t1199r1219b1274],
40	other	JJ	O	other	amod	41	SENT_53	[p2l1258t1173r1482b1252],
41	epithelial	NN	O	epithelial	conj_and	10	SENT_53	[p2l1523t1173r1913b1274],
42	can	MD	O	can	aux	43	SENT_53	[p2l1956t1199r2133b1252],
43	—	VB	O	—	rcmod	41	SENT_53	[p2l1956t1199r2133b1252],
44	cers	NNS	O	cer	dobj	43	SENT_53	[p2l11t1296r247b1378],
45	.4	CD	NUMBER	.4	num	47	SENT_53	[p2l11t1296r247b1378],
46	EGFR	NN	ORGANIZATION	egfr	nn	47	SENT_53	[p2l280t1306r539b1383],
47	signaling	NN	O	signaling	nsubjpass	49	SENT_53	[p2l566t1301r960b1400],
48	is	VBZ	O	be	auxpass	49	SENT_53	[p2l990t1301r1055b1378],
49	triggered	VBN	O	trigger	rcmod	44	SENT_53	[p2l1093t1301r1477b1400],
50	by	IN	O	by	_	0	SENT_53	[p2l1512t1301r1609b1400],
51	the	DT	O	the	det	52	SENT_53	[p2l1640t1300r1769b1378],
52	binding	NN	O	binding	agent	49	SENT_53	[p2l1805t1301r2138b1400],
53	of	IN	O	of	_	0	SENT_53	[p2l11t1428r112b1507],
54	growth	NN	O	growth	nn	55	SENT_53	[p2l117t1429r420b1529],
55	factors	NNS	O	factor	prep_of	52	SENT_53	[p2l444t1428r754b1524],
56	,	,	O	,	_	0	SENT_53	[p2l444t1428r754b1524],
57	such	JJ	O	such	_	0	SENT_53	[p2l786t1428r980b1508],
58	as	IN	O	as	_	0	SENT_53	[p2l1004t1455r1088b1507],
59	epidermal	JJ	O	epidermal	amod	64	SENT_53	[p2l1115t1429r1540b1529],
60	growth	NN	O	growth	nn	64	SENT_53	[p2l1564t1429r1868b1529],
61	factor	NN	O	factor	nn	64	SENT_53	[p2l1892t1428r2138b1507],
62	(	CD	NUMBER	(	num	64	SENT_53	[p2l15t1562r285b1652],
63	EGF	NN	ORGANIZATION	egf	nn	64	SENT_53	[p2l15t1562r285b1652],
64	)	NN	O	)	prep_such_as	52	SENT_53	[p2l15t1562r285b1652],
65	,	,	O	,	_	0	SENT_53	[p2l15t1562r285b1652],
66	resulting	VBG	O	result	partmod	64	SENT_53	[p2l317t1556r695b1657],
67	in	IN	O	in	_	0	SENT_53	[p2l718t1557r800b1634],
68	the	DT	O	the	det	69	SENT_53	[p2l826t1557r956b1635],
69	dimerization	NN	O	dimerization	prep_in	66	SENT_53	[p2l984t1556r1526b1635],
70	of	IN	O	of	_	0	SENT_53	[p2l1553t1556r1654b1635],
71	EGFR	NN	ORGANIZATION	egfr	nn	72	SENT_53	[p2l1660t1562r1919b1640],
72	molecules	NNS	O	molecule	prep_of	69	SENT_53	[p2l1936t1557r2133b1635, p2l11t1685r267b1764],
73	or	CC	O	or	_	0	SENT_53	[p2l296t1710r385b1763],
74	heterodimerization	NN	O	heterodimerization	conj_or	69	SENT_53	[p2l410t1684r1225b1763],
75	with	IN	O	with	_	0	SENT_53	[p2l1247t1685r1437b1764],
76	other	JJ	O	other	amod	79	SENT_53	[p2l1465t1685r1688b1763],
77	closely	RB	O	closely	advmod	78	SENT_53	[p2l1713t1684r1999b1785],
78	related	JJ	O	related	amod	79	SENT_53	[p2l2022t1711r2133b1763, p2l9t1812r213b1891],
79	receptors	NNS	O	receptor	prep_with	74	SENT_53	[p2l241t1829r656b1913],
80	,	,	O	,	_	0	SENT_53	[p2l241t1829r656b1913],
81	such	JJ	O	such	_	0	SENT_53	[p2l691t1813r885b1892],
82	as	IN	O	as	_	0	SENT_53	[p2l913t1839r997b1891],
83	HER2/neu	NN	O	her2/neu	prep_such_as	41	SENT_53	[p2l1026t1818r1487b1903],
84	.	.	O	.	_	0	SENT_53	[p2l1026t1818r1487b1903],

1	Autophospho	NN	O	autophospho	nn	3	SENT_54	[p2l1517t1812r2133b1913],
2	—	NN	O	—	nn	3	SENT_54	[p2l1517t1812r2133b1913],
3	rylation	NN	O	rylation	nsubj	14	SENT_54	[p2l10t1941r336b2041],
4	and	CC	O	and	_	0	SENT_54	[p2l359t1940r516b2019],
5	transphosphorylation	NN	O	transphosphorylation	conj_and	3	SENT_54	[p2l540t1941r1457b2041],
6	of	IN	O	of	_	0	SENT_54	[p2l1482t1940r1583b2019],
7	the	DT	O	the	det	8	SENT_54	[p2l1589t1941r1718b2019],
8	receptors	NNS	O	receptor	prep_of	5	SENT_54	[p2l1743t1957r2132b2041],
9	through	IN	O	through	_	0	SENT_54	[p2l11t2069r352b2169],
10	their	PRP$	O	they	poss	13	SENT_54	[p2l380t2069r578b2147],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_54	[p2l602t2069r936b2169],
12	kinase	NN	O	kinase	nn	13	SENT_54	[p2l963t2069r1233b2148],
13	domains	NNS	O	domain	prep_through	8	SENT_54	[p2l1261t2068r1627b2147],
14	leads	VBZ	O	lead	_	0	SENT_54	[p2l1655t2068r1868b2147],
15	to	TO	O	to	_	0	SENT_54	[p2l1897t2085r1976b2147],
16	the	DT	O	the	det	17	SENT_54	[p2l2005t2068r2135b2147],
17	recruitment	NN	O	recruitment	prep_to	14	SENT_54	[p2l10t2197r522b2276],
18	of	IN	O	of	_	0	SENT_54	[p2l542t2196r643b2275],
19	downstream	JJ	O	downstream	amod	20	SENT_54	[p2l651t2197r1187b2276],
20	effectors	NNS	O	effector	prep_of	17	SENT_54	[p2l1213t2196r1583b2275],
21	and	CC	O	and	_	0	SENT_54	[p2l1609t2196r1767b2275],
22	the	DT	O	the	det	24	SENT_54	[p2l1793t2197r1923b2275],
23	acti	NN	O	actus	nn	24	SENT_54	[p2l1948t2197r2132b2275],
24	—	NN	O	—	conj_and	20	SENT_54	[p2l1948t2197r2132b2275],

1	vation	NN	O	vation	nsubj	23	SENT_55	[p2l6t2324r262b2402],
2	of	IN	O	of	_	0	SENT_55	[p2l287t2323r386b2401],
3	proliferative	JJ	O	proliferative	amod	8	SENT_55	[p2l390t2323r891b2423],
4	and	CC	O	and	_	0	SENT_55	[p2l914t2323r1068b2401],
5	cell	NN	O	cell	conj_and	3	SENT_55	[p2l1093t2324r1583b2402],
6	—	NN	O	—	nn	8	SENT_55	[p2l1093t2324r1583b2402],
7	survival	NN	O	survival	nn	8	SENT_55	[p2l1093t2324r1583b2402],
8	signals	NNS	O	signal	prep_of	1	SENT_55	[p2l1607t2319r1961b2423],
9	.5	CD	NUMBER	.5	npadvmod	23	SENT_55	[p2l1607t2319r1961b2423],
10	Despite	IN	O	despite	_	0	SENT_55	[p2l1987t2330r2133b2401, p2l12t2452r206b2552],
11	its	PRP$	O	its	poss	13	SENT_55	[p2l237t2452r333b2530],
12	ubiquitous	JJ	O	ubiquitous	amod	13	SENT_55	[p2l366t2452r819b2552],
13	expression	NN	O	expression	prep_despite	23	SENT_55	[p2l853t2452r1331b2552],
14	,	,	O	,	_	0	SENT_55	[p2l853t2452r1331b2552],
15	inactivation	NN	O	inactivation	nsubj	23	SENT_55	[p2l1367t2452r1860b2531],
16	of	IN	O	of	_	0	SENT_55	[p2l1892t2451r1992b2530],
17	the	DT	O	the	det	19	SENT_55	[p2l2005t2451r2135b2530],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_55	[p2l8t2586r221b2659],
19	gene	NN	O	gene	prep_of	15	SENT_55	[p2l238t2604r437b2679],
20	in	IN	O	in	_	0	SENT_55	[p2l461t2580r542b2656],
21	the	DT	O	the	det	22	SENT_55	[p2l567t2579r696b2657],
22	mouse	NN	O	mouse	prep_in	19	SENT_55	[p2l721t2604r1001b2658],
23	causes	VBZ	O	cause	_	0	SENT_55	[p2l1026t2605r1299b2658],
24	minimal	JJ	O	minimal	amod	25	SENT_55	[p2l1324t2579r1683b2657],
25	defects	NNS	O	defect	nsubj	28	SENT_55	[p2l1707t2572r2134b2674],
26	,6	CD	NUMBER	,6	npadvmod	27	SENT_55	[p2l1707t2572r2134b2674],
27	>	JJR	O	>	dep	28	SENT_55	[p2l1707t2572r2134b2674],
28	7	CD	NUMBER	7	xcomp	23	SENT_55	[p2l1707t2572r2134b2674],
29	suggesting	VBG	O	suggest	partmod	28	SENT_55	[p2l12t2708r476b2808],
30	that	IN	O	that	complm	38	SENT_55	[p2l496t2708r662b2786],
31	pharmacologic	JJ	O	pharmacologic	amod	32	SENT_55	[p2l679t2708r1317b2808],
32	inhibition	NN	O	inhibition	nsubj	38	SENT_55	[p2l1338t2707r1759b2786],
33	of	IN	O	of	_	0	SENT_55	[p2l1782t2707r1883b2786],
34	EGFR	NN	ORGANIZATION	egfr	prep_of	32	SENT_55	[p2l1886t2713r2145b2791],
35	by	IN	O	by	_	0	SENT_55	[p2l11t2836r108b2936],
36	geﬁtinib	NN	O	geﬁtinib	prep_by	34	SENT_55	[p2l128t2835r482b2936],
37	should	MD	O	should	aux	38	SENT_55	[p2l511t2836r798b2915],
38	have	VB	O	have	ccomp	29	SENT_55	[p2l823t2836r1011b2915],
39	few	JJ	O	few	amod	41	SENT_55	[p2l1036t2835r1188b2915],
40	adverse	JJ	O	adverse	amod	41	SENT_55	[p2l1208t2836r1521b2915],
41	effects	NNS	O	effect	dobj	38	SENT_55	[p2l1547t2835r1843b2914],
42	.	.	O	.	_	0	SENT_55	[p2l1547t2835r1843b2914],

1	Geﬁtinib	NN	O	geﬁtinib	nsubj	2	SENT_56	[p2l139t2963r521b3042],
2	inhibits	VBZ	O	inhibit	_	0	SENT_56	[p2l557t2964r886b3042],
3	the	DT	O	the	det	4	SENT_56	[p2l924t2963r1055b3042],
4	growth	NN	O	growth	dobj	2	SENT_56	[p2l1091t2963r1400b3064],
5	of	IN	O	of	_	0	SENT_56	[p2l1436t2963r1538b3042],
6	some	DT	O	some	det	9	SENT_56	[p2l1557t2989r1784b3042],
7	cancerderived	JJ	O	cancerderived	amod	9	SENT_56	[p2l1821t2989r2132b3042, p2l11t3092r322b3171],
8	cell	NN	O	cell	nn	9	SENT_56	[p2l357t3092r501b3170],
9	lines	NNS	O	line	prep_of	4	SENT_56	[p2l533t3091r734b3170],
10	and	CC	O	and	_	0	SENT_56	[p2l768t3092r924b3170],
11	tumor	NN	O	tumor	nn	12	SENT_56	[p2l956t3108r1219b3171],
12	Xenografts	NNS	O	xenograft	prep_of	4	SENT_56	[p2l1244t3091r1717b3192],
13	,	,	O	,	_	0	SENT_56	[p2l1244t3091r1717b3192],
14	although	IN	O	although	mark	20	SENT_56	[p2l1754t3091r2135b3192],
15	this	DT	O	this	det	16	SENT_56	[p2l11t3220r163b3298],
16	effect	NN	O	effect	nsubjpass	20	SENT_56	[p2l190t3219r424b3298],
17	is	VBZ	O	be	auxpass	20	SENT_56	[p2l442t3220r507b3298],
18	not	RB	O	not	neg	20	SENT_56	[p2l532t3236r676b3298],
19	well	RB	O	well	advmod	20	SENT_56	[p2l690t3219r865b3299],
20	correlated	VBN	O	correlate	advcl	2	SENT_56	[p2l889t3220r1310b3298],
21	with	IN	O	with	_	0	SENT_56	[p2l1330t3220r1519b3299],
22	the	DT	O	the	det	23	SENT_56	[p2l1544t3219r1672b3298],
23	level	NN	O	level	prep_with	20	SENT_56	[p2l1696t3220r1882b3299],
24	of	IN	O	of	_	0	SENT_56	[p2l1906t3219r2007b3298],
25	expression	NN	O	expression	prep_of	23	SENT_56	[p2l2013t3246r2133b3298, p2l9t3348r371b3448],

1	of	IN	O	of	_	0	SENT_57	[p2l403t3347r503b3426],
2	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_57	[p2l514t3353r773b3431],
3	or	CC	O	or	_	0	SENT_57	[p2l794t3373r882b3426],
4	related	JJ	O	related	nn	5	SENT_57	[p2l910t3347r1197b3426],
5	members	NNS	O	member	pobj	1	SENT_57	[p2l1226t3348r1622b3426],
6	of	IN	O	of	_	0	SENT_57	[p2l1656t3347r1756b3426],
7	the	DT	O	the	det	9	SENT_57	[p2l1768t3348r1897b3426],
8	ErbB	NN	O	erbb	nn	9	SENT_57	[p2l1927t3347r2132b3426],
9	family	NN	O	family	prep_of	5	SENT_57	[p2l10t3474r276b3574],
10	of	IN	O	of	_	0	SENT_57	[p2l297t3474r397b3552],
11	receptors	NNS	O	receptor	prep_of	9	SENT_57	[p2l403t3470r863b3574],
12	.	.	O	.	_	0	SENT_57	[p2l403t3470r863b3574],

1	-	:	O	-	_	0	SENT_58	[p2l403t3470r863b3574],
2	°	NN	O	°	npadvmod	10	SENT_58	[p2l403t3470r863b3574],
3	’	CD	NUMBER	’	num	2	SENT_58	[p2l403t3470r863b3574],
4	In	IN	O	in	_	0	SENT_58	[p2l888t3481r975b3551],
5	initial	JJ	O	initial	amod	7	SENT_58	[p2l999t3475r1243b3552],
6	clinical	JJ	O	clinical	amod	7	SENT_58	[p2l1268t3475r1568b3552],
7	studies	NNS	O	study	prep_in	10	SENT_58	[p2l1594t3475r1913b3569],
8	,	,	O	,	_	0	SENT_58	[p2l1594t3475r1913b3569],
9	geﬁtinib	NN	O	geﬁtinib	nsubj	10	SENT_58	[p2l1944t3474r2133b3574, p2l11t3602r205b3680],
10	had	VBD	O	have	_	0	SENT_58	[p2l243t3602r401b3680],
11	minimal	JJ	O	minimal	amod	13	SENT_58	[p2l437t3602r802b3680],
12	adverse	JJ	O	adverse	amod	13	SENT_58	[p2l838t3602r1157b3681],
13	effects	NNS	O	effect	iobj	10	SENT_58	[p2l1195t3596r1656b3697],
14	,8	CD	NUMBER	,8	dobj	10	SENT_58	[p2l1195t3596r1656b3697],
15	'	''	O	'	_	0	SENT_58	[p2l1195t3596r1656b3697],
16	1	CD	NUMBER	1	num	17	SENT_58	[p2l1195t3596r1656b3697],
17	°	NN	O	°	nsubjpass	22	SENT_58	[p2l1195t3596r1656b3697],
18	but	CC	O	but	prep	17	SENT_58	[p2l1693t3602r1837b3681],
19	tumor	NN	O	tumor	nn	20	SENT_58	[p2l1869t3618r2136b3681],
20	responses	NNS	O	response	dep	18	SENT_58	[p3l10t49r428b124],
21	were	VBD	O	be	auxpass	22	SENT_58	[p3l449t50r649b103],
22	observed	VBN	O	observe	rcmod	14	SENT_58	[p3l673t24r1044b103],
23	in	IN	O	in	_	0	SENT_58	[p3l1066t24r1147b101],
24	only	RB	O	only	quantmod	27	SENT_58	[p3l1171t24r1350b124],
25	10	CD	NUMBER	10	number	27	SENT_58	[p3l1372t29r1469b102],
26	to	TO	O	to	dep	27	SENT_58	[p3l1493t40r1571b102],
27	19	CD	PERCENT	19	num	28	SENT_58	[p3l1599t29r1695b102],
28	percent	NN	PERCENT	percent	prep_in	22	SENT_58	[p3l1718t40r2035b124],
29	of	IN	O	of	_	0	SENT_58	[p3l2054t23r2154b102],
30	patients	NNS	O	patient	prep_of	28	SENT_58	[p3l9t152r351b252],
31	with	IN	O	with	_	0	SENT_58	[p3l389t151r582b231],
32	chemotherapy	NN	O	chemotherapy	prep_with	30	SENT_58	[p3l623t151r1699b252],
33	—	CD	NUMBER	—	num	37	SENT_58	[p3l623t151r1699b252],
34	refractory	JJ	O	refractory	amod	37	SENT_58	[p3l623t151r1699b252],
35	advanced	JJ	O	advanced	amod	37	SENT_58	[p3l1734t151r2134b231],
36	non	JJ	O	non	amod	37	SENT_58	[p3l10t280r649b358],
37	—	NN	O	—	tmod	22	SENT_58	[p3l10t280r649b358],
38	small	JJ	O	small	amod	42	SENT_58	[p3l10t280r649b358],
39	—	NN	O	—	nn	42	SENT_58	[p3l10t280r649b358],
40	cell	NN	O	cell	nn	42	SENT_58	[p3l10t280r649b358],
41	lung	NN	O	lung	nn	42	SENT_58	[p3l691t280r885b380],
42	cancer	NN	O	cancer	dep	37	SENT_58	[p3l927t274r1409b358],
43	.	.	O	.	_	0	SENT_58	[p3l927t274r1409b358],

1	“’	NN	O	“’	tmod	41	SENT_59	[p3l927t274r1409b358],
2	12	CD	NUMBER	12	num	1	SENT_59	[p3l927t274r1409b358],
3	The	DT	O	the	det	4	SENT_59	[p3l1450t280r1611b358],
4	addition	NN	O	addition	nsubj	10	SENT_59	[p3l1655t280r2007b358],
5	of	IN	O	of	_	0	SENT_59	[p3l2052t279r2153b358],
6	geﬁtinib	NN	O	geﬁtinib	prep_of	4	SENT_59	[p3l10t407r372b508],
7	to	TO	O	to	_	0	SENT_59	[p3l399t424r480b486],
8	traditional	JJ	O	traditional	amod	9	SENT_59	[p3l506t407r957b486],
9	chemotherapy	NN	O	chemotherapy	prep_to	6	SENT_59	[p3l983t408r1602b508],
10	provided	VBD	O	provide	rcmod	1	SENT_59	[p3l1621t407r2000b508],
11	no	DT	O	no	det	12	SENT_59	[p3l2025t433r2132b486],
12	beneﬁt	NN	O	beneﬁt	dobj	10	SENT_59	[p3l11t530r522b614],
13	.13	CD	NUMBER	.13	num	14	SENT_59	[p3l11t530r522b614],
14	’14	CD	NUMBER	’14	npadvmod	15	SENT_59	[p3l11t530r522b614],
15	Even	RB	O	even	advmod	10	SENT_59	[p3l547t543r748b615],
16	in	IN	O	in	_	0	SENT_59	[p3l775t537r855b613],
17	gliomas	NNS	O	glioma	prep_in	10	SENT_59	[p3l883t536r1243b636],
18	,	,	O	,	_	0	SENT_59	[p3l883t536r1243b636],
19	in	IN	O	in	_	0	SENT_59	[p3l1276t537r1357b613],
20	which	WDT	O	which	rel	32	SENT_59	[p3l1381t536r1641b615],
21	the	DT	O	the	det	22	SENT_59	[p3l1669t536r1798b614],
22	ﬁnding	NN	O	ﬁnding	nsubj	32	SENT_59	[p3l1826t535r2138b636],
23	of	IN	O	of	_	0	SENT_59	[p3l11t663r112b742],
24	frequent	JJ	O	frequent	amod	25	SENT_59	[p3l135t663r497b764],
25	ampliﬁcation	NN	O	ampliﬁcation	prep_of	22	SENT_59	[p3l534t663r1100b764],
26	and	CC	O	and	_	0	SENT_59	[p3l1141t664r1297b742],
27	rearrangements	NNS	O	rearrangement	prep_of	22	SENT_59	[p3l1339t680r2007b764],
28	of	IN	O	of	_	0	SENT_59	[p3l2052t663r2153b742],
29	the	DT	O	the	det	31	SENT_59	[p3l11t792r139b870],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_59	[p3l165t798r377b871],
31	gene	NN	O	gene	prep_of	25	SENT_59	[p3l397t817r596b892],
32	suggests	VBZ	O	suggest	rcmod	17	SENT_59	[p3l624t808r987b892],
33	that	IN	O	that	complm	35	SENT_59	[p3l1016t792r1183b870],
34	EGFR	NN	ORGANIZATION	egfr	nsubj	35	SENT_59	[p3l1202t797r1461b875],
35	plays	VBZ	O	play	ccomp	32	SENT_59	[p3l1476t792r1687b892],
36	an	DT	O	a	det	38	SENT_59	[p3l1715t817r1816b870],
37	important	JJ	O	important	amod	38	SENT_59	[p3l1842t792r2134b892, p3l11t936r180b998],
38	role	NN	O	role	dobj	35	SENT_59	[p3l200t920r384b1015],
39	,	,	O	,	_	0	SENT_59	[p3l200t920r384b1015],
40	geﬁtinib	NN	O	geﬁtinib	nsubj	41	SENT_59	[p3l415t919r770b1020],
41	failed	VBD	O	fail	_	0	SENT_59	[p3l795t919r1028b998],
42	to	TO	O	to	aux	43	SENT_59	[p3l1053t936r1132b998],
43	induce	VB	O	induce	xcomp	41	SENT_59	[p3l1158t920r1440b999],
44	clinically	RB	O	clinically	advmod	45	SENT_59	[p3l1466t919r1842b1020],
45	significant	JJ	O	significant	amod	46	SENT_59	[p3l1864t919r2134b1020, p3l10t1048r219b1125],
46	responses	NNS	O	response	dobj	43	SENT_59	[p3l262t1040r898b1147],
47	.15	CD	NUMBER	.15	number	48	SENT_59	[p3l262t1040r898b1147],
48	’16	CD	NUMBER	’16	num	46	SENT_59	[p3l262t1040r898b1147],
49	Despite	IN	O	despite	_	0	SENT_59	[p3l945t1048r1264b1147],
50	these	DT	O	these	det	52	SENT_59	[p3l1313t1047r1532b1125],
51	discouraging	JJ	O	discouraging	amod	52	SENT_59	[p3l1581t1047r2138b1147],
52	results	NNS	O	result	prep_despite	76	SENT_59	[p3l10t1176r321b1271],
53	,	,	O	,	_	0	SENT_59	[p3l10t1176r321b1271],
54	the	DT	O	the	det	60	SENT_59	[p3l357t1176r488b1254],
55	remarkably	RB	O	remarkably	advmod	56	SENT_59	[p3l518t1175r1009b1276],
56	rapid	JJ	O	rapid	amod	60	SENT_59	[p3l1035t1175r1258b1276],
57	and	CC	O	and	_	0	SENT_59	[p3l1288t1176r1446b1254],
58	often	RB	O	often	advmod	59	SENT_59	[p3l1477t1175r1698b1254],
59	profound	JJ	O	profound	amod	60	SENT_59	[p3l1727t1175r2134b1276],
60	response	NN	O	response	nsubj	76	SENT_59	[p3l10t1329r396b1404],
61	to	TO	O	to	_	0	SENT_59	[p3l418t1320r496b1382],
62	geﬁtinib	NN	O	geﬁtinib	prep_to	60	SENT_59	[p3l519t1303r874b1404],
63	in	IN	O	in	_	0	SENT_59	[p3l896t1304r977b1381],
64	a	DT	O	a	det	65	SENT_59	[p3l998t1330r1042b1382],
65	subgroup	NN	O	subgroup	prep_in	62	SENT_59	[p3l1064t1304r1467b1404],
66	of	IN	O	of	_	0	SENT_59	[p3l1490t1303r1590b1382],
67	patients	NNS	O	patient	prep_of	65	SENT_59	[p3l1592t1304r1926b1404],
68	with	IN	O	with	_	0	SENT_59	[p3l1945t1304r2135b1383],
69	non	JJ	O	non	amod	75	SENT_59	[p3l10t1431r642b1510],
70	—	JJ	O	—	amod	75	SENT_59	[p3l10t1431r642b1510],
71	small	JJ	O	small	amod	75	SENT_59	[p3l10t1431r642b1510],
72	—	NN	O	—	nn	75	SENT_59	[p3l10t1431r642b1510],
73	cell	NN	O	cell	nn	75	SENT_59	[p3l10t1431r642b1510],
74	lung	NN	O	lung	nn	75	SENT_59	[p3l681t1432r874b1532],
75	cancer	NN	O	cancer	prep_with	67	SENT_59	[p3l912t1457r1187b1510],
76	led	VBD	O	lead	rcmod	46	SENT_59	[p3l1222t1431r1348b1510],
77	to	TO	O	to	_	0	SENT_59	[p3l1388t1448r1467b1510],
78	its	PRP$	O	its	poss	79	SENT_59	[p3l1507t1432r1603b1510],
79	approval	NN	O	approval	prep_to	76	SENT_59	[p3l1645t1432r2010b1532],
80	as	IN	O	as	_	0	SENT_59	[p3l2048t1458r2132b1510],
81	single	JJ	O	single	amod	84	SENT_59	[p3l12t1560r493b1660],
82	—	NN	O	—	nn	84	SENT_59	[p3l12t1560r493b1660],
83	drug	NN	O	drug	nn	84	SENT_59	[p3l12t1560r493b1660],
84	therapy	NN	O	therapy	prep_as	76	SENT_59	[p3l512t1560r824b1660],
85	for	IN	O	for	_	0	SENT_59	[p3l842t1559r962b1638],
86	refractory	JJ	O	refractory	amod	88	SENT_59	[p3l982t1559r1385b1660],
87	lung	NN	O	lung	nn	88	SENT_59	[p3l1402t1560r1593b1660],
88	cancer	NN	O	cancer	prep_for	84	SENT_59	[p3l1612t1585r1899b1638],
89	.	.	O	.	_	0	SENT_59	[p3l1612t1585r1899b1638],

1	17	CD	NUMBER	17	nsubj	3	SENT_60	[p3l1909t1554r1983b1600],
2	We	PRP	O	we	nsubj	3	SENT_60	[p3l2002t1567r2135b1638],
3	evaluated	VBD	O	evaluate	_	0	SENT_60	[p3l11t1688r401b1767],
4	tumors	NNS	O	tumor	dobj	3	SENT_60	[p3l425t1704r726b1767],
5	from	IN	O	from	_	0	SENT_60	[p3l754t1687r961b1766],
6	patients	NNS	O	patient	prep_from	3	SENT_60	[p3l984t1688r1319b1788],
7	with	IN	O	with	_	0	SENT_60	[p3l1341t1688r1531b1767],
8	these	DT	O	these	det	17	SENT_60	[p3l1556t1687r1775b1766],
9	dramatic	JJ	O	dramatic	amod	17	SENT_60	[p3l1801t1687r2133b1766, p3l10t1816r79b1894],
10	responses	NNS	O	response	dep	9	SENT_60	[p3l115t1841r536b1916],
11	to	TO	O	to	aux	12	SENT_60	[p3l576t1832r655b1894],
12	determine	VB	O	determine	infmod	10	SENT_60	[p3l695t1816r1123b1894],
13	the	DT	O	the	det	16	SENT_60	[p3l1162t1815r1291b1894],
14	underlying	VBG	O	underlie	amod	16	SENT_60	[p3l1328t1815r1788b1916],
15	mecha	NN	O	mecha	nn	16	SENT_60	[p3l1822t1816r2133b1894],
16	—	NN	O	—	dobj	12	SENT_60	[p3l1822t1816r2133b1894],
17	nisms	NNS	O	nism	prep_with	3	SENT_60	[p3l10t1944r288b2021],
18	.	.	O	.	_	0	SENT_60	[p3l10t1944r288b2021],

1	METHODS	NNS	O	method	_	0	SENT_61	[p3l795t2280r1349b2340],

1	NUCLEOTIDE-SEQUENCE	JJ	O	nucleotide-sequence	amod	2	SENT_62	[p3l18t2501r1047b2566],
2	ANALYSIS	NNS	O	analysis	_	0	SENT_62	[p3l1085t2501r1488b2551],
3	OF	IN	O	of	_	0	SENT_62	[p3l11t2585r116b2636],
4	TUMOR	NN	O	tumor	nn	5	SENT_62	[p3l153t2585r458b2636],
5	SPECIMENS	NNS	O	specimen	prep_of	2	SENT_62	[p3l498t2585r980b2636],

1	Tumor	NN	O	tumor	nn	2	SENT_63	[p3l7t2691r300b2764],
2	specimens	NNS	O	specimen	nsubjpass	4	SENT_63	[p3l333t2686r780b2785],
3	were	VBD	O	be	auxpass	4	SENT_63	[p3l812t2711r1015b2764],
4	obtained	VBN	O	obtain	_	0	SENT_63	[p3l1050t2685r1424b2764],
5	during	IN	O	during	_	0	SENT_63	[p3l1459t2685r1745b2786],
6	diagnostic	JJ	O	diagnostic	amod	9	SENT_63	[p3l1777t2685r2146b2786, p3l11t2814r110b2892],
7	or	CC	O	or	_	0	SENT_63	[p3l138t2839r228b2893],
8	surgical	JJ	O	surgical	amod	9	SENT_63	[p3l254t2813r588b2915],
9	procedures	NNS	O	procedure	prep_during	4	SENT_63	[p3l613t2813r1086b2914],
10	from	IN	O	from	_	0	SENT_63	[p3l1116t2812r1324b2893],
11	patients	NNS	O	patient	prep_from	4	SENT_63	[p3l1350t2814r1687b2914],
12	With	IN	O	with	_	0	SENT_63	[p3l1712t2813r1902b2893],
13	nonsmall	JJ	O	nonsmall	amod	17	SENT_63	[p3l1930t2839r2151b2893, p3l12t2942r415b3020],
14	—	NN	O	—	nn	17	SENT_63	[p3l1930t2839r2151b2893, p3l12t2942r415b3020],
15	cell	NN	O	cell	nn	17	SENT_63	[p3l1930t2839r2151b2893, p3l12t2942r415b3020],
16	lung	NN	O	lung	nn	17	SENT_63	[p3l435t2942r628b3043],
17	cancer	NN	O	cancer	prep_with	11	SENT_63	[p3l647t2968r920b3021],
18	who	WP	O	who	nsubj	19	SENT_63	[p3l934t2942r1117b3021],
19	were	VBD	O	be	rcmod	17	SENT_63	[p3l1136t2968r1337b3021],
20	subsequently	RB	O	subsequently	advmod	19	SENT_63	[p3l1360t2942r1911b3042],
21	treat	VB	O	treat	ccomp	19	SENT_63	[p3l1929t2959r2146b3020],
22	—	CD	NUMBER	—	dobj	21	SENT_63	[p3l1929t2959r2146b3020],
23	ed	VBN	O	ed	partmod	22	SENT_63	[p3l11t3070r107b3150],
24	with	IN	O	with	_	0	SENT_63	[p3l132t3070r322b3150],
25	geﬁtinib	NN	O	geﬁtinib	prep_with	23	SENT_63	[p3l350t3069r707b3172],
26	according	VBG	O	accord	_	0	SENT_63	[p3l737t3070r1162b3172],
27	to	TO	O	to	prepc_according_to	23	SENT_63	[p3l1188t3087r1268b3150],
28	a	DT	O	a	det	29	SENT_63	[p3l1297t3097r1342b3149],
29	protocol	NN	O	protocol	pobj	23	SENT_63	[p3l1367t3070r1727b3171],
30	approved	VBN	O	approve	partmod	29	SENT_63	[p3l1755t3070r2148b3171],
31	by	IN	O	by	_	0	SENT_63	[p3l11t3198r110b3298],
32	the	DT	O	the	det	35	SENT_63	[p3l137t3198r271b3276],
33	institutional	JJ	O	institutional	amod	35	SENT_63	[p3l298t3198r817b3278],
34	review	NN	O	review	nn	35	SENT_63	[p3l845t3199r1119b3278],
35	board	NN	O	board	agent	30	SENT_63	[p3l1143t3198r1389b3277],
36	of	IN	O	of	_	0	SENT_63	[p3l1417t3197r1518b3277],
37	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	39	SENT_63	[p3l1525t3198r2145b3278],
38	General	NNP	ORGANIZATION	General	nn	39	SENT_63	[p3l10t3327r352b3406],
39	Hospital	NNP	ORGANIZATION	Hospital	prep_of	35	SENT_63	[p3l382t3327r756b3427],
40	in	IN	O	in	_	0	SENT_63	[p3l786t3328r868b3405],
41	Boston	NNP	LOCATION	Boston	prep_in	39	SENT_63	[p3l898t3333r1229b3406],
42	.	.	O	.	_	0	SENT_63	[p3l898t3333r1229b3406],

1	Frozen	JJ	O	frozen	amod	3	SENT_64	[p3l1264t3335r1564b3406],
2	tumor	NN	O	tumor	nn	3	SENT_64	[p3l1596t3344r1864b3406],
3	specimens	NNS	O	specimen	nsubj	12	SENT_64	[p3l1893t3328r2145b3427, p3l10t3482r269b3552],
4	,	,	O	,	_	0	SENT_64	[p3l1893t3328r2145b3427, p3l10t3482r269b3552],
5	along	IN	O	along	_	0	SENT_64	[p3l320t3456r566b3557],
6	with	IN	O	with	_	0	SENT_64	[p3l603t3456r797b3535],
7	matched	VBN	O	match	amod	9	SENT_64	[p3l842t3456r1216b3535],
8	normal	JJ	O	normal	amod	9	SENT_64	[p3l1261t3456r1575b3535],
9	tissue	NN	O	tissue	prep_along_with	12	SENT_64	[p3l1621t3457r1894b3552],
10	,	,	O	,	_	0	SENT_64	[p3l1621t3457r1894b3552],
11	were	VBD	O	be	cop	12	SENT_64	[p3l1940t3482r2147b3535],
12	available	JJ	O	available	_	0	SENT_64	[p3l10t3583r384b3663],
13	from	IN	O	from	_	0	SENT_64	[p3l417t3582r629b3662],
14	four	CD	NUMBER	four	num	15	SENT_64	[p3l660t3582r839b3663],
15	patients	NNS	O	patient	prep_from	12	SENT_64	[p3l865t3584r1228b3683],
16	,	,	O	,	_	0	SENT_64	[p3l865t3584r1228b3683],
17	and	CC	O	and	_	0	SENT_64	[p3l1264t3583r1420b3662],
18	parafﬁn	NN	O	parafﬁn	nsubj	20	SENT_64	[p3l1449t3582r2146b3683],
19	—	CD	NUMBER	—	num	18	SENT_64	[p3l1449t3582r2146b3683],
20	embed	VBD	O	embed	conj_and	12	SENT_64	[p3l1449t3582r2146b3683],
21	—	CD	NUMBER	—	nsubj	22	SENT_64	[p3l1449t3582r2146b3683],
22	ded	VBD	O	ded	ccomp	20	SENT_64	[p3l11t3711r163b3790],
23	material	NN	O	material	nsubjpass	25	SENT_64	[p3l196t3711r545b3789],
24	was	VBD	O	be	auxpass	25	SENT_64	[p3l573t3737r736b3791],
25	used	VBN	O	use	ccomp	22	SENT_64	[p3l771t3711r967b3791],
26	from	IN	O	from	_	0	SENT_64	[p3l1000t3710r1208b3790],
27	the	DT	O	the	det	29	SENT_64	[p3l1242t3711r1372b3789],
28	other	JJ	O	other	amod	29	SENT_64	[p3l1406t3711r1631b3790],
29	patients	NNS	O	patient	prep_from	25	SENT_64	[p3l1660t3712r2023b3811],
30	.	.	O	.	_	0	SENT_64	[p3l1660t3712r2023b3811],

1	In	IN	O	in	_	0	SENT_65	[p3l2060t3719r2148b3789],
2	addition	NN	O	addition	prep_in	50	SENT_65	[p4l10t23r388b119],
3	,	,	O	,	_	0	SENT_65	[p4l10t23r388b119],
4	specimens	NNS	O	specimen	nsubjpass	50	SENT_65	[p4l418t24r864b123],
5	from	IN	O	from	_	0	SENT_65	[p4l890t22r1098b102],
6	25	CD	NUMBER	25	num	7	SENT_65	[p4l1121t29r1220b102],
7	patients	NNS	O	patient	prep_from	4	SENT_65	[p4l1244t24r1581b123],
8	with	IN	O	with	_	0	SENT_65	[p4l1602t23r1792b103],
9	primary	JJ	O	primary	amod	11	SENT_65	[p4l1814t24r2153b123],
10	non	JJ	O	non	amod	11	SENT_65	[p4l10t152r646b231],
11	—	NN	O	—	prep_with	7	SENT_65	[p4l10t152r646b231],
12	small	JJ	O	small	amod	16	SENT_65	[p4l10t152r646b231],
13	—	NN	O	—	nn	16	SENT_65	[p4l10t152r646b231],
14	cell	NN	O	cell	nn	16	SENT_65	[p4l10t152r646b231],
15	lung	NN	O	lung	nn	16	SENT_65	[p4l678t152r873b253],
16	cancer	NN	O	cancer	dep	11	SENT_65	[p4l904t178r1181b230],
17	who	WP	O	who	nsubjpass	21	SENT_65	[p4l1208t152r1392b231],
18	had	VBD	O	have	aux	21	SENT_65	[p4l1427t152r1583b231],
19	not	RB	O	not	neg	21	SENT_65	[p4l1617t169r1761b231],
20	been	VBN	O	be	auxpass	21	SENT_65	[p4l1790t152r1991b231],
21	exposed	VBN	O	expose	rcmod	16	SENT_65	[p4l2025t178r2146b230, p4l9t280r267b381],
22	to	TO	O	to	aux	23	SENT_65	[p4l303t297r383b360],
23	geﬁtinib	VB	O	geﬁtinib	xcomp	21	SENT_65	[p4l420t279r785b382],
24	(	CD	NUMBER	(	number	25	SENT_65	[p4l827t286r958b372],
25	15	CD	NUMBER	15	dobj	23	SENT_65	[p4l827t286r958b372],
26	with	IN	O	with	_	0	SENT_65	[p4l992t280r1186b360],
27	bronchoalveolar	JJ	O	bronchoalveolar	amod	28	SENT_65	[p4l1222t280r1931b360],
28	cancer	NN	O	cancer	prep_with	25	SENT_65	[p4l1964t306r2145b359, p4l11t435r157b505],
29	,	,	O	,	_	0	SENT_65	[p4l1964t306r2145b359, p4l11t435r157b505],
30	7	CD	NUMBER	7	dobj	23	SENT_65	[p4l192t417r238b487],
31	with	IN	O	with	_	0	SENT_65	[p4l263t409r457b488],
32	adenocarcinoma	NN	O	adenocarcinoma	prep_with	30	SENT_65	[p4l484t409r1232b505],
33	,	,	O	,	_	0	SENT_65	[p4l484t409r1232b505],
34	and	CC	O	and	_	0	SENT_65	[p4l1265t409r1424b488],
35	3	CD	NUMBER	3	conj_and	25	SENT_65	[p4l1453t415r1497b488],
36	with	IN	O	with	_	0	SENT_65	[p4l1524t409r1718b488],
37	large	JJ	O	large	amod	42	SENT_65	[p4l1745t409r2147b510],
38	—	JJ	O	—	amod	42	SENT_65	[p4l1745t409r2147b510],
39	cell	NN	O	cell	nn	42	SENT_65	[p4l1745t409r2147b510],
40	lung	NN	O	lung	nn	42	SENT_65	[p4l10t537r207b638],
41	cancer	NN	O	cancer	nn	42	SENT_65	[p4l237t543r577b633],
42	)	NN	O	)	prep_with	35	SENT_65	[p4l237t543r577b633],
43	,	,	O	,	_	0	SENT_65	[p4l237t543r577b633],
44	with	IN	O	with	_	0	SENT_65	[p4l611t537r804b616],
45	matched	VBN	O	match	amod	47	SENT_65	[p4l837t537r1210b616],
46	normal	JJ	O	normal	amod	47	SENT_65	[p4l1242t537r1556b616],
47	tissues	NNS	O	tissue	prep_with	11	SENT_65	[p4l1588t538r1907b633],
48	,	,	O	,	_	0	SENT_65	[p4l1588t538r1907b633],
49	were	VBD	O	be	auxpass	50	SENT_65	[p4l1940t563r2146b616],
50	obtained	VBN	O	obtain	_	0	SENT_65	[p4l11t664r392b743],
51	from	IN	O	from	_	0	SENT_65	[p4l426t663r634b743],
52	the	DT	O	the	det	57	SENT_65	[p4l669t664r799b742],
53	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	57	SENT_65	[p4l830t664r1451b744],
54	General	NNP	ORGANIZATION	General	nn	57	SENT_65	[p4l1488t664r1823b743],
55	Hospital	NNP	ORGANIZATION	Hospital	nn	57	SENT_65	[p4l1857t665r2147b764, p4l11t792r115b870],
56	tumor	NN	O	tumor	nn	57	SENT_65	[p4l146t809r410b871],
57	bank	NN	O	bank	prep_from	50	SENT_65	[p4l438t792r671b872],
58	.	.	O	.	_	0	SENT_65	[p4l438t792r671b872],

1	For	IN	O	for	_	0	SENT_66	[p4l705t800r850b871],
2	mutational	JJ	O	mutational	amod	3	SENT_66	[p4l878t792r1345b872],
3	analysis	NN	O	analysis	nsubj	8	SENT_66	[p4l1374t792r1707b892],
4	of	IN	O	of	_	0	SENT_66	[p4l1740t791r1841b871],
5	the	DT	O	the	det	7	SENT_66	[p4l1853t792r1983b870],
6	entire	JJ	O	entire	amod	7	SENT_66	[p4l2015t818r2147b870, p4l11t922r146b1000],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	3	SENT_66	[p4l167t928r378b1002],
8	coding	VBG	O	code	prepc_for	13	SENT_66	[p4l394t921r683b1023],
9	sequence	NN	O	sequence	dobj	8	SENT_66	[p4l703t947r1109b1022],
10	,	,	O	,	_	0	SENT_66	[p4l703t947r1109b1022],
11	DNA	NN	O	dna	nsubjpass	13	SENT_66	[p4l1135t928r1347b1001],
12	was	VBD	O	be	auxpass	13	SENT_66	[p4l1361t948r1521b1001],
13	extracted	VBN	O	extract	_	0	SENT_66	[p4l1545t921r1921b1001],
14	from	IN	O	from	_	0	SENT_66	[p4l1943t920r2149b1001],
15	specimens	NNS	O	specimen	prep_from	13	SENT_66	[p4l12t1050r492b1149],
16	,	,	O	,	_	0	SENT_66	[p4l12t1050r492b1149],
17	all	DT	O	all	det	19	SENT_66	[p4l532t1049r634b1127],
18	28	CD	NUMBER	28	num	19	SENT_66	[p4l668t1055r769b1128],
19	exons	NNS	O	exon	nsubjpass	21	SENT_66	[p4l807t1075r1054b1128],
20	were	VBD	O	be	auxpass	21	SENT_66	[p4l1087t1075r1293b1129],
21	amplified	VBN	O	amplify	dep	13	SENT_66	[p4l1328t1048r1768b1149],
22	,	,	O	,	_	0	SENT_66	[p4l1328t1048r1768b1149],
23	and	CC	O	and	_	0	SENT_66	[p4l1808t1049r1966b1128],
24	uncloned	JJ	O	uncloned	amod	27	SENT_66	[p4l2001t1075r2145b1129, p4l11t1178r291b1258],
25	polymerase	NN	O	polymerase	nn	27	SENT_66	[p4l311t1178r1432b1279],
26	—	NN	O	—	nn	27	SENT_66	[p4l311t1178r1432b1279],
27	chain	NN	O	chain	tmod	35	SENT_66	[p4l311t1178r1432b1279],
28	—	CD	NUMBER	—	num	29	SENT_66	[p4l311t1178r1432b1279],
29	reaction	NN	O	reaction	dep	27	SENT_66	[p4l311t1178r1432b1279],
30	(	CD	NUMBER	(	num	33	SENT_66	[p4l1458t1184r1694b1270],
31	PCR	NN	O	pcr	nn	33	SENT_66	[p4l1458t1184r1694b1270],
32	)	NN	O	)	nn	33	SENT_66	[p4l1458t1184r1694b1270],
33	fragments	NNS	O	fragment	nsubjpass	37	SENT_66	[p4l1721t1177r2147b1280],
34	were	VBD	O	be	auxpass	35	SENT_66	[p4l6t1333r206b1386],
35	sequenced	VBN	O	sequence	conj_and	13	SENT_66	[p4l233t1307r671b1407],
36	and	CC	O	and	_	0	SENT_66	[p4l695t1307r850b1386],
37	analyzed	VBN	O	analyze	conj_and	13	SENT_66	[p4l874t1307r1237b1407],
38	in	IN	O	in	_	0	SENT_66	[p4l1261t1308r1342b1385],
39	both	CC	O	both	preconj	40	SENT_66	[p4l1367t1307r1558b1386],
40	sense	NN	O	sense	prep_in	35	SENT_66	[p4l1584t1333r1812b1385],
41	and	CC	O	and	_	0	SENT_66	[p4l1836t1307r1991b1386],
42	antisense	JJ	O	antisense	amod	43	SENT_66	[p4l2015t1333r2147b1385, p4l11t1437r297b1515],
43	directions	NNS	O	direction	prep_in	35	SENT_66	[p4l328t1436r741b1516],
44	for	IN	O	for	_	0	SENT_66	[p4l772t1435r894b1516],
45	the	DT	O	the	det	46	SENT_66	[p4l921t1436r1050b1515],
46	presence	NN	O	presence	prep_for	35	SENT_66	[p4l1078t1462r1448b1537],
47	of	IN	O	of	_	0	SENT_66	[p4l1478t1435r1578b1516],
48	heterozygous	JJ	O	heterozygous	amod	49	SENT_66	[p4l1589t1436r2147b1538],
49	mutations	NNS	O	mutation	prep_of	46	SENT_66	[p4l10t1565r479b1644],
50	.	.	O	.	_	0	SENT_66	[p4l10t1565r479b1644],

1	All	DT	O	all	det	3	SENT_67	[p4l512t1564r633b1642],
2	sequence	NN	O	sequence	nn	3	SENT_67	[p4l665t1590r1063b1664],
3	Variants	NNS	O	variant	nsubjpass	5	SENT_67	[p4l1090t1565r1430b1643],
4	were	VBD	O	be	auxpass	5	SENT_67	[p4l1459t1590r1665b1644],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_67	[p4l1697t1563r2147b1643],
6	by	IN	O	by	_	0	SENT_67	[p4l11t1692r110b1792],
7	multiple	JJ	O	multiple	amod	9	SENT_67	[p4l128t1692r480b1792],
8	independent	JJ	O	independent	amod	9	SENT_67	[p4l502t1692r1037b1792],
9	PCRampliﬁcations	NNS	O	pcrampliﬁcations	agent	5	SENT_67	[p4l1052t1691r1884b1792],
10	.	.	O	.	_	0	SENT_67	[p4l1052t1691r1884b1792],

1	Primer	NN	O	primer	nn	2	SENT_68	[p4l1910t1693r2145b1770, p4l11t1846r93b1898],
2	sequences	NNS	O	sequence	nsubjpass	7	SENT_68	[p4l118t1846r558b1920],
3	and	CC	O	and	_	0	SENT_68	[p4l586t1820r745b1899],
4	ampliﬁcation	NN	O	ampliﬁcation	nn	5	SENT_68	[p4l770t1819r1352b1920],
5	conditions	NNS	O	condition	conj_and	2	SENT_68	[p4l1379t1820r1838b1899],
6	are	VBP	O	be	auxpass	7	SENT_68	[p4l1866t1846r1995b1898],
7	explained	VBN	O	explain	_	0	SENT_68	[p4l2022t1846r2145b1898, p4l9t1949r332b2049],
8	in	IN	O	in	_	0	SENT_68	[p4l355t1950r438b2027],
9	the	DT	O	the	det	11	SENT_68	[p4l463t1949r595b2027],
10	Supplementary	NNP	O	Supplementary	nn	11	SENT_68	[p4l622t1949r1282b2049],
11	Appendix	NNP	O	Appendix	prep_in	7	SENT_68	[p4l1299t1949r1742b2049],
12	,	,	O	,	_	0	SENT_68	[p4l1299t1949r1742b2049],
13	available	JJ	O	available	acomp	7	SENT_68	[p4l1771t1949r2147b2029],
14	with	IN	O	with	_	0	SENT_68	[p4l6t2078r198b2158],
15	the	DT	O	the	det	17	SENT_68	[p4l241t2078r372b2157],
16	full	JJ	O	full	amod	17	SENT_68	[p4l415t2077r556b2158],
17	text	NN	O	text	prep_with	13	SENT_68	[p4l592t2095r743b2157],
18	of	IN	O	of	_	0	SENT_68	[p4l775t2077r874b2158],
19	this	DT	O	this	det	20	SENT_68	[p4l892t2078r1041b2157],
20	article	NN	O	article	prep_of	17	SENT_68	[p4l1078t2078r1336b2157],
21	at	IN	O	at	_	0	SENT_68	[p4l1375t2095r1455b2157],
22	WvvW.nejm.org	NNP	O	WvvW.nejm.org	prep_at	20	SENT_68	[p4l1484t2079r2142b2180],
23	.	.	O	.	_	0	SENT_68	[p4l1484t2079r2142b2180],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_69	[p4l8t2213r220b2287],
2	mutations	NNS	O	mutation	nsubjpass	10	SENT_69	[p4l233t2208r659b2286],
3	in	IN	O	in	_	0	SENT_69	[p4l681t2208r762b2285],
4	exons	NNS	O	exon	prep_in	2	SENT_69	[p4l782t2233r1021b2286],
5	19	CD	NUMBER	19	num	4	SENT_69	[p4l1046t2213r1142b2286],
6	and	CC	O	and	_	0	SENT_69	[p4l1163t2207r1317b2286],
7	21	CD	NUMBER	21	prep_in	2	SENT_69	[p4l1338t2213r1438b2285],
8	were	VBD	O	be	auxpass	10	SENT_69	[p4l1453t2233r1654b2286],
9	also	RB	O	also	advmod	10	SENT_69	[p4l1674t2207r1839b2286],
10	sought	VBN	O	seek	_	0	SENT_69	[p4l1862t2207r2153b2308],
11	in	IN	O	in	_	0	SENT_69	[p4l10t2335r92b2412],
12	primary	JJ	O	primary	amod	13	SENT_69	[p4l111t2335r450b2434],
13	tumors	NNS	O	tumor	prep_in	10	SENT_69	[p4l466t2351r769b2414],
14	of	IN	O	of	_	0	SENT_69	[p4l793t2333r894b2413],
15	the	DT	O	the	det	17	SENT_69	[p4l896t2334r1027b2412],
16	breast	NN	O	breast	nn	17	SENT_69	[p4l1048t2334r1310b2413],
17	(	NN	O	(	prep_of	13	SENT_69	[p4l1330t2340r1459b2425],
18	15	CD	NUMBER	15	num	19	SENT_69	[p4l1330t2340r1459b2425],
19	specimens	NNS	O	specimen	tmod	17	SENT_69	[p4l1484t2335r1991b2434],
20	)	RB	O	)	advmod	19	SENT_69	[p4l1484t2335r1991b2434],
21	,	,	O	,	_	0	SENT_69	[p4l1484t2335r1991b2434],
22	colon	NN	O	colon	nn	23	SENT_69	[p4l2019t2360r2147b2413, p4l10t2463r145b2542],
23	(	NN	O	(	prep_of	13	SENT_69	[p4l172t2469r301b2554],
24	20	CD	NUMBER	20	num	25	SENT_69	[p4l172t2469r301b2554],
25	specimens	NNS	O	specimen	tmod	23	SENT_69	[p4l326t2464r824b2563],
26	)	RB	O	)	advmod	25	SENT_69	[p4l326t2464r824b2563],
27	,	,	O	,	_	0	SENT_69	[p4l326t2464r824b2563],
28	kidney	NN	O	kidney	nn	29	SENT_69	[p4l851t2463r1132b2563],
29	(	NN	O	(	prep_of	13	SENT_69	[p4l1154t2469r1283b2554],
30	16	CD	NUMBER	16	num	31	SENT_69	[p4l1154t2469r1283b2554],
31	specimens	NNS	O	specimen	tmod	29	SENT_69	[p4l1308t2464r1806b2563],
32	)	RB	O	)	advmod	31	SENT_69	[p4l1308t2464r1806b2563],
33	,	,	O	,	_	0	SENT_69	[p4l1308t2464r1806b2563],
34	pancreas	NN	O	pancreas	prep_of	13	SENT_69	[p4l1832t2489r2147b2563, p4l10t2618r96b2670],
35	(	CD	NUMBER	(	number	36	SENT_69	[p4l129t2598r260b2683],
36	40	CD	NUMBER	40	num	37	SENT_69	[p4l129t2598r260b2683],
37	specimens	NNS	O	specimen	dep	34	SENT_69	[p4l289t2593r796b2692],
38	)	RB	O	)	advmod	37	SENT_69	[p4l289t2593r796b2692],
39	,	,	O	,	_	0	SENT_69	[p4l289t2593r796b2692],
40	and	CC	O	and	_	0	SENT_69	[p4l828t2592r985b2671],
41	brain	NN	O	brain	nn	42	SENT_69	[p4l1012t2592r1233b2671],
42	(	NN	O	(	prep_of	13	SENT_69	[p4l1265t2598r1343b2683],
43	4	CD	NUMBER	4	num	44	SENT_69	[p4l1265t2598r1343b2683],
44	specimens	NNS	O	specimen	tmod	42	SENT_69	[p4l1371t2593r1878b2692],
45	)	RB	O	)	advmod	44	SENT_69	[p4l1371t2593r1878b2692],
46	,	,	O	,	_	0	SENT_69	[p4l1371t2593r1878b2692],
47	along	IN	O	along	_	0	SENT_69	[p4l1910t2592r2152b2693],
48	with	IN	O	with	_	0	SENT_69	[p4l6t2719r199b2799],
49	a	DT	O	a	det	50	SENT_69	[p4l228t2745r272b2797],
50	panel	NN	O	panel	prep_along_with	13	SENT_69	[p4l297t2719r530b2819],
51	of	IN	O	of	_	0	SENT_69	[p4l557t2718r658b2798],
52	108	CD	NUMBER	108	num	54	SENT_69	[p4l670t2725r820b2798],
53	cancer	NN	O	cancer	nn	54	SENT_69	[p4l850t2719r1471b2799],
54	—	NN	O	—	prep_of	50	SENT_69	[p4l850t2719r1471b2799],
55	derived	VBN	O	derive	partmod	54	SENT_69	[p4l850t2719r1471b2799],
56	cell	NN	O	cell	nn	57	SENT_69	[p4l1499t2719r1641b2797],
57	lines	NNS	O	line	dobj	55	SENT_69	[p4l1666t2719r1865b2797],
58	representing	VBG	O	represent	xcomp	55	SENT_69	[p4l1894t2745r2147b2819, p4l12t2849r328b2949],
59	diverse	JJ	O	diverse	amod	61	SENT_69	[p4l358t2848r652b2927],
60	histologic	JJ	O	histologic	amod	61	SENT_69	[p4l684t2848r1106b2949],
61	types	NNS	O	type	nsubj	62	SENT_69	[p4l1138t2865r1351b2948],
62	(	VBP	O	(	ccomp	58	SENT_69	[p4l1389t2848r1647b2939],
63	listed	VBN	O	list	dep	62	SENT_69	[p4l1389t2848r1647b2939],
64	in	IN	O	in	_	0	SENT_69	[p4l1678t2849r1760b2926],
65	the	DT	O	the	det	68	SENT_69	[p4l1792t2848r1922b2926],
66	Supplementary	NNP	O	Supplementary	nn	68	SENT_69	[p4l1956t2854r2147b2948, p4l9t2976r494b3076],
67	Appendix	NNP	O	Appendix	nn	68	SENT_69	[p4l511t2976r981b3076],
68	)	NN	O	)	prep_in	63	SENT_69	[p4l511t2976r981b3076],
69	.	.	O	.	_	0	SENT_69	[p4l511t2976r981b3076],

1	FUNCTIONAL	JJ	O	functional	amod	2	SENT_70	[p4l15t3261r563b3312],
2	ANALYSIS	NNS	O	analysis	_	0	SENT_70	[p4l599t3261r1003b3312],
3	OF	IN	O	of	_	0	SENT_70	[p4l1043t3261r1148b3312],
4	MUTANT	JJ	O	mutant	amod	6	SENT_70	[p4l1195t3262r1543b3312],
5	EGFR	NN	O	egfr	nn	6	SENT_70	[p4l1582t3261r1790b3312],
6	CONSTRUCTS	NNS	O	construct	prep_of	2	SENT_70	[p4l11t3346r563b3397],

1	The	DT	O	the	det	2	SENT_71	[p4l7t3457r170b3535],
2	L858R	NN	O	l858r	_	0	SENT_71	[p4l193t3463r480b3540],
3	and	CC	O	and	_	0	SENT_71	[p4l494t3457r650b3536],
4	delL747	NN	O	dell747	conj_and	2	SENT_71	[p4l677t3457r1460b3536],
5	.	.	O	.	_	0	SENT_71	[p4l677t3457r1460b3536],

1	—	NN	O	—	_	0	SENT_72	[p4l677t3457r1460b3536],
2	.	.	O	.	_	0	SENT_72	[p4l677t3457r1460b3536],

1	P753insS	NN	O	p753inss	nn	2	SENT_73	[p4l677t3457r1460b3536],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_73	[p4l1488t3458r1921b3536],
3	were	VBD	O	be	auxpass	4	SENT_73	[p4l1944t3483r2148b3536],
4	introduced	VBN	O	introduce	_	0	SENT_73	[p4l10t3585r481b3665],
5	into	IN	O	into	_	0	SENT_73	[p4l526t3586r696b3665],
6	the	DT	O	the	det	12	SENT_73	[p4l744t3585r876b3664],
7	full	JJ	O	full	amod	12	SENT_73	[p4l921t3584r1382b3687],
8	—	NN	O	—	nn	12	SENT_73	[p4l921t3584r1382b3687],
9	length	NN	O	length	nn	12	SENT_73	[p4l921t3584r1382b3687],
10	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_73	[p4l1426t3592r1643b3666],
11	coding	VBG	O	code	amod	12	SENT_73	[p4l1683t3585r1982b3687],
12	sequence	NN	O	sequence	prep_into	4	SENT_73	[p4l2026t3612r2145b3664, p5l11t47r317b122],

1	with	IN	O	with	_	0	SENT_74	[p5l352t21r544b101],
2	the	DT	O	the	det	3	SENT_74	[p5l581t21r711b100],
3	use	NN	O	use	pobj	1	SENT_74	[p5l748t48r889b101],
4	of	IN	O	of	_	0	SENT_74	[p5l926t20r1028b101],
5	site-directed	JJ	O	site-directed	amod	6	SENT_74	[p5l1047t21r1571b101],
6	mutagenesis	NN	O	mutagenesis	prep_of	3	SENT_74	[p5l1608t22r2145b123],
7	and	CC	O	and	_	0	SENT_74	[p5l10t150r165b229],
8	inserted	VBN	O	insert	conj_and	1	SENT_74	[p5l190t150r527b229],
9	into	IN	O	into	_	0	SENT_74	[p5l553t151r717b229],
10	a	DT	O	a	det	14	SENT_74	[p5l745t176r789b228],
11	cytomegalovirus	NN	O	cytomegalovirus	nn	14	SENT_74	[p5l816t150r1496b251],
12	promoter	NN	O	promoter	nn	14	SENT_74	[p5l1523t150r2147b250],
13	—	CD	NUMBER	—	num	14	SENT_74	[p5l1523t150r2147b250],
14	driv	NN	O	driv	prep_into	8	SENT_74	[p5l1523t150r2147b250],
15	—	CD	NUMBER	—	dep	14	SENT_74	[p5l1523t150r2147b250],
16	en	IN	O	en	_	0	SENT_74	[p5l11t304r110b356],
17	expression	NN	O	expression	nn	18	SENT_74	[p5l154t279r619b378],
18	construct	NN	O	construct	prep_en	15	SENT_74	[p5l662t294r1073b357],
19	(	CD	NUMBER	(	num	20	SENT_74	[p5l1114t284r1407b378],
20	pUSE	NN	O	puse	dep	8	SENT_74	[p5l1114t284r1407b378],
21	,	,	O	,	_	0	SENT_74	[p5l1114t284r1407b378],
22	Upstate	JJ	O	upstate	amod	23	SENT_74	[p5l1454t284r1848b378],
23	)	NN	O	)	appos	20	SENT_74	[p5l1454t284r1848b378],
24	.	.	O	.	_	0	SENT_74	[p5l1454t284r1848b378],

1	Cos	NNP	O	Cos	nsubj	39	SENT_75	[p5l1896t284r2146b357],
2	—	CD	NUMBER	—	number	3	SENT_75	[p5l1896t284r2146b357],
3	7	CD	NUMBER	7	num	4	SENT_75	[p5l1896t284r2146b357],
4	cells	NNS	O	cell	nsubjpass	24	SENT_75	[p5l11t406r199b484],
5	were	VBD	O	be	auxpass	6	SENT_75	[p5l224t432r426b486],
6	transfected	VBN	O	transfect	rcmod	1	SENT_75	[p5l450t405r908b485],
7	(	NN	O	(	nn	8	SENT_75	[p5l936t405r1563b506],
8	Lipofectamine	NN	O	lipofectamine	dobj	6	SENT_75	[p5l936t405r1563b506],
9	2000	CD	DATE	2000	dep	8	SENT_75	[p5l1587t412r1813b502],
10	,	,	O	,	_	0	SENT_75	[p5l1587t412r1813b502],
11	InVitro	NNP	ORGANIZATION	InVitro	appos	8	SENT_75	[p5l1841t407r2148b485],
12	—	CD	NUMBER	—	num	14	SENT_75	[p5l1841t407r2148b485],
13	gen	NN	O	gen	nn	14	SENT_75	[p5l10t542r191b637],
14	)	NN	O	)	dep	11	SENT_75	[p5l10t542r191b637],
15	with	IN	O	with	_	0	SENT_75	[p5l213t535r401b615],
16	1	CD	NUMBER	1	num	17	SENT_75	[p5l425t541r470b613],
17	pg	NN	O	pg	prep_with	6	SENT_75	[p5l493t561r592b637],
18	of	IN	O	of	_	0	SENT_75	[p5l611t534r711b615],
19	the	DT	O	the	det	21	SENT_75	[p5l713t535r842b614],
20	expression	NN	O	expression	nn	21	SENT_75	[p5l864t536r1312b636],
21	constructs	NNS	O	construct	prep_of	17	SENT_75	[p5l1334t552r1764b615],
22	and	CC	O	and	_	0	SENT_75	[p5l1787t535r1942b615],
23	then	RB	O	then	advmod	24	SENT_75	[p5l1963t535r2149b614],
24	replated	VBN	O	replate	conj_and	6	SENT_75	[p5l10t664r352b764],
25	18	CD	DATE	18	num	26	SENT_75	[p5l381t670r477b743],
26	hours	NNS	DATE	hour	npadvmod	27	SENT_75	[p5l507t664r750b743],
27	later	RB	DATE	later	advmod	24	SENT_75	[p5l778t664r968b742],
28	at	IN	O	at	_	0	SENT_75	[p5l991t681r1071b742],
29	a	DT	O	a	det	30	SENT_75	[p5l1093t690r1138b742],
30	concentration	NN	O	concentration	prep_at	24	SENT_75	[p5l1164t665r1754b743],
31	of	IN	O	of	_	0	SENT_75	[p5l1782t663r1883b743],
32	5x104	NN	O	5x104	nn	33	SENT_75	[p5l1894t659r2148b743],
33	cells	NNS	O	cell	prep_of	30	SENT_75	[p5l11t793r193b871],
34	per	IN	O	per	prep	33	SENT_75	[p5l216t819r354b893],
35	well	RB	O	well	pcomp	34	SENT_75	[p5l369t793r541b873],
36	in	IN	O	in	_	0	SENT_75	[p5l563t794r643b871],
37	12-well	JJ	O	12-well	amod	38	SENT_75	[p5l669t793r971b873],
38	plates	NNS	O	plate	prep_in	24	SENT_75	[p5l991t793r1233b893],
39	(	VBP	O	(	_	0	SENT_75	[p5l1262t799r1591b884],
40	Costar	NN	O	costar	nn	41	SENT_75	[p5l1262t799r1591b884],
41	)	NN	O	)	dobj	39	SENT_75	[p5l1262t799r1591b884],
42	with	IN	O	with	_	0	SENT_75	[p5l1614t793r1801b872],
43	Dulbec	JJ	O	dulbec	amod	44	SENT_75	[p5l1822t793r2148b872],
44	—	NN	O	—	prep_with	39	SENT_75	[p5l1822t793r2148b872],

1	2130	CD	DATE	2130	num	3	SENT_76	[p5l149t968r226b990],
2	N	NN	O	n	nn	3	SENT_76	[p5l908t970r922b985],
3	ENGLJ	NN	O	englj	_	0	SENT_76	[p5l937t969r1021b991],
4	MED	VBD	O	med	partmod	3	SENT_76	[p5l1036t970r1089b985],
5	35o	CD	NUMBER	35o	dobj	4	SENT_76	[p5l1101t969r1180b991],
6	;	:	O	;	_	0	SENT_76	[p5l1101t969r1180b991],
7	21	CD	NUMBER	21	dep	3	SENT_76	[p5l1101t969r1180b991],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_76	[p5l1217t969r1429b991],
9	MAY	NNP	DATE	MAY	dep	7	SENT_76	[p5l1468t969r1519b985],
10	20	CD	DATE	20	num	9	SENT_76	[p5l1531t969r1570b989],
11	,	,	DATE	,	_	0	SENT_76	[p5l1531t969r1570b989],
12	2004	CD	DATE	2004	num	9	SENT_76	[p5l1583t969r1651b991],

1	The	DT	O	the	det	4	SENT_77	[p5l936t1002r987b1026],
2	New	NNP	O	New	nn	4	SENT_77	[p5l996t1003r1058b1026],
3	England	NNP	O	England	nn	4	SENT_77	[p5l1067t1002r1178b1033],
4	Journal	NNP	O	Journal	_	0	SENT_77	[p5l1187t1002r1284b1026],
5	of	IN	O	of	_	0	SENT_77	[p5l1294t1002r1323b1026],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_77	[p5l1330t1002r1455b1026],

1	M	NN	O	m	nn	5	SENT_78	[p5l588t1190r613b1209],
2	U	NN	O	u	nn	5	SENT_78	[p5l618t1190r639b1209],
3	T	NN	O	t	nn	5	SENT_78	[p5l642t1190r660b1209],
4	A	NN	O	a	nn	5	SENT_78	[p5l662t1190r682b1209],
5	T	NN	O	t	nsubj	11	SENT_78	[p5l684t1190r702b1209],
6	I	PRP	O	I	nsubj	7	SENT_78	[p5l706t1190r716b1209],
7	O	VBP	O	o	rcmod	5	SENT_78	[p5l721t1190r741b1209],
8	N	NN	O	n	nn	9	SENT_78	[p5l747t1190r769b1209],
9	S	NN	O	s	nsubj	10	SENT_78	[p5l775t1190r788b1209],
10	I	PRP	O	I	xcomp	7	SENT_78	[p5l803t1190r812b1209],
11	N	NN	O	n	_	0	SENT_78	[p5l819t1190r841b1209],
12	E	NN	O	e	nn	15	SENT_78	[p5l857t1190r873b1209],
13	G	NN	O	g	nn	15	SENT_78	[p5l877t1190r898b1209],
14	F	NN	O	f	nn	15	SENT_78	[p5l903t1190r918b1209],
15	R	NN	O	r	dobj	11	SENT_78	[p5l923t1190r943b1209],
16	I	PRP	O	I	dep	15	SENT_78	[p5l956t1190r966b1209],
17	N	NN	O	n	prep	16	SENT_78	[p5l972t1190r994b1209],
18	N	NN	O	n	dep	17	SENT_78	[p5l1010t1190r1032b1209],
19	ON	IN	O	on	prep	15	SENT_78	[p5l1038t1190r1230b1209],
20	.	.	O	.	_	0	SENT_78	[p5l1038t1190r1230b1209],

1	—	NN	O	—	_	0	SENT_79	[p5l1038t1190r1230b1209],
2	.	.	O	.	_	0	SENT_79	[p5l1038t1190r1230b1209],

1	SMALL	NNP	O	SMALL	_	0	SENT_80	[p5l1038t1190r1230b1209],
2	-	:	O	-	_	0	SENT_80	[p5l1038t1190r1230b1209],
3	CCCCCCCCCCCC	NN	O	cccccccccccc	nn	4	SENT_80	[p5l1235t1190r1525b1209],
4	ER	NN	O	er	dep	1	SENT_80	[p5l1530t1190r1572b1209],

1	co	NN	O	co	_	0	SENT_81	[p5l11t1409r175b1482],
2	’s	POS	O	’s	possessive	1	SENT_81	[p5l11t1409r175b1482],
3	minimal	JJ	O	minimal	amod	1	SENT_81	[p5l207t1404r571b1482],
4	essential	JJ	O	essential	amod	1	SENT_81	[p5l602t1403r975b1482],
5	medium	NN	O	medium	amod	1	SENT_81	[p5l1004t1404r1364b1483],
6	without	IN	O	without	_	0	SENT_81	[p5l1388t1404r1730b1483],
7	fetal	JJ	O	fetal	amod	10	SENT_81	[p5l1754t1403r2153b1482],
8	—	NN	O	—	nn	10	SENT_81	[p5l1754t1403r2153b1482],
9	calf	NN	O	calf	nn	10	SENT_81	[p5l1754t1403r2153b1482],
10	serum	NN	O	serum	prep_without	5	SENT_81	[p5l12t1557r303b1609],
11	.	.	O	.	_	0	SENT_81	[p5l12t1557r303b1609],

1	After	IN	O	after	_	0	SENT_82	[p5l344t1530r561b1608],
2	16	CD	DURATION	16	num	3	SENT_82	[p5l599t1536r698b1609],
3	hours	NNS	NUMBER	hour	prep_after	10	SENT_82	[p5l736t1531r982b1609],
4	of	IN	O	of	_	0	SENT_82	[p5l1022t1530r1124b1609],
5	serum	NN	O	serum	nn	6	SENT_82	[p5l1145t1557r1411b1609],
6	starvation	NN	O	starvation	prep_of	3	SENT_82	[p5l1451t1531r1901b1625],
7	,	,	O	,	_	0	SENT_82	[p5l1451t1531r1901b1625],
8	cells	NNS	O	cell	nsubjpass	10	SENT_82	[p5l1945t1531r2132b1608],
9	were	VBD	O	be	auxpass	10	SENT_82	[p5l6t1685r204b1738],
10	stimulated	VBN	O	stimulate	_	0	SENT_82	[p5l225t1659r660b1738],
11	with	IN	O	with	_	0	SENT_82	[p5l674t1659r859b1738],
12	10	CD	NUMBER	10	num	13	SENT_82	[p5l882t1664r978b1737],
13	ng	NN	O	ng	prep_with	10	SENT_82	[p5l997t1684r1107b1759],
14	of	IN	O	of	_	0	SENT_82	[p5l1123t1658r1222b1737],
15	EGF	NN	ORGANIZATION	egf	prep_of	13	SENT_82	[p5l1221t1664r1400b1737],
16	per	IN	O	per	_	0	SENT_82	[p5l1419t1685r1556b1759],
17	milliliter	NN	O	milliliter	nn	20	SENT_82	[p5l1571t1658r1927b1737],
18	(	CD	NUMBER	(	num	20	SENT_82	[p5l1948t1659r2135b1759, p5l11t1793r201b1878],
19	Sigma	NNP	O	Sigma	nn	20	SENT_82	[p5l1948t1659r2135b1759, p5l11t1793r201b1878],
20	)	NN	O	)	prep_per	15	SENT_82	[p5l1948t1659r2135b1759, p5l11t1793r201b1878],
21	.	.	O	.	_	0	SENT_82	[p5l1948t1659r2135b1759, p5l11t1793r201b1878],

1	To	TO	O	to	aux	2	SENT_83	[p5l235t1792r341b1865],
2	determine	VB	O	determine	purpcl	15	SENT_83	[p5l375t1787r812b1865],
3	whether	IN	O	whether	complm	8	SENT_83	[p5l839t1787r1197b1866],
4	the	DT	O	the	det	6	SENT_83	[p5l1226t1786r1357b1865],
5	mutant	JJ	O	mutant	amod	6	SENT_83	[p5l1389t1803r1707b1866],
6	receptors	NNS	O	receptor	nsubjpass	8	SENT_83	[p5l1734t1803r2132b1887],
7	were	VBD	O	be	auxpass	8	SENT_83	[p5l6t1941r211b1994],
8	inhibited	VBN	O	inhibit	ccomp	2	SENT_83	[p5l243t1914r628b1993],
9	by	IN	O	by	_	0	SENT_83	[p5l658t1915r755b2015],
10	geﬁtinib	NN	O	geﬁtinib	agent	8	SENT_83	[p5l780t1914r1160b2015],
11	,	,	O	,	_	0	SENT_83	[p5l780t1914r1160b2015],
12	the	DT	O	the	det	13	SENT_83	[p5l1196t1915r1325b1993],
13	drug	NN	O	drug	nsubjpass	15	SENT_83	[p5l1356t1914r1556b2015],
14	was	VBD	O	be	auxpass	15	SENT_83	[p5l1577t1941r1739b1994],
15	added	VBN	O	add	_	0	SENT_83	[p5l1770t1914r2024b1993],
16	to	TO	O	to	_	0	SENT_83	[p5l2055t1931r2134b1993],
17	the	DT	O	the	det	19	SENT_83	[p5l11t2043r139b2121],
18	culture	NN	O	culture	nn	19	SENT_83	[p5l166t2042r451b2122],
19	medium	NN	O	medium	prep_to	15	SENT_83	[p5l477t2043r826b2122],
20	three	CD	DURATION	three	num	21	SENT_83	[p5l851t2043r1060b2121],
21	hours	NNS	NUMBER	hour	tmod	15	SENT_83	[p5l1086t2043r1322b2122],
22	before	IN	O	before	_	0	SENT_83	[p5l1350t2042r1613b2121],
23	the	DT	O	the	det	24	SENT_83	[p5l1638t2043r1766b2121],
24	addition	NN	O	addition	prep_before	15	SENT_83	[p5l1790t2042r2136b2121],
25	of	IN	O	of	_	0	SENT_83	[p5l11t2170r111b2249],
26	100	CD	NUMBER	100	num	27	SENT_83	[p5l122t2176r272b2249],
27	ng	NN	O	ng	prep_of	24	SENT_83	[p5l300t2196r410b2271],
28	of	IN	O	of	_	0	SENT_83	[p5l436t2170r536b2249],
29	EGF	NN	O	egf	prep_of	27	SENT_83	[p5l544t2176r726b2249],
30	per	IN	O	per	_	0	SENT_83	[p5l754t2197r893b2271],
31	milliliter	NN	O	milliliter	prep_per	29	SENT_83	[p5l917t2171r1300b2249],
32	.	.	O	.	_	0	SENT_83	[p5l917t2171r1300b2249],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_84	[p5l1334t2170r1536b2249],
2	were	VBD	O	be	auxpass	3	SENT_84	[p5l1562t2197r1764b2250],
3	exposed	VBN	O	expose	_	0	SENT_84	[p5l1793t2170r2135b2271],
4	to	TO	O	to	_	0	SENT_84	[p5l11t2315r90b2377],
5	EGF	NN	O	egf	prep_to	3	SENT_84	[p5l122t2304r304b2377],
6	for	IN	O	for	_	0	SENT_84	[p5l337t2298r460b2377],
7	30	CD	DURATION	30	num	8	SENT_84	[p5l490t2304r589b2377],
8	minutes	NNS	NUMBER	minute	prep_for	5	SENT_84	[p5l623t2299r989b2378],
9	.	.	O	.	_	0	SENT_84	[p5l623t2299r989b2378],

1	Cell	NN	O	cell	nn	2	SENT_85	[p5l1027t2299r1189b2377],
2	lysates	NNS	O	lysate	nsubjpass	4	SENT_85	[p5l1220t2299r1495b2399],
3	were	VBD	O	be	auxpass	4	SENT_85	[p5l1525t2325r1726b2378],
4	prepared	VBN	O	prepare	_	0	SENT_85	[p5l1758t2298r2135b2399],
5	in	IN	O	in	_	0	SENT_85	[p5l10t2427r91b2504],
6	100	CD	NUMBER	100	num	7	SENT_85	[p5l130t2432r279b2505],
7	pl	NN	O	pl	prep_in	4	SENT_85	[p5l317t2427r387b2527],
8	of	IN	O	of	_	0	SENT_85	[p5l423t2426r522b2505],
9	Laemmli	JJ	LOCATION	laemmli	amod	11	SENT_85	[p5l538t2427r912b2505],
10	lysis	NN	O	lysis	nn	11	SENT_85	[p5l944t2427r1124b2527],
11	buffer	NN	O	buffer	prep_of	7	SENT_85	[p5l1162t2426r1435b2522],
12	,	,	O	,	_	0	SENT_85	[p5l1162t2426r1435b2522],
13	followed	VBN	O	follow	partmod	11	SENT_85	[p5l1475t2426r1843b2506],
14	by	IN	O	by	_	0	SENT_85	[p5l1878t2426r1975b2527],
15	the	DT	O	the	det	16	SENT_85	[p5l2006t2427r2135b2505],
16	resolution	NN	O	resolution	agent	13	SENT_85	[p5l11t2555r450b2634],
17	of	IN	O	of	_	0	SENT_85	[p5l486t2554r587b2633],
18	proteins	NNS	O	protein	prep_of	16	SENT_85	[p5l603t2555r958b2655],
19	on	IN	O	on	_	0	SENT_85	[p5l997t2580r1104b2633],
20	10	CD	PERCENT	10	num	23	SENT_85	[p5l1144t2560r1241b2633],
21	percent	NN	PERCENT	percent	nn	23	SENT_85	[p5l1277t2571r1603b2655],
22	sodium	NN	O	sodium	nn	23	SENT_85	[p5l1635t2555r1957b2634],
23	dodecyl	NN	O	dodecyl	prep_on	18	SENT_85	[p5l1994t2555r2133b2633, p5l11t2683r227b2783],
24	sulfate	NN	O	sulfate	nn	27	SENT_85	[p5l254t2682r1417b2783],
25	—	CD	NUMBER	—	num	27	SENT_85	[p5l254t2682r1417b2783],
26	polyacrylamide	NN	O	polyacrylamide	nn	27	SENT_85	[p5l254t2682r1417b2783],
27	—	NN	O	—	dobj	13	SENT_85	[p5l254t2682r1417b2783],
28	gel	NN	O	gel	nn	29	SENT_85	[p5l254t2682r1417b2783],
29	electrophoresis	NN	O	electrophoresis	dep	27	SENT_85	[p5l1443t2683r2130b2783],
30	,	,	O	,	_	0	SENT_85	[p5l1443t2683r2130b2783],
31	transfer	NN	O	transfer	dobj	13	SENT_85	[p5l11t2810r338b2889],
32	to	TO	O	to	_	0	SENT_85	[p5l366t2827r445b2889],
33	membranes	NNS	O	membrane	prep_to	31	SENT_85	[p5l478t2811r1005b2906],
34	,	,	O	,	_	0	SENT_85	[p5l478t2811r1005b2906],
35	and	CC	O	and	_	0	SENT_85	[p5l1042t2810r1197b2889],
36	Western	NN	MISC	western	nn	38	SENT_85	[p5l1225t2818r1575b2889],
37	blot	NN	O	blot	nn	38	SENT_85	[p5l1608t2810r1776b2889],
38	analysis	NN	O	analysis	dobj	13	SENT_85	[p5l1803t2810r2133b2911],
39	with	IN	O	with	_	0	SENT_85	[p5l6t2939r194b3018],
40	the	DT	O	the	det	41	SENT_85	[p5l216t2939r344b3017],
41	use	NN	O	use	prep_with	38	SENT_85	[p5l366t2965r504b3018],
42	of	IN	O	of	_	0	SENT_85	[p5l526t2938r626b3017],
43	an	DT	O	a	det	46	SENT_85	[p5l629t2964r729b3017],
44	enhanced	VBN	O	enhance	amod	46	SENT_85	[p5l752t2939r1152b3017],
45	chemiluminescence	NN	O	chemiluminescence	nn	46	SENT_85	[p5l1175t2939r2002b3018],
46	reagent	NN	O	reagent	prep_of	41	SENT_85	[p5l2025t2965r2135b3017, p5l10t3083r245b3167],
47	(	CD	NUMBER	(	num	49	SENT_85	[p5l273t3067r820b3158],
48	Amersham	NNP	LOCATION	Amersham	nn	49	SENT_85	[p5l273t3067r820b3158],
49	)	NN	O	)	dep	46	SENT_85	[p5l273t3067r820b3158],
50	.	.	O	.	_	0	SENT_85	[p5l273t3067r820b3158],

1	Autophosphorylation	NN	O	autophosphorylation	nsubj	17	SENT_86	[p5l851t3067r1751b3167],
2	of	IN	O	of	_	0	SENT_86	[p5l1780t3066r1880b3145],
3	EGFR	NN	ORGANIZATION	egfr	prep_of	1	SENT_86	[p5l1889t3072r2146b3150],
4	was	VBD	O	be	aux	5	SENT_86	[p5l6t3221r170b3274],
5	measured	VBN	O	measure	_	0	SENT_86	[p5l207t3194r627b3274],
6	with	IN	O	with	_	0	SENT_86	[p5l659t3195r851b3274],
7	antibody	NN	O	antibody	prep_with	5	SENT_86	[p5l886t3194r1265b3295],
8	against	IN	O	against	_	0	SENT_86	[p5l1295t3195r1611b3295],
9	phosphoty	JJ	O	phosphoty	amod	11	SENT_86	[p5l1641t3195r2133b3295],
10	—	NN	O	—	nn	11	SENT_86	[p5l1641t3195r2133b3295],
11	rosine	NN	O	rosine	prep_against	7	SENT_86	[p5l11t3323r277b3401],
12	at	IN	O	at	_	0	SENT_86	[p5l312t3339r391b3401],
13	position	NN	O	position	prep_at	5	SENT_86	[p5l416t3323r765b3423],
14	1068	CD	DATE	1068	num	13	SENT_86	[p5l801t3328r1028b3418],
15	,	,	O	,	_	0	SENT_86	[p5l801t3328r1028b3418],
16	and	CC	O	and	_	0	SENT_86	[p5l1065t3323r1220b3401],
17	standardized	JJ	O	standardized	conj_and	5	SENT_86	[p5l1254t3322r1801b3401],
18	to	TO	O	to	_	0	SENT_86	[p5l1833t3339r1912b3401],
19	total	JJ	O	total	amod	21	SENT_86	[p5l1946t3323r2136b3401],
20	protein	NN	O	protein	nn	21	SENT_86	[p5l10t3451r313b3551],
21	expression	NN	O	expression	prep_to	17	SENT_86	[p5l338t3451r810b3551],
22	,	,	O	,	_	0	SENT_86	[p5l338t3451r810b3551],
23	shown	VBN	O	show	dep	5	SENT_86	[p5l841t3451r1119b3530],
24	with	IN	O	with	_	0	SENT_86	[p5l1139t3451r1326b3530],
25	the	DT	O	the	det	26	SENT_86	[p5l1351t3451r1479b3529],
26	use	NN	O	use	prep_with	23	SENT_86	[p5l1504t3477r1642b3530],
27	of	IN	O	of	_	0	SENT_86	[p5l1668t3450r1767b3529],
28	antibody	NN	O	antibody	prep_of	26	SENT_86	[p5l1772t3451r2140b3551],
29	against	IN	O	against	_	0	SENT_86	[p5l10t3579r320b3678],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_86	[p5l335t3584r592b3661],
31	(	NN	O	(	prep_against	23	SENT_86	[p5l608t3579r991b3678],
32	working	VBG	O	work	partmod	31	SENT_86	[p5l608t3579r991b3678],
33	concentration	NN	O	concentration	dobj	32	SENT_86	[p5l1009t3579r1612b3673],
34	,	,	O	,	_	0	SENT_86	[p5l1009t3579r1612b3673],
35	1:1000	CD	NUMBER	1:1000	dobj	5	SENT_86	[p5l1643t3584r1951b3673],
36	;	:	O	;	_	0	SENT_86	[p5l1643t3584r1951b3673],
37	Cell	NN	O	cell	nn	40	SENT_86	[p5l1976t3579r2137b3656],
38	Signaling	NN	O	signaling	nn	40	SENT_86	[p5l13t3707r415b3807],
39	Technology	NN	O	technology	nn	40	SENT_86	[p5l433t3706r982b3807],
40	)	NN	O	)	dep	35	SENT_86	[p5l433t3706r982b3807],
41	.	.	O	.	_	0	SENT_86	[p5l433t3706r982b3807],

1	RESULTS	NNS	O	result	_	0	SENT_87	[p6l833t252r1313b310],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_88	[p6l11t476r400b527],
2	CHARACTERISTICS	NNS	O	characteristic	nsubjpass	26	SENT_88	[p6l438t476r1202b527],
3	OF	IN	O	of	_	0	SENT_88	[p6l1241t476r1346b527],
4	PATIENTS	NNS	O	patient	prep_of	2	SENT_88	[p6l1391t476r1785b527],
5	WITH	IN	O	with	_	0	SENT_88	[p6l8t560r223b610],
6	A	DT	O	a	det	7	SENT_88	[p6l267t560r314b609],
7	RESPONSE	NN	O	response	prep_with	2	SENT_88	[p6l356t560r787b610],
8	TO	TO	O	to	aux	10	SENT_88	[p6l825t560r930b610],
9	GEFITINIB	NNP	O	GEFITINIB	nn	10	SENT_88	[p6l973t560r1402b610],
10	Patients	NNS	O	patient	infmod	7	SENT_88	[p6l9t660r343b738],
11	with	IN	O	with	_	0	SENT_88	[p6l387t659r577b739],
12	advanced	JJ	O	advanced	amod	23	SENT_88	[p6l623t659r1041b755],
13	,	,	O	,	_	0	SENT_88	[p6l623t659r1041b755],
14	chemotherapy	NN	O	chemotherapy	dep	12	SENT_88	[p6l1093t659r2153b760],
15	—	CD	NUMBER	—	num	21	SENT_88	[p6l1093t659r2153b760],
16	refractory	JJ	O	refractory	amod	21	SENT_88	[p6l1093t659r2153b760],
17	non	JJ	O	non	amod	21	SENT_88	[p6l11t787r646b866],
18	—	NN	O	—	nn	21	SENT_88	[p6l11t787r646b866],
19	small	JJ	O	small	amod	21	SENT_88	[p6l11t787r646b866],
20	—	NN	O	—	nn	21	SENT_88	[p6l11t787r646b866],
21	cell	NN	O	cell	dep	14	SENT_88	[p6l11t787r646b866],
22	lung	NN	O	lung	nn	23	SENT_88	[p6l673t787r868b888],
23	cancer	NN	O	cancer	prep_with	10	SENT_88	[p6l894t813r1170b866],
24	have	VBP	O	have	aux	26	SENT_88	[p6l1196t787r1385b866],
25	been	VBN	O	be	auxpass	26	SENT_88	[p6l1414t787r1615b866],
26	treated	VBN	O	treat	_	0	SENT_88	[p6l1644t787r1934b866],
27	with	IN	O	with	_	0	SENT_88	[p6l1958t787r2148b866],
28	geﬁtinib	NN	O	geﬁtinib	prep_with	26	SENT_88	[p6l10t915r367b1016],
29	as	IN	O	as	_	0	SENT_88	[p6l394t942r479b994],
30	a	DT	O	a	det	32	SENT_88	[p6l506t942r551b994],
31	single	JJ	O	single	amod	32	SENT_88	[p6l577t915r829b1016],
32	agent	NN	O	agent	prep_as	26	SENT_88	[p6l855t932r1093b1016],
33	since	IN	O	since	_	0	SENT_88	[p6l1115t916r1329b994],
34	2000	CD	DATE	2000	prep_since	32	SENT_88	[p6l1356t921r1564b994],
35	at	IN	O	at	_	0	SENT_88	[p6l1589t932r1669b994],
36	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	38	SENT_88	[p6l1687t915r2147b994, p6l12t1060r200b1122],
37	General	NNP	ORGANIZATION	General	nn	38	SENT_88	[p6l226t1043r562b1122],
38	Hospital	NNP	ORGANIZATION	Hospital	prep_at	26	SENT_88	[p6l584t1043r974b1144],
39	.	.	O	.	_	0	SENT_88	[p6l584t1043r974b1144],

1	A	DT	O	a	det	2	SENT_89	[p6l1000t1051r1066b1121],
2	total	NN	O	total	nsubjpass	7	SENT_89	[p6l1087t1043r1278b1122],
3	of	IN	O	of	_	0	SENT_89	[p6l1303t1043r1404b1122],
4	275	CD	NUMBER	275	num	5	SENT_89	[p6l1409t1049r1561b1122],
5	patients	NNS	O	patient	prep_of	2	SENT_89	[p6l1587t1044r1923b1144],
6	were	VBD	O	be	auxpass	7	SENT_89	[p6l1945t1069r2148b1123],
7	treated	VBN	O	treat	_	0	SENT_89	[p6l11t1171r321b1267],
8	,	,	O	,	_	0	SENT_89	[p6l11t1171r321b1267],
9	both	DT	O	both	dep	7	SENT_89	[p6l349t1171r542b1250],
10	before	IN	O	before	_	0	SENT_89	[p6l564t1171r829b1250],
11	its	PRP$	O	its	poss	12	SENT_89	[p6l851t1172r946b1250],
12	approval	NN	O	approval	prep_before	7	SENT_89	[p6l969t1171r1333b1272],
13	on	IN	O	on	_	0	SENT_89	[p6l1354t1197r1461b1250],
14	May	NNP	DATE	May	prep_on	12	SENT_89	[p6l1479t1179r1659b1272],
15	2003	CD	DATE	2003	num	14	SENT_89	[p6l1676t1177r1879b1250],
16	by	IN	O	by	_	0	SENT_89	[p6l1905t1171r2002b1272],
17	the	DT	O	the	det	18	SENT_89	[p6l2019t1171r2148b1250],
18	Food	NNP	ORGANIZATION	Food	prep_by	14	SENT_89	[p6l9t1299r228b1378],
19	and	CC	ORGANIZATION	and	_	0	SENT_89	[p6l252t1299r411b1378],
20	Drug	NNP	ORGANIZATION	Drug	nn	21	SENT_89	[p6l435t1306r659b1400],
21	Administration	NNP	ORGANIZATION	Administration	prep_on	12	SENT_89	[p6l678t1299r1344b1378],
22	(	CD	NUMBER	(	num	23	SENT_89	[p6l1375t1306r1653b1395],
23	FDA	NNP	ORGANIZATION	FDA	dep	21	SENT_89	[p6l1375t1306r1653b1395],
24	)	CD	NUMBER	)	num	23	SENT_89	[p6l1375t1306r1653b1395],
25	,	,	O	,	_	0	SENT_89	[p6l1375t1306r1653b1395],
26	as	IN	O	as	mark	33	SENT_89	[p6l1684t1326r1770b1378],
27	part	NN	O	part	nsubj	33	SENT_89	[p6l1796t1316r1974b1400],
28	of	IN	O	of	_	0	SENT_89	[p6l1996t1299r2097b1378],
29	a	DT	O	a	det	32	SENT_89	[p6l2104t1326r2149b1378],
30	compassionate	JJ	O	compassionate	amod	32	SENT_89	[p6l11t1429r821b1529],
31	—	NN	O	—	nn	32	SENT_89	[p6l11t1429r821b1529],
32	use	NN	O	use	prep_of	27	SENT_89	[p6l11t1429r821b1529],
33	expanded	VBD	O	expand	advcl	7	SENT_89	[p6l845t1428r1549b1529],
34	—	CD	NUMBER	—	num	36	SENT_89	[p6l845t1428r1549b1529],
35	access	NN	O	access	nn	36	SENT_89	[p6l845t1428r1549b1529],
36	program	NN	O	program	dobj	33	SENT_89	[p6l1573t1454r1965b1529],
37	,	,	O	,	_	0	SENT_89	[p6l1573t1454r1965b1529],
38	and	CC	O	and	_	0	SENT_89	[p6l1993t1428r2149b1507],
39	subsequently	RB	O	subsequently	dobj	33	SENT_89	[p6l12t1556r586b1657],
40	,	,	O	,	_	0	SENT_89	[p6l12t1556r586b1657],
41	with	IN	O	with	_	0	SENT_89	[p6l612t1556r802b1635],
42	the	DT	O	the	det	43	SENT_89	[p6l827t1556r956b1635],
43	use	NN	O	use	prep_with	39	SENT_89	[p6l982t1583r1121b1635],
44	of	IN	O	of	_	0	SENT_89	[p6l1147t1556r1248b1635],
45	a	DT	O	a	det	47	SENT_89	[p6l1253t1583r1298b1635],
46	commercial	JJ	O	commercial	amod	47	SENT_89	[p6l1322t1556r1825b1635],
47	supply	NN	O	supply	prep_of	43	SENT_89	[p6l1850t1556r2143b1657],
48	.	.	O	.	_	0	SENT_89	[p6l1850t1556r2143b1657],

1	During	IN	O	during	_	0	SENT_90	[p6l9t1685r315b1785],
2	this	DT	O	this	det	3	SENT_90	[p6l346t1684r499b1763],
3	period	NN	O	period	prep_during	8	SENT_90	[p6l535t1684r834b1785],
4	,	,	O	,	_	0	SENT_90	[p6l535t1684r834b1785],
5	25	CD	NUMBER	25	num	6	SENT_90	[p6l874t1690r972b1763],
6	patients	NNS	O	patient	nsubjpass	8	SENT_90	[p6l1008t1685r1345b1785],
7	were	VBD	O	be	auxpass	8	SENT_90	[p6l1377t1711r1580b1763],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_90	[p6l1614t1684r2021b1763],
9	by	IN	O	by	_	0	SENT_90	[p6l2055t1684r2153b1785],
10	physicians	NNS	O	physician	agent	8	SENT_90	[p6l9t1812r455b1913],
11	as	IN	O	as	_	0	SENT_90	[p6l482t1839r566b1891],
12	having	VBG	O	have	prepc_as	8	SENT_90	[p6l594t1812r881b1913],
13	clinically	RB	O	clinically	advmod	14	SENT_90	[p6l904t1812r1281b1913],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_90	[p6l1304t1812r1758b1913],
15	responses	NNS	O	response	dobj	12	SENT_90	[p6l1778t1838r2147b1913, p6l11t1967r93b2019],
16	to	TO	O	to	_	0	SENT_90	[p6l120t1957r199b2019],
17	the	DT	O	the	det	18	SENT_90	[p6l224t1940r354b2019],
18	drug	NN	O	drug	prep_to	15	SENT_90	[p6l379t1940r599b2041],
19	.	.	O	.	_	0	SENT_90	[p6l379t1940r599b2041],

1	A	DT	O	a	det	4	SENT_91	[p6l625t1948r691b2018],
2	clinically	RB	O	clinically	advmod	3	SENT_91	[p6l713t1940r1090b2041],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_91	[p6l1111t1940r1565b2041],
4	response	NN	O	response	nsubjpass	6	SENT_91	[p6l1583t1966r1965b2041],
5	was	VBD	O	be	auxpass	6	SENT_91	[p6l1984t1967r2146b2020],
6	deﬁned	VBN	O	deﬁned	_	0	SENT_91	[p6l11t2068r329b2147],
7	as	IN	O	as	_	0	SENT_91	[p6l364t2095r449b2147],
8	a	DT	O	a	det	10	SENT_91	[p6l487t2095r532b2147],
9	partial	JJ	O	partial	amod	10	SENT_91	[p6l565t2068r838b2169],
10	response	NN	O	response	prep_as	6	SENT_91	[p6l874t2094r1255b2169],
11	according	VBG	O	accord	_	0	SENT_91	[p6l1292t2068r1717b2169],
12	to	TO	O	to	prepc_according_to	6	SENT_91	[p6l1750t2085r1830b2147],
13	the	DT	O	the	det	16	SENT_91	[p6l1868t2068r1998b2147],
14	response	NN	O	response	nn	16	SENT_91	[p6l2035t2094r2147b2147, p6l12t2222r308b2297],
15	evaluation	NN	O	evaluation	nn	16	SENT_91	[p6l335t2196r769b2275],
16	criteria	NNS	O	criterion	pobj	6	SENT_91	[p6l795t2197r1093b2275],
17	in	IN	O	in	_	0	SENT_91	[p6l1116t2197r1198b2274],
18	solid	JJ	O	solid	amod	19	SENT_91	[p6l1226t2196r1429b2275],
19	tumors18	NN	O	tumors18	prep_in	16	SENT_91	[p6l1455t2201r1840b2275],
20	for	IN	O	for	_	0	SENT_91	[p6l1867t2196r1991b2275],
21	patients	NNS	O	patient	prep_for	19	SENT_91	[p6l2013t2222r2146b2297, p6l11t2325r242b2403],
22	With	IN	O	with	_	0	SENT_91	[p6l267t2324r457b2403],
23	measurable	JJ	O	measurable	amod	24	SENT_91	[p6l485t2324r974b2403],
24	disease	NN	O	disease	prep_with	21	SENT_91	[p6l1003t2324r1333b2420],
25	;	:	O	;	_	0	SENT_91	[p6l1003t2324r1333b2420],
26	for	IN	O	for	_	0	SENT_91	[p6l1365t2324r1488b2403],
27	patients	NNS	O	patient	prep_for	16	SENT_91	[p6l1511t2325r1848b2425],
28	Whose	WP$	O	whose	poss	29	SENT_91	[p6l1872t2324r2148b2404],
29	tumor	NN	O	tumor	dobj	34	SENT_91	[p6l11t2469r275b2531],
30	burden	NN	O	burden	nsubjpass	34	SENT_91	[p6l299t2452r602b2531],
31	could	MD	O	could	aux	34	SENT_91	[p6l629t2452r863b2531],
32	not	RB	O	not	neg	34	SENT_91	[p6l889t2469r1033b2531],
33	be	VB	O	be	auxpass	34	SENT_91	[p6l1056t2452r1151b2531],
34	quantiﬁed	VBN	O	quantiﬁed	rcmod	27	SENT_91	[p6l1179t2452r1612b2553],
35	with	IN	O	with	_	0	SENT_91	[p6l1634t2452r1825b2531],
36	the	DT	O	the	det	37	SENT_91	[p6l1851t2452r1981b2531],
37	use	NN	O	use	prep_with	34	SENT_91	[p6l2007t2479r2148b2531],

1	Table	NNP	O	Table	_	0	SENT_92	[p7l120t31r191b56],
2	1	CD	NUMBER	1	dep	1	SENT_92	[p7l201t34r223b56],
3	.	.	O	.	_	0	SENT_92	[p7l201t34r223b56],

1	Characteristics	NNS	O	characteristic	_	0	SENT_93	[p7l233t31r435b56],
2	of	IN	O	of	_	0	SENT_93	[p7l445t31r476b56],
3	Nine	CD	NUMBER	nine	num	4	SENT_93	[p7l482t32r546b56],
4	Patients	NNS	O	patient	prep_of	1	SENT_93	[p7l557t32r665b56],
5	with	IN	O	with	_	0	SENT_93	[p7l674t31r732b56],
6	Non	NN	O	non	prep_with	1	SENT_93	[p7l744t31r954b56],
7	.	.	O	.	_	0	SENT_93	[p7l744t31r954b56],

1	—	NN	O	—	_	0	SENT_94	[p7l744t31r954b56],
2	.	.	O	.	_	0	SENT_94	[p7l744t31r954b56],

1	Small-Cell	JJ	O	small-cell	amod	2	SENT_95	[p7l744t31r954b56],
2	Lung	NN	O	lung	_	0	SENT_95	[p7l967t34r1034b64],
3	Cancer	NN	O	cancer	dep	2	SENT_95	[p7l1042t33r1137b56],
4	and	CC	O	and	_	0	SENT_95	[p7l1145t31r1194b56],
5	a	DT	O	a	det	6	SENT_95	[p7l1204t40r1218b56],
6	Response	NN	MISC	response	dep	2	SENT_95	[p7l1230t34r1360b64],
7	to	TO	MISC	to	_	0	SENT_95	[p7l1368t35r1396b56],
8	Geﬁtinib	NNP	MISC	Geﬁtinib	prep_to	2	SENT_95	[p7l1405t31r1530b57],
9	.	.	O	.	_	0	SENT_95	[p7l1405t31r1530b57],

1	Age	NN	O	age	_	0	SENT_96	[p7l344t104r396b135],
2	at	IN	O	at	dep	1	SENT_96	[p7l405t106r430b127],
3	Beginning	VBG	O	begin	pcomp	2	SENT_96	[p7l319t140r457b173],
4	No.	NN	O	no.	dobj	3	SENT_96	[p7l687t142r733b165],
5	of	IN	O	of	_	0	SENT_96	[p7l743t139r774b165],
6	Duration	NNP	O	Duration	prep_of	4	SENT_96	[p7l980t140r1098b165],

1	Patient	NN	O	patient	nn	2	SENT_97	[p7l126t178r221b202],
2	ofGeﬁtinib	NN	O	ofgeﬁtinib	_	0	SENT_97	[p7l311t177r463b202],
3	Pathological	JJ	O	pathological	amod	5	SENT_97	[p7l482t177r647b210],
4	Prior	JJ	O	prior	amod	5	SENT_97	[p7l696t178r760b202],
5	Smoking	NN	O	smoking	dep	2	SENT_97	[p7l818t177r947b210],
6	-	:	O	-	_	0	SENT_97	[p7l818t177r947b210],
7	of	IN	O	of	_	0	SENT_97	[p7l1026t177r1057b202],
8	Overall	JJ	O	overall	amod	10	SENT_97	[p7l1138t177r1235b202],
9	EGFR	NN	O	egfr	nn	10	SENT_97	[p7l1304t179r1381b202],
10	No.	NN	O	no.	prep_of	5	SENT_97	[p7l150t217r196b240],
11	.	.	O	.	_	0	SENT_97	[p7l150t217r196b240],

1	Sex	NN	O	sex	nn	3	SENT_98	[p7l246t217r294b240],
2	Therapy	NN	O	therapy	nn	3	SENT_98	[p7l331t215r442b248],
3	Type	NN	O	type	_	0	SENT_98	[p7l524t216r603b248],
4	*	CD	NUMBER	*	num	5	SENT_98	[p7l524t216r603b248],
5	Regimens	NNS	MISC	regimen	dep	3	SENT_98	[p7l661t215r794b248],
6	Statusl	NNP	MISC	Statusl	nn	8	SENT_98	[p7l832t213r932b240],
7	Therapy	NN	O	therapy	nn	8	SENT_98	[p7l983t215r1094b248],
8	Survivalzj	NNP	O	Survivalzj	dep	5	SENT_98	[p7l1123t215r1250b248],
9	:	:	O	:	_	0	SENT_98	[p7l1123t215r1250b248],
10	Mutationﬁ	NNP	O	Mutationﬁ	dep	5	SENT_98	[p7l1271t215r1412b248],
11	Response1	NN	O	response1	nn	12	SENT_98	[p7l1518t215r1669b248],
12	]	NN	O	]	dep	10	SENT_98	[p7l1518t215r1669b248],

1	yr	NN	DURATION	yr	nn	2	SENT_99	[p7l376t314r401b338],
2	mo	NN	DURATION	mo	dep	8	SENT_99	[p7l1091t314r1132b331],
3	70	CD	NUMBER	70	num	4	SENT_99	[p7l373t361r403b385],
4	BAC	NN	O	bac	dep	2	SENT_99	[p7l538t361r593b385],
5	3	CD	NUMBER	3	npadvmod	6	SENT_99	[p7l720t362r732b385],
6	Never	RB	O	never	advmod	4	SENT_99	[p7l845t362r924b385],
7	15.6	CD	NUMBER	15.6	dep	8	SENT_99	[p7l1013t362r1067b385],
8	18.8	CD	NUMBER	18.8	dep	12	SENT_99	[p7l1161t361r1214b385],
9	Yes	NNP	O	Yes	nn	10	SENT_99	[p7l1318t362r1362b385],
10	Major	NNP	O	Major	dep	8	SENT_99	[p7l1426t362r1511b392],
11	;	:	O	;	_	0	SENT_99	[p7l1426t362r1511b392],
12	improved	VBN	O	improve	_	0	SENT_99	[p7l1523t359r1650b392],
13	lung	NN	O	lung	nn	14	SENT_99	[p7l1663t359r1721b393],
14	lesions	NNS	O	lesion	dobj	12	SENT_99	[p7l1475t397r1568b422],

1	66	CD	NUMBER	66	dep	6	SENT_100	[p7l372t453r402b476],
2	BAC	NN	O	bac	dep	1	SENT_100	[p7l538t453r593b476],
3	Never	RB	O	never	rcmod	2	SENT_100	[p7l845t453r924b476],
4	>	JJR	O	>	dep	3	SENT_100	[p7l1002t453r1077b476],
5	14.0	CD	NUMBER	14.0	dep	6	SENT_100	[p7l1002t453r1077b476],
6	>	JJR	O	>	dep	11	SENT_100	[p7l1140t453r1215b476],
7	14.0	CD	NUMBER	14.0	num	9	SENT_100	[p7l1140t453r1215b476],
8	Yes	NNP	O	Yes	nn	9	SENT_100	[p7l1318t453r1362b476],
9	Major	NNP	O	Major	dep	6	SENT_100	[p7l1426t453r1511b484],
10	;	:	O	;	_	0	SENT_100	[p7l1426t453r1511b484],
11	improved	VBN	O	improve	_	0	SENT_100	[p7l1523t451r1650b484],
12	bilateral	JJ	O	bilateral	acomp	11	SENT_100	[p7l1663t451r1755b476, p7l1474t489r1494b514],

1	lung	NN	O	lung	nn	2	SENT_101	[p7l1506t489r1564b522],
2	lesions	NNS	O	lesion	_	0	SENT_101	[p7l1575t489r1668b514],

1	64	CD	NUMBER	64	num	3	SENT_102	[p7l372t545r402b568],
2	Adeno	NNP	O	Adeno	nn	3	SENT_102	[p7l520t543r608b568],
3	Never	NNP	O	Never	_	0	SENT_102	[p7l845t545r924b568],
4	9.6	CD	NUMBER	9.6	num	5	SENT_102	[p7l1019t545r1059b568],
5	12.9	CD	NUMBER	12.9	dep	3	SENT_102	[p7l1161t545r1215b568],
6	Yes	UH	O	yes	dep	7	SENT_102	[p7l1318t545r1362b568],
7	Partial	JJ	O	partial	rcmod	5	SENT_102	[p7l1426t543r1516b573],
8	;	:	O	;	_	0	SENT_102	[p7l1426t543r1516b573],
9	improved	VBN	O	improve	amod	11	SENT_102	[p7l1529t543r1656b576],
10	lung	NN	O	lung	nn	11	SENT_102	[p7l1669t543r1727b576],
11	lesions	NNS	O	lesion	dep	3	SENT_102	[p7l1475t580r1568b606],
12	and	CC	O	and	_	0	SENT_102	[p7l1579t580r1627b606],
13	softtissue	JJ	O	softtissue	dep	3	SENT_102	[p7l1639t580r1698b606, p7l1472t620r1553b643],
14	mass	NN	O	mass	dep	3	SENT_102	[p7l1565t627r1634b643],

1	81	CD	NUMBER	81	_	0	SENT_103	[p7l372t674r401b698],
2	Adeno	NNP	O	Adeno	nn	3	SENT_103	[p7l520t672r608b697],
3	Former	NNP	O	Former	dep	1	SENT_103	[p7l836t674r933b697],
4	.	.	O	.	_	0	SENT_103	[p7l1054t693r1058b697],

1	Yes	UH	O	yes	dep	2	SENT_104	[p7l1318t674r1362b697],
2	Minor	NNP	O	Minor	_	0	SENT_104	[p7l1426t674r1513b702],
3	;	:	O	;	_	0	SENT_104	[p7l1426t674r1513b702],
4	improved	VBN	O	improve	amod	6	SENT_104	[p7l1522t672r1650b705],
5	pleural	JJ	O	pleural	amod	6	SENT_104	[p7l1659t672r1749b705],
6	disease	NN	O	disease	dep	2	SENT_104	[p7l1473t710r1574b735],

1	45	CD	NUMBER	45	num	2	SENT_105	[p7l371t766r401b789],
2	Adeno	NNP	O	Adeno	nsubj	7	SENT_105	[p7l520t764r608b789],
3	Never	NNP	O	Never	dep	4	SENT_105	[p7l845t766r924b789],
4	Yes	NNP	O	Yes	dep	5	SENT_105	[p7l1318t766r1362b789],
5	Partial	JJ	O	partial	dep	7	SENT_105	[p7l1426t764r1516b794],
6	;	:	O	;	_	0	SENT_105	[p7l1426t764r1516b794],
7	improved	VBN	O	improve	_	0	SENT_105	[p7l1529t764r1656b797],
8	liver	NN	O	liver	nn	9	SENT_105	[p7l1669t764r1724b789],
9	lesions	NNS	O	lesion	dobj	7	SENT_105	[p7l1475t801r1568b827],

1	32	CD	NUMBER	32	num	2	SENT_106	[p7l372t858r402b881],
2	BAC	NN	O	bac	_	0	SENT_106	[p7l538t857r593b881],
3	Never	RB	O	never	neg	2	SENT_106	[p7l845t858r924b881],
4	.	.	O	.	_	0	SENT_106	[p7l1046t877r1050b881],

1	.	.	O	.	_	0	SENT_107	[p7l1193t877r1197b881],

1	Yes	RB	O	yes	advmod	2	SENT_108	[p7l1318t858r1362b881],
2	Major	JJ	O	major	_	0	SENT_108	[p7l1426t858r1511b889],
3	;	:	O	;	_	0	SENT_108	[p7l1426t858r1511b889],
4	improved	VBN	O	improve	amod	6	SENT_108	[p7l1523t856r1650b888],
5	lung	NN	O	lung	nn	6	SENT_108	[p7l1663t856r1721b889],
6	lesions	NNS	O	lesion	dep	2	SENT_108	[p7l1475t893r1568b918],

1	62	CD	NUMBER	62	_	0	SENT_109	[p7l372t949r402b973],
2	Adeno	NNP	O	Adeno	nn	3	SENT_109	[p7l520t947r608b972],
3	Former	NNP	O	Former	dep	1	SENT_109	[p7l836t950r933b972],
4	.	.	O	.	_	0	SENT_109	[p7l1046t968r1050b972],

1	.	.	O	.	_	0	SENT_110	[p7l1193t968r1197b972],

1	Yes	UH	O	yes	dep	2	SENT_111	[p7l1318t950r1362b972],
2	Partial	JJ	O	partial	_	0	SENT_111	[p7l1426t947r1516b977],
3	;	:	O	;	_	0	SENT_111	[p7l1426t947r1516b977],
4	improved	VBN	O	improve	amod	5	SENT_111	[p7l1529t947r1656b980],
5	liver	NN	O	liver	dobj	2	SENT_111	[p7l1669t947r1724b972],
6	and	CC	O	and	_	0	SENT_111	[p7l1474t985r1522b1010],
7	lung	NN	O	lung	nn	8	SENT_111	[p7l1534t985r1593b1018],
8	lesions	NNS	O	lesion	dobj	2	SENT_111	[p7l1603t985r1696b1010],
9	58	CD	NUMBER	58	num	11	SENT_111	[p7l372t1041r402b1064],
10	Adeno	NNP	O	Adeno	nn	11	SENT_111	[p7l520t1039r608b1064],
11	Former	NNP	O	Former	dep	8	SENT_111	[p7l836t1041r933b1064],
12	.	.	O	.	_	0	SENT_111	[p7l1045t1060r1049b1064],

1	.	.	O	.	_	0	SENT_112	[p7l1193t1060r1197b1064],

1	Yes	UH	O	yes	dep	4	SENT_113	[p7l1318t1041r1362b1064],
2	Partial	JJ	O	partial	dep	4	SENT_113	[p7l1426t1039r1516b1069],
3	;	:	O	;	_	0	SENT_113	[p7l1426t1039r1516b1069],
4	improved	VBN	O	improve	_	0	SENT_113	[p7l1529t1039r1656b1072],
5	liver	NN	O	liver	nn	6	SENT_113	[p7l1669t1039r1724b1064],
6	lesions	NNS	O	lesion	nsubj	4	SENT_113	[p7l1475t1076r1568b1102],

1	42	CD	NUMBER	42	num	2	SENT_114	[p7l371t1133r402b1155],
2	BAC	NN	O	bac	_	0	SENT_114	[p7l538t1132r593b1156],
3	Never	RB	O	never	neg	2	SENT_114	[p7l845t1133r924b1156],
4	.	.	O	.	_	0	SENT_114	[p7l1054t1152r1058b1156],

1	No	DT	O	no	det	2	SENT_115	[p7l1323t1133r1361b1156],
2	Partial	JJ	O	partial	_	0	SENT_115	[p7l1426t1131r1516b1160],
3	;	:	O	;	_	0	SENT_115	[p7l1426t1131r1516b1160],
4	improved	VBN	O	improve	amod	6	SENT_115	[p7l1529t1131r1656b1163],
5	lung	NN	O	lung	nn	6	SENT_115	[p7l1669t1131r1727b1164],
6	nodules	NNS	O	nodule	dep	2	SENT_115	[p7l1475t1168r1581b1193],

1	*	NN	O	*	nn	2	SENT_116	[p7l94t1262r109b1277],
2	Adenocarcinoma	NN	O	adenocarcinoma	nsubjpass	15	SENT_116	[p7l118t1260r351b1285],
3	(	CD	NUMBER	(	num	5	SENT_116	[p7l364t1260r470b1293],
4	Adeno	NNP	O	Adeno	nn	5	SENT_116	[p7l364t1260r470b1293],
5	)	NN	O	)	dep	2	SENT_116	[p7l364t1260r470b1293],
6	with	IN	O	with	_	0	SENT_116	[p7l482t1260r538b1285],
7	any	DT	O	any	det	8	SENT_116	[p7l549t1269r595b1293],
8	element	NN	O	element	prep_with	5	SENT_116	[p7l604t1260r714b1285],
9	ofbronchoalveolar	JJ	O	ofbronchoalveolar	amod	13	SENT_116	[p7l724t1260r980b1285],
10	carcinoma	NN	O	carcinoma	nn	13	SENT_116	[p7l989t1262r1131b1285],
11	(	NN	O	(	nn	13	SENT_116	[p7l1144t1262r1220b1293],
12	BAC	NN	O	bac	nn	13	SENT_116	[p7l1144t1262r1220b1293],
13	)	NN	O	)	dep	2	SENT_116	[p7l1144t1262r1220b1293],
14	is	VBZ	O	be	auxpass	15	SENT_116	[p7l1234t1262r1253b1285],
15	listed	VBN	O	list	_	0	SENT_116	[p7l1265t1260r1335b1285],
16	as	IN	O	as	_	0	SENT_116	[p7l1347t1269r1374b1285],
17	BAC	NN	O	bac	prep_as	15	SENT_116	[p7l1387t1262r1450b1285],
18	.	.	O	.	_	0	SENT_116	[p7l1387t1262r1450b1285],

1	1	CD	NUMBER	1	_	0	SENT_117	[p7l95t1300r110b1331],
2	'	''	O	'	_	0	SENT_117	[p7l95t1300r110b1331],
3	Smoking	VBG	O	smoke	amod	4	SENT_117	[p7l120t1297r240b1331],
4	status	NN	O	status	nsubjpass	6	SENT_117	[p7l250t1302r330b1323],
5	was	VBD	O	be	auxpass	6	SENT_117	[p7l340t1306r391b1323],
6	defined	VBN	O	define	rcmod	1	SENT_117	[p7l402t1297r501b1323],
7	as	IN	O	as	mark	13	SENT_117	[p7l513t1306r540b1323],
8	former	JJ	O	former	amod	10	SENT_117	[p7l551t1297r644b1323],
9	ifthe	JJ	O	ifthe	amod	10	SENT_117	[p7l654t1297r720b1323],
10	patient	NN	O	patient	nsubj	13	SENT_117	[p7l731t1300r824b1331],
11	had	VBD	O	have	aux	13	SENT_117	[p7l835t1297r882b1323],
12	not	RB	O	not	neg	13	SENT_117	[p7l895t1302r938b1323],
13	smoked	VBN	O	smoke	advcl	6	SENT_117	[p7l948t1297r1053b1323],
14	any	DT	O	any	det	15	SENT_117	[p7l1065t1306r1111b1331],
15	cigarettes	NNS	O	cigarette	dobj	13	SENT_117	[p7l1120t1300r1251b1331],
16	within	IN	O	within	_	0	SENT_117	[p7l1261t1297r1343b1323],
17	12	CD	DURATION	12	num	18	SENT_117	[p7l1356t1300r1385b1323],
18	months	NNS	NUMBER	month	prep_within	13	SENT_117	[p7l1397t1297r1500b1323],
19	before	IN	O	before	_	0	SENT_117	[p7l1512t1297r1595b1323],
20	entry	NN	O	entry	prep_before	13	SENT_117	[p7l1605t1302r1673b1331],
21	and	CC	O	and	_	0	SENT_117	[p7l1682t1297r1730b1323],
22	never	RB	O	never	neg	26	SENT_117	[p7l121t1343r194b1360],
23	ifthe	JJ	O	ifthe	amod	24	SENT_117	[p7l204t1334r270b1360],
24	patient	NN	O	patient	nsubj	26	SENT_117	[p7l281t1337r374b1368],
25	had	VBD	O	have	aux	26	SENT_117	[p7l385t1334r432b1360],
26	smoked	VBN	O	smoke	conj_and	6	SENT_117	[p7l444t1334r549b1360],
27	less	JJR	O	less	mwe	28	SENT_117	[p7l562t1334r611b1360],
28	than	IN	O	than	quantmod	29	SENT_117	[p7l621t1334r680b1360],
29	100	CD	NUMBER	100	num	30	SENT_117	[p7l694t1336r740b1360],
30	cigarettes	NNS	O	cigarette	dobj	26	SENT_117	[p7l750t1337r880b1368],
31	in	IN	O	in	_	0	SENT_117	[p7l892t1337r914b1360],
32	his	PRP$	O	he	amod	35	SENT_117	[p7l926t1334r963b1360],
33	or	CC	O	or	_	0	SENT_117	[p7l974t1343r1002b1360],
34	her	PRP$	O	she	conj_or	32	SENT_117	[p7l1012t1334r1054b1360],
35	lifetime	NN	O	lifetime	prep_in	26	SENT_117	[p7l1064t1334r1172b1360],
36	.	.	O	.	_	0	SENT_117	[p7l1064t1334r1172b1360],

1	:3	CD	NUMBER	:3	_	0	SENT_118	[p7l95t1374r110b1405],
2	:	:	O	:	_	0	SENT_118	[p7l95t1374r110b1405],
3	Overall	JJ	O	overall	amod	4	SENT_118	[p7l119t1371r215b1397],
4	survival	NN	O	survival	nsubjpass	6	SENT_118	[p7l227t1371r328b1397],
5	was	VBD	O	be	auxpass	6	SENT_118	[p7l339t1380r390b1397],
6	measured	VBN	O	measure	dep	1	SENT_118	[p7l402t1371r534b1397],
7	from	IN	O	from	_	0	SENT_118	[p7l545t1371r609b1397],
8	the	DT	O	the	det	11	SENT_118	[p7l619t1371r662b1397],
9	beginning	VBG	O	begin	amod	11	SENT_118	[p7l673t1371r808b1405],
10	ofgefitinib	NN	O	ofgefitinib	nn	11	SENT_118	[p7l817t1371r963b1405],
11	treatment	NN	O	treatment	prep_from	6	SENT_118	[p7l972t1376r1107b1397],
12	to	TO	O	to	_	0	SENT_118	[p7l1115t1376r1142b1397],
13	death	NN	O	death	prep_to	11	SENT_118	[p7l1152t1371r1235b1397],
14	.	.	O	.	_	0	SENT_118	[p7l1152t1371r1235b1397],

1	§	JJ	O	§	amod	2	SENT_119	[p7l94t1408r105b1442],
2	EGFR	NN	ORGANIZATION	egfr	nsubj	3	SENT_119	[p7l121t1410r196b1434],
3	denotes	VBZ	O	denote	_	0	SENT_119	[p7l206t1408r313b1434],
4	the	DT	O	the	det	9	SENT_119	[p7l323t1408r365b1434],
5	epidermal	JJ	O	epidermal	amod	9	SENT_119	[p7l375t1408r510b1442],
6	growth	NN	O	growth	nn	9	SENT_119	[p7l522t1408r614b1442],
7	factor	NN	O	factor	nn	9	SENT_119	[p7l625t1408r704b1434],
8	receptor	NN	O	receptor	nn	9	SENT_119	[p7l714t1413r826b1442],
9	gene	NN	O	gene	dobj	3	SENT_119	[p7l836t1417r907b1442],
10	.	.	O	.	_	0	SENT_119	[p7l836t1417r907b1442],

1	1	CD	NUMBER	1	number	2	SENT_120	[p7l95t1445r111b1478],
2	]	CD	NUMBER	]	num	5	SENT_120	[p7l95t1445r111b1478],
3	A	DT	O	a	det	5	SENT_120	[p7l118t1447r138b1471],
4	partial	JJ	O	partial	amod	5	SENT_120	[p7l147t1445r229b1479],
5	response	NN	O	response	nsubjpass	7	SENT_120	[p7l240t1454r363b1479],
6	was	VBD	O	be	auxpass	7	SENT_120	[p7l370t1454r421b1471],
7	evaluated	VBN	O	evaluate	_	0	SENT_120	[p7l431t1445r559b1471],
8	with	IN	O	with	_	0	SENT_120	[p7l568t1445r624b1471],
9	the	DT	O	the	det	13	SENT_120	[p7l633t1445r675b1471],
10	use	NN	O	use	nn	13	SENT_120	[p7l685t1454r730b1471],
11	ofresponse	NN	O	ofresponse	nn	13	SENT_120	[p7l738t1445r896b1479],
12	evaluation	NN	O	evaluation	nn	13	SENT_120	[p7l904t1445r1043b1471],
13	criteria	NNS	O	criterion	prep_with	7	SENT_120	[p7l1053t1448r1146b1471],
14	in	IN	O	in	_	0	SENT_120	[p7l1156t1448r1177b1471],
15	solid	JJ	O	solid	amod	16	SENT_120	[p7l1188t1445r1251b1471],
16	tumors	NNS	O	tumor	prep_in	13	SENT_120	[p7l1259t1450r1366b1475],
17	;	:	O	;	_	0	SENT_120	[p7l1259t1450r1366b1475],
18	major	JJ	O	major	amod	21	SENT_120	[p7l1377t1448r1455b1479],
19	and	CC	O	and	_	0	SENT_120	[p7l1463t1445r1511b1471],
20	minor	JJ	O	minor	conj_and	18	SENT_120	[p7l1522t1448r1603b1471],
21	responses	NNS	O	response	nsubjpass	23	SENT_120	[p7l1612t1454r1749b1479],
22	were	VBD	O	be	auxpass	23	SENT_120	[p7l118t1491r182b1508],
23	evaluated	VBN	O	evaluate	parataxis	7	SENT_120	[p7l191t1482r319b1508],
24	by	IN	O	by	_	0	SENT_120	[p7l338t1482r366b1516],
25	two	CD	NUMBER	two	num	26	SENT_120	[p7l374t1487r423b1508],
26	physicians	NNS	O	physician	agent	23	SENT_120	[p7l434t1482r574b1516],
27	in	IN	O	in	_	0	SENT_120	[p7l585t1485r606b1508],
28	patients	NNS	O	patient	prep_in	26	SENT_120	[p7l618t1485r725b1516],
29	in	IN	O	in	_	0	SENT_120	[p7l737t1485r758b1508],
30	whom	WP	O	whom	rel	36	SENT_120	[p7l768t1482r851b1508],
31	the	DT	O	the	det	32	SENT_120	[p7l861t1482r903b1508],
32	response	NN	O	response	nsubjpass	36	SENT_120	[p7l914t1491r1037b1516],
33	could	MD	O	could	aux	36	SENT_120	[p7l1046t1482r1119b1508],
34	not	RB	O	not	neg	36	SENT_120	[p7l1131t1487r1174b1508],
35	be	VB	O	be	auxpass	36	SENT_120	[p7l1184t1482r1213b1508],
36	measured	VBN	O	measure	rcmod	28	SENT_120	[p7l1224t1482r1356b1508],
37	with	IN	O	with	_	0	SENT_120	[p7l1366t1482r1422b1508],
38	the	DT	O	the	det	41	SENT_120	[p7l1432t1482r1474b1508],
39	use	NN	O	use	nn	41	SENT_120	[p7l1485t1491r1530b1508],
40	ofthese	NN	O	ofthese	nn	41	SENT_120	[p7l1539t1482r1645b1508],
41	criteria	NNS	O	criterion	prep_with	36	SENT_120	[p7l1654t1485r1755b1508],
42	.	.	O	.	_	0	SENT_120	[p7l1654t1485r1755b1508],

1	N	NN	O	n	nn	2	SENT_121	[p7l566t1624r580b1639],
2	ENGLJ	NN	O	englj	_	0	SENT_121	[p7l595t1623r679b1645],
3	MED	VBD	O	med	partmod	2	SENT_121	[p7l694t1624r747b1639],
4	35o	CD	NUMBER	35o	dobj	3	SENT_121	[p7l759t1623r837b1645],
5	;	:	O	;	_	0	SENT_121	[p7l759t1623r837b1645],
6	21	CD	NUMBER	21	num	7	SENT_121	[p7l759t1623r837b1645],
7	www.NEjM.oRG	NN	O	www.nejm.org	dep	2	SENT_121	[p7l875t1623r1086b1645],
8	MAY	NNP	DATE	MAY	dep	7	SENT_121	[p7l1126t1623r1177b1639],
9	20	CD	DATE	20	num	8	SENT_121	[p7l1189t1623r1228b1643],
10	,	,	DATE	,	_	0	SENT_121	[p7l1189t1623r1228b1643],
11	2004	CD	DATE	2004	num	8	SENT_121	[p7l1241t1623r1309b1645],
12	2131	CD	DATE	2131	dep	7	SENT_121	[p7l1990t1622r2067b1644],

1	The	DT	O	the	det	4	SENT_122	[p7l752t1720r803b1744],
2	New	NNP	O	New	nn	4	SENT_122	[p7l812t1721r874b1744],
3	England	NNP	O	England	nn	4	SENT_122	[p7l884t1720r994b1751],
4	Journal	NNP	O	Journal	_	0	SENT_122	[p7l1003t1720r1100b1744],
5	of	IN	O	of	_	0	SENT_122	[p7l1110t1720r1139b1744],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_122	[p7l1146t1720r1271b1744],

1	The	DT	O	the	det	4	SENT_123	[p7l715t1908r752b1929],
2	NEW	NNP	O	NEW	nn	4	SENT_123	[p7l764t1910r845b1929],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_123	[p7l859t1910r1034b1929],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_123	[p7l1048t1910r1214b1936],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_123	[p7l1228t1908r1444b1935],

1	of	IN	O	of	_	0	SENT_124	[p7l11t2131r112b2210],
2	these	DT	O	these	det	3	SENT_124	[p7l121t2132r341b2210],
3	criteria	NNS	O	criterion	prep_of	8	SENT_124	[p7l371t2132r690b2227],
4	,	,	O	,	_	0	SENT_124	[p7l371t2132r690b2227],
5	the	DT	O	the	det	6	SENT_124	[p7l724t2132r854b2210],
6	response	NN	O	response	nsubjpass	8	SENT_124	[p7l881t2157r1263b2232],
7	was	VBD	O	be	auxpass	8	SENT_124	[p7l1286t2158r1448b2211],
8	assessed	VBN	O	assess	_	0	SENT_124	[p7l1478t2132r1844b2210],
9	by	IN	O	by	_	0	SENT_124	[p7l1872t2132r1970b2232],
10	two	CD	NUMBER	two	num	11	SENT_124	[p7l1993t2148r2147b2211],
11	physicians	NNS	O	physician	agent	8	SENT_124	[p7l9t2261r480b2361],
12	.	.	O	.	_	0	SENT_124	[p7l9t2261r480b2361],

1	Table	NNP	O	Table	nsubj	3	SENT_125	[p7l137t2389r366b2467],
2	1	CD	NUMBER	1	num	1	SENT_125	[p7l391t2394r436b2466],
3	shows	VBZ	O	show	_	0	SENT_125	[p7l459t2389r724b2468],
4	the	DT	O	the	det	6	SENT_125	[p7l748t2389r878b2467],
5	clinical	JJ	O	clinical	amod	6	SENT_125	[p7l901t2389r1204b2467],
6	characteristics	NNS	O	characteristic	dobj	3	SENT_125	[p7l1226t2389r1834b2467],
7	of	IN	O	of	_	0	SENT_125	[p7l1858t2388r1960b2467],
8	nine	CD	NUMBER	nine	num	9	SENT_125	[p7l1962t2389r2148b2467],
9	patients	NNS	O	patient	prep_of	6	SENT_125	[p7l9t2517r352b2617],
10	for	IN	O	for	_	0	SENT_125	[p7l390t2516r516b2595],
11	Whom	WP	O	whom	dobj	21	SENT_125	[p7l544t2517r821b2596],
12	tumor	NN	O	tumor	nn	13	SENT_125	[p7l857t2533r1126b2596],
13	specimens	NNS	O	specimen	nsubj	21	SENT_125	[p7l1160t2517r1616b2617],
14	obtained	VBN	O	obtain	partmod	13	SENT_125	[p7l1654t2517r2036b2595],
15	at	IN	O	at	_	0	SENT_125	[p7l2071t2533r2152b2595],
16	the	DT	O	the	det	17	SENT_125	[p7l11t2645r141b2723],
17	time	NN	O	time	prep_at	14	SENT_125	[p7l164t2645r350b2723],
18	of	IN	O	of	_	0	SENT_125	[p7l374t2644r475b2723],
19	diagnosis	NN	O	diagnosis	prep_of	17	SENT_125	[p7l479t2645r881b2745],
20	were	VBD	O	be	cop	21	SENT_125	[p7l900t2671r1102b2724],
21	available	JJ	O	available	prepc_for	9	SENT_125	[p7l1124t2644r1509b2724],
22	.	.	O	.	_	0	SENT_125	[p7l1124t2644r1509b2724],

1	Tissue	NN	O	tissue	nsubj	4	SENT_126	[p7l1534t2645r1807b2724],
2	was	VBD	O	be	cop	4	SENT_126	[p7l1825t2671r1986b2724],
3	not	RB	O	not	neg	4	SENT_126	[p7l2010t2661r2153b2723],
4	available	JJ	O	available	_	0	SENT_126	[p7l10t2773r385b2852],
5	from	IN	O	from	_	0	SENT_126	[p7l417t2772r629b2851],
6	the	DT	O	the	det	8	SENT_126	[p7l661t2773r793b2851],
7	other	JJ	O	other	amod	8	SENT_126	[p7l826t2773r1056b2851],
8	patients	NNS	O	patient	prep_from	4	SENT_126	[p7l1083t2773r1428b2873],
9	with	IN	O	with	_	0	SENT_126	[p7l1457t2772r1651b2852],
10	a	DT	O	a	det	11	SENT_126	[p7l1683t2799r1727b2851],
11	response	NN	O	response	prep_with	8	SENT_126	[p7l1757t2798r2147b2873],
12	to	TO	O	to	_	0	SENT_126	[p7l11t2917r92b2979],
13	geﬁtinib	NN	O	geﬁtinib	prep_to	4	SENT_126	[p7l142t2900r532b3001],
14	,	,	O	,	_	0	SENT_126	[p7l142t2900r532b3001],
15	most	JJS	O	most	attr	4	SENT_126	[p7l583t2917r799b2979],
16	commonly	RB	O	commonly	advmod	15	SENT_126	[p7l840t2901r1294b3001],
17	because	IN	O	because	mark	21	SENT_126	[p7l1335t2901r1666b2980],
18	diagnostic	JJ	O	diagnostic	amod	19	SENT_126	[p7l1713t2901r2149b3001],
19	specimens	NNS	O	specimen	nsubjpass	21	SENT_126	[p7l12t3029r457b3129],
20	were	VBD	O	be	auxpass	21	SENT_126	[p7l494t3055r697b3108],
21	limited	VBN	O	limit	dep	15	SENT_126	[p7l735t3029r1037b3107],
22	to	TO	O	to	_	0	SENT_126	[p7l1078t3045r1157b3107],
23	needle	NN	O	needle	nn	24	SENT_126	[p7l1199t3029r1474b3107],
24	aspirates	NNS	O	aspirate	prep_to	21	SENT_126	[p7l1514t3029r1916b3129],
25	.	.	O	.	_	0	SENT_126	[p7l1514t3029r1916b3129],

1	As	IN	O	as	_	0	SENT_127	[p7l1958t3036r2062b3107],
2	a	DT	O	a	det	3	SENT_127	[p7l2105t3055r2149b3107],
3	group	NN	O	group	prep_as	8	SENT_127	[p7l10t3182r288b3257],
4	,	,	O	,	_	0	SENT_127	[p7l10t3182r288b3257],
5	the	DT	O	the	det	7	SENT_127	[p7l321t3157r451b3235],
6	nine	CD	NUMBER	nine	num	7	SENT_127	[p7l480t3157r664b3235],
7	patients	NNS	O	patient	nsubj	8	SENT_127	[p7l691t3157r1028b3257],
8	derived	VBD	O	derive	_	0	SENT_127	[p7l1059t3157r1365b3235],
9	a	DT	O	a	det	11	SENT_127	[p7l1392t3183r1437b3235],
10	substantial	JJ	O	substantial	amod	11	SENT_127	[p7l1465t3157r1931b3236],
11	beneﬁt	NN	O	beneﬁt	dobj	8	SENT_127	[p7l1959t3157r2147b3235, p7l11t3284r149b3363],
12	from	IN	O	from	_	0	SENT_127	[p7l180t3284r389b3363],
13	geﬂtinib	NN	O	geﬂtinib	nn	14	SENT_127	[p7l425t3284r790b3385],
14	therapy	NN	O	therapy	prep_from	8	SENT_127	[p7l831t3285r1169b3385],
15	.	.	O	.	_	0	SENT_127	[p7l831t3285r1169b3385],

1	The	DT	O	the	det	3	SENT_128	[p7l1210t3285r1374b3363],
2	median	JJ	O	median	amod	3	SENT_128	[p7l1414t3285r1738b3363],
3	duration	NN	O	duration	nsubj	12	SENT_128	[p7l1777t3285r2147b3364],
4	of	IN	O	of	_	0	SENT_128	[p7l11t3412r111b3491],
5	survival	NN	O	survival	prep_of	3	SENT_128	[p7l114t3412r428b3492],
6	from	IN	O	from	_	0	SENT_128	[p7l447t3412r653b3491],
7	the	DT	O	the	det	8	SENT_128	[p7l673t3413r801b3491],
8	start	NN	O	start	prep_from	5	SENT_128	[p7l822t3429r1012b3491],
9	of	IN	O	of	_	0	SENT_128	[p7l1027t3412r1128b3491],
10	drug	NN	O	drug	nn	11	SENT_128	[p7l1129t3413r1328b3513],
11	treatment	NN	O	treatment	prep_of	8	SENT_128	[p7l1344t3429r1754b3491],
12	exceeded	VBD	O	exceed	_	0	SENT_128	[p7l1770t3412r2147b3491],
13	18	CD	DURATION	18	num	14	SENT_128	[p7l14t3546r111b3619],
14	months	NNS	NUMBER	month	tmod	12	SENT_128	[p7l159t3541r518b3636],
15	,	,	O	,	_	0	SENT_128	[p7l159t3541r518b3636],
16	and	CC	O	and	_	0	SENT_128	[p7l567t3540r724b3619],
17	the	DT	O	the	det	19	SENT_128	[p7l767t3541r897b3619],
18	median	JJ	O	median	amod	19	SENT_128	[p7l940t3541r1258b3619],
19	duration	NN	O	duration	nsubj	26	SENT_128	[p7l1301t3540r1664b3620],
20	of	IN	O	of	_	0	SENT_128	[p7l1708t3540r1808b3619],
21	therapy	NN	O	therapy	prep_of	19	SENT_128	[p7l1833t3541r2152b3641],
22	was	VBD	O	be	cop	26	SENT_128	[p7l6t3696r168b3749],
23	greater	JJR	O	greater	mwe	24	SENT_128	[p7l191t3685r490b3770],
24	than	IN	O	than	quantmod	25	SENT_128	[p7l510t3670r698b3748],
25	16	CD	DURATION	16	num	26	SENT_128	[p7l724t3675r821b3748],
26	months	NNS	NUMBER	month	conj_and	12	SENT_128	[p7l843t3670r1195b3748],
27	.	.	O	.	_	0	SENT_128	[p7l843t3670r1195b3748],

1	Consistent	JJ	O	consistent	_	0	SENT_129	[p7l1222t3670r1683b3748],
2	with	IN	O	with	_	0	SENT_129	[p7l1695t3670r1886b3749],
3	previous	JJ	O	previous	prep_with	1	SENT_129	[p7l1906t3670r2147b3770, p8l11t46r157b100],

1	reports	NNS	O	report	nsubj	21	SENT_130	[p8l185t37r511b121],
2	,	,	O	,	_	0	SENT_130	[p8l185t37r511b121],
3	we	PRP	O	we	nsubj	4	SENT_130	[p8l539t47r658b100],
4	found	VBD	O	find	parataxis	18	SENT_130	[p8l685t20r937b100],
5	that	IN	O	that	complm	14	SENT_130	[p8l963t21r1130b99],
6	most	JJS	O	most	amod	7	SENT_130	[p8l1151t37r1369b99],
7	patients	NNS	O	patient	nsubj	14	SENT_130	[p8l1389t21r1726b121],
8	with	IN	O	with	_	0	SENT_130	[p8l1749t21r1940b100],
9	a	DT	O	a	det	10	SENT_130	[p8l1965t47r2010b99],
10	response	NN	O	response	prep_with	7	SENT_130	[p8l2035t47r2147b99, p8l12t174r304b249],
11	to	TO	O	to	_	0	SENT_130	[p8l325t165r403b227],
12	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_130	[p8l424t148r775b249],
13	were	VBD	O	be	cop	14	SENT_130	[p8l791t175r991b228],
14	Women	NNS	O	woman	ccomp	4	SENT_130	[p8l1007t174r1346b244],
15	,	,	O	,	_	0	SENT_130	[p8l1007t174r1346b244],
16	had	VBD	O	have	aux	18	SENT_130	[p8l1371t148r1526b227],
17	never	RB	O	never	neg	18	SENT_130	[p8l1545t174r1770b228],
18	smoked	VBN	O	smoke	_	0	SENT_130	[p8l1789t149r2143b244],
19	,	,	O	,	_	0	SENT_130	[p8l1789t149r2143b244],
20	and	CC	O	and	_	0	SENT_130	[p8l10t277r166b356],
21	had	VBD	O	have	conj_and	18	SENT_130	[p8l189t277r344b356],
22	bronchoalveolar	JJ	O	bronchoalveolar	amod	23	SENT_130	[p8l368t277r1050b357],
23	tumors	NNS	O	tumor	dobj	21	SENT_130	[p8l1071t271r1583b357],
24	.	.	O	.	_	0	SENT_130	[p8l1071t271r1583b357],

1	“’	NN	O	“’	nsubj	6	SENT_131	[p8l1071t271r1583b357],
2	12	CD	NUMBER	12	num	1	SENT_131	[p8l1071t271r1583b357],
3	Patient	NN	O	patient	dep	1	SENT_131	[p8l1606t278r1899b356],
4	6	CD	NUMBER	6	num	3	SENT_131	[p8l1918t283r1965b356],
5	was	VBD	O	be	cop	6	SENT_131	[p8l1985t303r2145b357],
6	representative	NN	O	representative	_	0	SENT_131	[p8l10t406r596b506],
7	of	IN	O	of	_	0	SENT_131	[p8l620t405r720b484],
8	the	DT	O	the	det	9	SENT_131	[p8l725t406r853b484],
9	cohort	NN	O	cohort	prep_of	6	SENT_131	[p8l877t406r1171b484],
10	.	.	O	.	_	0	SENT_131	[p8l877t406r1171b484],

1	This	DT	O	this	det	2	SENT_132	[p8l1196t406r1380b484],
2	patient	NN	O	patient	nsubj	13	SENT_132	[p8l1403t406r1716b506],
3	,	,	O	,	_	0	SENT_132	[p8l1403t406r1716b506],
4	a	DT	O	a	det	6	SENT_132	[p8l1744t432r1788b484],
5	32yearold	JJ	O	32yearold	amod	6	SENT_132	[p8l1810t411r2147b506, p8l11t534r142b612],
6	man	NN	O	man	appos	2	SENT_132	[p8l163t559r350b612],
7	with	IN	O	with	_	0	SENT_132	[p8l367t534r554b613],
8	no	DT	O	no	det	9	SENT_132	[p8l576t559r681b612],
9	history	NN	O	history	prep_with	6	SENT_132	[p8l704t534r994b634],
10	of	IN	O	of	_	0	SENT_132	[p8l1012t533r1112b612],
11	smoking	NN	O	smoking	prep_of	9	SENT_132	[p8l1117t534r1508b634],
12	,	,	O	,	_	0	SENT_132	[p8l1117t534r1508b634],
13	presented	VBN	O	present	_	0	SENT_132	[p8l1534t534r1944b634],
14	with	IN	O	with	_	0	SENT_132	[p8l1961t534r2149b613],
15	multiple	JJ	O	multiple	amod	17	SENT_132	[p8l10t661r366b762],
16	brain	NN	O	brain	nn	17	SENT_132	[p8l403t662r624b740],
17	lesions	NNS	O	lesion	prep_with	13	SENT_132	[p8l659t662r955b740],
18	and	CC	O	and	_	0	SENT_132	[p8l994t661r1151b740],
19	bronchoalveolar	JJ	O	bronchoalveolar	amod	20	SENT_132	[p8l1187t662r1881b740],
20	carcinoma	NN	O	carcinoma	conj_and	17	SENT_132	[p8l1915t662r2147b740, p8l10t815r255b868],
21	in	IN	O	in	_	0	SENT_132	[p8l276t790r358b867],
22	the	DT	O	the	det	24	SENT_132	[p8l382t790r511b868],
23	right	JJ	O	right	amod	24	SENT_132	[p8l535t790r745b890],
24	lung	NN	O	lung	prep_in	13	SENT_132	[p8l763t790r978b890],
25	.	.	O	.	_	0	SENT_132	[p8l763t790r978b890],

1	He	PRP	O	he	nsubjpass	3	SENT_133	[p8l1007t797r1126b868],
2	was	VBD	O	be	auxpass	3	SENT_133	[p8l1146t816r1308b869],
3	treated	VBN	O	treat	_	0	SENT_133	[p8l1334t790r1625b868],
4	with	IN	O	with	_	0	SENT_133	[p8l1644t790r1834b869],
5	wholebrain	NN	O	wholebrain	nn	6	SENT_133	[p8l1853t790r2147b869, p8l11t918r232b996],
6	radiotherapy	NN	O	radiotherapy	prep_with	3	SENT_133	[p8l261t918r815b1018],
7	,	,	O	,	_	0	SENT_133	[p8l261t918r815b1018],
8	followed	VBN	O	follow	_	0	SENT_133	[p8l850t917r1220b997],
9	by	IN	O	by	prepc_followed_by	3	SENT_133	[p8l1249t918r1347b1018],
10	a	DT	O	a	det	11	SENT_133	[p8l1371t944r1416b996],
11	series	NN	O	series	pobj	3	SENT_133	[p8l1445t918r1682b996],
12	of	IN	O	of	_	0	SENT_133	[p8l1714t917r1816b996],
13	chemotherapy	NN	O	chemotherapy	nn	14	SENT_133	[p8l1827t918r2147b996, p8l11t1046r335b1146],
14	regimens	NNS	O	regimen	prep_of	11	SENT_133	[p8l369t1046r772b1146],
15	(	VBP	O	(	rcmod	14	SENT_133	[p8l817t1046r1344b1146],
16	carboplatin	NN	O	carboplatin	dobj	15	SENT_133	[p8l817t1046r1344b1146],
17	and	CC	O	and	_	0	SENT_133	[p8l1382t1046r1541b1124],
18	gemcitabine	NN	O	gemcitabine	conj_and	16	SENT_133	[p8l1579t1046r2141b1146],
19	,	,	O	,	_	0	SENT_133	[p8l1579t1046r2141b1146],
20	docetaxel	NN	O	docetaxel	dobj	15	SENT_133	[p8l11t1173r444b1269],
21	,	,	O	,	_	0	SENT_133	[p8l11t1173r444b1269],
22	and	CC	O	and	_	0	SENT_133	[p8l495t1174r654b1252],
23	vinorelbine	NN	O	vinorelbine	dobj	15	SENT_133	[p8l695t1174r1219b1265],
24	)	CD	NUMBER	)	num	23	SENT_133	[p8l695t1174r1219b1265],
25	to	TO	O	to	_	0	SENT_133	[p8l1271t1190r1352b1252],
26	Which	WP	O	which	dobj	31	SENT_133	[p8l1395t1174r1661b1253],
27	his	PRP$	O	he	poss	28	SENT_133	[p8l1708t1174r1832b1252],
28	tumor	NN	O	tumor	nsubj	31	SENT_133	[p8l1881t1190r2149b1253],
29	did	VBD	O	do	aux	31	SENT_133	[p8l11t1302r147b1381],
30	not	RB	O	not	neg	31	SENT_133	[p8l177t1319r324b1381],
31	respond	VB	O	respond	prepc_to	15	SENT_133	[p8l350t1303r728b1403],
32	.	.	O	.	_	0	SENT_133	[p8l350t1303r728b1403],

1	With	IN	O	with	_	0	SENT_134	[p8l760t1302r975b1381],
2	a	DT	O	a	det	5	SENT_134	[p8l1004t1329r1049b1381],
3	declining	VBG	O	decline	amod	5	SENT_134	[p8l1079t1303r1487b1403],
4	functional	JJ	O	functional	amod	5	SENT_134	[p8l1514t1302r1958b1382],
5	status	NN	O	status	prep_with	14	SENT_134	[p8l1990t1319r2145b1381, p8l11t1447r136b1510],
6	and	CC	O	and	_	0	SENT_134	[p8l168t1431r327b1509],
7	progressive	JJ	O	progressive	amod	11	SENT_134	[p8l355t1431r854b1531],
8	lung	NN	O	lung	nn	11	SENT_134	[p8l884t1431r1390b1531],
9	—	NN	O	—	nn	11	SENT_134	[p8l884t1431r1390b1531],
10	tumor	NN	O	tumor	nn	11	SENT_134	[p8l884t1431r1390b1531],
11	burden	NN	O	burden	conj_and	5	SENT_134	[p8l1418t1430r1751b1526],
12	,	,	O	,	_	0	SENT_134	[p8l1418t1430r1751b1526],
13	he	PRP	O	he	nsubj	14	SENT_134	[p8l1787t1431r1887b1509],
14	started	VBD	O	start	_	0	SENT_134	[p8l1919t1447r2145b1509, p8l11t1559r109b1637],
15	therapy	NN	O	therapy	dobj	14	SENT_134	[p8l146t1559r471b1659],
16	with	IN	O	with	_	0	SENT_134	[p8l499t1559r693b1638],
17	250	CD	NUMBER	250	num	18	SENT_134	[p8l729t1564r885b1637],
18	mg	NN	O	mg	prep_with	14	SENT_134	[p8l923t1585r1065b1659],
19	of	IN	O	of	_	0	SENT_134	[p8l1099t1558r1201b1637],
20	geﬁtinib	NN	O	geﬁtinib	prep_of	18	SENT_134	[p8l1219t1558r1585b1659],
21	per	IN	O	per	_	0	SENT_134	[p8l1622t1585r1764b1659],
22	day	NN	DURATION	day	prep_per	20	SENT_134	[p8l1798t1559r1957b1659],
23	.	.	O	.	_	0	SENT_134	[p8l1798t1559r1957b1659],

1	His	PRP$	O	he	poss	2	SENT_135	[p8l1999t1559r2144b1637],
2	dyspnea	NN	O	dyspnea	nsubj	7	SENT_135	[p8l11t1686r354b1787],
3	promptly	RB	O	promptly	advmod	4	SENT_135	[p8l371t1687r761b1787],
4	improved	VBD	O	improve	_	0	SENT_135	[p8l776t1687r1198b1787],
5	,	,	O	,	_	0	SENT_135	[p8l776t1687r1198b1787],
6	and	CC	O	and	_	0	SENT_135	[p8l1223t1687r1378b1765],
7	computed	VBD	O	compute	conj_and	4	SENT_135	[p8l1399t1687r1820b1787],
8	tomography	NN	O	tomography	dobj	7	SENT_135	[p8l1840t1703r2147b1787, p8l10t1815r249b1915],
9	of	IN	O	of	_	0	SENT_135	[p8l280t1814r379b1893],
10	the	DT	O	the	det	11	SENT_135	[p8l398t1815r526b1893],
11	lung	NN	O	lung	prep_of	8	SENT_135	[p8l563t1815r757b1915],
12	six	CD	DURATION	six	num	13	SENT_135	[p8l793t1815r907b1893],
13	Weeks	NNS	DURATION	week	dep	19	SENT_135	[p8l937t1815r1197b1894],
14	after	IN	O	after	dep	19	SENT_135	[p8l1235t1814r1428b1893],
15	the	DT	O	the	det	16	SENT_135	[p8l1463t1815r1592b1893],
16	initiation	NN	O	initiation	nsubj	19	SENT_135	[p8l1629t1815r2015b1893],
17	of	IN	O	of	_	0	SENT_135	[p8l2053t1814r2153b1893],
18	treatment	NN	O	treatment	prep_of	16	SENT_135	[p8l11t1959r416b2021],
19	revealed	VBD	O	reveal	dep	7	SENT_135	[p8l433t1943r768b2022],
20	a	DT	O	a	det	24	SENT_135	[p8l789t1969r833b2021],
21	dramatic	JJ	O	dramatic	amod	24	SENT_135	[p8l854t1942r1218b2021],
22	improvement	NN	O	improvement	nn	24	SENT_135	[p8l1238t1943r1800b2043],
23	(	CD	NUMBER	(	num	24	SENT_135	[p8l1821t1943r2000b2043],
24	Fig	NN	O	fig	dobj	19	SENT_135	[p8l1821t1943r2000b2043],
25	.	.	O	.	_	0	SENT_135	[p8l1821t1943r2000b2043],

1	1	CD	NUMBER	1	_	0	SENT_136	[p8l2030t1948r2130b2034],
2	)	NN	O	)	dep	1	SENT_136	[p8l2030t1948r2130b2034],
3	.	.	O	.	_	0	SENT_136	[p8l2030t1948r2130b2034],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_137	[p8l12t2227r219b2276],
2	MUTATIONS	NNS	O	mutation	_	0	SENT_137	[p8l260t2227r756b2276],
3	IN	IN	O	in	dep	2	SENT_137	[p8l794t2227r875b2276],
4	PATIENTS	NNS	O	patient	pobj	3	SENT_137	[p8l921t2227r1312b2276],
5	WITH	IN	O	with	dep	2	SENT_137	[p8l1344t2227r1557b2276],
6	A	DT	O	a	det	7	SENT_137	[p8l1595t2227r1641b2276],
7	RESPONSE	NN	O	response	pobj	5	SENT_137	[p8l1677t2227r2105b2276],
8	TO	TO	O	to	infmod	7	SENT_137	[p8l8t2310r113b2360],
9	GEFITINIB	NN	O	gefitinib	dobj	8	SENT_137	[p8l155t2310r582b2360],

1	We	PRP	O	we	nsubj	2	SENT_138	[p8l7t2425r140b2496],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_138	[p8l168t2418r724b2518],
3	that	IN	O	that	complm	20	SENT_138	[p8l752t2418r917b2496],
4	patients	NNS	O	patient	nsubj	20	SENT_138	[p8l939t2418r1269b2518],
5	with	IN	O	with	_	0	SENT_138	[p8l1295t2418r1483b2497],
6	non	JJ	O	non	amod	12	SENT_138	[p8l1511t2418r2136b2496],
7	—	JJ	O	—	amod	12	SENT_138	[p8l1511t2418r2136b2496],
8	small	JJ	O	small	amod	12	SENT_138	[p8l1511t2418r2136b2496],
9	—	NN	O	—	nn	12	SENT_138	[p8l1511t2418r2136b2496],
10	cell	NN	O	cell	nn	12	SENT_138	[p8l1511t2418r2136b2496],
11	lung	NN	O	lung	nn	12	SENT_138	[p8l10t2546r203b2646],
12	cancer	NN	O	cancer	prep_with	4	SENT_138	[p8l239t2571r520b2624],
13	who	WP	O	who	nsubj	14	SENT_138	[p8l552t2546r737b2625],
14	had	VBD	O	have	rcmod	12	SENT_138	[p8l777t2546r935b2624],
15	striking	JJ	O	striking	amod	16	SENT_138	[p8l975t2546r1312b2646],
16	responses	NNS	O	response	dobj	14	SENT_138	[p8l1348t2571r1777b2646],
17	to	TO	O	to	aux	18	SENT_138	[p8l1819t2562r1899b2624],
18	geﬁ	VB	O	geﬁ	infmod	16	SENT_138	[p8l1939t2545r2133b2646],
19	tinib	NN	O	tinib	dobj	18	SENT_138	[p8l11t2674r208b2752],
20	had	VBD	O	have	ccomp	2	SENT_138	[p8l234t2674r392b2752],
21	somatic	JJ	O	somatic	amod	22	SENT_138	[p8l419t2674r753b2752],
22	mutations	NNS	O	mutation	dobj	20	SENT_138	[p8l779t2674r1217b2753],
23	in	IN	O	in	_	0	SENT_138	[p8l1244t2674r1326b2751],
24	the	DT	O	the	det	26	SENT_138	[p8l1352t2674r1483b2752],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_138	[p8l1506t2680r1722b2753],
26	gene	NN	O	gene	prep_in	22	SENT_138	[p8l1740t2699r1943b2774],
27	that	WDT	O	that	nsubj	29	SENT_138	[p8l1968t2673r2138b2752],
28	Would	MD	O	would	aux	29	SENT_138	[p8l6t2802r276b2881],
29	indicate	VB	O	indicate	rcmod	22	SENT_138	[p8l303t2802r644b2880],
30	the	DT	O	the	det	32	SENT_138	[p8l672t2802r804b2880],
31	essential	JJ	O	essential	amod	32	SENT_138	[p8l832t2802r1206b2880],
32	role	NN	O	role	dobj	29	SENT_138	[p8l1233t2802r1397b2880],
33	of	IN	O	of	_	0	SENT_138	[p8l1426t2801r1528b2880],
34	the	DT	O	the	det	37	SENT_138	[p8l1537t2802r1669b2880],
35	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_138	[p8l1696t2807r1958b2885],
36	signaling	NN	O	signaling	nn	37	SENT_138	[p8l1977t2802r2133b2902, p8l10t2930r276b3030],
37	pathway	NN	O	pathway	prep_of	32	SENT_138	[p8l291t2930r642b3030],
38	in	IN	O	in	_	0	SENT_138	[p8l657t2930r737b3007],
39	the	DT	O	the	det	40	SENT_138	[p8l757t2930r885b3008],
40	tumor	NN	O	tumor	prep_in	29	SENT_138	[p8l905t2946r1180b3009],
41	.	.	O	.	_	0	SENT_138	[p8l905t2946r1180b3009],

1	To	TO	O	to	aux	2	SENT_139	[p8l1202t2935r1306b3008],
2	search	VB	O	search	purpcl	8	SENT_139	[p8l1329t2930r1595b3008],
3	for	IN	O	for	_	0	SENT_139	[p8l1615t2929r1735b3008],
4	such	JJ	O	such	amod	5	SENT_139	[p8l1754t2930r1946b3009],
5	mutations	NNS	O	mutation	prep_for	2	SENT_139	[p8l1966t2956r2134b3009, p8l11t3058r318b3153],
6	,	,	O	,	_	0	SENT_139	[p8l1966t2956r2134b3009, p8l11t3058r318b3153],
7	we	PRP	O	we	nsubj	8	SENT_139	[p8l341t3084r460b3137],
8	ﬁrst	VBP	O	ﬁrst	_	0	SENT_139	[p8l486t3057r664b3136],
9	looked	VBD	O	look	ccomp	8	SENT_139	[p8l683t3058r976b3137],
10	for	IN	O	for	_	0	SENT_139	[p8l1001t3057r1126b3136],
11	rearrangements	NNS	O	rearrangement	prepc_for	9	SENT_139	[p8l1149t3074r1831b3158],
12	Within	IN	O	within	dep	11	SENT_139	[p8l1854t3058r2134b3137],
13	the	DT	O	the	det	15	SENT_139	[p8l11t3186r142b3264],
14	extracellular	JJ	O	extracellular	amod	15	SENT_139	[p8l170t3186r703b3265],
15	domain	NN	O	domain	pobj	12	SENT_139	[p8l727t3186r1057b3264],
16	of	IN	O	of	_	0	SENT_139	[p8l1084t3185r1186b3264],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_139	[p8l1193t3191r1455b3269],
18	that	WDT	O	that	nsubj	20	SENT_139	[p8l1473t3186r1642b3264],
19	are	VBP	O	be	cop	20	SENT_139	[p8l1664t3212r1792b3264],
20	characteristic	JJ	O	characteristic	rcmod	15	SENT_139	[p8l1820t3186r2132b3264, p8l11t3315r292b3392],
21	of	IN	O	of	_	0	SENT_139	[p8l317t3313r416b3392],
22	gliomas15	NN	O	gliomas15	prep_of	20	SENT_139	[p8l422t3308r859b3414],
23	;	:	O	;	_	0	SENT_139	[p8l422t3308r859b3414],
24	none	NN	O	none	nsubjpass	26	SENT_139	[p8l887t3339r1095b3392],
25	were	VBD	O	be	auxpass	26	SENT_139	[p8l1116t3340r1315b3393],
26	detected	VBN	O	detect	parataxis	8	SENT_139	[p8l1341t3314r1708b3392],
27	.	.	O	.	_	0	SENT_139	[p8l1341t3314r1708b3392],

1	We	PRP	O	we	nsubj	3	SENT_140	[p8l1735t3321r1867b3392],
2	therefore	RB	O	therefore	advmod	3	SENT_140	[p8l1893t3314r2134b3392, p8l10t3441r174b3520],
3	sequenced	VBD	O	sequence	_	0	SENT_140	[p8l201t3442r637b3542],
4	the	DT	O	the	det	7	SENT_140	[p8l662t3442r789b3520],
5	entire	JJ	O	entire	amod	7	SENT_140	[p8l815t3442r1051b3520],
6	coding	NN	O	coding	nn	7	SENT_140	[p8l1077t3442r1365b3542],
7	region	NN	O	region	dobj	3	SENT_140	[p8l1386t3442r1655b3542],
8	of	IN	O	of	_	0	SENT_140	[p8l1681t3441r1780b3520],
9	the	DT	O	the	det	10	SENT_140	[p8l1788t3442r1915b3520],
10	gene	NN	O	gene	prep_of	7	SENT_140	[p8l1940t3467r2136b3542],
11	using	VBG	O	use	partmod	10	SENT_140	[p8l10t3570r244b3670],
12	PCR	NN	O	pcr	nn	13	SENT_140	[p8l264t3575r455b3653],
13	ampliﬁcation	NN	O	ampliﬁcation	dobj	11	SENT_140	[p8l469t3569r1036b3670],
14	of	IN	O	of	_	0	SENT_140	[p8l1061t3569r1161b3648],
15	individual	JJ	O	individual	amod	16	SENT_140	[p8l1167t3570r1588b3649],
16	exons	NNS	O	exon	prep_of	13	SENT_140	[p8l1613t3595r1880b3648],
17	.	.	O	.	_	0	SENT_140	[p8l1613t3595r1880b3648],

1	Heterozygous	JJ	O	heterozygous	amod	2	SENT_141	[p8l139t3705r717b3798],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_141	[p8l745t3698r1171b3777],
3	were	VBD	O	be	auxpass	4	SENT_141	[p8l1195t3724r1395b3777],
4	observed	VBN	O	observe	_	0	SENT_141	[p8l1422t3698r1793b3777],
5	in	IN	O	in	_	0	SENT_141	[p8l1819t3698r1899b3775],
6	eight	CD	TIME	eight	prep_in	4	SENT_141	[p8l1926t3698r2140b3798],
7	of	IN	TIME	of	_	0	SENT_141	[p9l11t20r111b99],
8	nine	CD	TIME	nine	num	9	SENT_141	[p9l113t21r297b99],
9	patients	NNS	O	patient	prep_of	6	SENT_141	[p9l319t21r689b121],
10	,	,	O	,	_	0	SENT_141	[p9l319t21r689b121],
11	all	DT	O	all	dep	12	SENT_141	[p9l717t21r818b99],
12	of	IN	O	of	nsubjpass	15	SENT_141	[p9l842t20r944b99],
13	Which	WDT	O	which	pobj	12	SENT_141	[p9l945t21r1210b100],
14	were	VBD	O	be	auxpass	15	SENT_141	[p9l1229t47r1433b100],
15	clustered	VBN	O	cluster	rcmod	9	SENT_141	[p9l1459t21r1849b100],
16	within	IN	O	within	_	0	SENT_141	[p9l1868t21r2136b100],
17	the	DT	O	the	det	20	SENT_141	[p9l11t148r139b227],
18	tyrosine	NN	O	tyrosine	nn	20	SENT_141	[p9l171t149r513b249],
19	kinase	NN	O	kinase	nn	20	SENT_141	[p9l543t148r819b228],
20	domain	NN	O	domain	prep_within	15	SENT_141	[p9l850t149r1179b227],
21	of	IN	O	of	_	0	SENT_141	[p9l1210t148r1312b227],
22	EGFR	NN	ORGANIZATION	egfr	prep_of	20	SENT_141	[p9l1322t154r1584b232],
23	(	CD	NUMBER	(	num	22	SENT_141	[p9l1608t149r1868b240],
24	Table	NNP	O	Table	tmod	15	SENT_141	[p9l1608t149r1868b240],
25	2	CD	NUMBER	2	num	24	SENT_141	[p9l1899t154r1945b226],
26	and	CC	O	and	_	0	SENT_141	[p9l1976t148r2134b227],
27	Fig	NN	O	fig	tmod	15	SENT_141	[p9l9t277r165b377],
28	.	.	O	.	_	0	SENT_141	[p9l9t277r165b377],

1	2	CD	NUMBER	2	num	2	SENT_142	[p9l191t282r296b368],
2	)	CD	NUMBER	)	_	0	SENT_142	[p9l191t282r296b368],
3	.	.	O	.	_	0	SENT_142	[p9l191t282r296b368],

1	Four	CD	NUMBER	four	num	2	SENT_143	[p9l321t284r518b356],
2	tumors	NNS	O	tumor	nsubj	3	SENT_143	[p9l536t293r834b356],
3	had	VBD	O	have	_	0	SENT_143	[p9l856t277r1010b355],
4	in	IN	O	in	_	0	SENT_143	[p9l1030t276r1392b355],
5	—	NN	O	—	nn	7	SENT_143	[p9l1030t276r1392b355],
6	frame	NN	O	frame	nn	7	SENT_143	[p9l1030t276r1392b355],
7	deletions	NNS	O	deletion	prep_in	3	SENT_143	[p9l1413t276r1816b372],
8	,	,	O	,	_	0	SENT_143	[p9l1413t276r1816b372],
9	removing	VBG	O	remove	xcomp	3	SENT_143	[p9l1842t302r2135b356, p9l10t405r148b505],
10	amino	NN	O	amino	nn	11	SENT_143	[p9l167t405r440b483],
11	acids	NNS	O	acid	dobj	9	SENT_143	[p9l464t405r681b483],
12	746	CD	NUMBER	746	npadvmod	9	SENT_143	[p9l707t410r861b483],
13	through	IN	O	through	_	0	SENT_143	[p9l886t405r1234b505],
14	750	CD	NUMBER	750	number	15	SENT_143	[p9l1259t410r1413b483],
15	(	CD	NUMBER	(	num	16	SENT_143	[p9l1442t405r2129b496],
16	delE746	NN	O	dele746	prep_through	9	SENT_143	[p9l1442t405r2129b496],
17	.	.	O	.	_	0	SENT_143	[p9l1442t405r2129b496],

1	—	NN	O	—	_	0	SENT_144	[p9l1442t405r2129b496],
2	.	.	O	.	_	0	SENT_144	[p9l1442t405r2129b496],

1	A750	NN	O	a750	nn	2	SENT_145	[p9l1442t405r2129b496],
2	)	NN	O	)	_	0	SENT_145	[p9l1442t405r2129b496],
3	in	IN	O	in	_	0	SENT_145	[p9l10t533r90b610],
4	Patient	NN	O	patient	prep_in	2	SENT_145	[p9l108t533r397b611],
5	1	CD	NUMBER	1	num	4	SENT_145	[p9l415t538r482b628],
6	,	,	O	,	_	0	SENT_145	[p9l415t538r482b628],
7	747	CD	NUMBER	747	appos	2	SENT_145	[p9l508t538r658b611],
8	through	IN	O	through	_	0	SENT_145	[p9l678t533r1014b633],
9	751	CD	NUMBER	751	number	10	SENT_145	[p9l1034t538r1184b611],
10	(	CD	NUMBER	(	num	11	SENT_145	[p9l1208t533r2032b624],
11	delL747	NN	O	dell747	prep_through	7	SENT_145	[p9l1208t533r2032b624],
12	.	.	O	.	_	0	SENT_145	[p9l1208t533r2032b624],

1	—	NN	O	—	_	0	SENT_146	[p9l1208t533r2032b624],
2	.	.	O	.	_	0	SENT_146	[p9l1208t533r2032b624],

1	T751insS	NN	O	t751inss	nn	2	SENT_147	[p9l1208t533r2032b624],
2	)	NN	O	)	_	0	SENT_147	[p9l1208t533r2032b624],
3	in	IN	O	in	_	0	SENT_147	[p9l2056t533r2136b610],
4	Patient	NN	O	patient	prep_in	2	SENT_147	[p9l9t661r302b739],
5	2	CD	NUMBER	2	num	4	SENT_147	[p9l317t666r388b756],
6	,	,	O	,	_	0	SENT_147	[p9l317t666r388b756],
7	and	CC	NUMBER	and	_	0	SENT_147	[p9l413t661r568b739],
8	747	CD	NUMBER	747	prep_in	2	SENT_147	[p9l589t666r739b739],
9	through	IN	O	through	_	0	SENT_147	[p9l761t661r1100b761],
10	753	CD	NUMBER	753	number	11	SENT_147	[p9l1121t666r1269b739],
11	(	CD	NUMBER	(	num	12	SENT_147	[p9l1297t661r2130b752],
12	delL747	NN	O	dell747	prep_through	2	SENT_147	[p9l1297t661r2130b752],
13	.	.	O	.	_	0	SENT_147	[p9l1297t661r2130b752],

1	—	NN	O	—	_	0	SENT_148	[p9l1297t661r2130b752],
2	.	.	O	.	_	0	SENT_148	[p9l1297t661r2130b752],

1	P753insS	NN	O	p753inss	nn	2	SENT_149	[p9l1297t661r2130b752],
2	)	NN	O	)	_	0	SENT_149	[p9l1297t661r2130b752],
3	in	IN	O	in	_	0	SENT_149	[p9l10t790r91b867],
4	Patients	NNS	O	patient	prep_in	2	SENT_149	[p9l115t790r447b868],
5	3	CD	NUMBER	3	num	4	SENT_149	[p9l476t795r520b868],
6	and	CC	O	and	_	0	SENT_149	[p9l549t790r704b868],
7	4	CD	NUMBER	4	prep_in	2	SENT_149	[p9l728t795r801b868],
8	.	.	O	.	_	0	SENT_149	[p9l728t795r801b868],

1	The	DT	O	the	det	5	SENT_150	[p9l829t790r991b868],
2	second	JJ	ORDINAL	second	amod	5	SENT_150	[p9l1019t790r1314b868],
3	and	CC	ORDINAL	and	_	0	SENT_150	[p9l1339t790r1495b868],
4	third	JJ	ORDINAL	third	conj_and	2	SENT_150	[p9l1521t790r1725b868],
5	deletions	NNS	O	deletion	nsubjpass	7	SENT_150	[p9l1751t790r2133b868],
6	were	VBD	O	be	auxpass	7	SENT_150	[p9l6t944r207b997],
7	associated	VBN	O	associate	_	0	SENT_150	[p9l237t918r673b996],
8	with	IN	O	with	_	0	SENT_150	[p9l699t918r887b997],
9	the	DT	O	the	det	10	SENT_150	[p9l918t918r1046b996],
10	insertion	NN	O	insertion	prep_with	7	SENT_150	[p9l1075t918r1455b996],
11	of	IN	O	of	_	0	SENT_150	[p9l1485t917r1585b996],
12	a	DT	O	a	det	14	SENT_150	[p9l1596t944r1640b996],
13	serine	NN	O	serine	nn	14	SENT_150	[p9l1670t918r1921b996],
14	residue	NN	O	residue	prep_of	10	SENT_150	[p9l1951t918r2134b996, p9l11t1046r185b1141],
15	,	,	O	,	_	0	SENT_150	[p9l1951t918r2134b996, p9l11t1046r185b1141],
16	resulting	VBG	O	result	xcomp	7	SENT_150	[p9l211t1046r590b1146],
17	from	IN	O	from	_	0	SENT_150	[p9l607t1045r815b1124],
18	the	DT	O	the	det	19	SENT_150	[p9l837t1046r965b1124],
19	generation	NN	O	generation	prep_from	16	SENT_150	[p9l986t1046r1441b1146],
20	of	IN	O	of	_	0	SENT_150	[p9l1463t1045r1563b1124],
21	a	DT	O	a	det	23	SENT_150	[p9l1565t1072r1609b1124],
22	novel	JJ	O	novel	amod	23	SENT_150	[p9l1629t1046r1853b1125],
23	codon	NN	O	codon	prep_of	19	SENT_150	[p9l1874t1045r2135b1124],
24	at	IN	O	at	_	0	SENT_150	[p9l10t1190r88b1252],
25	the	DT	O	the	det	27	SENT_150	[p9l104t1174r232b1252],
26	deletion	NN	O	deletion	nn	27	SENT_150	[p9l254t1174r589b1252],
27	breakpoint	NN	O	breakpoint	prep_at	23	SENT_150	[p9l611t1174r1086b1274],
28	.	.	O	.	_	0	SENT_150	[p9l611t1174r1086b1274],

1	Remarkably	RB	O	remarkably	advmod	6	SENT_151	[p9l1112t1173r1625b1274],
2	,	,	O	,	_	0	SENT_151	[p9l1112t1173r1625b1274],
3	all	PDT	O	all	predet	5	SENT_151	[p9l1651t1174r1749b1252],
4	these	DT	O	these	det	5	SENT_151	[p9l1770t1174r1985b1252],
5	deletions	NNS	O	deletion	nsubj	6	SENT_151	[p9l2007t1174r2134b1252, p9l10t1302r285b1380],
6	overlapped	VBD	O	overlap	_	0	SENT_151	[p9l309t1302r785b1402],
7	,	,	O	,	_	0	SENT_151	[p9l309t1302r785b1402],
8	sharing	VBG	O	share	xcomp	6	SENT_151	[p9l814t1302r1129b1402],
9	the	DT	O	the	det	10	SENT_151	[p9l1148t1302r1275b1380],
10	deletion	NN	O	deletion	dobj	8	SENT_151	[p9l1297t1301r1630b1380],
11	of	IN	O	of	_	0	SENT_151	[p9l1652t1301r1752b1380],
12	four	CD	NUMBER	four	num	13	SENT_151	[p9l1754t1301r1929b1381],
13	amiFigure	NN	O	amifigure	prep_of	10	SENT_151	[p9l1947t1302r2135b1380, p9l406t2365r490b2396],

1	1	LS	NUMBER	1	_	0	SENT_152	[p9l501t2366r522b2389],
2	.	.	O	.	_	0	SENT_152	[p9l501t2366r522b2389],

1	Example	NN	O	example	_	0	SENT_153	[p9l534t2364r649b2396],
2	of	IN	O	of	_	0	SENT_153	[p9l658t2363r689b2389],
3	the	DT	O	the	det	4	SENT_153	[p9l692t2364r736b2389],
4	Response	NN	MISC	response	prep_of	1	SENT_153	[p9l747t2366r877b2396],
5	to	TO	MISC	to	_	0	SENT_153	[p9l885t2368r912b2389],
6	Geﬁtinib	NNP	MISC	Geﬁtinib	prep_to	4	SENT_153	[p9l921t2363r1039b2389],
7	in	IN	O	in	_	0	SENT_153	[p9l1049t2364r1072b2389],
8	a	DT	O	a	det	9	SENT_153	[p9l1083t2372r1097b2389],
9	Patient	NN	O	patient	prep_in	1	SENT_153	[p9l1108t2364r1203b2389],
10	with	IN	O	with	_	0	SENT_153	[p9l1210t2364r1268b2389],
11	Refractory	JJ	O	refractory	amod	12	SENT_153	[p9l1281t2363r1418b2397],
12	Non	NN	O	non	prep_with	9	SENT_153	[p9l1429t2364r1639b2389],
13	.	.	O	.	_	0	SENT_153	[p9l1429t2364r1639b2389],

1	—	NN	O	—	_	0	SENT_154	[p9l1429t2364r1639b2389],
2	.	.	O	.	_	0	SENT_154	[p9l1429t2364r1639b2389],

1	Sma	NN	O	sma	_	0	SENT_155	[p9l1429t2364r1639b2389],
2	|	CD	NUMBER	|	amod	1	SENT_155	[p9l1429t2364r1639b2389],
3	|	SYM	O	|	dep	5	SENT_155	[p9l1429t2364r1639b2389],
4	-	:	O	-	_	0	SENT_155	[p9l1429t2364r1639b2389],
5	Cell	NN	O	cell	dep	1	SENT_155	[p9l1429t2364r1639b2389],
6	Lung	NN	O	lung	dep	7	SENT_155	[p9l1651t2366r1718b2397],
7	Cancer	NN	O	cancer	dep	5	SENT_155	[p9l1726t2366r1825b2389],
8	.	.	O	.	_	0	SENT_155	[p9l1726t2366r1825b2389],

1	A	DT	O	a	det	3	SENT_156	[p9l404t2415r423b2439],
2	computed	JJ	O	computed	amod	3	SENT_156	[p9l432t2414r569b2447],
3	tomographic	JJ	O	tomographic	nsubj	10	SENT_156	[p9l580t2414r756b2447],
4	scan	VB	O	scan	rcmod	3	SENT_156	[p9l766t2423r826b2439],
5	ofthe	NN	O	ofthe	nn	6	SENT_156	[p9l837t2414r914b2439],
6	chest	NN	O	chest	dobj	4	SENT_156	[p9l924t2414r995b2439],
7	in	IN	O	in	_	0	SENT_156	[p9l1006t2416r1028b2439],
8	Patient	NN	O	patient	prep_in	4	SENT_156	[p9l1041t2416r1134b2439],
9	6	CD	NUMBER	6	num	8	SENT_156	[p9l1144t2416r1158b2439],
10	shows	VBZ	O	show	_	0	SENT_156	[p9l1169t2414r1253b2439],
11	a	DT	O	a	det	13	SENT_156	[p9l1264t2423r1277b2439],
12	large	JJ	O	large	amod	13	SENT_156	[p9l1289t2414r1353b2447],
13	mass	NN	O	mass	dobj	10	SENT_156	[p9l1364t2423r1434b2439],
14	in	IN	O	in	_	0	SENT_156	[p9l1446t2416r1467b2439],
15	the	DT	O	the	det	17	SENT_156	[p9l1478t2414r1520b2439],
16	right	JJ	O	right	amod	17	SENT_156	[p9l1532t2414r1593b2447],
17	lung	NN	O	lung	prep_in	13	SENT_156	[p9l1604t2414r1662b2447],
18	before	IN	O	before	_	0	SENT_156	[p9l1673t2414r1756b2439],
19	treatment	NN	O	treatment	prep_before	10	SENT_156	[p9l1765t2419r1900b2439],
20	with	IN	O	with	_	0	SENT_156	[p9l1909t2414r1965b2439],
21	gefir	NN	O	gefir	prep_with	19	SENT_156	[p9l1976t2414r2033b2447, p9l1320t2464r1328b2480],

1	gef	NN	O	gef	_	0	SENT_157	[p9l1337t2455r1384b2489],
2	‘	SYM	O	‘	dep	1	SENT_157	[p9l1337t2455r1384b2489],

1	tinib	NN	O	tinib	nsubjpass	3	SENT_158	[p9l404t2456r465b2481],
2	was	VBD	O	be	auxpass	3	SENT_158	[p9l474t2464r525b2481],
3	begun	VBN	O	begin	_	0	SENT_158	[p9l537t2456r618b2489],
4	(	CD	NUMBER	(	num	5	SENT_158	[p9l633t2456r714b2489],
5	Panel	NN	O	panel	dobj	3	SENT_158	[p9l633t2456r714b2489],
6	A	DT	O	a	det	10	SENT_158	[p9l725t2457r753b2488],
7	)	NN	O	)	nn	10	SENT_158	[p9l725t2457r753b2488],
8	and	CC	O	and	_	0	SENT_158	[p9l766t2456r814b2481],
9	marked	JJ	O	marked	nn	10	SENT_158	[p9l827t2456r926b2481],
10	improvement	NN	O	improvement	nsubj	13	SENT_158	[p9l938t2458r1122b2488],
11	six	CD	DURATION	six	num	12	SENT_158	[p9l1132t2458r1166b2481],
12	weeks	NNS	NUMBER	week	tmod	10	SENT_158	[p9l1174t2456r1256b2481],
13	afte	VBP	O	afte	rcmod	5	SENT_158	[p9l1267t2455r1316b2481],
14	[	JJ	O	[	amod	15	SENT_158	[p9l1380t2455r1447b2481],
15	tinib	NN	O	tinib	nsubjpass	17	SENT_158	[p9l1380t2455r1447b2481],
16	was	VBD	O	be	auxpass	17	SENT_158	[p9l1456t2464r1508b2481],
17	initiated	VBN	O	initiate	ccomp	13	SENT_158	[p9l1519t2455r1628b2481],
18	(	CD	NUMBER	(	num	21	SENT_158	[p9l1642t2455r1724b2489],
19	Panel	NN	O	panel	nn	21	SENT_158	[p9l1642t2455r1724b2489],
20	B	NN	O	b	nn	21	SENT_158	[p9l1737t2458r1772b2489],
21	)	NN	O	)	dobj	17	SENT_158	[p9l1737t2458r1772b2489],
22	.	.	O	.	_	0	SENT_158	[p9l1737t2458r1772b2489],

1	2132	CD	DATE	2132	num	3	SENT_159	[p9l93t2613r170b2635],
2	N	NN	O	n	nn	3	SENT_159	[p9l852t2615r866b2630],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_159	[p9l881t2614r965b2636],
4	MED	VBD	O	med	_	0	SENT_159	[p9l980t2615r1033b2630],
5	35o	CD	NUMBER	35o	num	7	SENT_159	[p9l1045t2614r1124b2636],
6	;	:	O	;	_	0	SENT_159	[p9l1045t2614r1124b2636],
7	21	CD	NUMBER	21	dobj	4	SENT_159	[p9l1045t2614r1124b2636],
8	WWW	NNP	O	WWW	dep	7	SENT_159	[p9l1161t2615r1273b2630],
9	.	.	O	.	_	0	SENT_159	[p9l1161t2615r1273b2630],

1	NE	NN	O	ne	nn	2	SENT_160	[p9l1161t2615r1273b2630],
2	M.ORG	NN	O	m.org	_	0	SENT_160	[p9l1289t2614r1373b2630],
3	MAY	NNP	DATE	MAY	dep	2	SENT_160	[p9l1412t2614r1463b2630],
4	20	CD	DATE	20	num	3	SENT_160	[p9l1475t2614r1514b2634],
5	,	,	DATE	,	_	0	SENT_160	[p9l1475t2614r1514b2634],
6	2004	CD	DATE	2004	num	3	SENT_160	[p9l1527t2614r1595b2636],

1	The	DT	O	the	det	5	SENT_161	[p9l880t2647r931b2671],
2	New	NNP	O	New	nn	5	SENT_161	[p9l940t2648r1002b2671],
3	England	NNP	O	England	nn	5	SENT_161	[p9l1011t2647r1122b2678],
4	Journal	NNP	O	Journal	nn	5	SENT_161	[p9l1131t2647r1228b2671],
5	o	NN	O	o	_	0	SENT_161	[p9l1238t2655r1253b2671],
6	edicine	NN	O	edicine	dep	5	SENT_161	[p9l1304t2647r1399b2671],

1	Downloaded	VBN	O	download	_	0	SENT_162	[p9l322t2688r492b2711],
2	from	IN	O	from	_	0	SENT_162	[p9l501t2688r565b2711],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_162	[p9l574t2688r692b2718],
4	at	IN	O	at	_	0	SENT_162	[p9l703t2692r726b2711],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_162	[p9l734t2688r917b2711],
6	on	IN	O	on	_	0	SENT_162	[p9l926t2695r958b2711],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_162	[p9l967t2688r1028b2711],
8	5	CD	DATE	5	num	7	SENT_162	[p9l1080t2688r1103b2715],
9	,	,	DATE	,	_	0	SENT_162	[p9l1080t2688r1103b2715],
10	2014	CD	DATE	2014	num	7	SENT_162	[p9l1113t2688r1185b2711],
11	.	.	O	.	_	0	SENT_162	[p9l1113t2688r1185b2711],

1	For	IN	O	for	_	0	SENT_163	[p9l1196t2688r1243b2711],
2	personal	JJ	O	personal	amod	3	SENT_163	[p9l1251t2688r1363b2718],
3	use	NN	O	use	pobj	1	SENT_163	[p9l1372t2695r1416b2711],
4	only	RB	O	only	advmod	3	SENT_163	[p9l1426t2688r1490b2718],
5	.	.	O	.	_	0	SENT_163	[p9l1426t2688r1490b2718],

1	No	DT	O	no	det	3	SENT_164	[p9l1501t2688r1541b2711],
2	other	JJ	O	other	amod	3	SENT_164	[p9l1551t2688r1619b2711],
3	uses	NNS	O	use	_	0	SENT_164	[p9l1627t2695r1683b2711],
4	without	IN	O	without	_	0	SENT_164	[p9l1693t2688r1794b2711],
5	permission	NN	O	permission	prep_without	3	SENT_164	[p9l1803t2688r1955b2718],
6	.	.	O	.	_	0	SENT_164	[p9l1803t2688r1955b2718],

1	Copyright	NN	O	copyright	nn	5	SENT_165	[p9l672t2729r807b2760],
2	©	CD	NUMBER	©	num	5	SENT_165	[p9l816t2729r840b2753],
3	2004	CD	DATE	2004	num	5	SENT_165	[p9l850t2729r915b2753],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_165	[p9l924t2730r1009b2753],
5	usetts	NNP	O	usetts	_	0	SENT_165	[p9l1041t2733r1115b2753],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_165	[p9l1125t2729r1233b2753],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_165	[p9l1244t2729r1349b2760],
8	.	.	O	.	_	0	SENT_165	[p9l1244t2729r1349b2760],

1	All	DT	O	all	det	2	SENT_166	[p9l1360t2729r1401b2753],
2	rights	NNS	O	rights	nsubj	3	SENT_166	[p9l1410t2729r1485b2760],
3	reserved	VBN	O	reserve	_	0	SENT_166	[p9l1495t2729r1614b2753],
4	.	.	O	.	_	0	SENT_166	[p9l1495t2729r1614b2753],

1	MUTATIONS	NNS	O	mutation	_	0	SENT_167	[p9l588t2835r788b2854],
2	IN	IN	O	in	_	0	SENT_167	[p9l803t2835r841b2854],
3	EGFR	NN	O	egfr	prep_in	1	SENT_167	[p9l857t2835r943b2854],
4	IN	IN	O	in	_	0	SENT_167	[p9l956t2835r994b2854],
5	NON	NNP	O	NON	prep_in	1	SENT_167	[p9l1010t2835r1314b2854],
6	.	.	O	.	_	0	SENT_167	[p9l1010t2835r1314b2854],

1	—	NN	O	—	_	0	SENT_168	[p9l1010t2835r1314b2854],
2	.	.	O	.	_	0	SENT_168	[p9l1010t2835r1314b2854],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_169	[p9l1010t2835r1314b2854],
2	LUNG	NN	O	lung	_	0	SENT_169	[p9l1328t2835r1423b2854],
3	CANCER	NNP	O	CANCER	dep	2	SENT_169	[p9l1436t2835r1572b2854],

1	no	DT	O	no	det	2	SENT_170	[p9l8t3075r113b3128],
2	acids	NNS	O	acid	_	0	SENT_170	[p9l138t3049r352b3128],
3	(	CD	NUMBER	(	num	4	SENT_170	[p9l386t3049r742b3145],
4	leucine	NN	O	leucine	dep	2	SENT_170	[p9l386t3049r742b3145],
5	,	,	O	,	_	0	SENT_170	[p9l386t3049r742b3145],
6	arginine	NN	O	arginine	dep	2	SENT_170	[p9l774t3050r1151b3150],
7	,	,	O	,	_	0	SENT_170	[p9l774t3050r1151b3150],
8	glutamic	JJ	O	glutamic	amod	9	SENT_170	[p9l1183t3050r1559b3150],
9	acid	NN	O	acid	dep	2	SENT_170	[p9l1585t3049r1780b3145],
10	,	,	O	,	_	0	SENT_170	[p9l1585t3049r1780b3145],
11	and	CC	O	and	_	0	SENT_170	[p9l1812t3049r1969b3128],
12	alanine	NN	O	alanine	dep	2	SENT_170	[p9l1995t3050r2147b3128, p9l8t3178r193b3256],
13	at	IN	O	at	_	0	SENT_170	[p9l217t3194r297b3256],
14	codons	NNS	O	codon	prep_at	2	SENT_170	[p9l319t3178r623b3256],
15	747	CD	NUMBER	747	rcmod	14	SENT_170	[p9l652t3183r805b3256],
16	through	IN	O	through	_	0	SENT_170	[p9l831t3177r1176b3278],
17	750	CD	NUMBER	750	number	18	SENT_170	[p9l1202t3183r1385b3269],
18	)	CD	NUMBER	)	prep_through	15	SENT_170	[p9l1202t3183r1385b3269],
19	Within	IN	O	within	dep	15	SENT_170	[p9l1412t3178r1688b3257],
20	exon	NN	O	exon	pobj	19	SENT_170	[p9l1714t3203r1915b3256],
21	19	CD	NUMBER	19	num	20	SENT_170	[p9l1944t3183r2066b3256],
22	.	.	O	.	_	0	SENT_170	[p9l1944t3183r2066b3256],

1	Another	DT	O	another	det	3	SENT_171	[p9l134t3306r487b3386],
2	three	CD	NUMBER	three	num	3	SENT_171	[p9l513t3307r726b3386],
3	tumors	NNS	O	tumor	nsubj	4	SENT_171	[p9l756t3323r1059b3387],
4	had	VBD	O	have	_	0	SENT_171	[p9l1090t3307r1246b3386],
5	amino	NN	O	amino	nn	7	SENT_171	[p9l1273t3307r1544b3386],
6	acid	NN	O	acid	nn	7	SENT_171	[p9l1573t3306r1745b3386],
7	substitutions	NNS	O	substitution	dobj	4	SENT_171	[p9l1775t3307r2147b3387, p9l8t3436r217b3514],
8	within	IN	O	within	_	0	SENT_171	[p9l246t3436r522b3515],
9	exon	NN	O	exon	prep_within	7	SENT_171	[p9l554t3461r756b3514],
10	21	CD	NUMBER	21	num	9	SENT_171	[p9l787t3441r913b3514],
11	:	:	O	:	_	0	SENT_171	[p9l787t3441r913b3514],
12	leucine	NN	O	leucine	dep	7	SENT_171	[p9l948t3435r1251b3515],
13	to	TO	O	to	_	0	SENT_171	[p9l1283t3452r1363b3514],
14	arginine	NN	O	arginine	prep_to	12	SENT_171	[p9l1395t3436r1748b3536],
15	at	IN	O	at	_	0	SENT_171	[p9l1779t3452r1858b3514],
16	codon	NN	O	codon	prep_at	14	SENT_171	[p9l1885t3435r2148b3514],
17	858	CD	NUMBER	858	number	18	SENT_171	[p9l8t3570r163b3643],
18	(	CD	NUMBER	(	num	20	SENT_171	[p9l215t3570r555b3656],
19	L858R	NN	O	l858r	nn	20	SENT_171	[p9l215t3570r555b3656],
20	)	NN	O	)	dep	35	SENT_171	[p9l215t3570r555b3656],
21	in	IN	O	in	_	0	SENT_171	[p9l605t3565r687b3642],
22	Patients	NNS	O	patient	prep_in	20	SENT_171	[p9l731t3565r1073b3643],
23	5	CD	NUMBER	5	num	22	SENT_171	[p9l1122t3572r1164b3643],
24	and	CC	O	and	_	0	SENT_171	[p9l1212t3564r1371b3643],
25	6	CD	NUMBER	6	prep_in	20	SENT_171	[p9l1416t3570r1463b3643],
26	and	CC	O	and	_	0	SENT_171	[p9l1508t3565r1667b3643],
27	leucine	NN	O	leucine	dep	35	SENT_171	[p9l1710t3565r2020b3644],
28	to	TO	O	to	_	0	SENT_171	[p9l2065t3581r2145b3643],
29	glutamine	NN	O	glutamine	prep_to	27	SENT_171	[p9l7t3693r448b3793],
30	at	IN	O	at	_	0	SENT_171	[p9l478t3709r558b3771],
31	codon	NN	O	codon	prep_at	29	SENT_171	[p9l585t3692r848b3771],
32	861	CD	NUMBER	861	dep	35	SENT_171	[p9l879t3698r1033b3771],
33	(	CD	NUMBER	(	num	35	SENT_171	[p9l1069t3698r1411b3791],
34	L861Q	NN	O	l861q	nn	35	SENT_171	[p9l1069t3698r1411b3791],
35	)	NN	O	)	dep	7	SENT_171	[p9l1069t3698r1411b3791],
36	in	IN	O	in	_	0	SENT_171	[p9l1446t3693r1528b3770],
37	Patient	NN	O	patient	prep_in	35	SENT_171	[p9l1557t3693r1855b3771],
38	7	CD	NUMBER	7	num	37	SENT_171	[p9l1882t3700r1953b3771],
39	.	.	O	.	_	0	SENT_171	[p9l1882t3700r1953b3771],

1	The	DT	O	the	_	0	SENT_172	[p9l1985t3693r2148b3771],

1	L861Q	NN	O	l861q	nn	2	SENT_173	[p10l7t26r299b119],
2	mutation	NN	O	mutation	nsubj	3	SENT_173	[p10l321t21r713b100],
3	is	VBZ	O	be	_	0	SENT_173	[p10l743t21r808b99],
4	of	IN	O	of	_	0	SENT_173	[p10l841t20r942b99],
5	particular	JJ	O	particular	amod	6	SENT_173	[p10l952t21r1367b121],
6	interest	NN	O	interest	prep_of	3	SENT_173	[p10l1393t21r1735b116],
7	,	,	O	,	_	0	SENT_173	[p10l1393t21r1735b116],
8	since	IN	O	since	mark	20	SENT_173	[p10l1772t21r1987b99],
9	the	DT	O	the	det	13	SENT_173	[p10l2018t21r2148b99],
10	same	JJ	O	same	amod	13	SENT_173	[p10l9t175r228b227],
11	amino	NN	O	amino	nn	13	SENT_173	[p10l259t149r529b227],
12	acid	NN	O	acid	nn	13	SENT_173	[p10l561t148r733b227],
13	change	NN	O	change	nsubj	20	SENT_173	[p10l765t149r1068b249],
14	in	IN	O	in	_	0	SENT_173	[p10l1099t149r1181b226],
15	the	DT	O	the	det	18	SENT_173	[p10l1212t149r1342b227],
16	mouse	NN	O	mouse	nn	18	SENT_173	[p10l1373t174r1656b228],
17	egfr	NN	O	egfr	nn	18	SENT_173	[p10l1689t148r1824b249],
18	gene	NN	O	gene	prep_in	13	SENT_173	[p10l1849t174r2049b249],
19	is	VBZ	O	be	cop	20	SENT_173	[p10l2080t149r2145b227],
20	responsible	JJ	O	responsible	advcl	3	SENT_173	[p10l8t277r501b377],
21	for	IN	O	for	_	0	SENT_173	[p10l524t276r648b355],
22	the	DT	O	the	det	26	SENT_173	[p10l668t276r798b355],
23	Dark	JJ	MISC	dark	amod	26	SENT_173	[p10l819t277r1032b356],
24	Skin	NN	MISC	skin	nn	26	SENT_173	[p10l1052t276r1238b356],
25	(	NN	O	(	nn	26	SENT_173	[p10l1265t277r1526b368],
26	dsk5	NN	O	dsk5	prep_for	20	SENT_173	[p10l1265t277r1526b368],
27	)	CD	NUMBER	)	num	28	SENT_173	[p10l1265t277r1526b368],
28	trait	NN	O	trait	dep	26	SENT_173	[p10l1555t277r1749b372],
29	,	,	O	,	_	0	SENT_173	[p10l1555t277r1749b372],
30	associated	VBN	O	associate	partmod	26	SENT_173	[p10l1776t277r2147b355, p10l8t405r105b484],
31	with	IN	O	with	_	0	SENT_173	[p10l143t405r334b485],
32	altered	JJ	O	altered	amod	34	SENT_173	[p10l376t405r665b484],
33	EGFR	NN	O	egfr	nn	34	SENT_173	[p10l705t411r966b489],
34	signaling	NN	O	signaling	prep_with	30	SENT_173	[p10l1000t399r1504b506],
35	.	.	O	.	_	0	SENT_173	[p10l1000t399r1504b506],

1	”	NN	O	”	nn	2	SENT_174	[p10l1000t399r1504b506],
2	A	NN	O	a	nsubj	11	SENT_174	[p10l1544t412r1611b483],
3	fourth	JJ	ORDINAL	fourth	amod	5	SENT_174	[p10l1650t404r1916b485],
4	missense	NN	O	missense	nn	5	SENT_174	[p10l1958t406r2147b484, p10l9t559r241b612],
5	mutation	NN	O	mutation	dep	2	SENT_174	[p10l277t534r669b613],
6	in	IN	O	in	_	0	SENT_174	[p10l705t534r786b611],
7	the	DT	O	the	det	10	SENT_174	[p10l823t533r952b612],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_174	[p10l990t534r1327b634],
9	kinase	NN	O	kinase	nn	10	SENT_174	[p10l1363t533r1636b613],
10	domain	NN	O	domain	prep_in	2	SENT_174	[p10l1672t533r1999b612],
11	resulted	VBD	O	result	_	0	SENT_174	[p10l2035t560r2147b612, p10l9t661r263b741],
12	in	IN	O	in	_	0	SENT_174	[p10l294t662r375b739],
13	the	DT	O	the	det	14	SENT_174	[p10l407t661r536b740],
14	substitution	NN	O	substitution	prep_in	11	SENT_174	[p10l570t662r1080b741],
15	of	IN	O	of	_	0	SENT_174	[p10l1112t661r1213b740],
16	cysteine	NN	O	cysteine	prep_of	14	SENT_174	[p10l1226t662r1562b762],
17	for	IN	O	for	_	0	SENT_174	[p10l1593t661r1718b740],
18	glycine	NN	O	glycine	prep_for	16	SENT_174	[p10l1745t662r2043b762],
19	at	IN	O	at	_	0	SENT_174	[p10l2074t678r2153b740],
20	codon	NN	O	codon	prep_at	11	SENT_174	[p10l8t791r271b869],
21	719	CD	NUMBER	719	num	20	SENT_174	[p10l298t796r451b869],
22	within	IN	O	within	_	0	SENT_174	[p10l472t791r749b870],
23	exon	NN	O	exon	prep_within	20	SENT_174	[p10l775t816r977b869],
24	18	CD	NUMBER	18	number	25	SENT_174	[p10l1005t796r1102b869],
25	(	CD	NUMBER	(	num	27	SENT_174	[p10l1134t796r1490b882],
26	G719C	NN	O	g719c	nn	27	SENT_174	[p10l1134t796r1490b882],
27	)	NN	O	)	dobj	11	SENT_174	[p10l1134t796r1490b882],
28	in	IN	O	in	_	0	SENT_174	[p10l1520t791r1602b868],
29	Patient	NN	O	patient	prep_in	27	SENT_174	[p10l1625t791r1924b869],
30	8	CD	NUMBER	8	num	29	SENT_174	[p10l1945t796r2016b869],
31	.	.	O	.	_	0	SENT_174	[p10l1945t796r2016b869],

1	Matched	VBN	O	match	_	0	SENT_175	[p10l134t919r510b999],
2	normal	JJ	O	normal	amod	3	SENT_175	[p10l557t920r872b999],
3	tissue	NN	O	tissue	dobj	1	SENT_175	[p10l918t920r1167b1000],
4	was	VBD	O	be	cop	5	SENT_175	[p10l1209t946r1373b1000],
5	available	JJ	O	available	auxpass	1	SENT_175	[p10l1421t919r1797b1000],
6	for	IN	O	for	mark	7	SENT_175	[p10l1844t919r1970b999],
7	Patients	NNS	O	patient	dep	5	SENT_175	[p10l2012t926r2145b999, p10l8t1049r245b1127],
8	1	CD	NUMBER	1	num	7	SENT_175	[p10l279t1054r349b1144],
9	,	,	O	,	_	0	SENT_175	[p10l279t1054r349b1144],
10	4	CD	NUMBER	4	num	7	SENT_175	[p10l381t1054r457b1144],
11	,	,	O	,	_	0	SENT_175	[p10l381t1054r457b1144],
12	5	CD	NUMBER	5	num	7	SENT_175	[p10l493t1056r564b1144],
13	,	,	O	,	_	0	SENT_175	[p10l493t1056r564b1144],
14	and	CC	NUMBER	and	_	0	SENT_175	[p10l597t1049r755b1127],
15	6	CD	NUMBER	6	conj_and	7	SENT_175	[p10l781t1054r829b1127],
16	and	CC	O	and	_	0	SENT_175	[p10l855t1048r1012b1127],
17	showed	VBD	O	show	auxpass	1	SENT_175	[p10l1040t1049r1366b1128],
18	only	RB	O	only	advmod	17	SENT_175	[p10l1394t1048r1576b1149],
19	the	DT	O	the	det	23	SENT_175	[p10l1599t1048r1728b1127],
20	Wild	NNP	O	Wild	nn	23	SENT_175	[p10l1751t1049r2148b1149],
21	—	CD	NUMBER	—	num	23	SENT_175	[p10l1751t1049r2148b1149],
22	type	NN	O	type	nn	23	SENT_175	[p10l1751t1049r2148b1149],
23	sequence	NN	O	sequence	nsubjpass	1	SENT_175	[p10l9t1202r423b1277],
24	,	,	O	,	_	0	SENT_175	[p10l9t1202r423b1277],
25	indicating	VBG	O	indicate	partmod	23	SENT_175	[p10l453t1177r887b1277],
26	that	IN	O	that	complm	30	SENT_175	[p10l908t1177r1076b1255],
27	the	DT	O	the	det	28	SENT_175	[p10l1096t1176r1226b1255],
28	mutations	NNS	O	mutation	nsubj	30	SENT_175	[p10l1251t1177r1684b1256],
29	had	VBD	O	have	aux	30	SENT_175	[p10l1711t1176r1867b1255],
30	arisen	VBN	O	arise	ccomp	25	SENT_175	[p10l1891t1177r2148b1255],
31	somatically	RB	O	somatically	advmod	30	SENT_175	[p10l9t1304r493b1405],
32	during	IN	O	during	_	0	SENT_175	[p10l523t1304r809b1405],
33	tumor	NN	O	tumor	nn	34	SENT_175	[p10l840t1321r1105b1384],
34	formation	NN	O	formation	prep_during	30	SENT_175	[p10l1136t1304r1588b1383],
35	.	.	O	.	_	0	SENT_175	[p10l1136t1304r1588b1383],

1	By	IN	O	by	_	0	SENT_176	[p10l1626t1311r1732b1405],
2	comparison	NN	O	comparison	agent	7	SENT_176	[p10l1762t1305r2147b1405, p10l12t1458r184b1528],
3	,	,	O	,	_	0	SENT_176	[p10l1762t1305r2147b1405, p10l12t1458r184b1528],
4	no	DT	O	no	det	5	SENT_176	[p10l216t1458r322b1511],
5	mutations	NNS	O	mutation	nsubjpass	7	SENT_176	[p10l350t1433r781b1512],
6	were	VBD	O	be	auxpass	7	SENT_176	[p10l805t1459r1006b1512],
7	observed	VBN	O	observe	_	0	SENT_176	[p10l1034t1432r1410b1512],
8	in	IN	O	in	_	0	SENT_176	[p10l1435t1433r1516b1510],
9	seven	CD	NUMBER	seven	num	10	SENT_176	[p10l1544t1458r1774b1512],
10	patients	NNS	O	patient	prep_in	7	SENT_176	[p10l1798t1433r2133b1533],
11	With	IN	O	with	_	0	SENT_176	[p10l6t1561r196b1640],
12	non	JJ	O	non	amod	18	SENT_176	[p10l231t1560r863b1639],
13	—	JJ	O	—	amod	18	SENT_176	[p10l231t1560r863b1639],
14	small	JJ	O	small	amod	18	SENT_176	[p10l231t1560r863b1639],
15	—	NN	O	—	nn	18	SENT_176	[p10l231t1560r863b1639],
16	cell	NN	O	cell	nn	18	SENT_176	[p10l231t1560r863b1639],
17	lung	NN	O	lung	nn	18	SENT_176	[p10l897t1561r1091b1661],
18	cancer	NN	O	cancer	prep_with	10	SENT_176	[p10l1124t1586r1399b1639],
19	who	WP	O	who	nsubj	21	SENT_176	[p10l1427t1561r1610b1640],
20	had	VBD	O	have	aux	21	SENT_176	[p10l1647t1561r1802b1639],
21	had	VBN	O	have	rcmod	10	SENT_176	[p10l1838t1560r1993b1639],
22	no	DT	O	no	det	23	SENT_176	[p10l2028t1586r2134b1639],
23	response	NN	O	response	dobj	21	SENT_176	[p10l11t1714r389b1789],
24	to	TO	O	to	_	0	SENT_176	[p10l414t1705r493b1767],
25	geﬁtinib	NN	O	geﬁtinib	prep_to	21	SENT_176	[p10l517t1688r872b1789],
26	(	CD	NUMBER	(	num	27	SENT_176	[p10l901t1694r1280b1780],
27	P	NN	O	p	npadvmod	28	SENT_176	[p10l901t1694r1280b1780],
28	<	JJR	O	<	amod	25	SENT_176	[p10l901t1694r1280b1780],
29	0.001	CD	NUMBER	0.001	nsubj	34	SENT_176	[p10l901t1694r1280b1780],
30	by	IN	O	by	_	0	SENT_176	[p10l1304t1688r1401b1789],
31	a	DT	O	a	det	33	SENT_176	[p10l1419t1715r1463b1767],
32	tvvo	NN	O	tvvo	nn	33	SENT_176	[p10l1486t1688r1901b1768],
33	—	NN	O	—	prep_by	29	SENT_176	[p10l1486t1688r1901b1768],
34	sided	VBD	O	side	ccomp	28	SENT_176	[p10l1486t1688r1901b1768],
35	Fisher	NNP	PERSON	Fisher	poss	39	SENT_176	[p10l1923t1689r2134b1767, p10l11t1822r158b1894],
36	’s	POS	O	’s	_	0	SENT_176	[p10l1923t1689r2134b1767, p10l11t1822r158b1894],
37	exact	JJ	O	exact	amod	39	SENT_176	[p10l186t1832r402b1894],
38	test	NN	O	test	nn	39	SENT_176	[p10l423t1823r627b1907],
39	)	NN	O	)	dobj	34	SENT_176	[p10l423t1823r627b1907],
40	.	.	O	.	_	0	SENT_176	[p10l423t1823r627b1907],

1	PREVALENCE	NN	O	prevalence	_	0	SENT_177	[p10l16t2101r538b2151],
2	OF	IN	O	of	_	0	SENT_177	[p10l579t2101r683b2150],
3	SPECIFIC	JJ	O	specific	amod	5	SENT_177	[p10l722t2101r1094b2150],
4	EGFR	NN	O	egfr	nn	5	SENT_177	[p10l1133t2101r1340b2150],
5	MUTATIONS	NNS	O	mutation	prep_of	1	SENT_177	[p10l1385t2101r1882b2150],
6	IN	IN	O	in	_	0	SENT_177	[p10l16t2186r96b2234],
7	NON	NNP	O	NON	prep_in	1	SENT_177	[p10l149t2185r904b2235],
8	.	.	O	.	_	0	SENT_177	[p10l149t2185r904b2235],

1	—	NN	O	—	_	0	SENT_178	[p10l149t2185r904b2235],
2	.	.	O	.	_	0	SENT_178	[p10l149t2185r904b2235],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_179	[p10l149t2185r904b2235],
2	LUNG	NN	O	lung	nsubjpass	42	SENT_179	[p10l947t2185r1173b2235],
3	CANCER	NNP	O	CANCER	nn	6	SENT_179	[p10l1216t2185r1543b2235],
4	AND	CC	O	and	_	0	SENT_179	[p10l9t2269r187b2318],
5	OTHER	NNP	O	OTHER	conj_and	3	SENT_179	[p10l227t2269r506b2318],
6	TYPES	NNPS	O	TYPES	dep	2	SENT_179	[p10l543t2269r786b2318],
7	OF	IN	O	of	_	0	SENT_179	[p10l826t2269r931b2318],
8	CANCER	NNP	O	CANCER	prep_of	2	SENT_179	[p10l970t2269r1296b2318],
9	Unlike	IN	O	unlike	_	0	SENT_179	[p10l10t2370r287b2449],
10	gliomas	NNS	O	glioma	prep_unlike	42	SENT_179	[p10l312t2370r669b2470],
11	,	,	O	,	_	0	SENT_179	[p10l312t2370r669b2470],
12	in	IN	O	in	_	0	SENT_179	[p10l699t2370r779b2447],
13	which	WDT	O	which	rel	23	SENT_179	[p10l799t2369r1058b2449],
14	rearrangements	NNS	O	rearrangement	nsubjpass	23	SENT_179	[p10l1082t2386r1743b2470],
15	affecting	VBG	O	affect	partmod	14	SENT_179	[p10l1770t2369r2139b2470],
16	the	DT	O	the	det	19	SENT_179	[p10l11t2498r139b2576],
17	EGFR	NN	O	egfr	nn	19	SENT_179	[p10l176t2503r438b2581],
18	extracellular	JJ	O	extracellular	amod	19	SENT_179	[p10l466t2497r1000b2577],
19	domain	NN	O	domain	dobj	15	SENT_179	[p10l1035t2498r1365b2576],
20	have	VBP	O	have	aux	23	SENT_179	[p10l1402t2498r1593b2577],
21	been	VBN	O	be	auxpass	23	SENT_179	[p10l1633t2498r1835b2576],
22	extensively	RB	O	extensively	advmod	23	SENT_179	[p10l1874t2514r2134b2576, p10l12t2626r238b2726],
23	studied	VBN	O	study	rcmod	10	SENT_179	[p10l257t2626r584b2721],
24	,	,	O	,	_	0	SENT_179	[p10l257t2626r584b2721],
25	15	CD	NUMBER	15	appos	10	SENT_179	[p10l597t2620r667b2667],
26	the	DT	O	the	det	27	SENT_179	[p10l694t2626r822b2704],
27	frequency	NN	O	frequency	dep	25	SENT_179	[p10l844t2625r1258b2726],
28	of	IN	O	of	_	0	SENT_179	[p10l1276t2625r1376b2704],
29	EGFR	NN	O	egfr	nn	30	SENT_179	[p10l1378t2633r1589b2705],
30	mutations	NNS	O	mutation	prep_of	27	SENT_179	[p10l1605t2627r2031b2705],
31	in	IN	O	in	_	0	SENT_179	[p10l2055t2627r2135b2703],
32	non	JJ	O	non	amod	38	SENT_179	[p10l11t2753r649b2832],
33	—	JJ	O	—	amod	38	SENT_179	[p10l11t2753r649b2832],
34	small	JJ	O	small	amod	38	SENT_179	[p10l11t2753r649b2832],
35	—	NN	O	—	nn	38	SENT_179	[p10l11t2753r649b2832],
36	cell	NN	O	cell	nn	38	SENT_179	[p10l11t2753r649b2832],
37	lung	NN	O	lung	nn	38	SENT_179	[p10l680t2754r874b2854],
38	cancer	NN	O	cancer	prep_in	30	SENT_179	[p10l904t2779r1179b2832],
39	has	VBZ	O	have	aux	42	SENT_179	[p10l1210t2754r1351b2832],
40	not	RB	O	not	neg	42	SENT_179	[p10l1385t2770r1529b2832],
41	been	VBN	O	be	auxpass	42	SENT_179	[p10l1558t2754r1757b2832],
42	defined	VBN	O	define	_	0	SENT_179	[p10l1791t2753r2130b2832],
43	.	.	O	.	_	0	SENT_179	[p10l1791t2753r2130b2832],

1	We	PRP	O	we	nsubj	3	SENT_180	[p10l7t2889r140b2960],
2	therefore	RB	O	therefore	advmod	3	SENT_180	[p10l162t2881r546b2960],
3	sequenced	VBD	O	sequence	_	0	SENT_180	[p10l570t2882r1013b2982],
4	the	DT	O	the	det	7	SENT_180	[p10l1034t2882r1163b2960],
5	entire	JJ	O	entire	amod	7	SENT_180	[p10l1186t2882r1426b2960],
6	coding	NN	O	coding	nn	7	SENT_180	[p10l1448t2881r1740b2982],
7	region	NN	O	region	dobj	3	SENT_180	[p10l1758t2882r2031b2982],
8	of	IN	O	of	_	0	SENT_180	[p10l2053t2881r2153b2960],
9	the	DT	O	the	det	10	SENT_180	[p10l11t3010r140b3088],
10	gene	NN	O	gene	prep_of	7	SENT_180	[p10l172t3035r370b3110],
11	in	IN	O	in	_	0	SENT_180	[p10l402t3010r483b3087],
12	tumors	NNS	O	tumor	prep_in	10	SENT_180	[p10l515t3026r816b3089],
13	from	IN	O	from	_	0	SENT_180	[p10l850t3009r1058b3088],
14	25	CD	NUMBER	25	num	15	SENT_180	[p10l1088t3015r1186b3088],
15	patients	NNS	O	patient	prep_from	3	SENT_180	[p10l1220t3010r1555b3110],
16	With	IN	O	with	_	0	SENT_180	[p10l1584t3010r1774b3089],
17	primary	JJ	O	primary	amod	19	SENT_180	[p10l1803t3010r2140b3110],
18	non	JJ	O	non	amod	19	SENT_180	[p10l11t3137r642b3216],
19	—	NN	O	—	prep_with	15	SENT_180	[p10l11t3137r642b3216],
20	small	JJ	O	small	amod	24	SENT_180	[p10l11t3137r642b3216],
21	—	NN	O	—	nn	24	SENT_180	[p10l11t3137r642b3216],
22	cell	NN	O	cell	nn	24	SENT_180	[p10l11t3137r642b3216],
23	lung	NN	O	lung	nn	24	SENT_180	[p10l669t3138r863b3238],
24	cancer	NN	O	cancer	dep	19	SENT_180	[p10l887t3163r1162b3216],
25	who	WP	O	who	nsubjpass	28	SENT_180	[p10l1183t3138r1366b3217],
26	were	VBD	O	be	auxpass	28	SENT_180	[p10l1390t3164r1592b3217],
27	not	RB	O	not	neg	28	SENT_180	[p10l1620t3154r1763b3216],
28	involved	VBN	O	involve	rcmod	24	SENT_180	[p10l1785t3137r2135b3217],
29	in	IN	O	in	_	0	SENT_180	[p10l10t3266r91b3343],
30	the	DT	O	the	det	32	SENT_180	[p10l114t3266r243b3344],
31	geﬁtinib	NN	O	geﬁtinib	nn	32	SENT_180	[p10l265t3265r620b3366],
32	study	NN	O	study	prep_in	28	SENT_180	[p10l646t3265r882b3366],
33	,	,	O	,	_	0	SENT_180	[p10l646t3265r882b3366],
34	including	VBG	O	include	_	0	SENT_180	[p10l910t3265r1317b3366],
35	15	CD	NUMBER	15	prep_including	19	SENT_180	[p10l1340t3271r1434b3344],
36	With	IN	O	with	_	0	SENT_180	[p10l1455t3266r1645b3345],
37	bronchoal	JJ	O	bronchoal	amod	41	SENT_180	[p10l1668t3265r2133b3344],
38	—	NN	O	—	nn	41	SENT_180	[p10l1668t3265r2133b3344],
39	veolar	JJ	O	veolar	amod	41	SENT_180	[p10l6t3394r260b3473],
40	lung	NN	O	lung	nn	41	SENT_180	[p10l286t3394r476b3494],
41	cancer	NN	O	cancer	prep_with	35	SENT_180	[p10l504t3419r788b3489],
42	,	,	O	,	_	0	SENT_180	[p10l504t3419r788b3489],
43	which	WDT	O	which	nsubjpass	46	SENT_180	[p10l819t3394r1074b3473],
44	has	VBZ	O	have	aux	46	SENT_180	[p10l1104t3394r1242b3472],
45	been	VBN	O	be	auxpass	46	SENT_180	[p10l1275t3394r1471b3472],
46	associated	VBN	O	associate	rcmod	19	SENT_180	[p10l1500t3394r1926b3472],
47	with	IN	O	with	prep	46	SENT_180	[p10l1951t3393r2136b3473],

1	Table	NNP	O	Table	_	0	SENT_181	[p11l120t79r191b104],
2	2	CD	NUMBER	2	dep	1	SENT_181	[p11l200t81r223b104],
3	.	.	O	.	_	0	SENT_181	[p11l200t81r223b104],

1	Somatic	JJ	O	somatic	amod	2	SENT_182	[p11l233t79r344b104],
2	Mutations	NNS	O	mutation	_	0	SENT_182	[p11l355t79r493b104],
3	in	IN	O	in	_	0	SENT_182	[p11l503t79r526b103],
4	the	DT	O	the	det	8	SENT_182	[p11l536t78r580b104],
5	Tyrosine	NN	MISC	tyrosine	nn	8	SENT_182	[p11l588t79r702b111],
6	Kinase	NN	MISC	kinase	nn	8	SENT_182	[p11l713t79r802b104],
7	Domain	NN	MISC	domain	nn	8	SENT_182	[p11l813t79r919b104],
8	ofEGFR	NN	O	ofegfr	prep_in	2	SENT_182	[p11l929t78r1041b104],
9	in	IN	O	in	_	0	SENT_182	[p11l1051t79r1074b103],
10	Patients	NNS	O	patient	prep_in	2	SENT_182	[p11l1086t79r1194b104],
11	with	IN	O	with	_	0	SENT_182	[p11l1203t78r1261b104],
12	Non	NN	O	non	prep_with	10	SENT_182	[p11l1274t78r1484b104],
13	.	.	O	.	_	0	SENT_182	[p11l1274t78r1484b104],

1	—	NN	O	—	_	0	SENT_183	[p11l1274t78r1484b104],
2	.	.	O	.	_	0	SENT_183	[p11l1274t78r1484b104],

1	Sma	FW	O	sma	nn	4	SENT_184	[p11l1274t78r1484b104],
2	|	FW	O	|	nn	4	SENT_184	[p11l1274t78r1484b104],
3	l-Cell	NN	O	l-cell	nn	4	SENT_184	[p11l1274t78r1484b104],
4	Lung	NN	O	lung	_	0	SENT_184	[p11l1496t81r1563b111],
5	Cancer	NN	O	cancer	dep	4	SENT_184	[p11l1572t80r1670b104],
6	.	.	O	.	_	0	SENT_184	[p11l1572t80r1670b104],

1	Patient	NN	O	patient	nn	2	SENT_185	[p11l123t154r217b179],
2	Patients	NNS	O	patient	_	0	SENT_185	[p11l123t224r231b249],
3	with	IN	O	with	dep	2	SENT_185	[p11l240t223r298b248],
4	a	DT	O	a	det	5	SENT_185	[p11l309t232r323b248],
5	response	NN	O	response	pobj	3	SENT_185	[p11l333t232r456b256],
6	to	TO	O	to	aux	7	SENT_185	[p11l464t227r491b249],
7	geﬁtinib	VB	O	geﬁtinib	infmod	5	SENT_185	[p11l500t223r612b256],
8	Patient	NN	O	patient	dobj	7	SENT_185	[p11l123t284r217b307],
9	1	CD	NUMBER	1	num	8	SENT_185	[p11l228t284r239b306],

1	Patient	NN	O	patient	_	0	SENT_186	[p11l123t380r217b403],
2	2	CD	NUMBER	2	num	1	SENT_186	[p11l226t380r240b402],

1	Patient	NN	O	patient	_	0	SENT_187	[p11l123t476r217b499],
2	3	CD	NUMBER	3	num	1	SENT_187	[p11l227t475r239b498],

1	Patient	NN	O	patient	_	0	SENT_188	[p11l123t572r217b594],
2	4	CD	NUMBER	4	num	1	SENT_188	[p11l226t571r240b594],

1	Patient	NN	O	patient	_	0	SENT_189	[p11l123t667r217b690],
2	5	CD	NUMBER	5	num	1	SENT_189	[p11l227t667r239b690],

1	Patient	NN	O	patient	_	0	SENT_190	[p11l123t763r217b786],
2	6	CD	NUMBER	6	num	1	SENT_190	[p11l227t763r240b786],

1	Patient	NN	O	patient	_	0	SENT_191	[p11l123t859r217b882],
2	7	CD	NUMBER	7	num	1	SENT_191	[p11l228t859r240b882],

1	Patient	NN	O	patient	_	0	SENT_192	[p11l123t955r217b978],
2	8	CD	NUMBER	8	num	1	SENT_192	[p11l226t954r240b978],

1	Patients	NNS	O	patient	_	0	SENT_193	[p11l123t1049r231b1074],
2	with	IN	O	with	_	0	SENT_193	[p11l240t1049r298b1074],
3	no	DT	O	no	det	4	SENT_193	[p11l310t1057r342b1074],
4	exposure	NN	O	exposure	prep_with	1	SENT_193	[p11l351t1057r476b1081],
5	to	TO	O	to	_	0	SENT_193	[p11l484t1053r511b1074],
6	gefitinib	NN	O	gefitinib	nn	9	SENT_193	[p11l520t1048r648b1082],
7	*	CD	NUMBER	*	num	9	SENT_193	[p11l520t1048r648b1082],
8	Patient	NN	O	patient	nn	9	SENT_193	[p11l123t1109r217b1132],
9	A	NN	O	a	prep_to	1	SENT_193	[p11l225t1109r244b1132],

1	Patient	NN	O	patient	nn	4	SENT_194	[p11l123t1226r217b1249],
2	B	NN	O	b	nn	4	SENT_194	[p11l228t1226r243b1249],
3	M	NN	O	m	nn	4	SENT_194	[p11l898t156r921b178],
4	utation	NN	O	utation	_	0	SENT_194	[p11l926t154r1021b179],

1	Deletion	NN	O	deletion	_	0	SENT_195	[p11l717t282r828b307],
2	of15	NN	O	of15	nn	3	SENT_195	[p11l840t281r904b307],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_195	[p11l917t282r1072b307],

1	Deletion	NN	O	deletion	_	0	SENT_196	[p11l717t378r828b403],
2	of12	NN	O	of12	nn	3	SENT_196	[p11l840t377r905b403],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_196	[p11l917t378r1072b403],

1	Deletion	NN	O	deletion	_	0	SENT_197	[p11l717t473r828b499],
2	of18	NN	O	of18	nn	3	SENT_197	[p11l840t473r905b499],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_197	[p11l917t473r1072b499],

1	Deletion	NN	O	deletion	_	0	SENT_198	[p11l717t569r828b594],
2	of18	NN	O	of18	nn	3	SENT_198	[p11l840t569r905b595],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_198	[p11l917t569r1072b594],

1	Substitution	NN	O	substitution	nn	3	SENT_199	[p11l715t665r880b690],
2	ofG	NN	O	ofg	nn	3	SENT_199	[p11l890t665r943b690],
3	forT	NN	O	fort	_	0	SENT_199	[p11l953t665r1015b690],
4	at	IN	O	at	_	0	SENT_199	[p11l1023t670r1047b690],
5	nucleotide	NN	O	nucleotide	nn	9	SENT_199	[p11l1056t665r1197b690],
6	2573	CD	DATE	2573	num	9	SENT_199	[p11l764t705r827b728],
7	Substitution	NN	O	substitution	nn	9	SENT_199	[p11l715t761r880b786],
8	ofG	NN	O	ofg	nn	9	SENT_199	[p11l890t761r943b786],
9	forT	NN	O	fort	prep_at	3	SENT_199	[p11l953t761r1015b786],
10	at	IN	O	at	dep	3	SENT_199	[p11l1023t766r1047b786],
11	nucleotide	NN	O	nucleotide	nn	15	SENT_199	[p11l1056t761r1197b786],
12	2573	CD	DATE	2573	num	15	SENT_199	[p11l764t801r827b824],
13	Substitution	NN	O	substitution	nn	15	SENT_199	[p11l715t857r880b882],
14	ofA	NN	O	ofa	nn	15	SENT_199	[p11l891t857r943b882],
15	forT	NN	O	fort	pobj	10	SENT_199	[p11l951t857r1013b882],
16	at	IN	O	at	dep	3	SENT_199	[p11l1022t862r1046b882],
17	nucleotide	NN	O	nucleotide	pobj	16	SENT_199	[p11l1056t857r1196b882],

1	Substitution	NN	O	substitution	nn	2	SENT_200	[p11l715t953r880b978],
2	ofT	NN	O	oft	_	0	SENT_200	[p11l890t953r940b978],
3	for	IN	O	for	_	0	SENT_200	[p11l947t953r985b978],
4	G	NN	O	g	prep_for	2	SENT_200	[p11l993t955r1012b978],
5	at	IN	O	at	_	0	SENT_200	[p11l1023t958r1047b978],
6	nucleotide	NN	O	nucleotide	prep_at	2	SENT_200	[p11l1056t953r1197b978],
7	2155	CD	DATE	2155	num	6	SENT_200	[p11l764t993r827b1016],

1	Deletion	NN	O	deletion	_	0	SENT_201	[p11l717t1107r828b1132],
2	of18	NN	O	of18	nn	3	SENT_201	[p11l840t1107r905b1132],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_201	[p11l917t1107r1072b1132],

1	Deletion	NN	O	deletion	_	0	SENT_202	[p11l717t1224r828b1249],
2	of15	NN	O	of15	nn	3	SENT_202	[p11l840t1223r904b1249],
3	nucleotides	NNS	O	nucleotide	dep	1	SENT_202	[p11l917t1224r1072b1249],

1	Effect	NN	O	effect	_	0	SENT_203	[p11l1391t153r1466b179],
2	of	IN	O	of	_	0	SENT_203	[p11l1474t153r1506b179],
3	Mutation	NN	O	mutation	prep_of	1	SENT_203	[p11l1511t154r1634b179],

1	In-frame	RB	O	in-frame	dep	2	SENT_204	[p11l1271t281r1384b307],
2	deletion	NN	O	deletion	dep	7	SENT_204	[p11l1394t282r1502b307],
3	(	CD	NUMBER	(	num	2	SENT_204	[p11l1516t283r1649b315],
4	746-750	CD	NUMBER	746-750	number	5	SENT_204	[p11l1516t283r1649b315],
5	)	CD	NUMBER	)	num	7	SENT_204	[p11l1516t283r1649b315],
6	In-frame	JJ	O	in-frame	amod	7	SENT_204	[p11l1271t377r1384b403],
7	deletion	NN	O	deletion	dep	30	SENT_204	[p11l1394t378r1502b403],
8	(	CD	NUMBER	(	num	10	SENT_204	[p11l1516t380r1649b411],
9	747-751	CD	NUMBER	747-751	num	10	SENT_204	[p11l1516t380r1649b411],
10	)	NN	O	)	dep	7	SENT_204	[p11l1516t380r1649b411],
11	and	CC	O	and	_	0	SENT_204	[p11l1319t415r1367b440],
12	insertion	NN	O	insertion	nn	15	SENT_204	[p11l1379t417r1497b440],
13	ofa	NN	O	ofa	nn	15	SENT_204	[p11l1508t415r1555b440],
14	serine	NN	O	serine	nn	15	SENT_204	[p11l1566t417r1647b440],
15	residue	NN	O	residue	conj_and	7	SENT_204	[p11l1657t415r1755b440],
16	In-frame	RB	MISC	in-frame	advmod	17	SENT_204	[p11l1271t473r1384b499],
17	deletion	NN	O	deletion	rcmod	15	SENT_204	[p11l1394t473r1502b499],
18	(	CD	NUMBER	(	num	17	SENT_204	[p11l1516t475r1649b506],
19	747-753	CD	NUMBER	747-753	num	20	SENT_204	[p11l1516t475r1649b506],
20	)	NN	O	)	dep	17	SENT_204	[p11l1516t475r1649b506],
21	and	CC	O	and	_	0	SENT_204	[p11l1319t511r1367b536],
22	insertion	NN	O	insertion	nn	25	SENT_204	[p11l1378t513r1495b536],
23	ofa	NN	O	ofa	nn	25	SENT_204	[p11l1505t511r1551b536],
24	serine	NN	O	serine	nn	25	SENT_204	[p11l1561t513r1642b536],
25	residue	NN	O	residue	rcmod	15	SENT_204	[p11l1651t511r1749b536],
26	In-frame	RB	MISC	in-frame	advmod	27	SENT_204	[p11l1271t569r1384b594],
27	deletion	NN	O	deletion	rcmod	25	SENT_204	[p11l1394t569r1502b594],
28	(	CD	NUMBER	(	num	27	SENT_204	[p11l1516t571r1649b602],
29	747-753	CD	NUMBER	747-753	num	30	SENT_204	[p11l1516t571r1649b602],
30	)	NN	O	)	dep	40	SENT_204	[p11l1516t571r1649b602],
31	and	CC	O	and	_	0	SENT_204	[p11l1319t607r1367b632],
32	insertion	NN	O	insertion	nn	38	SENT_204	[p11l1379t609r1497b632],
33	ofa	NN	O	ofa	nn	38	SENT_204	[p11l1508t606r1555b632],
34	serine	NN	O	serine	nn	38	SENT_204	[p11l1566t609r1647b632],
35	residue	NN	O	residue	nn	38	SENT_204	[p11l1657t607r1755b632],
36	Amino	NN	O	amino	nn	38	SENT_204	[p11l1268t667r1358b690],
37	acid	NN	O	acid	nn	38	SENT_204	[p11l1369t665r1422b690],
38	substitution	NN	O	substitution	conj_and	30	SENT_204	[p11l1434t665r1596b690],
39	(	CD	NUMBER	(	num	40	SENT_204	[p11l1611t667r1713b698],
40	L858R	NN	O	l858r	dep	46	SENT_204	[p11l1611t667r1713b698],
41	)	CD	NUMBER	)	num	44	SENT_204	[p11l1611t667r1713b698],
42	Amino	NN	O	amino	nn	44	SENT_204	[p11l1268t763r1358b786],
43	acid	NN	O	acid	nn	44	SENT_204	[p11l1369t761r1422b786],
44	substitution	NN	O	substitution	dep	40	SENT_204	[p11l1434t761r1596b786],
45	(	CD	NUMBER	(	num	46	SENT_204	[p11l1611t763r1713b794],
46	L858R	NN	O	l858r	dep	50	SENT_204	[p11l1611t763r1713b794],
47	)	CD	NUMBER	)	num	49	SENT_204	[p11l1611t763r1713b794],
48	Amino	NN	O	amino	nn	49	SENT_204	[p11l1268t859r1358b882],
49	acid	NN	O	acid	dep	46	SENT_204	[p11l1369t857r1422b882],
50	substitution	NN	O	substitution	dep	55	SENT_204	[p11l1434t857r1596b882],
51	(	CD	NUMBER	(	num	50	SENT_204	[p11l1611t858r1719b890],
52	L861Q	NN	O	l861q	nn	55	SENT_204	[p11l1611t858r1719b890],
53	)	CD	NUMBER	)	num	55	SENT_204	[p11l1611t858r1719b890],
54	Amino	NN	O	amino	nn	55	SENT_204	[p11l1268t954r1358b978],
55	acid	NN	O	acid	_	0	SENT_204	[p11l1369t953r1422b978],
56	substitution	NN	O	substitution	nn	59	SENT_204	[p11l1434t953r1596b978],
57	(	CD	NUMBER	(	num	59	SENT_204	[p11l1611t955r1721b986],
58	G719C	NN	O	g719c	nn	59	SENT_204	[p11l1611t955r1721b986],
59	)	NN	O	)	dep	55	SENT_204	[p11l1611t955r1721b986],

1	In-frame	RB	O	in-frame	dep	2	SENT_205	[p11l1271t1107r1384b1132],
2	deletion	NN	O	deletion	dep	5	SENT_205	[p11l1394t1107r1502b1132],
3	(	CD	NUMBER	(	number	4	SENT_205	[p11l1516t1109r1649b1140],
4	747-753	CD	NUMBER	747-753	num	5	SENT_205	[p11l1516t1109r1649b1140],
5	)	NN	O	)	dep	12	SENT_205	[p11l1516t1109r1649b1140],
6	and	CC	O	and	_	0	SENT_205	[p11l1319t1144r1367b1170],
7	insertion	NN	O	insertion	nn	10	SENT_205	[p11l1378t1147r1495b1170],
8	ofa	NN	O	ofa	nn	10	SENT_205	[p11l1505t1144r1551b1170],
9	serine	NN	O	serine	nn	10	SENT_205	[p11l1561t1147r1642b1170],
10	residue	NN	O	residue	conj_and	5	SENT_205	[p11l1651t1144r1749b1170],
11	In-frame	RB	MISC	in-frame	advmod	10	SENT_205	[p11l1271t1223r1384b1249],
12	deletion	NN	O	deletion	dep	15	SENT_205	[p11l1394t1224r1502b1249],
13	(	CD	NUMBER	(	num	12	SENT_205	[p11l1516t1225r1649b1257],
14	746-750	CD	NUMBER	746-750	num	15	SENT_205	[p11l1516t1225r1649b1257],
15	)	NN	O	)	_	0	SENT_205	[p11l1516t1225r1649b1257],

1	*	RB	O	*	advmod	38	SENT_206	[p11l94t1357r109b1372],
2	Among	IN	O	among	_	0	SENT_206	[p11l118t1357r219b1388],
3	the	DT	O	the	det	5	SENT_206	[p11l227t1355r269b1380],
4	25	CD	NUMBER	25	num	5	SENT_206	[p11l280t1357r309b1380],
5	patients	NNS	O	patient	prep_among	38	SENT_206	[p11l322t1357r429b1388],
6	with	IN	O	with	_	0	SENT_206	[p11l439t1355r495b1380],
7	no	DT	O	no	det	8	SENT_206	[p11l508t1364r540b1380],
8	exposure	NN	O	exposure	prep_with	5	SENT_206	[p11l550t1364r672b1388],
9	to	TO	O	to	aux	10	SENT_206	[p11l681t1360r708b1380],
10	gefitinib	VB	O	gefitinib	infmod	8	SENT_206	[p11l718t1355r828b1388],
11	(	CD	NUMBER	(	number	12	SENT_206	[p11l841t1357r880b1388],
12	15	CD	NUMBER	15	dobj	10	SENT_206	[p11l841t1357r880b1388],
13	with	IN	O	with	_	0	SENT_206	[p11l891t1355r947b1380],
14	bronchoalveolar	JJ	O	bronchoalveolar	amod	15	SENT_206	[p11l959t1355r1179b1380],
15	cancer	NN	O	cancer	prep_with	12	SENT_206	[p11l1188t1364r1281b1385],
16	,	,	O	,	_	0	SENT_206	[p11l1188t1364r1281b1385],
17	7	CD	NUMBER	7	conj_and	12	SENT_206	[p11l1294t1357r1307b1380],
18	with	IN	O	with	_	0	SENT_206	[p11l1316t1355r1372b1380],
19	adenocarcinoma	NN	O	adenocarcinoma	prep_with	17	SENT_206	[p11l1383t1355r1618b1385],
20	,	,	O	,	_	0	SENT_206	[p11l1383t1355r1618b1385],
21	and	CC	O	and	_	0	SENT_206	[p11l1630t1355r1678b1380],
22	3	CD	NUMBER	3	conj_and	12	SENT_206	[p11l120t1394r132b1417],
23	with	IN	O	with	_	0	SENT_206	[p11l142t1392r198b1417],
24	large-cell	JJ	O	large-cell	amod	26	SENT_206	[p11l210t1392r328b1425],
25	carcinoma	NN	O	carcinoma	nn	26	SENT_206	[p11l339t1394r501b1425],
26	)	NN	O	)	prep_with	22	SENT_206	[p11l339t1394r501b1425],
27	,	,	O	,	_	0	SENT_206	[p11l339t1394r501b1425],
28	2	CD	NUMBER	2	number	29	SENT_206	[p11l512t1394r526b1417],
29	(	CD	NUMBER	(	num	30	SENT_206	[p11l538t1394r657b1425],
30	Patients	NNS	O	patient	appos	26	SENT_206	[p11l538t1394r657b1425],
31	A	DT	O	a	dep	30	SENT_206	[p11l666t1394r685b1417],
32	and	CC	O	and	_	0	SENT_206	[p11l694t1392r742b1417],
33	B	NN	O	b	dep	30	SENT_206	[p11l755t1394r780b1425],
34	)	CD	NUMBER	)	number	35	SENT_206	[p11l755t1394r780b1425],
35	—	CD	NUMBER	—	num	37	SENT_206	[p11l790t1408r824b1410],
36	both	DT	O	both	det	37	SENT_206	[p11l833t1392r892b1417],
37	ofwhom	NN	O	ofwhom	nsubj	38	SENT_206	[p11l903t1392r1020b1417],
38	had	VBD	O	have	_	0	SENT_206	[p11l1032t1392r1078b1417],
39	bronchoalveolar	JJ	O	bronchoalveolar	amod	41	SENT_206	[p11l1090t1392r1310b1417],
40	cancer	NN	O	cancer	nn	41	SENT_206	[p11l1319t1401r1449b1417],
41	—	NN	O	—	dobj	38	SENT_206	[p11l1319t1401r1449b1417],
42	had	VBD	O	have	rcmod	41	SENT_206	[p11l1458t1392r1505b1417],
43	EGFR	NN	O	egfr	nn	44	SENT_206	[p11l1518t1394r1593b1417],
44	mutations	NNS	O	mutation	dobj	42	SENT_206	[p11l1604t1394r1749b1417],
45	.	.	O	.	_	0	SENT_206	[p11l1604t1394r1749b1417],

1	No	DT	O	no	det	2	SENT_207	[p11l121t1431r160b1454],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_207	[p11l171t1431r309b1454],
3	were	VBD	O	be	auxpass	4	SENT_207	[p11l319t1438r382b1454],
4	found	VBN	O	find	_	0	SENT_207	[p11l391t1429r470b1454],
5	in	IN	O	in	_	0	SENT_207	[p11l482t1431r504b1454],
6	14	CD	NUMBER	14	num	9	SENT_207	[p11l517t1431r546b1454],
7	lung-cancer	JJ	O	lung-cancer	amod	9	SENT_207	[p11l558t1429r716b1462],
8	cell	NN	O	cell	nn	9	SENT_207	[p11l725t1429r768b1454],
9	lines	NNS	O	line	prep_in	4	SENT_207	[p11l780t1429r841b1454],
10	representing	VBG	O	represent	partmod	9	SENT_207	[p11l853t1431r1024b1462],
11	diverse	JJ	O	diverse	amod	13	SENT_207	[p11l1034t1429r1130b1454],
12	histologic	JJ	O	histologic	amod	13	SENT_207	[p11l1141t1429r1273b1462],
13	types	NNS	O	type	dobj	10	SENT_207	[p11l1281t1434r1360b1462],
14	:	:	O	:	_	0	SENT_207	[p11l1281t1434r1360b1462],
15	non	JJ	O	non	amod	17	SENT_207	[p11l1372t1429r1568b1454],
16	—	JJ	O	—	amod	17	SENT_207	[p11l1372t1429r1568b1454],
17	small-cell	NN	O	small-cell	prep_in	4	SENT_207	[p11l1372t1429r1568b1454],
18	lung	NN	O	lung	nn	19	SENT_207	[p11l1581t1429r1639b1462],
19	cancer	NN	O	cancer	dep	17	SENT_207	[p11l1649t1438r1738b1454],
20	(	CD	NUMBER	(	number	21	SENT_207	[p11l122t1468r146b1499],
21	6	CD	NUMBER	6	num	22	SENT_207	[p11l122t1468r146b1499],
22	specimens	NNS	O	specimen	dep	19	SENT_207	[p11l156t1468r321b1499],
23	)	RB	O	)	advmod	19	SENT_207	[p11l156t1468r321b1499],
24	,	,	O	,	_	0	SENT_207	[p11l156t1468r321b1499],
25	small-cell	JJ	O	small-cell	amod	27	SENT_207	[p11l333t1466r459b1491],
26	lung	NN	O	lung	nn	27	SENT_207	[p11l472t1466r530b1499],
27	cancer	NN	O	cancer	prep_in	4	SENT_207	[p11l540t1475r629b1491],
28	(	CD	NUMBER	(	number	29	SENT_207	[p11l641t1468r664b1499],
29	6	CD	NUMBER	6	num	30	SENT_207	[p11l641t1468r664b1499],
30	specimens	NNS	O	specimen	dep	27	SENT_207	[p11l675t1468r840b1499],
31	)	RB	O	)	advmod	30	SENT_207	[p11l675t1468r840b1499],
32	,	,	O	,	_	0	SENT_207	[p11l675t1468r840b1499],
33	bronchus	NN	O	bronchus	nn	38	SENT_207	[p11l853t1466r979b1491],
34	carcinoid	NN	O	carcinoid	nn	38	SENT_207	[p11l989t1466r1113b1491],
35	(	NN	O	(	nn	38	SENT_207	[p11l1127t1468r1149b1499],
36	1	CD	NUMBER	1	num	38	SENT_207	[p11l1127t1468r1149b1499],
37	specimen	NN	O	specimen	nn	38	SENT_207	[p11l1161t1468r1311b1499],
38	)	NN	O	)	prep_in	4	SENT_207	[p11l1161t1468r1311b1499],
39	,	,	O	,	_	0	SENT_207	[p11l1161t1468r1311b1499],
40	and	CC	O	and	_	0	SENT_207	[p11l1323t1466r1371b1491],
41	an	DT	O	a	det	43	SENT_207	[p11l1383t1475r1413b1491],
42	unknown	JJ	O	unknown	amod	43	SENT_207	[p11l1425t1466r1548b1491],
43	type	NN	O	type	prep_in	4	SENT_207	[p11l1559t1471r1615b1499],
44	(	CD	NUMBER	(	number	45	SENT_207	[p11l1628t1468r1650b1499],
45	1	CD	NUMBER	1	num	47	SENT_207	[p11l1628t1468r1650b1499],
46	specimen	NN	O	specimen	nn	47	SENT_207	[p11l1662t1468r1740b1499, p11l121t1505r198b1536],
47	)	NN	O	)	dep	43	SENT_207	[p11l1662t1468r1740b1499, p11l121t1505r198b1536],
48	.	.	O	.	_	0	SENT_207	[p11l1662t1468r1740b1499, p11l121t1505r198b1536],

1	Polymorphic	JJ	MISC	polymorphic	amod	2	SENT_208	[p11l211t1503r381b1536],
2	variants	NNS	O	variant	nsubj	6	SENT_208	[p11l388t1505r495b1528],
3	identified	VBN	O	identify	partmod	2	SENT_208	[p11l506t1503r631b1528],
4	within	IN	O	within	_	0	SENT_208	[p11l640t1503r722b1528],
5	EGFR	NN	O	egfr	prep_within	3	SENT_208	[p11l735t1505r810b1528],
6	included	VBD	O	include	_	0	SENT_208	[p11l819t1503r933b1528],
7	the	DT	O	the	det	8	SENT_208	[p11l942t1503r985b1528],
8	following	NN	O	following	dobj	6	SENT_208	[p11l993t1503r1125b1536],
9	:	:	O	:	_	0	SENT_208	[p11l993t1503r1125b1536],
10	the	DT	O	the	det	12	SENT_208	[p11l1134t1503r1177b1528],
11	substitution	NN	O	substitution	nn	12	SENT_208	[p11l1186t1503r1348b1528],
12	ofA	NN	O	ofa	dep	8	SENT_208	[p11l1359t1503r1411b1528],
13	for	IN	O	for	_	0	SENT_208	[p11l1418t1503r1456b1528],
14	G	NN	O	g	prep_for	12	SENT_208	[p11l1464t1505r1483b1528],
15	at	IN	O	at	_	0	SENT_208	[p11l1494t1508r1518b1528],
16	nucleotide	NN	O	nucleotide	prep_at	14	SENT_208	[p11l1528t1503r1669b1528],
17	1562	CD	DATE	1562	num	16	SENT_208	[p11l1679t1505r1749b1533],
18	,	,	O	,	_	0	SENT_208	[p11l1679t1505r1749b1533],
19	the	DT	O	the	det	21	SENT_208	[p11l118t1540r161b1565],
20	substitution	NN	O	substitution	nn	21	SENT_208	[p11l171t1540r334b1565],
21	ofA	NN	O	ofa	conj_and	8	SENT_208	[p11l345t1540r399b1565],
22	for	IN	O	for	_	0	SENT_208	[p11l407t1540r445b1565],
23	T	NN	O	t	prep_for	21	SENT_208	[p11l453t1542r471b1565],
24	at	IN	O	at	_	0	SENT_208	[p11l480t1545r504b1565],
25	nucleotide	NN	O	nucleotide	prep_at	23	SENT_208	[p11l515t1540r656b1565],
26	1887	CD	DATE	1887	num	25	SENT_208	[p11l668t1542r737b1570],
27	,	,	O	,	_	0	SENT_208	[p11l668t1542r737b1570],
28	and	CC	O	and	_	0	SENT_208	[p11l749t1540r797b1565],
29	a	DT	O	a	det	32	SENT_208	[p11l809t1549r821b1565],
30	germ-line	NN	O	germ-line	nn	32	SENT_208	[p11l832t1540r961b1573],
31	variant	JJ	O	variant	amod	32	SENT_208	[p11l970t1542r1064b1565],
32	ofunknown	NN	O	ofunknown	conj_and	8	SENT_208	[p11l1073t1540r1232b1565],
33	functional	JJ	O	functional	amod	32	SENT_208	[p11l1243t1540r1379b1565],
34	signiﬁcance	NN	O	signiﬁcance	tmod	33	SENT_208	[p11l1391t1540r1558b1573],
35	,	,	O	,	_	0	SENT_208	[p11l1391t1540r1558b1573],
36	the	DT	O	the	det	38	SENT_208	[p11l1569t1540r1611b1565],
37	substitution	NN	O	substitution	nn	38	SENT_208	[p11l1622t1540r1740b1565, p11l118t1579r170b1602],
38	ofA	NN	O	ofa	appos	34	SENT_208	[p11l181t1577r235b1602],
39	for	IN	O	for	_	0	SENT_208	[p11l243t1577r281b1602],
40	G	NN	O	g	prep_for	6	SENT_208	[p11l290t1579r310b1602],
41	at	IN	O	at	_	0	SENT_208	[p11l322t1582r346b1602],
42	nucleotide	NN	O	nucleotide	prep_at	6	SENT_208	[p11l357t1577r498b1602],
43	2885	CD	DATE	2885	num	42	SENT_208	[p11l508t1579r579b1607],
44	,	,	O	,	_	0	SENT_208	[p11l508t1579r579b1607],
45	within	IN	O	within	_	0	SENT_208	[p11l589t1577r672b1602],
46	the	DT	O	the	det	49	SENT_208	[p11l682t1577r725b1602],
47	tyrosine	NN	O	tyrosine	nn	49	SENT_208	[p11l734t1579r842b1610],
48	kinase	NN	O	kinase	nn	49	SENT_208	[p11l854t1577r938b1602],
49	domain	NN	O	domain	prep_within	6	SENT_208	[p11l948t1577r1059b1602],
50	.	.	O	.	_	0	SENT_208	[p11l948t1577r1059b1602],

1	N	NN	O	n	nn	2	SENT_209	[p11l566t1717r580b1732],
2	ENGLJ	NN	O	englj	_	0	SENT_209	[p11l595t1716r679b1738],
3	MED	VBD	O	med	partmod	2	SENT_209	[p11l694t1717r747b1732],
4	35o	CD	NUMBER	35o	dobj	3	SENT_209	[p11l759t1716r837b1738],
5	;	:	O	;	_	0	SENT_209	[p11l759t1716r837b1738],
6	21	CD	NUMBER	21	dep	2	SENT_209	[p11l759t1716r837b1738],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_209	[p11l875t1716r1086b1738],
8	MAY	NNP	DATE	MAY	dep	6	SENT_209	[p11l1126t1716r1177b1732],
9	20	CD	DATE	20	num	8	SENT_209	[p11l1189t1716r1228b1736],
10	,	,	DATE	,	_	0	SENT_209	[p11l1189t1716r1228b1736],
11	2004	CD	DATE	2004	num	8	SENT_209	[p11l1241t1716r1309b1738],

1	The	DT	O	the	det	4	SENT_210	[p11l752t1813r803b1837],
2	New	NNP	O	New	nn	4	SENT_210	[p11l812t1814r874b1837],
3	England	NNP	O	England	nn	4	SENT_210	[p11l884t1813r994b1844],
4	Journal	NNP	O	Journal	_	0	SENT_210	[p11l1003t1813r1100b1837],
5	of	IN	O	of	_	0	SENT_210	[p11l1110t1813r1139b1837],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_210	[p11l1146t1813r1271b1837],

1	The	DT	O	the	det	4	SENT_211	[p11l858t1937r895b1958],
2	NEW	NNP	O	NEW	nn	4	SENT_211	[p11l907t1939r988b1958],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_211	[p11l1002t1939r1177b1958],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_211	[p11l1191t1939r1357b1965],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_211	[p11l1371t1937r1587b1964],

1	A	DT	O	a	_	0	SENT_212	[p12l111t30r133b55],

1	de	IN	O	de	amod	3	SENT_213	[p12l178t82r397b104],
2	|	CD	NUMBER	|	num	3	SENT_213	[p12l178t82r397b104],
3	L747	NN	O	l747	_	0	SENT_213	[p12l178t82r397b104],
4	.	.	O	.	_	0	SENT_213	[p12l178t82r397b104],

1	—	NN	O	—	_	0	SENT_214	[p12l178t82r397b104],
2	.	.	O	.	_	0	SENT_214	[p12l178t82r397b104],

1	P753insS	NN	O	p753inss	nn	3	SENT_215	[p12l178t82r397b104],
2	(	CD	NUMBER	(	num	3	SENT_215	[p12l410t83r493b111],
3	sense	NN	O	sense	_	0	SENT_215	[p12l410t83r493b111],
4	)	CD	NUMBER	)	num	7	SENT_215	[p12l410t83r493b111],
5	Wild	NNP	O	Wild	nn	7	SENT_215	[p12l1156t77r1209b99],
6	type	NN	O	type	nn	7	SENT_215	[p12l1218t81r1268b105],
7	T	NN	O	t	dep	3	SENT_215	[p12l179t114r454b126],
8	»	CD	NUMBER	»	dep	3	SENT_215	[p12l179t114r454b126],

1	l	NN	O	l	_	0	SENT_216	[p12l1614t165r1617b202],
2	l	NN	O	l	dep	1	SENT_216	[p12l1648t165r1651b202],
3	l	NN	O	l	tmod	2	SENT_216	[p12l1678t165r1680b202],
4	l	NN	O	l	tmod	2	SENT_216	[p12l1712t165r1715b202],

1	,1	NN	O	,1	nn	2	SENT_217	[p12l419t193r426b212],
2	ll	NN	O	ll	nsubj	32	SENT_217	[p12l465t157r477b205],
3	ll	NN	O	ll	amod	2	SENT_217	[p12l140t155r148b175],
4	‘	FW	O	‘	dep	3	SENT_217	[p12l140t155r148b175],
5	la	FW	O	la	prep	2	SENT_217	[p12l138t165r158b270],
6	N	NN	O	n	pobj	5	SENT_217	[p12l174t141r192b233],
7	(	CD	NUMBER	(	num	6	SENT_217	[p12l313t183r345b223],
8	llvil	NN	O	llvil	dep	6	SENT_217	[p12l313t183r345b223],
9	)	CD	NUMBER	)	num	10	SENT_217	[p12l313t183r345b223],
10	ll	NN	O	ll	dobj	8	SENT_217	[p12l355t189r365b219],
11	)	NN	O	)	nn	13	SENT_217	[p12l355t189r365b219],
12	,	,	O	,	_	0	SENT_217	[p12l427t207r429b217],
13	W	NN	O	w	rcmod	10	SENT_217	[p12l515t209r521b213],
14	,	,	O	,	_	0	SENT_217	[p12l531t209r537b217],
15	'	''	O	'	_	0	SENT_217	[p12l639t193r643b199],
16	(	CD	NUMBER	(	dep	13	SENT_217	[p12l903t203r904b214],
17	@	SYM	O	@	dep	13	SENT_217	[p12l1201t155r1215b238],
18	/	:	O	/	punct	19	SENT_217	[p12l1201t155r1215b238],
19	d	NN	O	d	dep	10	SENT_217	[p12l1201t155r1215b238],
20	*	SYM	O	*	dep	10	SENT_217	[p12l1201t155r1215b238],
21	-	:	O	-	_	0	SENT_217	[p12l1271t203r1275b209],
22	'	''	O	'	_	0	SENT_217	[p12l1271t203r1275b209],
23	r	NN	O	r	tmod	32	SENT_217	[p12l1315t203r1319b209],
24	I	PRP	O	I	nsubj	32	SENT_217	[p12l158t213r164b227],
25	"	``	O	"	punct	26	SENT_217	[p12l158t213r164b227],
26	(	CD	NUMBER	(	dep	24	SENT_217	[p12l220t207r250b253],
27	‘	CD	NUMBER	‘	number	28	SENT_217	[p12l220t207r250b253],
28	,1	CD	NUMBER	,1	dep	24	SENT_217	[p12l220t207r250b253],
29	I	PRP	O	I	dep	28	SENT_217	[p12l310t217r313b233],
30	is	VBZ	O	be	cop	32	SENT_217	[p12l325t207r330b221],
31	|	JJ	O	|	amod	32	SENT_217	[p12l353t216r355b229],
32	(	NN	O	(	_	0	SENT_217	[p12l365t219r369b255],
33	)	CD	NUMBER	)	number	34	SENT_217	[p12l377t213r406b251],
34	(	CD	NUMBER	(	num	36	SENT_217	[p12l377t213r406b251],
35	’	NN	O	’	nn	36	SENT_217	[p12l377t213r406b251],
36	Ii‘iI	NN	O	ii‘ii	dep	32	SENT_217	[p12l377t213r406b251],
37	‘	CD	NUMBER	‘	num	38	SENT_217	[p12l377t213r406b251],
38	J	NNP	O	J	dep	36	SENT_217	[p12l413t212r419b252],
39	‘	CD	NUMBER	‘	num	38	SENT_217	[p12l413t212r419b252],
40	)	CD	NUMBER	)	number	41	SENT_217	[p12l429t217r431b234],
41	‘	CD	NUMBER	‘	num	44	SENT_217	[p12l459t205r465b253],
42	ll	NN	O	ll	nn	44	SENT_217	[p12l459t205r465b253],
43	l’	NN	O	l’	nn	44	SENT_217	[p12l477t205r481b235],
44	(	NN	O	(	dep	38	SENT_217	[p12l511t212r541b233],
45	'	''	O	'	_	0	SENT_217	[p12l511t212r541b233],
46	-	:	O	-	_	0	SENT_217	[p12l511t212r541b233],
47	.	.	O	.	_	0	SENT_217	[p12l511t212r541b233],

1	,	,	O	,	_	0	SENT_218	[p12l511t212r541b233],
2	>	JJR	O	>	amod	3	SENT_218	[p12l511t212r541b233],
3	‘	NN	O	‘	_	0	SENT_218	[p12l511t212r541b233],
4	.	.	O	.	_	0	SENT_218	[p12l511t212r541b233],

1	wni	NN	O	wnus	_	0	SENT_219	[p12l597t217r625b249],
2	l	NN	O	l	rcmod	1	SENT_219	[p12l635t199r640b227],
3	r	NN	O	r	prep	2	SENT_219	[p12l657t240r667b257],
4	’	CD	NUMBER	’	dep	3	SENT_219	[p12l657t240r667b257],
5	I	PRP	O	I	dep	2	SENT_219	[p12l679t219r687b234],
6	-	:	O	-	_	0	SENT_219	[p12l679t219r687b234],
7	.	.	O	.	_	0	SENT_219	[p12l679t219r687b234],

1	In	IN	O	in	dep	2	SENT_220	[p12l703t221r715b247],
2	In	IN	O	in	_	0	SENT_220	[p12l727t215r737b237],
3	Iv	NN	O	iv	pobj	2	SENT_220	[p12l774t215r797b250],
4	)	CD	NUMBER	)	num	5	SENT_220	[p12l774t215r797b250],
5	“	NN	O	“	dep	3	SENT_220	[p12l774t215r797b250],
6	.	.	O	.	_	0	SENT_220	[p12l774t215r797b250],

1	(	NN	O	(	nn	3	SENT_221	[p12l827t211r833b247],
2	I	CD	NUMBER	i	num	3	SENT_221	[p12l827t211r833b247],
3	VI	NNP	O	VI	_	0	SENT_221	[p12l867t233r871b243],
4	I	PRP	O	I	nsubj	5	SENT_221	[p12l1223t232r1225b239],
5	’	VBP	O	’	rcmod	3	SENT_221	[p12l1235t244r1237b249],
6	I	PRP	O	I	nsubj	7	SENT_221	[p12l1323t227r1324b235],
7	H	NN	O	h	xcomp	5	SENT_221	[p12l126t212r138b285],
8	)	CD	NUMBER	)	num	9	SENT_221	[p12l126t212r138b285],
9	l	NN	O	l	tmod	7	SENT_221	[p12l156t222r170b290],
10	(	CD	NUMBER	(	dep	3	SENT_221	[p12l156t222r170b290],
11	I	PRP	O	I	nsubj	12	SENT_221	[p12l192t215r202b290],
12	(	VBP	O	(	rcmod	10	SENT_221	[p12l192t215r202b290],
13	(	CD	NUMBER	(	number	14	SENT_221	[p12l212t215r222b290],
14	,1	CD	NUMBER	,1	num	15	SENT_221	[p12l232t233r240b259],
15	I.	NN	O	i.	dobj	12	SENT_221	[p12l250t237r254b263],
16	.	.	O	.	_	0	SENT_221	[p12l306t233r310b267],

1	|	NN	O	|	_	0	SENT_222	[p12l306t233r310b267],
2	(	CD	NUMBER	(	num	1	SENT_222	[p12l345t223r353b284],
3	I	PRP	O	I	dep	1	SENT_222	[p12l345t223r353b284],
4	,	,	O	,	_	0	SENT_222	[p12l369t239r376b265],
5	i	FW	O	i	appos	3	SENT_222	[p12l369t239r376b265],
6	.	.	O	.	_	0	SENT_222	[p12l407t234r435b288],

1	I.	NN	O	i.	nsubj	5	SENT_223	[p12l407t234r435b288],
2	,	,	O	,	_	0	SENT_223	[p12l445t253r459b264],
3	,	,	O	,	_	0	SENT_223	[p12l445t253r459b264],
4	%	NN	O	%	dep	1	SENT_223	[p12l521t195r785b290],
5	d	NN	O	d	_	0	SENT_223	[p12l521t195r785b290],
6	*	NN	O	*	nn	7	SENT_223	[p12l521t195r785b290],
7	A	NN	O	a	dobj	5	SENT_223	[p12l805t267r807b271],
8	-	:	O	-	_	0	SENT_223	[p12l833t231r867b278],
9	.	.	O	.	_	0	SENT_223	[p12l833t231r867b278],

1	I	PRP	O	I	nsubj	2	SENT_224	[p12l833t231r867b278],
2	"	``	O	"	_	0	SENT_224	[p12l833t231r867b278],
3	.	.	O	.	_	0	SENT_224	[p12l833t231r867b278],

1	\	NN	O	\	_	0	SENT_225	[p12l833t231r867b278],
2	‘	CD	NUMBER	‘	num	1	SENT_225	[p12l833t231r867b278],
3	,	,	O	,	_	0	SENT_225	[p12l833t231r867b278],
4	(	CD	NUMBER	(	number	5	SENT_225	[p12l833t231r867b278],
5	)	CD	NUMBER	)	appos	1	SENT_225	[p12l1303t250r1311b277],
6	Receptor	NN	O	receptor	nn	8	SENT_225	[p12l1484t273r1588b300],
7	TATCAAGGAATTAAGAGAAGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagaagcaacatctccgaaag	nn	8	SENT_225	[p12l134t295r909b307],
8	GGGCTGGCCAACTG	NN	O	gggctggccaactg	dep	5	SENT_225	[p12l1025t295r1349b307],
9	.	.	O	.	_	0	SENT_225	[p12l1574t307r1578b310],

1	Ldomam	NN	O	ldomam	nn	2	SENT_226	[p12l1484t305r1593b327],
2	cgaaagccaacaaggaaatcgtcg	NN	O	cgaaagccaacaaggaaatcgtcg	_	0	SENT_226	[p12l382t332r909b346],

1	L858R	NN	O	l858r	nn	2	SENT_227	[p12l1108t343r1179b364],
2	mutation	NN	O	mutation	_	0	SENT_227	[p12l1190t344r1297b364],
3	de	IN	O	de	_	0	SENT_227	[p12l538t370r758b393],
4	|	CD	NUMBER	|	num	5	SENT_227	[p12l538t370r758b393],
5	L747	NN	O	l747	prep_de	2	SENT_227	[p12l538t370r758b393],
6	.	.	O	.	_	0	SENT_227	[p12l538t370r758b393],

1	—	NN	O	—	_	0	SENT_228	[p12l538t370r758b393],
2	.	.	O	.	_	0	SENT_228	[p12l538t370r758b393],

1	P753insS	NN	O	p753inss	_	0	SENT_229	[p12l538t370r758b393],
2	(	CD	NUMBER	(	num	4	SENT_229	[p12l770t372r900b399],
3	antisense	JJ	O	antisense	amod	4	SENT_229	[p12l770t372r900b399],
4	)	NN	O	)	dep	1	SENT_229	[p12l770t372r900b399],

1	l	NN	O	l	_	0	SENT_230	[p12l1614t401r1616b424],
2	l	NN	O	l	dep	1	SENT_230	[p12l1650t401r1651b424],
3	l	NN	O	l	nn	4	SENT_230	[p12l237t434r242b454],
4	ls	NNS	O	l	dep	2	SENT_230	[p12l303t434r313b464],
5	,	,	O	,	_	0	SENT_230	[p12l367t428r417b472],
6	l	NN	O	l	dep	4	SENT_230	[p12l367t428r417b472],
7	,	,	O	,	_	0	SENT_230	[p12l367t428r417b472],
8	,	,	O	,	_	0	SENT_230	[p12l367t428r417b472],
9	.	.	O	.	_	0	SENT_230	[p12l367t428r417b472],

1	K	NNP	O	K	nn	2	SENT_231	[p12l457t468r461b472],
2	A	NNP	O	A	nsubj	3	SENT_231	[p12l523t460r531b476],
3	l	NN	O	l	_	0	SENT_231	[p12l618t412r628b448],
4	pi	NN	O	pi	nn	5	SENT_231	[p12l662t444r690b478],
5	il	NN	O	il	dobj	3	SENT_231	[p12l844t409r874b438],
6	.	.	O	.	_	0	SENT_231	[p12l1317t457r1319b464],

1	ll	NN	O	ll	nn	2	SENT_232	[p12l1678t401r1715b424],
2	rili	NNS	O	rilus	nsubj	3	SENT_232	[p12l125t412r904b539],
3	’ll	VBP	O	’ll	_	0	SENT_232	[p12l125t412r904b539],
4	lll	NN	O	lll	nn	7	SENT_232	[p12l125t412r904b539],
5	‘	CD	NUMBER	‘	num	7	SENT_232	[p12l125t412r904b539],
6	llW	NN	O	llw	nn	7	SENT_232	[p12l125t412r904b539],
7	’	NN	O	’	dobj	3	SENT_232	[p12l125t412r904b539],
8	l	NN	O	l	prep	7	SENT_232	[p12l125t412r904b539],
9	»’	CD	NUMBER	»’	num	10	SENT_232	[p12l125t412r904b539],
10	T	NN	O	t	dep	8	SENT_232	[p12l125t412r904b539],
11	?	.	O	?	_	0	SENT_232	[p12l125t412r904b539],

1	V1illll	NN	O	v1illll	nn	2	SENT_233	[p12l125t412r904b539],
2	»	NN	O	»	_	0	SENT_233	[p12l125t412r904b539],
3	;	:	O	;	_	0	SENT_233	[p12l125t412r904b539],
4	illllxillllllllll	NN	O	illllxillllllllll	dep	2	SENT_233	[p12l125t412r904b539],
5	.	.	O	.	_	0	SENT_233	[p12l1029t518r1044b532],

1	1	CD	NUMBER	1	num	2	SENT_234	[p12l1123t485r1137b531],
2	l	NN	O	l	_	0	SENT_234	[p12l1203t417r1213b486],
3	i	FW	O	i	nn	7	SENT_234	[p12l1257t509r1263b527],
4	1Bd	FW	O	1bd	nn	7	SENT_234	[p12l1277t483r1299b520],
5	*	FW	O	*	nn	7	SENT_234	[p12l1277t483r1299b520],
6	l	NN	O	l	nn	7	SENT_234	[p12l1349t517r1351b523],
7	P	NN	O	p	dep	2	SENT_234	[p12l1482t516r1590b539],
8	/	:	O	/	punct	2	SENT_234	[p12l1482t516r1590b539],
9	$	$	O	$	dep	10	SENT_234	[p12l1482t516r1590b539],
10	d	FW	O	d	dep	2	SENT_234	[p12l1482t516r1590b539],
11	*	FW	O	*	dep	10	SENT_234	[p12l1482t516r1590b539],
12	D	NN	O	d	prep	10	SENT_234	[p12l1678t427r1715b628],
13	#d	JJ	O	#d	amod	16	SENT_234	[p12l1678t427r1715b628],
14	*	NN	O	*	nn	16	SENT_234	[p12l1678t427r1715b628],
15	l	NN	O	l	nn	16	SENT_234	[p12l1678t631r1680b678],
16	l	NN	O	l	dep	12	SENT_234	[p12l1712t631r1715b678],

1	TATCAAGGAATTAAGAGAAGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagaagcaacatctccgaaag	_	0	SENT_235	[p12l126t542r901b554],
2	.	.	O	.	_	0	SENT_235	[p12l1560t552r1563b555],

1	domain	NN	O	domain	nn	2	SENT_236	[p12l1489t550r1579b572],
2	agttaaaattcccgtgqctatgaaqgaat	NN	O	agttaaaattcccgtgqctatgaaqgaat	_	0	SENT_236	[p12l126t579r765b594],
3	3	CD	NUMBER	3	num	4	SENT_236	[p12l114t652r132b677],
4	l	NN	O	l	dep	2	SENT_236	[p12l1614t631r1617b677],
5	l	NN	O	l	nn	6	SENT_236	[p12l1649t631r1651b678],
6	delE746	NN	O	dele746	dep	4	SENT_236	[p12l198t701r369b723],
7	.	.	O	.	_	0	SENT_236	[p12l198t701r369b723],

1	—	NN	O	—	_	0	SENT_237	[p12l198t701r369b723],
2	.	.	O	.	_	0	SENT_237	[p12l198t701r369b723],

1	A750	NN	O	a750	_	0	SENT_238	[p12l198t701r369b723],
2	(	CD	NUMBER	(	num	3	SENT_238	[p12l381t703r464b742],
3	sense	NN	O	sense	dep	1	SENT_238	[p12l381t703r464b742],
4	)	CD	NUMBER	)	number	5	SENT_238	[p12l381t703r464b742],
5	[	CD	NUMBER	[	num	6	SENT_238	[p12l1678t680r1715b876],
6	|	NNS	O	|	dep	3	SENT_238	[p12l1678t680r1715b876],

1	Ldomain	NNP	LOCATION	Ldomain	_	0	SENT_239	[p12l1480t782r1590b804],

1	TATCAAGGAATTAAGAGABGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagabgcaacatctccgaaag	nn	2	SENT_240	[p12l124t919r882b931],
2	GGGCTGGCCABCTTG	NN	O	gggctggccabcttg	_	0	SENT_240	[p12l1025t912r1350b931],

1	P*@d�*	NN	O	p*@d�*	nn	2	SENT_241	[p12l1650t919r1651b950],
2	l	NN	O	l	_	0	SENT_241	[p12l1678t879r1679b958],
3	Extracellular	JJ	O	extracellular	amod	5	SENT_241	[p12l1731t922r1876b944],
4	domain	NN	O	domain	nn	5	SENT_241	[p12l1884t922r1974b944],
5	aacatctccqaaaqccaacaaggaatcc	NN	O	aacatctccqaaaqccaacaaggaatcc	dep	2	SENT_241	[p12l258t956r875b970],
6	@	IN	O	@	_	0	SENT_241	[p12l1451t879r1687b1023],
7	c	NN	O	c	prep_@	5	SENT_241	[p12l1451t879r1687b1023],
8	*	CD	NUMBER	*	num	7	SENT_241	[p12l1451t879r1687b1023],

1	de	IN	O	de	amod	3	SENT_242	[p12l598t994r769b1016],
2	|	CD	NUMBER	|	num	3	SENT_242	[p12l598t994r769b1016],
3	E746	NN	O	e746	_	0	SENT_242	[p12l598t994r769b1016],
4	.	.	O	.	_	0	SENT_242	[p12l598t994r769b1016],

1	—	NN	O	—	_	0	SENT_243	[p12l598t994r769b1016],
2	.	.	O	.	_	0	SENT_243	[p12l598t994r769b1016],

1	A750	NN	O	a750	_	0	SENT_244	[p12l598t994r769b1016],
2	(	CD	NUMBER	(	num	1	SENT_244	[p12l781t995r910b1023],
3	antisense	JJ	O	antisense	amod	8	SENT_244	[p12l781t995r910b1023],
4	)	NN	O	)	nn	8	SENT_244	[p12l781t995r910b1023],
5	l-351Q	NN	O	l-351q	nn	8	SENT_244	[p12l1105t992r1182b1018],
6	mutation	NN	O	mutation	nn	8	SENT_244	[p12l1192t992r1299b1012],
7	Transmembrane	NN	O	transmembrane	nn	8	SENT_244	[p12l1728t981r1923b1003],
8	region	NN	O	region	dep	1	SENT_244	[p12l1933t983r2005b1010],
9	Intracellular	JJ	MISC	intracellular	amod	10	SENT_244	[p12l1731t1036r1873b1059],
10	domain	NN	O	domain	dep	1	SENT_244	[p12l1881t1037r1971b1059],

1	I	PRP	O	I	_	0	SENT_245	[p12l876t1067r878b1089],

1	&	CC	O	&	cc	3	SENT_246	[p12l125t1037r904b1185],
2	=	JJ	O	=	amod	3	SENT_246	[p12l125t1037r904b1185],
3	d	NN	O	d	nsubj	13	SENT_246	[p12l125t1037r904b1185],
4	*	CD	NUMBER	*	number	5	SENT_246	[p12l125t1037r904b1185],
5	K	NN	O	k	dep	3	SENT_246	[p12l1022t1184r1026b1187],
6	;	:	O	;	_	0	SENT_246	[p12l1058t1106r1082b1187],
7	d	NN	O	d	nn	9	SENT_246	[p12l1058t1106r1082b1187],
8	*	CD	NUMBER	*	num	9	SENT_246	[p12l1058t1106r1082b1187],
9	I.	NN	O	i.	dep	3	SENT_246	[p12l1120t1097r1138b1180],
10	A	DT	O	a	det	12	SENT_246	[p12l1182t1097r1184b1099],
11	ll	NN	O	ll	nn	12	SENT_246	[p12l1238t1087r1266b1169],
12	‘	NN	O	‘	dep	9	SENT_246	[p12l1238t1087r1266b1169],
13	c	NN	O	c	_	0	SENT_246	[p12l1315t1107r1333b1173],
14	*	CD	NUMBER	*	num	15	SENT_246	[p12l1315t1107r1333b1173],
15	<	JJR	O	<	dobj	13	SENT_246	[p12l1726t1168r1848b1188],
16	.	.	O	.	_	0	SENT_246	[p12l1726t1168r1848b1188],

1	—	NN	O	—	_	0	SENT_247	[p12l1726t1168r1848b1188],
2	.	.	O	.	_	0	SENT_247	[p12l1726t1168r1848b1188],

1	c719c	NN	O	c719c	nn	2	SENT_248	[p12l1726t1168r1848b1188],
2	TATCAAGGAATTAAGAGAAGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagaagcaacatctccgaaag	_	0	SENT_248	[p12l126t1189r901b1201],
3	tataattcccgtggctatcaa	JJ	O	tataattcccgtggctatcaa	amod	5	SENT_248	[p12l126t1226r585b1240],
4	T	NN	O	t	nn	5	SENT_248	[p12l1308t1211r1336b1237],
5	Catalytic	NNP	MISC	Catalytic	dep	2	SENT_248	[p12l1485t1232r1585b1261],
6	de	IN	O	de	_	0	SENT_248	[p12l1768t1227r1939b1249],
7	|	CD	NUMBER	|	prep_de	5	SENT_248	[p12l1768t1227r1939b1249],
8	E746_A750	NN	O	e746_a750	nn	10	SENT_248	[p12l1768t1227r1939b1249],
9	'	''	O	'	_	0	SENT_248	[p12l986t1274r989b1275],
10	kinase	NN	O	kinase	dep	2	SENT_248	[p12l1498t1266r1572b1288],
11	de	IN	O	de	_	0	SENT_248	[p12l1768t1266r1987b1288],
12	|	CD	NUMBER	|	num	13	SENT_248	[p12l1768t1266r1987b1288],
13	L747	NN	O	l747	prep_de	10	SENT_248	[p12l1768t1266r1987b1288],
14	.	.	O	.	_	0	SENT_248	[p12l1768t1266r1987b1288],

1	—	NN	O	—	_	0	SENT_249	[p12l1768t1266r1987b1288],
2	.	.	O	.	_	0	SENT_249	[p12l1768t1266r1987b1288],

1	T751insS	NN	O	t751inss	nn	2	SENT_250	[p12l1768t1266r1987b1288],
2	domain	NN	O	domain	_	0	SENT_250	[p12l1489t1299r1579b1321],
3	de	IN	O	de	_	0	SENT_250	[p12l1768t1302r1987b1324],
4	|	CD	NUMBER	|	num	5	SENT_250	[p12l1768t1302r1987b1324],
5	L747	NN	O	l747	prep_de	2	SENT_250	[p12l1768t1302r1987b1324],
6	.	.	O	.	_	0	SENT_250	[p12l1768t1302r1987b1324],

1	—	NN	O	—	_	0	SENT_251	[p12l1768t1302r1987b1324],
2	.	.	O	.	_	0	SENT_251	[p12l1768t1302r1987b1324],

1	P753insS	NN	O	p753inss	_	0	SENT_252	[p12l1768t1302r1987b1324],

1	de	IN	O	de	amod	3	SENT_253	[p12l206t1341r425b1363],
2	|	CD	NUMBER	|	num	3	SENT_253	[p12l206t1341r425b1363],
3	L747	NN	O	l747	_	0	SENT_253	[p12l206t1341r425b1363],
4	.	.	O	.	_	0	SENT_253	[p12l206t1341r425b1363],

1	—	NN	O	—	_	0	SENT_254	[p12l206t1341r425b1363],
2	.	.	O	.	_	0	SENT_254	[p12l206t1341r425b1363],

1	T751insS	NN	O	t751inss	_	0	SENT_255	[p12l206t1341r425b1363],
2	(	CD	NUMBER	(	num	4	SENT_255	[p12l437t1343r521b1370],
3	sense	NN	O	sense	nn	4	SENT_255	[p12l437t1343r521b1370],
4	)	NN	O	)	dep	1	SENT_255	[p12l437t1343r521b1370],

1	‘	NN	O	‘	_	0	SENT_256	[p12l1725t1375r1758b1384],
2	L858R	NN	O	l858r	dep	1	SENT_256	[p12l1770t1370r1841b1390],
3	.	.	O	.	_	0	SENT_256	[p12l1725t1436r1758b1445],

1	.	.	O	.	_	0	SENT_257	[p12l1725t1436r1758b1445],

1	L861Q	NN	O	l861q	_	0	SENT_258	[p12l1769t1427r1845b1453],

1	TATCAAGGAATTAAGAGAAGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagaagcaacatctccgaaag	nn	2	SENT_259	[p12l134t1600r908b1611],
2	coatctccgaaagccaacaaqgaaa	NN	O	coatctccgaaagccaacaaqgaaa	_	0	SENT_259	[p12l360t1636r909b1651],
3	de	IN	O	de	_	0	SENT_259	[p12l614t1672r833b1695],
4	|	CD	NUMBER	|	num	5	SENT_259	[p12l614t1672r833b1695],
5	L747	NN	O	l747	prep_de	2	SENT_259	[p12l614t1672r833b1695],
6	.	.	O	.	_	0	SENT_259	[p12l614t1672r833b1695],

1	—	NN	O	—	_	0	SENT_260	[p12l614t1672r833b1695],
2	.	.	O	.	_	0	SENT_260	[p12l614t1672r833b1695],

1	T751insS	NN	O	t751inss	_	0	SENT_261	[p12l614t1672r833b1695],
2	(	CD	NUMBER	(	num	4	SENT_261	[p12l846t1674r975b1701],
3	antisense	JJ	O	antisense	amod	4	SENT_261	[p12l846t1674r975b1701],
4	)	NN	O	)	dep	1	SENT_261	[p12l846t1674r975b1701],

1	l	NN	O	l	nn	2	SENT_262	[p12l426t1713r435b1789],
2	r.	NN	O	r.	_	0	SENT_262	[p12l130t1722r937b1883],
3	;	:	O	;	_	0	SENT_262	[p12l130t1722r937b1883],
4	lTfl	NN	O	ltfl	dep	2	SENT_262	[p12l130t1722r937b1883],
5	,	,	O	,	_	0	SENT_262	[p12l130t1722r937b1883],
6	llil	NN	O	llil	nn	8	SENT_262	[p12l130t1722r937b1883],
7	“	NN	O	“	nn	8	SENT_262	[p12l130t1722r937b1883],
8	lll	NN	O	lll	appos	4	SENT_262	[p12l130t1722r937b1883],
9	?	.	O	?	_	0	SENT_262	[p12l130t1722r937b1883],

1	:	:	O	:	_	0	SENT_263	[p12l130t1722r937b1883],
2	llllilllll	NN	O	llllilllll	_	0	SENT_263	[p12l130t1722r937b1883],
3	,	,	O	,	_	0	SENT_263	[p12l1468t1757r1870b1895],
4	l.	NN	O	l.	appos	2	SENT_263	[p12l1468t1757r1870b1895],
5	,	,	O	,	_	0	SENT_263	[p12l1468t1757r1870b1895],
6	\	NN	O	\	dep	2	SENT_263	[p12l1468t1757r1870b1895],
7	.	.	O	.	_	0	SENT_263	[p12l1468t1757r1870b1895],

1	.	.	O	.	_	0	SENT_264	[p12l1468t1757r1870b1895],

1	TATCAAGGAATTAAGAGAAGCAACATCTCCGAAAG	NN	O	tatcaaggaattaagagaagcaacatctccgaaag	nn	2	SENT_265	[p12l134t1888r934b1899],
2	tatccccgtccctatcaaggccc	NN	O	tatccccgtccctatcaaggccc	_	0	SENT_265	[p12l133t1925r654b1939],

1	Figure	NN	O	figure	_	0	SENT_266	[p12l122t2006r206b2038],
2	2	CD	NUMBER	2	dep	1	SENT_266	[p12l215t2008r238b2031],
3	.	.	O	.	_	0	SENT_266	[p12l215t2008r238b2031],

1	Mutations	NNS	O	mutation	_	0	SENT_267	[p12l250t2006r389b2031],
2	in	IN	O	in	_	0	SENT_267	[p12l399t2006r422b2030],
3	the	DT	O	the	det	5	SENT_267	[p12l432t2005r476b2031],
4	EGFR	NN	O	egfr	nn	5	SENT_267	[p12l486t2007r563b2031],
5	Gene	NN	O	gene	prep_in	1	SENT_267	[p12l571t2007r643b2031],
6	in	IN	O	in	_	0	SENT_267	[p12l653t2006r675b2030],
7	Geﬁtinib-Responsive	JJ	O	geﬁtinib-responsive	amod	8	SENT_267	[p12l686t2005r971b2038],
8	Tumors	NNS	O	tumor	prep_in	1	SENT_267	[p12l979t2008r1090b2031],
9	.	.	O	.	_	0	SENT_267	[p12l979t2008r1090b2031],

1	Panels	NNS	O	panel	nsubj	8	SENT_268	[p12l123t2055r209b2081],
2	A	DT	O	a	amod	1	SENT_268	[p12l218t2057r244b2085],
3	,	,	O	,	_	0	SENT_268	[p12l218t2057r244b2085],
4	B	NN	O	b	dep	2	SENT_268	[p12l257t2058r280b2085],
5	,	,	O	,	_	0	SENT_268	[p12l257t2058r280b2085],
6	and	CC	O	and	_	0	SENT_268	[p12l292t2055r340b2081],
7	C	NN	O	c	conj_and	1	SENT_268	[p12l351t2057r369b2081],
8	show	VBP	O	show	_	0	SENT_268	[p12l380t2055r450b2081],
9	the	DT	O	the	det	14	SENT_268	[p12l458t2055r501b2081],
10	nucleotide	NN	O	nucleotide	nn	14	SENT_268	[p12l512t2055r653b2081],
11	sequence	NN	O	sequence	nn	14	SENT_268	[p12l664t2064r791b2088],
12	ofthe	NN	O	ofthe	nn	14	SENT_268	[p12l801t2055r878b2081],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_268	[p12l890t2057r965b2081],
14	gene	NN	O	gene	dobj	8	SENT_268	[p12l975t2064r1039b2089],
15	in	IN	O	in	_	0	SENT_268	[p12l1050t2058r1071b2080],
16	tumor	NN	O	tumor	nn	17	SENT_268	[p12l1082t2060r1167b2081],
17	specimens	NNS	O	specimen	prep_in	14	SENT_268	[p12l1177t2058r1322b2088],
18	with	IN	O	with	_	0	SENT_268	[p12l1332t2055r1388b2081],
19	heterozygous	JJ	O	heterozygous	amod	21	SENT_268	[p12l1400t2055r1581b2089],
20	in-frame	RB	O	in-frame	advmod	19	SENT_268	[p12l1593t2055r1706b2081],
21	deletions	NNS	O	deletion	prep_with	17	SENT_268	[p12l1715t2055r1839b2081],
22	within	IN	O	within	_	0	SENT_268	[p12l1849t2055r1931b2081],
23	the	DT	O	the	det	26	SENT_268	[p12l1942t2055r1984b2081],
24	tyrosine	NN	O	tyrosine	nn	26	SENT_268	[p12l1993t2060r2025b2088, p12l122t2099r204b2122],
25	kinase	NN	O	kinase	nn	26	SENT_268	[p12l215t2097r300b2122],
26	domain	NN	O	domain	prep_within	21	SENT_268	[p12l310t2097r412b2122],
27	(	RB	O	(	advmod	17	SENT_268	[p12l427t2097r529b2130],
28	double	JJ	O	double	amod	29	SENT_268	[p12l427t2097r529b2130],
29	peaks	NNS	O	peak	dep	17	SENT_268	[p12l540t2097r635b2130],
30	)	RB	O	)	advmod	8	SENT_268	[p12l540t2097r635b2130],
31	.	.	O	.	_	0	SENT_268	[p12l540t2097r635b2130],

1	Tracings	NNS	MISC	tracing	nsubjpass	9	SENT_269	[p12l645t2099r758b2130],
2	in	IN	O	in	_	0	SENT_269	[p12l770t2099r791b2122],
3	both	DT	O	both	det	4	SENT_269	[p12l804t2097r863b2122],
4	sense	NN	O	sense	prep_in	1	SENT_269	[p12l875t2106r951b2122],
5	and	CC	O	and	_	0	SENT_269	[p12l961t2097r1009b2122],
6	antisense	JJ	O	antisense	amod	7	SENT_269	[p12l1021t2099r1150b2122],
7	directions	NNS	O	direction	prep_in	1	SENT_269	[p12l1160t2097r1294b2122],
8	are	VBP	O	be	auxpass	9	SENT_269	[p12l1305t2106r1346b2122],
9	shown	VBN	O	show	_	0	SENT_269	[p12l1356t2097r1443b2122],
10	to	TO	O	to	aux	11	SENT_269	[p12l1453t2102r1480b2122],
11	demonstrate	VB	O	demonstrate	xcomp	9	SENT_269	[p12l1490t2097r1664b2122],
12	the	DT	O	the	det	14	SENT_269	[p12l1673t2097r1715b2122],
13	two	CD	NUMBER	two	num	14	SENT_269	[p12l1724t2102r1773b2122],
14	breakpoints	NNS	O	breakpoint	nsubj	15	SENT_269	[p12l1784t2097r1943b2130],
15	ofthe	VBP	O	ofthe	ccomp	11	SENT_269	[p12l1954t2097r2030b2122],
16	deletion	NN	O	deletion	dobj	15	SENT_269	[p12l121t2139r237b2169],
17	;	:	O	;	_	0	SENT_269	[p12l121t2139r237b2169],
18	the	DT	O	the	det	21	SENT_269	[p12l247t2139r290b2164],
19	wild-type	JJ	O	wild-type	amod	21	SENT_269	[p12l299t2139r421b2172],
20	nucleotide	NN	O	nucleotide	nn	21	SENT_269	[p12l432t2139r573b2164],
21	sequence	NN	O	sequence	nsubjpass	23	SENT_269	[p12l584t2148r711b2172],
22	is	VBZ	O	be	auxpass	23	SENT_269	[p12l722t2141r741b2164],
23	shown	VBN	O	show	parataxis	9	SENT_269	[p12l753t2139r839b2164],
24	in	IN	O	in	_	0	SENT_269	[p12l852t2141r873b2164],
25	capital	NN	O	capital	nn	26	SENT_269	[p12l885t2139r972b2172],
26	letters	NNS	O	letter	prep_in	23	SENT_269	[p12l985t2139r1075b2169],
27	,	,	O	,	_	0	SENT_269	[p12l985t2139r1075b2169],
28	and	CC	O	and	_	0	SENT_269	[p12l1086t2139r1134b2164],
29	the	DT	O	the	det	31	SENT_269	[p12l1145t2139r1187b2164],
30	mutant	JJ	O	mutant	amod	31	SENT_269	[p12l1199t2144r1297b2164],
31	sequence	NN	O	sequence	nsubj	32	SENT_269	[p12l1307t2148r1434b2172],
32	is	VBZ	O	be	conj_and	23	SENT_269	[p12l1445t2141r1464b2164],
33	in	IN	O	in	_	0	SENT_269	[p12l1476t2141r1498b2164],
34	lowercase	JJ	O	lowercase	amod	35	SENT_269	[p12l1510t2139r1643b2164],
35	letters	NNS	O	letter	prep_in	32	SENT_269	[p12l1654t2139r1744b2164],
36	.	.	O	.	_	0	SENT_269	[p12l1654t2139r1744b2164],

1	The	DT	O	the	det	4	SENT_270	[p12l1754t2139r1804b2164],
2	5	CD	NUMBER	5	amod	4	SENT_270	[p12l1815t2141r1835b2164],
3	'	''	O	'	_	0	SENT_270	[p12l1815t2141r1835b2164],
4	breakpoint	NN	O	breakpoint	_	0	SENT_270	[p12l1848t2139r1993b2172],
5	of	IN	O	of	_	0	SENT_270	[p12l2003t2138r2032b2164],
6	the	DT	O	the	det	9	SENT_270	[p12l120t2180r162b2206],
7	de	FW	O	de	nn	8	SENT_270	[p12l171t2180r420b2206],
8	|	FW	O	|	amod	9	SENT_270	[p12l171t2180r420b2206],
9	L747	NN	O	l747	prep_of	4	SENT_270	[p12l171t2180r420b2206],
10	.	.	O	.	_	0	SENT_270	[p12l171t2180r420b2206],

1	—	NN	O	—	_	0	SENT_271	[p12l171t2180r420b2206],
2	.	.	O	.	_	0	SENT_271	[p12l171t2180r420b2206],

1	T751insS	NN	O	t751inss	nn	2	SENT_272	[p12l171t2180r420b2206],
2	mutation	NN	O	mutation	nsubjpass	4	SENT_272	[p12l431t2183r553b2206],
3	is	VBZ	O	be	auxpass	4	SENT_272	[p12l565t2183r584b2206],
4	preceded	VBN	O	precede	_	0	SENT_272	[p12l595t2180r717b2213],
5	by	IN	O	by	_	0	SENT_272	[p12l729t2180r757b2214],
6	a	DT	O	a	det	8	SENT_272	[p12l766t2189r778b2206],
7	T-to-C	NN	O	t-to-c	nn	8	SENT_272	[p12l787t2182r871b2206],
8	substitution	NN	O	substitution	agent	4	SENT_272	[p12l880t2180r1043b2206],
9	that	WDT	O	that	nsubj	12	SENT_272	[p12l1052t2180r1106b2206],
10	does	VBZ	O	do	aux	12	SENT_272	[p12l1114t2180r1178b2206],
11	not	RB	O	not	neg	12	SENT_272	[p12l1189t2185r1232b2206],
12	alter	VB	O	alter	rcmod	8	SENT_272	[p12l1241t2180r1300b2206],
13	the	DT	O	the	dobj	12	SENT_272	[p12l1307t2180r1350b2206],
14	encoded	VBN	O	encode	partmod	13	SENT_272	[p12l1359t2180r1473b2206],
15	amino	NN	O	amino	nn	16	SENT_272	[p12l1484t2183r1569b2206],
16	acid	NN	O	acid	dobj	14	SENT_272	[p12l1579t2180r1641b2206],
17	.	.	O	.	_	0	SENT_272	[p12l1579t2180r1641b2206],

1	Panels	NNS	O	panel	nn	2	SENT_273	[p12l1653t2180r1739b2206],
2	D	NN	O	d	nsubj	5	SENT_273	[p12l1751t2183r1770b2205],
3	and	CC	O	and	_	0	SENT_273	[p12l1780t2180r1828b2206],
4	E	NN	O	e	conj_and	2	SENT_273	[p12l1840t2183r1853b2205],
5	show	VBP	O	show	_	0	SENT_273	[p12l1863t2180r1934b2206],
6	heterozygous	JJ	O	heterozygous	amod	8	SENT_273	[p12l1944t2180r2038b2206, p12l120t2231r214b2255],
7	missense	NN	O	missense	nn	8	SENT_273	[p12l226t2224r353b2247],
8	mutations	NNS	O	mutation	nsubj	9	SENT_273	[p12l365t2224r502b2247],
9	(	VBP	O	(	ccomp	5	SENT_273	[p12l516t2224r625b2255],
10	arrows	NNS	O	arrow	dobj	9	SENT_273	[p12l516t2224r625b2255],
11	)	CD	NUMBER	)	num	10	SENT_273	[p12l516t2224r625b2255],
12	resulting	VBG	O	result	partmod	10	SENT_273	[p12l639t2222r758b2255],
13	in	IN	O	in	_	0	SENT_273	[p12l768t2225r790b2247],
14	amino	NN	O	amino	nn	16	SENT_273	[p12l802t2224r887b2247],
15	acid	NN	O	acid	nn	16	SENT_273	[p12l898t2222r951b2247],
16	substitutions	NNS	O	substitution	prep_in	12	SENT_273	[p12l962t2222r1141b2247],
17	within	IN	O	within	_	0	SENT_273	[p12l1150t2222r1233b2247],
18	the	DT	O	the	det	21	SENT_273	[p12l1243t2222r1286b2247],
19	tyrosine	NN	O	tyrosine	nn	21	SENT_273	[p12l1295t2224r1403b2255],
20	kinase	NN	O	kinase	nn	21	SENT_273	[p12l1415t2222r1499b2247],
21	domain	NN	O	domain	prep_within	12	SENT_273	[p12l1509t2222r1620b2247],
22	.	.	O	.	_	0	SENT_273	[p12l1509t2222r1620b2247],

1	The	DT	O	the	det	3	SENT_274	[p12l1630t2222r1681b2247],
2	double	JJ	O	double	amod	3	SENT_274	[p12l1691t2222r1783b2247],
3	peaks	NNS	O	peak	nsubj	4	SENT_274	[p12l1795t2222r1870b2255],
4	represent	VBP	O	represent	_	0	SENT_274	[p12l1882t2227r2010b2255],
5	two	CD	NUMBER	two	num	6	SENT_274	[p12l119t2269r168b2289],
6	nucleotides	NNS	O	nucleotide	dobj	4	SENT_274	[p12l180t2264r335b2289],
7	at	IN	O	at	_	0	SENT_274	[p12l346t2269r370b2289],
8	the	DT	O	the	det	9	SENT_274	[p12l378t2264r421b2289],
9	site	NN	O	site	prep_at	4	SENT_274	[p12l431t2266r478b2289],
10	of	IN	O	of	_	0	SENT_274	[p12l487t2264r517b2289],
11	heterozygous	JJ	O	heterozygous	amod	12	SENT_274	[p12l523t2264r704b2297],
12	mutations	NNS	O	mutation	prep_of	9	SENT_274	[p12l716t2266r861b2289],
13	.	.	O	.	_	0	SENT_274	[p12l716t2266r861b2289],

1	For	IN	O	for	_	0	SENT_275	[p12l874t2266r916b2289],
2	comparison	NN	O	comparison	prep_for	10	SENT_275	[p12l925t2266r1095b2297],
3	,	,	O	,	_	0	SENT_275	[p12l925t2266r1095b2297],
4	the	DT	O	the	det	7	SENT_275	[p12l1105t2264r1148b2289],
5	corresponding	JJ	O	corresponding	amod	7	SENT_275	[p12l1157t2264r1357b2297],
6	wild-type	JJ	O	wild-type	amod	7	SENT_275	[p12l1365t2264r1487b2297],
7	sequence	NN	O	sequence	nsubjpass	10	SENT_275	[p12l1497t2273r1625b2297],
8	is	VBZ	O	be	auxpass	10	SENT_275	[p12l1636t2266r1655b2289],
9	also	RB	O	also	advmod	10	SENT_275	[p12l1665t2264r1719b2289],
10	shown	VBN	O	show	_	0	SENT_275	[p12l1730t2264r1825b2289],
11	.	.	O	.	_	0	SENT_275	[p12l1730t2264r1825b2289],

1	Panel	NN	O	panel	nn	2	SENT_276	[p12l1838t2264r1909b2289],
2	F	NN	O	f	nsubj	3	SENT_276	[p12l1922t2266r1935b2289],
3	shows	VBZ	O	show	_	0	SENT_276	[p12l1945t2264r2030b2289],
4	dimerized	JJ	O	dimerized	amod	6	SENT_276	[p12l121t2306r255b2331],
5	EGFR	NN	O	egfr	nn	6	SENT_276	[p12l269t2308r343b2331],
6	molecules	NNS	O	molecule	dobj	3	SENT_276	[p12l354t2306r491b2331],
7	bound	VBN	O	bind	partmod	6	SENT_276	[p12l503t2306r588b2331],
8	by	IN	O	by	_	0	SENT_276	[p12l600t2306r629b2339],
9	the	DT	O	the	det	11	SENT_276	[p12l637t2306r680b2331],
10	EGF	NN	ORGANIZATION	egf	nn	11	SENT_276	[p12l691t2308r746b2331],
11	ligand	NN	O	ligand	agent	7	SENT_276	[p12l757t2306r846b2339],
12	.	.	O	.	_	0	SENT_276	[p12l757t2306r846b2339],

1	The	DT	O	the	det	4	SENT_277	[p12l856t2306r907b2331],
2	extracellular	JJ	O	extracellular	amod	4	SENT_277	[p12l917t2306r1081b2331],
3	domain	NN	O	domain	nn	4	SENT_277	[p12l1090t2306r1193b2331],
4	(	NN	O	(	nsubjpass	35	SENT_277	[p12l1207t2308r1362b2339],
5	containing	VBG	O	contain	partmod	4	SENT_277	[p12l1207t2308r1362b2339],
6	two	CD	NUMBER	two	num	8	SENT_277	[p12l1370t2310r1419b2331],
7	receptor	NN	O	receptor	nn	8	SENT_277	[p12l1430t2310r1542b2338],
8	ligand	NN	O	ligand	dobj	5	SENT_277	[p12l1553t2306r1633b2339],
9	[	CD	NUMBER	[	num	12	SENT_277	[p12l1645t2308r1674b2339],
10	L	NN	O	l	nn	12	SENT_277	[p12l1645t2308r1674b2339],
11	]	NN	O	]	nn	12	SENT_277	[p12l1645t2308r1674b2339],
12	domains	NNS	O	domain	dep	8	SENT_277	[p12l1693t2306r1811b2331],
13	and	CC	O	and	_	0	SENT_277	[p12l1822t2306r1870b2331],
14	a	DT	O	a	det	17	SENT_277	[p12l1882t2314r1895b2331],
15	furin-like	JJ	O	furin-like	amod	17	SENT_277	[p12l1905t2305r2024b2331],
16	domain	NN	O	domain	nn	17	SENT_277	[p12l121t2347r244b2380],
17	)	NN	O	)	dobj	5	SENT_277	[p12l121t2347r244b2380],
18	,	,	O	,	_	0	SENT_277	[p12l121t2347r244b2380],
19	the	DT	O	the	det	21	SENT_277	[p12l254t2347r297b2372],
20	transmembrane	JJ	O	transmembrane	amod	21	SENT_277	[p12l306t2347r526b2372],
21	region	NN	O	region	appos	17	SENT_277	[p12l537t2350r628b2380],
22	,	,	O	,	_	0	SENT_277	[p12l537t2350r628b2380],
23	and	CC	O	and	_	0	SENT_277	[p12l640t2347r688b2372],
24	the	DT	O	the	det	27	SENT_277	[p12l698t2347r741b2372],
25	cytoplasmic	JJ	O	cytoplasmic	amod	27	SENT_277	[p12l751t2347r914b2380],
26	domain	NN	O	domain	nn	27	SENT_277	[p12l923t2347r1026b2372],
27	(	NN	O	(	conj_and	8	SENT_277	[p12l1040t2349r1194b2380],
28	containing	VBG	O	contain	partmod	27	SENT_277	[p12l1040t2349r1194b2380],
29	the	DT	O	the	det	33	SENT_277	[p12l1203t2347r1245b2372],
30	catalytic	JJ	O	catalytic	amod	33	SENT_277	[p12l1255t2347r1365b2380],
31	kinase	NN	O	kinase	nn	33	SENT_277	[p12l1376t2347r1461b2372],
32	domain	NN	O	domain	nn	33	SENT_277	[p12l1470t2347r1584b2380],
33	)	NN	O	)	dobj	28	SENT_277	[p12l1470t2347r1584b2380],
34	are	VBP	O	be	auxpass	35	SENT_277	[p12l1597t2356r1637b2372],
35	highlighted	VBN	O	highlight	_	0	SENT_277	[p12l1648t2347r1808b2380],
36	.	.	O	.	_	0	SENT_277	[p12l1648t2347r1808b2380],

1	The	DT	O	the	det	2	SENT_278	[p12l1818t2347r1868b2372],
2	position	NN	O	position	nsubj	29	SENT_278	[p12l1879t2349r1988b2380],
3	of	IN	O	of	_	0	SENT_278	[p12l1999t2347r2029b2372],
4	tyrosine1	NN	O	tyrosine1	prep_of	2	SENT_278	[p12l119t2391r280b2422],
5	°	CD	NUMBER	°	num	4	SENT_278	[p12l119t2391r280b2422],
6	53	CD	NUMBER	53	number	7	SENT_278	[p12l119t2391r280b2422],
7	(	CD	NUMBER	(	num	9	SENT_278	[p12l292t2390r403b2422],
8	Y1068	NN	O	y1068	nn	9	SENT_278	[p12l292t2390r403b2422],
9	)	NN	O	)	nsubjpass	23	SENT_278	[p12l292t2390r403b2422],
10	,	,	O	,	_	0	SENT_278	[p12l292t2390r403b2422],
11	a	DT	O	a	det	13	SENT_278	[p12l415t2398r427b2414],
12	site	NN	O	site	nn	13	SENT_278	[p12l438t2391r484b2414],
13	ofautophosphorylation	NN	O	ofautophosphorylation	appos	9	SENT_278	[p12l494t2389r812b2422],
14	used	VBN	O	use	partmod	13	SENT_278	[p12l825t2389r886b2414],
15	as	IN	O	as	_	0	SENT_278	[p12l898t2398r925b2414],
16	a	DT	O	a	det	17	SENT_278	[p12l936t2398r949b2414],
17	marker	NN	O	marker	prep_as	14	SENT_278	[p12l960t2389r1055b2414],
18	of	IN	O	of	_	0	SENT_278	[p12l1064t2389r1093b2414],
19	receptor	NN	O	receptor	nn	20	SENT_278	[p12l1099t2394r1212b2422],
20	activation	NN	O	activation	prep_of	17	SENT_278	[p12l1221t2391r1360b2419],
21	,	,	O	,	_	0	SENT_278	[p12l1221t2391r1360b2419],
22	is	VBZ	O	be	auxpass	23	SENT_278	[p12l1372t2391r1391b2414],
23	indicated	VBN	O	indicate	rcmod	4	SENT_278	[p12l1402t2389r1533b2419],
24	,	,	O	,	_	0	SENT_278	[p12l1402t2389r1533b2419],
25	along	IN	O	along	_	0	SENT_278	[p12l1544t2389r1619b2422],
26	with	IN	O	with	_	0	SENT_278	[p12l1627t2389r1683b2414],
27	downstream	JJ	O	downstream	amod	28	SENT_278	[p12l1694t2389r1863b2414],
28	effectors	NNS	O	effector	prep_along_with	29	SENT_278	[p12l1874t2389r1990b2414],
29	activated	VBN	O	activate	_	0	SENT_278	[p12l2001t2398r2038b2414, p12l119t2431r210b2456],
30	by	IN	O	by	_	0	SENT_278	[p12l223t2431r251b2464],
31	EGFR	NN	O	egfr	nn	32	SENT_278	[p12l262t2433r337b2456],
32	autophosphorylation	NN	O	autophosphorylation	prep_by	29	SENT_278	[p12l347t2431r630b2464],
33	—	CD	NUMBER	—	num	34	SENT_278	[p12l640t2446r674b2449],
34	STAT3	NN	O	stat3	dobj	29	SENT_278	[p12l683t2432r773b2460],
35	,	,	O	,	_	0	SENT_278	[p12l683t2432r773b2460],
36	MAP	NN	O	map	nn	37	SENT_278	[p12l787t2432r850b2455],
37	kinase	NN	O	kinase	conj_and	34	SENT_278	[p12l861t2431r946b2456],
38	(	CD	NUMBER	(	num	40	SENT_278	[p12l959t2432r1071b2464],
39	MAPK	NN	O	mapk	nn	40	SENT_278	[p12l959t2432r1071b2464],
40	)	NN	O	)	dep	37	SENT_278	[p12l959t2432r1071b2464],
41	,	,	O	,	_	0	SENT_278	[p12l959t2432r1071b2464],
42	and	CC	O	and	_	0	SENT_278	[p12l1083t2431r1131b2456],
43	AKT	NNP	O	AKT	dobj	29	SENT_278	[p12l1141t2432r1201b2456],
44	.	.	O	.	_	0	SENT_278	[p12l1141t2432r1201b2456],

1	The	DT	O	the	det	4	SENT_279	[p12l1211t2431r1261b2456],
2	locations	NNS	O	location	nn	4	SENT_279	[p12l1272t2431r1394b2456],
3	oftumor-associated	JJ	O	oftumor-associated	amod	4	SENT_279	[p12l1405t2430r1677b2456],
4	mutations	NNS	O	mutation	nsubjpass	14	SENT_279	[p12l1690t2433r1835b2460],
5	,	,	O	,	_	0	SENT_279	[p12l1690t2433r1835b2460],
6	all	DT	O	all	appos	4	SENT_279	[p12l1847t2431r1875b2456],
7	within	IN	O	within	_	0	SENT_279	[p12l1885t2431r1967b2456],
8	the	DT	O	the	det	11	SENT_279	[p12l1978t2431r2020b2456],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_279	[p12l120t2475r228b2505],
10	kinase	NN	O	kinase	nn	11	SENT_279	[p12l239t2472r324b2497],
11	domain	NN	O	domain	prep_within	6	SENT_279	[p12l334t2472r445b2502],
12	,	,	O	,	_	0	SENT_279	[p12l334t2472r445b2502],
13	are	VBP	O	be	auxpass	14	SENT_279	[p12l457t2481r497b2497],
14	shown	VBN	O	show	_	0	SENT_279	[p12l507t2472r594b2497],
15	in	IN	O	in	_	0	SENT_279	[p12l606t2475r628b2497],
16	red	JJ	O	red	prep_in	14	SENT_279	[p12l641t2472r690b2497],
17	.	.	O	.	_	0	SENT_279	[p12l641t2472r690b2497],

1	2134	CD	DATE	2134	num	4	SENT_280	[p12l94t2630r171b2652],
2	N	NN	MISC	n	nn	4	SENT_280	[p12l853t2632r867b2647],
3	ENGLj	NN	MISC	englj	nn	4	SENT_280	[p12l882t2631r966b2653],
4	MED	NN	MISC	med	_	0	SENT_280	[p12l981t2632r1034b2647],
5	350	CD	NUMBER	350	num	7	SENT_280	[p12l1046t2631r1125b2653],
6	;	:	O	;	_	0	SENT_280	[p12l1046t2631r1125b2653],
7	2	CD	NUMBER	2	dep	4	SENT_280	[p12l1046t2631r1125b2653],
8	'	''	O	'	_	0	SENT_280	[p12l1046t2631r1125b2653],
9	[	CD	NUMBER	[	dep	7	SENT_280	[p12l1046t2631r1125b2653],
10	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	11	SENT_280	[p12l1162t2631r1374b2653],
11	MAY	NNP	DATE	MAY	dep	4	SENT_280	[p12l1413t2631r1464b2647],
12	20	CD	DATE	20	num	11	SENT_280	[p12l1476t2631r1515b2651],
13	,	,	DATE	,	_	0	SENT_280	[p12l1476t2631r1515b2651],
14	2004	CD	DATE	2004	num	11	SENT_280	[p12l1528t2631r1596b2653],

1	The	DT	O	the	det	4	SENT_281	[p12l881t2663r932b2687],
2	New	NNP	O	New	nn	4	SENT_281	[p12l941t2664r1003b2687],
3	England	NNP	O	England	nn	4	SENT_281	[p12l1012t2663r1123b2694],
4	Joumal	NNP	O	Joumal	_	0	SENT_281	[p12l1132t2663r1229b2687],
5	of	IN	O	of	_	0	SENT_281	[p12l1239t2663r1268b2687],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_281	[p12l1275t2663r1400b2687],

1	MUTATIONS	NNS	O	mutation	_	0	SENT_282	[p12l588t2848r788b2867],
2	IN	IN	O	in	_	0	SENT_282	[p12l803t2848r841b2867],
3	EGFR	NN	O	egfr	prep_in	1	SENT_282	[p12l857t2848r943b2867],
4	IN	IN	O	in	_	0	SENT_282	[p12l956t2848r994b2867],
5	NON	NNP	O	NON	prep_in	1	SENT_282	[p12l1010t2848r1314b2867],
6	.	.	O	.	_	0	SENT_282	[p12l1010t2848r1314b2867],

1	—	NN	O	—	_	0	SENT_283	[p12l1010t2848r1314b2867],
2	.	.	O	.	_	0	SENT_283	[p12l1010t2848r1314b2867],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_284	[p12l1010t2848r1314b2867],
2	LUNG	NN	O	lung	_	0	SENT_284	[p12l1328t2848r1423b2867],
3	CANCER	NNP	O	CANCER	dep	2	SENT_284	[p12l1436t2848r1572b2867],

1	responsiveness	NN	O	responsiveness	nsubjpass	13	SENT_285	[p12l11t3063r646b3163],
2	to	TO	O	to	_	0	SENT_285	[p12l682t3079r762b3141],
3	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_285	[p12l795t3062r1152b3163],
4	in	IN	O	in	_	0	SENT_285	[p12l1186t3063r1268b3140],
5	previous	JJ	O	previous	amod	7	SENT_285	[p12l1299t3063r1658b3163],
6	clinical	JJ	O	clinical	amod	7	SENT_285	[p12l1694t3062r1995b3141],
7	trials	NNS	O	trial	prep_in	13	SENT_285	[p12l2026t3063r2148b3141, p12l10t3185r344b3269],
8	.11	CD	NUMBER	.11	number	9	SENT_285	[p12l2026t3063r2148b3141, p12l10t3185r344b3269],
9	’12	CD	NUMBER	’12	num	11	SENT_285	[p12l2026t3063r2148b3141, p12l10t3185r344b3269],
10	Heterozygous	JJ	O	heterozygous	amod	11	SENT_285	[p12l367t3198r966b3291],
11	mutations	NNS	O	mutation	nsubjpass	13	SENT_285	[p12l991t3191r1433b3270],
12	were	VBD	O	be	auxpass	13	SENT_285	[p12l1453t3217r1660b3270],
13	detected	VBN	O	detect	_	0	SENT_285	[p12l1683t3190r2044b3269],
14	in	IN	O	in	_	0	SENT_285	[p12l2066t3191r2149b3268],
15	two	CD	NUMBER	two	num	16	SENT_285	[p12l11t3335r165b3398],
16	patients	NNS	O	patient	prep_in	13	SENT_285	[p12l201t3319r545b3419],
17	with	IN	O	with	_	0	SENT_285	[p12l579t3319r773b3398],
18	bronchoalveolar	JJ	O	bronchoalveolar	amod	19	SENT_285	[p12l810t3318r1518b3398],
19	cancers	NNS	O	cancer	prep_with	16	SENT_285	[p12l1552t3344r1901b3397],
20	.	.	O	.	_	0	SENT_285	[p12l1552t3344r1901b3397],

1	Both	DT	O	both	nsubj	2	SENT_286	[p12l1941t3318r2147b3397],
2	had	VBD	O	have	_	0	SENT_286	[p12l11t3446r169b3525],
3	in-frame	RB	O	in-frame	advmod	4	SENT_286	[p12l199t3446r575b3525],
4	deletions	NNS	O	deletion	dobj	2	SENT_286	[p12l607t3446r1000b3525],
5	in	IN	O	in	_	0	SENT_286	[p12l1032t3447r1115b3524],
6	the	DT	O	the	det	8	SENT_286	[p12l1147t3447r1278b3525],
7	kinase	NN	O	kinase	nn	8	SENT_286	[p12l1309t3447r1587b3526],
8	domain	NN	O	domain	prep_in	4	SENT_286	[p12l1618t3446r1950b3525],
9	that	WDT	O	that	rcmod	4	SENT_286	[p12l1981t3447r2152b3525],

1	Were	VBD	O	be	cop	2	SENT_287	[p12l6t3601r209b3654],
2	identical	JJ	O	identical	_	0	SENT_287	[p12l237t3574r594b3653],
3	to	TO	O	to	_	0	SENT_287	[p12l624t3591r702b3653],
4	those	DT	O	those	prep_to	2	SENT_287	[p12l734t3575r959b3653],
5	found	VBN	O	find	partmod	4	SENT_287	[p12l988t3574r1237b3654],
6	in	IN	O	in	_	0	SENT_287	[p12l1265t3575r1346b3652],
7	the	DT	O	the	det	8	SENT_287	[p12l1375t3574r1504b3653],
8	patients	NNS	O	patient	prep_in	5	SENT_287	[p12l1532t3575r1863b3675],
9	with	IN	O	with	_	0	SENT_287	[p12l1889t3575r2078b3654],
10	a	DT	O	a	det	11	SENT_287	[p12l2106t3601r2151b3653],
11	response	NN	O	response	prep_with	8	SENT_287	[p12l11t3728r386b3803],
12	to	TO	O	to	_	0	SENT_287	[p12l413t3719r492b3781],
13	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_287	[p12l520t3702r871b3803],
14	—	NN	O	—	prep_to	2	SENT_287	[p12l895t3747r1003b3755],
15	namely	RB	O	namely	advmod	14	SENT_287	[p12l1026t3702r1342b3803],
16	,	,	O	,	_	0	SENT_287	[p12l1026t3702r1342b3803],
17	delL747	NN	O	dell747	attr	2	SENT_287	[p12l1375t3702r2146b3781],
18	.	.	O	.	_	0	SENT_287	[p12l1375t3702r2146b3781],

1	—	NN	O	—	_	0	SENT_288	[p12l1375t3702r2146b3781],
2	.	.	O	.	_	0	SENT_288	[p12l1375t3702r2146b3781],

1	P753insS	NN	O	p753inss	_	0	SENT_289	[p12l1375t3702r2146b3781],

1	and	CC	O	and	_	0	SENT_290	[p13l10t21r169b99],
2	delE746	NN	O	dele746	dep	1	SENT_290	[p13l203t20r832b99],
3	.	.	O	.	_	0	SENT_290	[p13l203t20r832b99],

1	—	NN	O	—	_	0	SENT_291	[p13l203t20r832b99],
2	.	.	O	.	_	0	SENT_291	[p13l203t20r832b99],

1	A750	NN	O	a750	nn	3	SENT_292	[p13l203t20r832b99],
2	(	CD	NUMBER	(	num	3	SENT_292	[p13l870t21r1132b112],
3	Table	NNP	O	Table	_	0	SENT_292	[p13l870t21r1132b112],
4	2	CD	NUMBER	2	number	5	SENT_292	[p13l1165t26r1274b112],
5	)	CD	NUMBER	)	num	3	SENT_292	[p13l1165t26r1274b112],
6	.	.	O	.	_	0	SENT_292	[p13l1165t26r1274b112],

1	Given	VBN	O	give	prep	10	SENT_293	[p13l1313t21r1564b100],
2	the	DT	O	the	det	4	SENT_293	[p13l1598t21r1730b99],
3	apparent	JJ	O	apparent	amod	4	SENT_293	[p13l1763t37r2152b121],
4	clustering	NN	O	clustering	dep	1	SENT_293	[p13l11t149r446b249],
5	of	IN	O	of	_	0	SENT_293	[p13l484t148r586b227],
6	EGFR	NN	O	egfr	nn	7	SENT_293	[p13l606t155r823b228],
7	mutations	NNS	O	mutation	prep_of	4	SENT_293	[p13l856t149r1324b244],
8	,	,	O	,	_	0	SENT_293	[p13l856t149r1324b244],
9	We	PRP	O	we	nsubj	10	SENT_293	[p13l1365t175r1486b228],
10	sequenced	VBD	O	sequence	_	0	SENT_293	[p13l1527t149r1982b249],
11	exons	NNS	O	exon	nsubj	34	SENT_293	[p13l2022t175r2145b227, p13l11t302r162b355],
12	19	CD	NUMBER	19	num	11	SENT_293	[p13l197t282r296b355],
13	and	CC	O	and	_	0	SENT_293	[p13l325t277r484b355],
14	21	CD	NUMBER	21	conj_and	11	SENT_293	[p13l513t282r615b354],
15	in	IN	O	in	_	0	SENT_293	[p13l644t277r727b354],
16	a	DT	O	a	det	17	SENT_293	[p13l756t303r801b355],
17	total	NN	O	total	prep_in	11	SENT_293	[p13l829t277r1024b355],
18	of	IN	O	of	_	0	SENT_293	[p13l1053t276r1155b355],
19	95	CD	NUMBER	95	num	21	SENT_293	[p13l1166t282r1265b355],
20	primary	JJ	O	primary	amod	21	SENT_293	[p13l1296t277r1642b377],
21	tumors	NNS	O	tumor	prep_of	17	SENT_293	[p13l1667t293r1967b356],
22	and	CC	O	and	_	0	SENT_293	[p13l1994t277r2149b355],
23	108	CD	NUMBER	108	num	25	SENT_293	[p13l14t410r163b483],
24	cancer	NN	O	cancer	nn	25	SENT_293	[p13l197t405r818b484],
25	—	NN	O	—	prep_in	11	SENT_293	[p13l197t405r818b484],
26	derived	VBN	O	derive	partmod	25	SENT_293	[p13l197t405r818b484],
27	cell	NN	O	cell	nn	28	SENT_293	[p13l850t404r992b483],
28	lines	NNS	O	line	dobj	26	SENT_293	[p13l1022t404r1246b500],
29	,	,	O	,	_	0	SENT_293	[p13l1022t404r1246b500],
30	representing	VBG	O	represent	partmod	26	SENT_293	[p13l1282t405r1825b505],
31	diverse	JJ	O	diverse	amod	33	SENT_293	[p13l1853t404r2148b484],
32	tumor	NN	O	tumor	nn	33	SENT_293	[p13l11t549r273b612],
33	types	NNS	O	type	dobj	30	SENT_293	[p13l295t549r506b633],
34	(	VBP	O	(	ccomp	10	SENT_293	[p13l538t540r696b624],
35	see	VB	O	see	xcomp	34	SENT_293	[p13l538t540r696b624],
36	the	DT	O	the	det	39	SENT_293	[p13l722t532r850b611],
37	Supplementary	NNP	O	Supplementary	nn	39	SENT_293	[p13l878t533r1513b633],
38	Appendix	NNP	O	Appendix	nn	39	SENT_293	[p13l1531t533r1992b633],
39	)	NN	O	)	dobj	35	SENT_293	[p13l1531t533r1992b633],
40	.	.	O	.	_	0	SENT_293	[p13l1531t533r1992b633],

1	No	DT	O	no	det	2	SENT_294	[p13l2022t540r2148b611],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_294	[p13l11t661r453b740],
3	were	VBD	O	be	auxpass	4	SENT_294	[p13l495t687r701b740],
4	detected	VBN	O	detect	_	0	SENT_294	[p13l747t660r1131b756],
5	,	,	O	,	_	0	SENT_294	[p13l747t660r1131b756],
6	suggesting	VBG	O	suggest	xcomp	4	SENT_294	[p13l1183t661r1656b761],
7	that	IN	O	that	complm	26	SENT_294	[p13l1692t661r1857b739],
8	only	RB	O	only	advmod	10	SENT_294	[p13l1892t660r2071b761],
9	a	DT	O	a	det	10	SENT_294	[p13l2106t687r2151b739],
10	subgroup	NN	O	subgroup	nsubj	26	SENT_294	[p13l12t789r411b889],
11	of	IN	O	of	_	0	SENT_294	[p13l437t788r537b867],
12	cancers	NNS	O	cancer	prep_of	10	SENT_294	[p13l542t814r877b884],
13	,	,	O	,	_	0	SENT_294	[p13l542t814r877b884],
14	in	IN	O	in	_	0	SENT_294	[p13l905t789r986b866],
15	which	WDT	O	which	rel	19	SENT_294	[p13l1005t789r1264b868],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_294	[p13l1285t794r1543b872],
17	signaling	NN	O	signaling	nsubj	19	SENT_294	[p13l1558t789r1953b889],
18	may	MD	O	may	aux	19	SENT_294	[p13l1975t815r2153b889],
19	play	VB	O	play	rcmod	10	SENT_294	[p13l10t917r185b1017],
20	a	DT	O	a	det	22	SENT_294	[p13l216t943r261b995],
21	critical	JJ	O	critical	amod	22	SENT_294	[p13l297t917r583b995],
22	role	NN	O	role	dobj	19	SENT_294	[p13l619t917r780b995],
23	in	IN	O	in	_	0	SENT_294	[p13l816t917r898b994],
24	tumorigenesis	NN	O	tumorigenesis	prep_in	19	SENT_294	[p13l935t917r1569b1017],
25	,	,	O	,	_	0	SENT_294	[p13l935t917r1569b1017],
26	harbor	VBP	O	harbor	ccomp	6	SENT_294	[p13l1611t916r1903b995],
27	EGFR	NN	O	egfr	nn	28	SENT_294	[p13l1936t923r2153b996],
28	mutations	NNS	O	mutation	dobj	26	SENT_294	[p13l11t1021r480b1100],
29	.	.	O	.	_	0	SENT_294	[p13l11t1021r480b1100],

1	INCREASE	NN	O	increase	npadvmod	23	SENT_295	[p13l16t1295r421b1345],
2	IN	IN	O	in	_	0	SENT_295	[p13l467t1295r547b1345],
3	EGF-INDUCED	JJ	O	egf-induced	amod	4	SENT_295	[p13l598t1295r1183b1345],
4	ACTIVATION	NN	O	activation	prep_in	23	SENT_295	[p13l1221t1295r1728b1346],
5	AND	CC	O	and	_	0	SENT_295	[p13l9t1380r188b1429],
6	GEFITINIB-INDUCED	NN	O	gefitinib-induced	nn	7	SENT_295	[p13l230t1379r1094b1430],
7	INHIBITION	NN	O	inhibition	prep_in	23	SENT_295	[p13l1139t1379r1636b1430],
8	OF	IN	O	of	_	0	SENT_295	[p13l11t1464r117b1513],
9	MUTANT	JJ	O	mutant	amod	11	SENT_295	[p13l163t1464r512b1513],
10	EGFR	NN	O	egfr	nn	11	SENT_295	[p13l554t1464r758b1513],
11	PROTEINS	NNS	O	protein	prep_of	4	SENT_295	[p13l803t1464r1216b1513],
12	To	TO	O	to	aux	13	SENT_295	[p13l7t1570r113b1643],
13	study	VB	O	study	infmod	4	SENT_295	[p13l171t1564r401b1665],
14	the	DT	O	the	det	16	SENT_295	[p13l452t1565r584b1643],
15	functional	JJ	O	functional	amod	16	SENT_295	[p13l638t1564r1083b1644],
16	properties	NNS	O	property	dobj	13	SENT_295	[p13l1135t1565r1578b1665],
17	encoded	VBN	O	encode	partmod	16	SENT_295	[p13l1635t1564r1998b1643],
18	by	IN	O	by	_	0	SENT_295	[p13l2053t1564r2152b1665],
19	these	DT	O	these	det	20	SENT_295	[p13l11t1692r235b1771],
20	mutations	NNS	O	mutation	agent	17	SENT_295	[p13l271t1693r740b1788],
21	,	,	O	,	_	0	SENT_295	[p13l271t1693r740b1788],
22	We	PRP	O	we	nsubj	23	SENT_295	[p13l777t1719r897b1772],
23	expressed	VBD	O	express	_	0	SENT_295	[p13l934t1693r1360b1793],
24	the	DT	O	the	det	25	SENT_295	[p13l1396t1692r1528b1771],
25	receptor	NN	O	receptor	dobj	23	SENT_295	[p13l1564t1709r1925b1793],
26	with	IN	O	with	_	0	SENT_295	[p13l1953t1692r2147b1772],
27	the	DT	O	the	det	28	SENT_295	[p13l11t1820r143b1899],
28	L747	NN	O	l747	prep_with	23	SENT_295	[p13l172t1821r838b1899],
29	.	.	O	.	_	0	SENT_295	[p13l172t1821r838b1899],

1	—	NN	O	—	_	0	SENT_296	[p13l172t1821r838b1899],
2	.	.	O	.	_	0	SENT_296	[p13l172t1821r838b1899],

1	P753insS	NN	O	p753inss	nn	2	SENT_297	[p13l172t1821r838b1899],
2	deletion	NN	O	deletion	nsubj	12	SENT_297	[p13l870t1820r1212b1899],
3	and	CC	O	and	_	0	SENT_297	[p13l1240t1821r1397b1899],
4	the	DT	O	the	det	5	SENT_297	[p13l1425t1821r1555b1899],
5	receptor	NN	O	receptor	nsubj	12	SENT_297	[p13l1583t1837r1937b1921],
6	with	IN	O	with	_	0	SENT_297	[p13l1958t1821r2148b1900],
7	the	DT	O	the	det	10	SENT_297	[p13l11t1949r141b2027],
8	L858R	NN	O	l858r	nn	10	SENT_297	[p13l184t1954r475b2032],
9	missense	NN	O	missense	nn	10	SENT_297	[p13l509t1949r909b2027],
10	mutation	NN	O	mutation	prep_with	5	SENT_297	[p13l954t1949r1353b2028],
11	in	IN	O	in	advmod	12	SENT_297	[p13l1397t1949r1480b2026],
12	cultured	VBN	O	culture	_	0	SENT_297	[p13l1525t1949r1882b2028],
13	cells	NNS	O	cell	dobj	12	SENT_297	[p13l1927t1949r2141b2027],
14	.	.	O	.	_	0	SENT_297	[p13l1927t1949r2141b2027],

1	Transient	JJ	O	transient	amod	2	SENT_298	[p13l7t2077r412b2155],
2	transfection	NN	O	transfection	nsubj	15	SENT_298	[p13l429t2076r929b2155],
3	of	IN	O	of	_	0	SENT_298	[p13l952t2076r1052b2155],
4	wild	JJ	O	wild	amod	6	SENT_298	[p13l1051t2076r1440b2177],
5	—	NN	O	—	nn	6	SENT_298	[p13l1051t2076r1440b2177],
6	type	NN	O	type	prep_of	2	SENT_298	[p13l1051t2076r1440b2177],
7	and	CC	O	and	_	0	SENT_298	[p13l1461t2076r1616b2155],
8	mutant	JJ	O	mutant	amod	9	SENT_298	[p13l1638t2093r1948b2156],
9	constructs	NNS	O	construct	prep_of	2	SENT_298	[p13l1965t2102r2148b2155, p13l12t2221r293b2284],
10	into	IN	O	into	_	0	SENT_298	[p13l333t2205r503b2283],
11	Cos	NNP	O	Cos	nn	14	SENT_298	[p13l543t2210r793b2283],
12	—	CD	NUMBER	—	num	14	SENT_298	[p13l543t2210r793b2283],
13	7	CD	NUMBER	7	num	14	SENT_298	[p13l543t2210r793b2283],
14	cells	NNS	O	cell	prep_into	6	SENT_298	[p13l834t2205r1021b2283],
15	demonstrated	VBD	O	demonstrate	_	0	SENT_298	[p13l1063t2205r1665b2283],
16	equivalent	JJ	O	equivalent	amod	18	SENT_298	[p13l1704t2204r2152b2305],
17	expression	NN	O	expression	nn	18	SENT_298	[p13l11t2333r477b2433],
18	levels	NNS	O	level	dobj	15	SENT_298	[p13l506t2332r755b2428],
19	,	,	O	,	_	0	SENT_298	[p13l506t2332r755b2428],
20	indicating	VBG	O	indicate	partmod	15	SENT_298	[p13l789t2332r1214b2433],
21	that	IN	O	that	complm	26	SENT_298	[p13l1240t2333r1405b2411],
22	the	DT	O	the	det	23	SENT_298	[p13l1430t2333r1557b2411],
23	mutations	NNS	O	mutation	nsubj	26	SENT_298	[p13l1587t2333r2013b2412],
24	do	VBP	O	do	aux	26	SENT_298	[p13l2045t2332r2148b2411],
25	not	RB	O	not	neg	26	SENT_298	[p13l11t2477r154b2539],
26	affect	VB	O	affect	ccomp	20	SENT_298	[p13l176t2460r412b2539],
27	the	DT	O	the	det	28	SENT_298	[p13l437t2461r566b2539],
28	stability	NN	O	stability	dobj	26	SENT_298	[p13l596t2460r933b2561],
29	of	IN	O	of	_	0	SENT_298	[p13l959t2460r1060b2539],
30	the	DT	O	the	det	31	SENT_298	[p13l1072t2461r1202b2539],
31	protein	NN	O	protein	prep_of	28	SENT_298	[p13l1230t2461r1563b2561],
32	.	.	O	.	_	0	SENT_298	[p13l1230t2461r1563b2561],

1	EGFR	NN	O	egfr	nn	2	SENT_299	[p13l1596t2466r1857b2544],
2	activation	NN	O	activation	nsubjpass	4	SENT_299	[p13l1875t2461r2147b2540, p13l11t2589r178b2667],
3	was	VBD	O	be	auxpass	4	SENT_299	[p13l216t2615r380b2668],
4	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_299	[p13l429t2588r872b2689],
5	by	IN	O	by	_	0	SENT_299	[p13l919t2589r1017b2689],
6	measuring	VBG	O	measure	agent	4	SENT_299	[p13l1060t2589r1525b2689],
7	phosphoryla	NN	O	phosphorylum	nn	9	SENT_299	[p13l1566t2588r2145b2689],
8	—	NN	O	—	nn	9	SENT_299	[p13l1566t2588r2145b2689],
9	tion	NN	O	tion	dobj	6	SENT_299	[p13l11t2717r181b2795],
10	of	IN	O	of	_	0	SENT_299	[p13l214t2716r316b2795],
11	the	DT	O	the	det	15	SENT_299	[p13l329t2717r459b2795],
12	tyrosine1	NN	O	tyrosine1	nn	15	SENT_299	[p13l488t2717r979b2817],
13	°	CD	NUMBER	°	number	14	SENT_299	[p13l488t2717r979b2817],
14	68	CD	NUMBER	68	num	15	SENT_299	[p13l488t2717r979b2817],
15	residue	NN	O	residue	prep_of	9	SENT_299	[p13l1008t2716r1333b2812],
16	,	,	O	,	_	0	SENT_299	[p13l1008t2716r1333b2812],
17	commonly	RB	O	commonly	advmod	18	SENT_299	[p13l1367t2717r1819b2817],
18	used	VBN	O	use	partmod	15	SENT_299	[p13l1843t2717r2036b2796],
19	as	IN	O	as	_	0	SENT_299	[p13l2063t2743r2147b2795],
20	a	DT	O	a	det	21	SENT_299	[p13l10t2872r54b2924],
21	marker	NN	O	marker	prep_as	18	SENT_299	[p13l84t2846r390b2925],
22	of	IN	O	of	_	0	SENT_299	[p13l424t2845r526b2924],
23	the	DT	O	the	det	24	SENT_299	[p13l544t2846r676b2924],
24	autophosphorylation	NN	O	autophosphorylation	prep_of	21	SENT_299	[p13l711t2846r1625b2946],
25	of	IN	O	of	_	0	SENT_299	[p13l1662t2845r1764b2924],
26	EGFR	NN	O	egfr	prep_of	24	SENT_299	[p13l1780t2841r2147b2929],
27	.	.	O	.	_	0	SENT_299	[p13l1780t2841r2147b2929],

1	”	NN	O	”	npadvmod	19	SENT_300	[p13l1780t2841r2147b2929],
2	In	IN	O	in	_	0	SENT_300	[p13l9t2981r96b3051],
3	the	DT	O	the	det	4	SENT_300	[p13l123t2974r251b3052],
4	absence	NN	O	absence	prep_in	19	SENT_300	[p13l276t2973r609b3052],
5	of	IN	O	of	_	0	SENT_300	[p13l637t2973r737b3052],
6	serum	NN	O	serum	nn	10	SENT_300	[p13l746t3000r1006b3053],
7	and	CC	O	and	_	0	SENT_300	[p13l1031t2973r1186b3052],
8	associated	VBN	O	associate	nn	10	SENT_300	[p13l1212t2973r1643b3052],
9	growth	NN	O	growth	nn	10	SENT_300	[p13l1669t2974r1970b3074],
10	factors	NNS	O	factor	prep_of	4	SENT_300	[p13l1996t2973r2148b3052, p13l11t3118r199b3197],
11	,	,	O	,	_	0	SENT_300	[p13l1996t2973r2148b3052, p13l11t3118r199b3197],
12	neither	CC	O	neither	preconj	15	SENT_300	[p13l236t3101r546b3180],
13	wild	JJ	O	wild	amod	15	SENT_300	[p13l569t3102r974b3202],
14	—	NN	O	—	nn	15	SENT_300	[p13l569t3102r974b3202],
15	type	NN	O	type	nsubj	19	SENT_300	[p13l569t3102r974b3202],
16	nor	CC	O	nor	_	0	SENT_300	[p13l1005t3127r1156b3180],
17	mutant	JJ	O	mutant	amod	18	SENT_300	[p13l1183t3118r1503b3181],
18	EGFR	NN	O	egfr	nsubj	19	SENT_300	[p13l1527t3107r1791b3185],
19	demonstrated	VBD	O	demonstrate	_	0	SENT_300	[p13l1813t3102r2148b3180, p13l12t3229r292b3308],
20	autophosphorylation	NN	O	autophosphorylation	nn	22	SENT_300	[p13l312t3229r1185b3330],
21	(	CD	NUMBER	(	num	22	SENT_300	[p13l1211t3230r1390b3330],
22	Fig	NN	O	fig	dobj	19	SENT_300	[p13l1211t3230r1390b3330],
23	.	.	O	.	_	0	SENT_300	[p13l1211t3230r1390b3330],

1	3A	NN	O	3a	_	0	SENT_301	[p13l1418t3235r1532b3308],
2	and	CC	O	and	_	0	SENT_301	[p13l1550t3229r1704b3308],
3	3B	NN	O	3b	conj_and	1	SENT_301	[p13l1726t3235r1890b3321],
4	)	NN	O	)	dep	1	SENT_301	[p13l1726t3235r1890b3321],
5	.	.	O	.	_	0	SENT_301	[p13l1726t3235r1890b3321],

1	However	RB	O	however	advmod	7	SENT_302	[p13l1917t3237r2148b3309, p13l11t3384r200b3453],
2	,	,	O	,	_	0	SENT_302	[p13l1917t3237r2148b3309, p13l11t3384r200b3453],
3	the	DT	O	the	det	4	SENT_302	[p13l246t3357r378b3436],
4	addition	NN	O	addition	nsubj	9	SENT_302	[p13l417t3358r780b3436],
5	of	IN	O	of	_	0	SENT_302	[p13l820t3357r923b3436],
6	EGF	NN	ORGANIZATION	egf	prep_of	4	SENT_302	[p13l942t3363r1127b3436],
7	doubled	VBD	O	double	_	0	SENT_302	[p13l1169t3357r1521b3437],
8	or	CC	O	or	_	0	SENT_302	[p13l1562t3383r1652b3436],
9	tripled	VBD	O	triple	conj_or	7	SENT_302	[p13l1691t3357r1974b3458],
10	the	DT	O	the	det	11	SENT_302	[p13l2015t3358r2147b3436],
11	activation	NN	O	activation	dobj	9	SENT_302	[p13l10t3486r416b3565],
12	of	IN	O	of	_	0	SENT_302	[p13l438t3485r538b3564],
13	both	DT	O	both	det	15	SENT_302	[p13l542t3486r733b3564],
14	mutant	JJ	O	mutant	amod	15	SENT_302	[p13l754t3502r1064b3565],
15	EGFRS	NN	O	egfr	prep_of	11	SENT_302	[p13l1078t3491r1391b3581],
16	,	,	O	,	_	0	SENT_302	[p13l1078t3491r1391b3581],
17	as	IN	O	as	conj_or	7	SENT_302	[p13l1418t3512r1501b3564],
18	compared	VBN	O	compare	pcomp	17	SENT_302	[p13l1526t3486r1945b3586],
19	With	IN	O	with	pcomp	18	SENT_302	[p13l1961t3486r2149b3565],
20	the	DT	O	the	det	21	SENT_302	[p13l11t3614r139b3692],
21	activation	NN	O	activation	pobj	19	SENT_302	[p13l169t3614r579b3693],
22	of	IN	O	of	_	0	SENT_302	[p13l611t3613r712b3692],
23	the	DT	O	the	det	27	SENT_302	[p13l726t3614r856b3692],
24	wild	JJ	O	wild	amod	27	SENT_302	[p13l884t3614r1280b3714],
25	—	NN	O	—	nn	27	SENT_302	[p13l884t3614r1280b3714],
26	type	NN	O	type	nn	27	SENT_302	[p13l884t3614r1280b3714],
27	receptor	NN	O	receptor	prep_of	21	SENT_302	[p13l1313t3630r1682b3714],
28	.	.	O	.	_	0	SENT_302	[p13l1313t3630r1682b3714],

1	Moreover	RB	O	moreover	_	0	SENT_303	[p13l1717t3621r2143b3709],
2	,	,	O	,	_	0	SENT_303	[p13l1717t3621r2143b3709],

1	Whereas	IN	O	whereas	mark	7	SENT_304	[p14l6t21r356b100],
2	the	DT	O	the	det	3	SENT_304	[p14l385t21r514b99],
3	activation	NN	O	activation	nsubj	7	SENT_304	[p14l539t21r950b100],
4	of	IN	O	of	_	0	SENT_304	[p14l976t20r1077b99],
5	normal	JJ	O	normal	amod	6	SENT_304	[p14l1083t21r1393b99],
6	EGFRWas	NN	O	egfrwa	prep_of	3	SENT_304	[p14l1416t26r1849b104],
7	downregulated	VBD	O	downregulate	_	0	SENT_304	[p14l1878t20r2147b100, p14l11t148r408b249],

1	after	IN	O	after	_	0	SENT_305	[p14l437t148r632b227],
2	15	CD	DURATION	15	num	3	SENT_305	[p14l661t154r756b227],
3	minutes	NNS	NUMBER	minute	prep_after	17	SENT_305	[p14l789t149r1158b244],
4	,	,	O	,	_	0	SENT_305	[p14l789t149r1158b244],
5	consistent	JJ	O	consistent	amod	3	SENT_305	[p14l1194t149r1633b227],
6	with	IN	O	with	_	0	SENT_305	[p14l1653t149r1843b228],
7	the	DT	O	the	det	8	SENT_305	[p14l1874t149r2003b227],
8	internalization	NN	O	internalization	prep_with	5	SENT_305	[p14l2032t149r2147b226, p14l11t277r550b355],
9	of	IN	O	of	_	0	SENT_305	[p14l573t276r673b355],
10	the	DT	O	the	det	11	SENT_305	[p14l677t277r807b355],
11	receptor	NN	O	receptor	prep_of	8	SENT_305	[p14l829t293r1199b377],
12	,	,	O	,	_	0	SENT_305	[p14l829t293r1199b377],
13	the	DT	O	the	det	16	SENT_305	[p14l1227t276r1357b355],
14	two	CD	NUMBER	two	num	16	SENT_305	[p14l1380t293r1533b356],
15	mutant	JJ	O	mutant	amod	16	SENT_305	[p14l1556t293r1870b356],
16	receptors	NNS	O	receptor	nsubj	17	SENT_305	[p14l1887t303r2147b377, p14l11t421r171b483],
17	demonstrated	VBD	O	demonstrate	_	0	SENT_305	[p14l214t404r804b483],
18	continued	JJ	O	continued	amod	19	SENT_305	[p14l844t404r1271b484],
19	activation	NN	O	activation	dobj	17	SENT_305	[p14l1310t405r1720b484],
20	for	IN	O	for	_	0	SENT_305	[p14l1760t404r1883b483],
21	up	RB	DURATION	up	dep	25	SENT_305	[p14l1920t431r2026b505],
22	to	TO	DURATION	to	_	0	SENT_305	[p14l2067t421r2147b483],
23	three	CD	DURATION	three	num	24	SENT_305	[p14l11t533r225b611],
24	hours	NNS	NUMBER	hour	prep_to	21	SENT_305	[p14l246t533r489b612],
25	(	CD	NUMBER	(	num	26	SENT_305	[p14l516t533r701b633],
26	Fig	NN	O	fig	prep_for	17	SENT_305	[p14l516t533r701b633],
27	.	.	O	.	_	0	SENT_305	[p14l516t533r701b633],

1	3A	NN	O	3a	_	0	SENT_306	[p14l729t538r899b624],
2	)	NN	O	)	dep	1	SENT_306	[p14l729t538r899b624],
3	.	.	O	.	_	0	SENT_306	[p14l729t538r899b624],

1	Similar	JJ	O	similar	amod	2	SENT_307	[p14l928t533r1233b611],
2	results	NNS	O	result	nsubjpass	4	SENT_307	[p14l1251t533r1530b612],
3	were	VBD	O	be	auxpass	4	SENT_307	[p14l1549t559r1752b612],
4	obtained	VBN	O	obtain	_	0	SENT_307	[p14l1774t532r2148b611],
5	With	IN	O	with	_	0	SENT_307	[p14l6t661r193b740],
6	the	DT	O	the	det	7	SENT_307	[p14l215t661r342b739],
7	use	NN	O	use	prep_with	4	SENT_307	[p14l364t687r501b740],
8	of	IN	O	of	_	0	SENT_307	[p14l524t660r624b739],
9	antibodies	NNS	O	antibody	prep_of	7	SENT_307	[p14l626t660r1057b739],
10	to	TO	O	to	aux	11	SENT_307	[p14l1081t677r1159b739],
11	measure	VB	O	measure	xcomp	4	SENT_307	[p14l1182t687r1534b740],
12	the	DT	O	the	det	14	SENT_307	[p14l1556t661r1683b739],
13	total	JJ	O	total	amod	14	SENT_307	[p14l1705t661r1891b739],
14	phosphorylation	NN	O	phosphorylation	dobj	11	SENT_307	[p14l1910t661r2148b761, p14l10t789r511b889],
15	of	IN	O	of	_	0	SENT_307	[p14l561t788r663b867],
16	EGFR	NN	O	egfr	prep_of	14	SENT_307	[p14l691t794r955b872],
17	after	IN	O	after	_	0	SENT_307	[p14l993t788r1192b867],
18	the	DT	O	the	det	19	SENT_307	[p14l1238t789r1370b867],
19	addition	NN	O	addition	prep_after	11	SENT_307	[p14l1418t789r1781b867],
20	of	IN	O	of	_	0	SENT_307	[p14l1830t788r1932b867],
21	EGF	NN	O	egf	prep_of	19	SENT_307	[p14l1961t794r2145b867],
22	(	CD	NUMBER	(	num	23	SENT_307	[p14l15t917r231b1009],
23	data	NNS	O	datum	npadvmod	24	SENT_307	[p14l15t917r231b1009],
24	not	RB	O	not	neg	25	SENT_307	[p14l256t934r403b996],
25	shown	VBN	O	show	partmod	21	SENT_307	[p14l424t918r764b1009],
26	)	NN	O	)	dobj	25	SENT_307	[p14l424t918r764b1009],
27	.	.	O	.	_	0	SENT_307	[p14l424t918r764b1009],

1	Since	IN	O	since	_	0	SENT_308	[p14l143t1046r366b1124],
2	seven	CD	NUMBER	seven	prep_since	10	SENT_308	[p14l405t1071r636b1125],
3	of	IN	O	of	_	0	SENT_308	[p14l674t1045r776b1124],
4	the	DT	O	the	det	7	SENT_308	[p14l795t1046r925b1124],
5	eight	CD	NUMBER	eight	num	7	SENT_308	[p14l964t1045r1181b1146],
6	EGFR	NN	O	egfr	nn	7	SENT_308	[p14l1213t1051r1473b1129],
7	tyrosine	NN	O	tyrosine	prep_of	2	SENT_308	[p14l1501t1046r1838b1146],
8	kinase	NN	O	kinase	nn	9	SENT_308	[p14l1876t1046r2148b1125],
9	mutations	NNS	O	mutation	nsubj	10	SENT_308	[p14l11t1174r440b1253],
10	reside	VBP	O	reside	_	0	SENT_308	[p14l463t1173r712b1252],
11	near	IN	O	near	_	0	SENT_308	[p14l734t1199r920b1252],
12	the	DT	O	the	det	14	SENT_308	[p14l939t1174r1068b1252],
13	ATP	NN	O	atp	nn	14	SENT_308	[p14l1086t1179r1260b1251],
14	cleft	NN	O	cleft	prep_near	10	SENT_308	[p14l1280t1173r1479b1269],
15	,	,	O	,	_	0	SENT_308	[p14l1280t1173r1479b1269],
16	which	WDT	O	which	nsubj	18	SENT_308	[p14l1502t1173r1762b1253],
17	is	VBZ	O	be	cop	18	SENT_308	[p14l1783t1174r1848b1252],
18	target	NN	O	target	rcmod	14	SENT_308	[p14l1872t1190r2148b1274],
19	—	CD	NUMBER	—	num	18	SENT_308	[p14l1872t1190r2148b1274],
20	ed	VBN	O	ed	partmod	18	SENT_308	[p14l11t1301r109b1380],
21	by	IN	O	by	_	0	SENT_308	[p14l146t1301r245b1402],
22	geﬁtinib	NN	O	geﬁtinib	agent	20	SENT_308	[p14l277t1301r668b1402],
23	,	,	O	,	_	0	SENT_308	[p14l277t1301r668b1402],
24	We	PRP	O	we	nsubj	25	SENT_308	[p14l707t1328r827b1381],
25	assessed	VBD	O	assess	parataxis	10	SENT_308	[p14l864t1301r1237b1380],
26	Whether	IN	O	whether	complm	31	SENT_308	[p14l1269t1301r1629b1381],
27	the	DT	O	the	det	29	SENT_308	[p14l1664t1302r1796b1380],
28	mutant	JJ	O	mutant	amod	29	SENT_308	[p14l1833t1318r2152b1381],
29	proteins	NNS	O	protein	nsubj	31	SENT_308	[p14l9t1430r367b1530],
30	have	VBP	O	have	aux	31	SENT_308	[p14l409t1429r601b1509],
31	altered	VBN	O	alter	dep	10	SENT_308	[p14l641t1430r935b1508],
32	sensitivity	NN	O	sensitivity	dobj	31	SENT_308	[p14l976t1430r1409b1530],
33	to	TO	O	to	_	0	SENT_308	[p14l1444t1446r1525b1508],
34	the	DT	O	the	det	35	SENT_308	[p14l1566t1430r1699b1508],
35	inhibitor	NN	O	inhibitor	prep_to	31	SENT_308	[p14l1737t1430r2141b1508],
36	.	.	O	.	_	0	SENT_308	[p14l1737t1430r2141b1508],

1	EGF	NN	O	egf	nn	2	SENT_309	[p14l9t1558r579b1637],
2	—	NN	O	—	nsubj	3	SENT_309	[p14l9t1558r579b1637],
3	induced	VBD	O	induce	_	0	SENT_309	[p14l9t1558r579b1637],
4	autophosphorylation	NN	O	autophosphorylation	nsubjpass	8	SENT_309	[p14l624t1557r1518b1658],
5	of	IN	O	of	_	0	SENT_309	[p14l1565t1557r1666b1636],
6	EGFR	NN	O	egfr	prep_of	4	SENT_309	[p14l1692t1563r1953b1641],
7	Was	VBD	O	be	auxpass	8	SENT_309	[p14l1984t1584r2146b1637],
8	measured	VBN	O	measure	ccomp	3	SENT_309	[p14l11t1686r425b1765],
9	in	IN	O	in	_	0	SENT_309	[p14l458t1686r539b1763],
10	cells	NNS	O	cell	prep_in	8	SENT_309	[p14l573t1686r756b1764],
11	pretreated	VBN	O	pretreat	partmod	10	SENT_309	[p14l790t1686r1222b1786],
12	with	IN	O	with	_	0	SENT_309	[p14l1251t1685r1441b1765],
13	various	JJ	O	various	amod	14	SENT_309	[p14l1469t1686r1776b1765],
14	concentrations	NNS	O	concentration	prep_with	11	SENT_309	[p14l1812t1711r2147b1764, p14l11t1814r336b1892],
15	of	IN	O	of	_	0	SENT_309	[p14l371t1813r472b1892],
16	geﬁtinib	NN	O	geﬁtinib	prep_of	14	SENT_309	[p14l485t1813r867b1914],
17	.	.	O	.	_	0	SENT_309	[p14l485t1813r867b1914],

1	Remarkably	RB	O	remarkably	advmod	8	SENT_310	[p14l904t1814r1429b1914],
2	,	,	O	,	_	0	SENT_310	[p14l904t1814r1429b1914],
3	both	DT	O	both	det	5	SENT_310	[p14l1467t1814r1661b1892],
4	mutant	JJ	O	mutant	amod	5	SENT_310	[p14l1693t1830r2008b1893],
5	receptors	NNS	O	receptor	nsubj	8	SENT_310	[p14l2035t1840r2147b1892, p14l11t1958r319b2042],
6	Were	VBD	O	be	cop	8	SENT_310	[p14l348t1968r550b2021],
7	more	RBR	O	more	advmod	8	SENT_310	[p14l582t1967r803b2020],
8	sensitive	JJ	O	sensitive	_	0	SENT_310	[p14l837t1942r1198b2021],
9	than	IN	O	than	_	0	SENT_310	[p14l1230t1942r1419b2020],
10	the	DT	O	the	det	14	SENT_310	[p14l1451t1942r1581b2020],
11	Wild	NNP	O	Wild	nn	14	SENT_310	[p14l1607t1942r2003b2042],
12	—	CD	NUMBER	—	num	14	SENT_310	[p14l1607t1942r2003b2042],
13	type	NN	O	type	nn	14	SENT_310	[p14l1607t1942r2003b2042],
14	receptor	NN	O	receptor	prep_than	8	SENT_310	[p14l2035t1968r2147b2020, p14l11t2086r279b2170],
15	to	TO	O	to	_	0	SENT_310	[p14l313t2086r392b2148],
16	inhibition	NN	O	inhibition	prep_to	8	SENT_310	[p14l430t2069r851b2148],
17	by	IN	O	by	_	0	SENT_310	[p14l888t2070r985b2170],
18	geﬁtinib	NN	O	geﬁtinib	prep_by	8	SENT_310	[p14l1018t2069r1397b2170],
19	.	.	O	.	_	0	SENT_310	[p14l1018t2069r1397b2170],

1	Wild	NNP	O	Wild	nsubjpass	20	SENT_311	[p14l1437t2070r1851b2170],
2	—	CD	NUMBER	—	num	4	SENT_311	[p14l1437t2070r1851b2170],
3	type	NN	O	type	nn	4	SENT_311	[p14l1437t2070r1851b2170],
4	EGFR	NN	O	egfr	dep	1	SENT_311	[p14l1887t2075r2146b2153],
5	Was	VBD	O	be	auxpass	6	SENT_311	[p14l6t2224r168b2277],
6	inhibited	VBN	O	inhibit	_	0	SENT_311	[p14l199t2197r590b2276],
7	by	IN	O	by	_	0	SENT_311	[p14l620t2198r717b2298],
8	50	CD	PERCENT	50	num	9	SENT_311	[p14l744t2203r844b2276],
9	percent	NN	PERCENT	percent	agent	6	SENT_311	[p14l873t2214r1200b2298],
10	at	IN	O	at	_	0	SENT_311	[p14l1223t2214r1303b2276],
11	a	DT	O	a	det	13	SENT_311	[p14l1327t2224r1371b2276],
12	geﬁtinib	JJ	O	geﬁtinib	amod	13	SENT_311	[p14l1398t2197r1762b2298],
13	concentration	NN	O	concentration	prep_at	6	SENT_311	[p14l1793t2223r2133b2276, p14l11t2326r299b2404],
14	of	IN	O	of	_	0	SENT_311	[p14l327t2325r428b2404],
15	0.1	CD	NUMBER	0.1	num	16	SENT_311	[p14l437t2331r568b2404],
16	pM	NN	O	pm	prep_of	13	SENT_311	[p14l598t2333r726b2426],
17	and	CC	O	and	_	0	SENT_311	[p14l754t2325r912b2404],
18	was	VBD	O	be	auxpass	20	SENT_311	[p14l935t2352r1098b2405],
19	completely	RB	O	completely	advmod	20	SENT_311	[p14l1128t2325r1601b2426],
20	inhibited	VBN	O	inhibit	conj_and	6	SENT_311	[p14l1623t2326r2014b2404],
21	by	IN	O	by	_	0	SENT_311	[p14l2041t2325r2139b2426],
22	a	DT	O	a	det	23	SENT_311	[p14l10t2480r54b2532],
23	concentration	NN	O	concentration	agent	20	SENT_311	[p14l81t2454r681b2532],
24	of	IN	O	of	_	0	SENT_311	[p14l709t2453r810b2532],
25	2.0	CD	NUMBER	2.0	num	26	SENT_311	[p14l819t2459r951b2532],
26	uM	NN	O	um	prep_of	23	SENT_311	[p14l981t2461r1136b2554],
27	,	,	O	,	_	0	SENT_311	[p14l981t2461r1136b2554],
28	Whereas	IN	O	whereas	mark	39	SENT_311	[p14l1165t2454r1519b2533],
29	the	DT	O	the	det	31	SENT_311	[p14l1549t2453r1680b2532],
30	respective	JJ	O	respective	amod	31	SENT_311	[p14l1708t2454r2134b2554],
31	values	NNS	O	value	nsubj	39	SENT_311	[p14l6t2581r271b2661],
32	for	IN	O	for	_	0	SENT_311	[p14l304t2581r427b2660],
33	the	DT	O	the	det	36	SENT_311	[p14l454t2582r583b2660],
34	two	CD	NUMBER	two	num	36	SENT_311	[p14l614t2598r765b2661],
35	mutant	JJ	O	mutant	amod	36	SENT_311	[p14l797t2598r1108b2661],
36	proteins	NNS	O	protein	prep_for	31	SENT_311	[p14l1131t2582r1480b2682],
37	were	VBD	O	be	cop	39	SENT_311	[p14l1507t2608r1708b2661],
38	0.015	CD	NUMBER	0.015	num	39	SENT_311	[p14l1739t2587r1971b2660],
39	pM	NN	O	pm	dep	6	SENT_311	[p14l2006t2589r2134b2682],
40	and	CC	O	and	_	0	SENT_311	[p14l10t2709r164b2788],
41	0.2	CD	NUMBER	0.2	num	42	SENT_311	[p14l185t2715r312b2788],
42	pM	NN	O	pm	conj_and	39	SENT_311	[p14l336t2717r463b2810],
43	(	CD	NUMBER	(	num	44	SENT_311	[p14l490t2710r669b2810],
44	Fig	NN	O	fig	dep	42	SENT_311	[p14l490t2710r669b2810],
45	.	.	O	.	_	0	SENT_311	[p14l490t2710r669b2810],

1	3C	NN	O	3c	_	0	SENT_312	[p14l696t2715r806b2788],
2	and	CC	O	and	_	0	SENT_312	[p14l828t2709r982b2788],
3	3D	NN	O	3d	conj_and	1	SENT_312	[p14l1003t2715r1179b2801],
4	)	NN	O	)	dep	1	SENT_312	[p14l1003t2715r1179b2801],
5	.	.	O	.	_	0	SENT_312	[p14l1003t2715r1179b2801],

1	This	DT	O	this	det	2	SENT_313	[p14l1201t2710r1383b2788],
2	difference	NN	O	difference	nsubj	9	SENT_313	[p14l1407t2709r1820b2788],
3	in	IN	O	in	_	0	SENT_313	[p14l1841t2710r1921b2787],
4	drug	NN	O	drug	nn	5	SENT_313	[p14l1943t2709r2139b2810],
5	sensitivity	NN	O	sensitivity	prep_in	2	SENT_313	[p14l12t2838r430b2938],
6	may	MD	O	may	aux	9	SENT_313	[p14l448t2864r624b2938],
7	be	VB	O	be	cop	9	SENT_313	[p14l643t2838r738b2916],
8	clinically	RB	O	clinically	advmod	9	SENT_313	[p14l762t2837r1137b2938],
9	relevant	JJ	O	relevant	_	0	SENT_313	[p14l1154t2838r1509b2933],
10	,	,	O	,	_	0	SENT_313	[p14l1154t2838r1509b2933],
11	since	IN	O	since	mark	14	SENT_313	[p14l1538t2838r1751b2916],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_313	[p14l1772t2837r2134b2938, p14l11t2966r395b3045],
13	studies	NNS	O	study	nsubj	14	SENT_313	[p14l432t2966r725b3045],
14	indicate	VBP	O	indicate	advcl	9	SENT_313	[p14l763t2966r1095b3044],
15	that	IN	O	that	complm	32	SENT_313	[p14l1132t2966r1299b3044],
16	daily	JJ	SET	daily	amod	18	SENT_313	[p14l1331t2966r1530b3066],
17	oral	JJ	O	oral	amod	18	SENT_313	[p14l1562t2966r1724b3044],
18	administration	NN	O	administration	nsubj	32	SENT_313	[p14l1759t2966r2134b3044, p14l11t3094r298b3172],
19	of	IN	O	of	_	0	SENT_313	[p14l335t3093r436b3172],
20	400	CD	NUMBER	400	number	22	SENT_313	[p14l452t3099r610b3172],
21	to	TO	O	to	dep	22	SENT_313	[p14l647t3110r727b3172],
22	600	CD	NUMBER	600	num	23	SENT_313	[p14l766t3099r920b3172],
23	mg	NN	O	mg	prep_of	18	SENT_313	[p14l958t3120r1099b3194],
24	of	IN	O	of	_	0	SENT_313	[p14l1132t3093r1233b3172],
25	geﬁtinib	JJ	O	geﬁtinib	amod	26	SENT_313	[p14l1251t3093r1615b3194],
26	results	NNS	O	result	prep_of	23	SENT_313	[p14l1652t3094r1936b3173],
27	in	IN	O	in	_	0	SENT_313	[p14l1974t3094r2056b3171],
28	a	DT	O	a	det	31	SENT_313	[p14l2092t3120r2136b3172],
29	mean	JJ	O	mean	amod	31	SENT_313	[p14l11t3247r247b3300],
30	steady	JJ	O	steady	amod	31	SENT_313	[p14l277t3221r773b3322],
31	—	NN	O	—	prep_in	26	SENT_313	[p14l277t3221r773b3322],
32	state	NN	O	state	ccomp	14	SENT_313	[p14l277t3221r773b3322],
33	trough	NN	O	trough	nn	35	SENT_313	[p14l799t3221r1084b3322],
34	plasma	NN	O	plasma	nn	35	SENT_313	[p14l1108t3221r1415b3322],
35	concentration	NN	O	concentration	dobj	32	SENT_313	[p14l1440t3222r2027b3300],
36	of	IN	O	of	_	0	SENT_313	[p14l2053t3221r2153b3300],
37	1.1	CD	NUMBER	1.1	number	39	SENT_313	[p14l14t3355r140b3428],
38	to	TO	O	to	dep	39	SENT_313	[p14l164t3366r243b3428],
39	1.4	CD	NUMBER	1.4	num	40	SENT_313	[p14l271t3355r398b3428],
40	pM	NN	O	pm	prep_of	35	SENT_313	[p14l423t3357r575b3450],
41	,	,	O	,	_	0	SENT_313	[p14l423t3357r575b3450],
42	whereas	IN	O	whereas	mark	51	SENT_313	[p14l599t3350r947b3429],
43	the	DT	O	the	det	47	SENT_313	[p14l973t3350r1102b3428],
44	currently	RB	DATE	currently	advmod	47	SENT_313	[p14l1126t3350r1504b3450],
45	recommended	VBN	O	recommend	amod	47	SENT_313	[p14l1523t3349r2135b3428],
46	daily	JJ	SET	daily	amod	47	SENT_313	[p14l11t3477r211b3578],
47	dose	NN	O	dose	nsubj	51	SENT_313	[p14l239t3477r432b3556],
48	of	IN	O	of	_	0	SENT_313	[p14l465t3477r566b3556],
49	250	CD	NUMBER	250	num	50	SENT_313	[p14l579t3483r733b3556],
50	mg	NN	O	mg	prep_of	47	SENT_313	[p14l766t3504r905b3578],
51	leads	VBZ	O	lead	dep	40	SENT_313	[p14l933t3478r1147b3556],
52	to	TO	O	to	_	0	SENT_313	[p14l1181t3494r1260b3556],
53	a	DT	O	a	det	56	SENT_313	[p14l1292t3504r1337b3556],
54	mean	JJ	O	mean	amod	56	SENT_313	[p14l1367t3503r1600b3556],
55	trough	NN	O	trough	nn	56	SENT_313	[p14l1633t3478r1917b3578],
56	concentration	NN	O	concentration	prep_to	51	SENT_313	[p14l1949t3503r2134b3556, p14l11t3606r441b3684],
57	of	IN	O	of	_	0	SENT_313	[p14l467t3605r567b3684],
58	0.4	CD	NUMBER	0.4	num	59	SENT_313	[p14l574t3612r704b3684],
59	pM	NN	O	pm	prep_of	56	SENT_313	[p14l731t3600r970b3706],
60	.21	CD	NUMBER	.21	dep	59	SENT_313	[p14l731t3600r970b3706],

1	DISCUSSION	NN	O	discussion	_	0	SENT_314	[p15l717t158r1415b217],

1	Geﬁtinib	NNP	O	Geﬁtinib	nsubj	5	SENT_315	[p15l11t352r387b431],
2	is	VBZ	O	be	cop	5	SENT_315	[p15l420t353r485b431],
3	the	DT	O	the	det	5	SENT_315	[p15l518t353r647b431],
4	ﬁrst	JJ	O	ﬁrst	amod	5	SENT_315	[p15l679t352r853b431],
5	agent	NN	O	agent	_	0	SENT_315	[p15l878t369r1115b453],
6	designed	VBN	O	design	partmod	5	SENT_315	[p15l1143t352r1522b453],
7	with	IN	O	with	_	0	SENT_315	[p15l1549t353r1739b432],
8	a	DT	O	a	det	11	SENT_315	[p15l1770t379r1814b431],
9	known	JJ	O	known	amod	11	SENT_315	[p15l1844t353r2135b432],
10	molecular	JJ	O	molecular	amod	11	SENT_315	[p15l11t481r436b560],
11	target	NN	O	target	prep_with	6	SENT_315	[p15l476t497r725b581],
12	to	TO	O	to	aux	13	SENT_315	[p15l762t497r841b559],
13	receive	VB	O	receive	xcomp	6	SENT_315	[p15l885t481r1170b560],
14	FDA	NNP	ORGANIZATION	FDA	nn	15	SENT_315	[p15l1211t487r1399b559],
15	approval	NN	O	approval	dobj	13	SENT_315	[p15l1437t480r1802b581],
16	for	IN	O	for	_	0	SENT_315	[p15l1843t480r1966b559],
17	the	DT	O	the	det	18	SENT_315	[p15l2006t481r2135b559],
18	treatment	NN	O	treatment	prep_for	13	SENT_315	[p15l11t625r432b687],
19	of	IN	O	of	_	0	SENT_315	[p15l457t608r559b687],
20	lung	NN	O	lung	nn	21	SENT_315	[p15l570t609r767b709],
21	cancer	NN	O	cancer	prep_of	18	SENT_315	[p15l794t634r1092b704],
22	,	,	O	,	_	0	SENT_315	[p15l794t634r1092b704],
23	yet	RB	O	yet	advmod	5	SENT_315	[p15l1123t625r1250b709],
24	its	PRP$	O	its	poss	25	SENT_315	[p15l1274t609r1372b687],
25	activity	NN	O	activity	nsubjpass	27	SENT_315	[p15l1403t609r1707b709],
26	is	VBZ	O	be	auxpass	27	SENT_315	[p15l1732t609r1797b687],
27	limited	VBN	O	limit	ccomp	5	SENT_315	[p15l1829t608r2135b687],
28	to	TO	O	to	_	0	SENT_315	[p15l11t753r91b815],
29	a	DT	O	a	det	30	SENT_315	[p15l117t763r161b815],
30	subgroup	NN	O	subgroup	prep_to	27	SENT_315	[p15l185t737r588b837],
31	of	IN	O	of	_	0	SENT_315	[p15l615t736r715b815],
32	patients	NNS	O	patient	prep_of	30	SENT_315	[p15l719t737r1054b837],
33	with	IN	O	with	_	0	SENT_315	[p15l1077t736r1265b816],
34	non	JJ	O	non	amod	40	SENT_315	[p15l1290t736r1922b815],
35	—	JJ	O	—	amod	40	SENT_315	[p15l1290t736r1922b815],
36	small	JJ	O	small	amod	40	SENT_315	[p15l1290t736r1922b815],
37	—	NN	O	—	nn	40	SENT_315	[p15l1290t736r1922b815],
38	cell	NN	O	cell	nn	40	SENT_315	[p15l1290t736r1922b815],
39	lung	NN	O	lung	nn	40	SENT_315	[p15l1945t737r2139b837],
40	cancer	NN	O	cancer	prep_with	32	SENT_315	[p15l11t890r308b943],
41	.	.	O	.	_	0	SENT_315	[p15l11t890r308b943],

1	We	PRP	O	we	nsubj	3	SENT_316	[p15l345t872r479b943],
2	have	VBP	O	have	aux	3	SENT_316	[p15l512t865r700b944],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_316	[p15l734t864r1137b943],
4	speciﬁc	NN	O	speciﬁc	dobj	3	SENT_316	[p15l1172t864r1490b965],
5	activating	VBG	O	activate	xcomp	3	SENT_316	[p15l1523t865r1934b965],
6	mutations	NNS	O	mutation	nsubj	23	SENT_316	[p15l1963t891r2134b944, p15l11t993r299b1071],
7	Within	IN	O	within	_	0	SENT_316	[p15l327t993r602b1072],
8	the	DT	O	the	det	11	SENT_316	[p15l634t993r763b1071],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_316	[p15l794t993r1129b1093],
10	kinase	NN	O	kinase	nn	11	SENT_316	[p15l1160t993r1431b1072],
11	domain	NN	O	domain	prep_within	23	SENT_316	[p15l1463t992r1787b1071],
12	of	IN	O	of	_	0	SENT_316	[p15l1818t992r1918b1071],
13	EGFR	NN	O	egfr	prep_of	11	SENT_316	[p15l1929t999r2141b1072],
14	as	IN	O	as	_	0	SENT_316	[p15l10t1147r94b1199],
15	the	DT	O	the	det	17	SENT_316	[p15l121t1120r250b1199],
16	molecular	JJ	O	molecular	amod	17	SENT_316	[p15l273t1121r699b1200],
17	correlate	NN	O	correlate	prep_as	13	SENT_316	[p15l721t1121r1087b1199],
18	of	IN	O	of	_	0	SENT_316	[p15l1112t1120r1212b1199],
19	the	DT	O	the	det	21	SENT_316	[p15l1217t1121r1347b1199],
20	dramatic	JJ	O	dramatic	amod	21	SENT_316	[p15l1371t1121r1744b1199],
21	responses	NNS	O	response	prep_of	17	SENT_316	[p15l1767t1146r2134b1221, p15l11t1275r93b1327],
22	to	TO	O	to	aux	23	SENT_316	[p15l118t1265r197b1327],
23	geﬁtinib	VB	O	geﬁtinib	xcomp	5	SENT_316	[p15l221t1248r576b1349],
24	in	IN	O	in	_	0	SENT_316	[p15l600t1249r681b1326],
25	this	DT	O	this	det	26	SENT_316	[p15l704t1249r856b1327],
26	subgroup	NN	O	subgroup	prep_in	23	SENT_316	[p15l883t1248r1311b1349],
27	.	.	O	.	_	0	SENT_316	[p15l883t1248r1311b1349],

1	These	DT	O	these	det	3	SENT_317	[p15l1336t1248r1587b1327],
2	somatic	JJ	O	somatic	amod	3	SENT_317	[p15l1611t1249r1942b1327],
3	mutations	NNS	O	mutation	nsubjpass	5	SENT_317	[p15l1964t1275r2134b1328, p15l11t1377r296b1455],
4	were	VBD	O	be	auxpass	5	SENT_317	[p15l316t1403r516b1456],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_317	[p15l537t1376r936b1455],
6	in	IN	O	in	_	0	SENT_317	[p15l958t1377r1038b1454],
7	eight	CD	TIME	eight	prep_in	5	SENT_317	[p15l1060t1376r1275b1477],
8	of	IN	TIME	of	_	0	SENT_317	[p15l1292t1376r1392b1455],
9	nine	CD	TIME	nine	num	10	SENT_317	[p15l1395t1377r1578b1455],
10	patients	NNS	O	patient	prep_of	7	SENT_317	[p15l1598t1377r1929b1477],
11	with	IN	O	with	_	0	SENT_317	[p15l1949t1377r2136b1456],
12	a	DT	O	a	det	13	SENT_317	[p15l10t1531r54b1583],
13	response	NN	O	response	prep_with	10	SENT_317	[p15l81t1530r460b1605],
14	to	TO	O	to	_	0	SENT_317	[p15l489t1521r568b1583],
15	geﬁtinib	NN	O	geﬁtinib	prep_to	5	SENT_317	[p15l598t1504r979b1605],
16	;	:	O	;	_	0	SENT_317	[p15l598t1504r979b1605],
17	the	DT	O	the	det	19	SENT_317	[p15l1012t1505r1141b1583],
18	ninth	JJ	ORDINAL	ninth	amod	19	SENT_317	[p15l1170t1505r1397b1583],
19	patient	NN	O	patient	nsubj	22	SENT_317	[p15l1424t1505r1722b1605],
20	may	MD	O	may	aux	22	SENT_317	[p15l1746t1531r1922b1605],
21	have	VB	O	have	aux	22	SENT_317	[p15l1946t1505r2135b1584],
22	had	VBD	O	have	parataxis	5	SENT_317	[p15l11t1632r166b1711],
23	an	DT	O	a	det	25	SENT_317	[p15l189t1658r289b1711],
24	undetected	JJ	O	undetected	amod	25	SENT_317	[p15l313t1633r776b1712],
25	mutation	NN	O	mutation	dobj	22	SENT_317	[p15l799t1633r1189b1712],
26	or	CC	O	or	_	0	SENT_317	[p15l1213t1658r1302b1711],
27	a	DT	O	a	det	28	SENT_317	[p15l1322t1659r1366b1711],
28	mutation	NN	O	mutation	dobj	22	SENT_317	[p15l1389t1633r1778b1712],
29	in	IN	O	in	_	0	SENT_317	[p15l1801t1633r1882b1710],
30	a	DT	O	a	det	32	SENT_317	[p15l1905t1659r1949b1711],
31	heterodimerization	NN	O	heterodimerization	nn	32	SENT_317	[p15l1971t1633r2134b1711, p15l11t1761r704b1839],
32	partner	NN	O	partner	prep_in	28	SENT_317	[p15l740t1777r1058b1861],
33	of	IN	O	of	_	0	SENT_317	[p15l1092t1760r1194b1839],
34	EGFR	NN	O	egfr	prep_of	32	SENT_317	[p15l1211t1766r1487b1844],
35	.	.	O	.	_	0	SENT_317	[p15l1211t1766r1487b1844],

1	These	DT	O	these	det	2	SENT_318	[p15l1526t1761r1782b1839],
2	results	NNS	O	result	nsubj	38	SENT_318	[p15l1819t1760r2129b1856],
3	,	,	O	,	_	0	SENT_318	[p15l1819t1760r2129b1856],
4	together	RB	O	together	_	0	SENT_318	[p15l11t1889r374b1989],
5	with	IN	O	with	_	0	SENT_318	[p15l392t1889r584b1968],
6	the	DT	O	the	det	7	SENT_318	[p15l609t1888r740b1967],
7	ﬁnding	NN	O	ﬁnding	prep_together_with	38	SENT_318	[p15l765t1888r1083b1989],
8	of	IN	O	of	_	0	SENT_318	[p15l1105t1888r1206b1967],
9	EGFR	NN	O	egfr	nn	10	SENT_318	[p15l1210t1895r1426b1968],
10	mutations	NNS	O	mutation	prep_of	7	SENT_318	[p15l1444t1889r1883b1968],
11	in	IN	O	in	_	0	SENT_318	[p15l1909t1889r1992b1966],
12	tu	FW	O	tu	nn	14	SENT_318	[p15l2016t1905r2133b1968],
13	—	FW	O	—	nn	14	SENT_318	[p15l2016t1905r2133b1968],
14	mors	NNS	O	mor	prep_in	10	SENT_318	[p15l11t2042r229b2095],
15	from	IN	O	from	_	0	SENT_318	[p15l272t2016r482b2095],
16	2	CD	NUMBER	2	prep_from	14	SENT_318	[p15l522t2022r570b2094],
17	of	IN	O	of	_	0	SENT_318	[p15l611t2016r713b2095],
18	25	CD	NUMBER	25	num	19	SENT_318	[p15l735t2022r833b2095],
19	patients	NNS	O	patient	prep_of	16	SENT_318	[p15l876t2017r1218b2117],
20	with	IN	O	with	_	0	SENT_318	[p15l1256t2017r1449b2096],
21	non	JJ	O	non	amod	27	SENT_318	[p15l1488t2016r2135b2095],
22	—	JJ	O	—	amod	27	SENT_318	[p15l1488t2016r2135b2095],
23	small	JJ	O	small	amod	27	SENT_318	[p15l1488t2016r2135b2095],
24	—	NN	O	—	nn	27	SENT_318	[p15l1488t2016r2135b2095],
25	cell	NN	O	cell	nn	27	SENT_318	[p15l1488t2016r2135b2095],
26	lung	NN	O	lung	nn	27	SENT_318	[p15l10t2145r207b2245],
27	cancer	NN	O	cancer	prep_with	19	SENT_318	[p15l229t2170r510b2223],
28	who	WP	O	who	nsubj	31	SENT_318	[p15l528t2145r713b2224],
29	had	VBD	O	have	aux	31	SENT_318	[p15l740t2145r898b2223],
30	not	RB	O	not	neg	31	SENT_318	[p15l923t2161r1068b2223],
31	received	VBN	O	receive	rcmod	7	SENT_318	[p15l1089t2144r1438b2224],
32	geﬁtinib	NN	O	geﬁtinib	nn	33	SENT_318	[p15l1463t2144r1826b2245],
33	(	NN	O	(	nsubj	36	SENT_318	[p15l1858t2150r1935b2236],
34	8	CD	PERCENT	8	num	36	SENT_318	[p15l1858t2150r1935b2236],
35	percent	NN	PERCENT	percent	nn	36	SENT_318	[p15l1961t2171r2133b2245, p15l11t2280r242b2368],
36	)	NN	O	)	xcomp	31	SENT_318	[p15l1961t2171r2133b2245, p15l11t2280r242b2368],
37	,	,	O	,	_	0	SENT_318	[p15l1961t2171r2133b2245, p15l11t2280r242b2368],
38	suggest	VBP	O	suggest	_	0	SENT_318	[p15l279t2289r602b2373],
39	that	IN	O	that	complm	42	SENT_318	[p15l628t2272r793b2351],
40	such	JJ	O	such	amod	41	SENT_318	[p15l820t2273r1013b2352],
41	mutations	NNS	O	mutation	nsubj	42	SENT_318	[p15l1042t2273r1468b2352],
42	account	VBP	O	account	ccomp	38	SENT_318	[p15l1500t2289r1833b2352],
43	for	IN	O	for	mark	50	SENT_318	[p15l1858t2272r1980b2351],
44	the	DT	O	the	det	45	SENT_318	[p15l2007t2273r2135b2351],
45	majority	NN	O	majority	nsubj	50	SENT_318	[p15l11t2401r362b2501],
46	of	IN	O	of	_	0	SENT_318	[p15l383t2400r485b2479],
47	responses	NNS	O	response	prep_of	45	SENT_318	[p15l491t2426r921b2501],
48	to	TO	O	to	_	0	SENT_318	[p15l948t2417r1028b2479],
49	geﬁtinib	NN	O	geﬁtinib	prep_to	47	SENT_318	[p15l1055t2400r1418b2501],
50	reported	VBD	O	report	advcl	42	SENT_318	[p15l1444t2400r1811b2501],
51	in	IN	O	in	_	0	SENT_318	[p15l1835t2401r1917b2478],
52	clinical	JJ	O	clinical	amod	53	SENT_318	[p15l1943t2401r2133b2479, p15l10t2529r157b2607],
53	studies	NNS	O	study	prep_in	50	SENT_318	[p15l185t2523r707b2608],
54	.	.	O	.	_	0	SENT_318	[p15l185t2523r707b2608],

1	“’	NN	O	“’	_	0	SENT_319	[p15l185t2523r707b2608],
2	12	CD	NUMBER	12	num	1	SENT_319	[p15l185t2523r707b2608],

1	The	DT	O	the	det	3	SENT_320	[p15l136t2657r297b2735],
2	heterozygous	JJ	O	heterozygous	amod	3	SENT_320	[p15l318t2656r872b2757],
3	nature	NN	O	nature	nsubj	7	SENT_320	[p15l896t2673r1161b2736],
4	of	IN	O	of	_	0	SENT_320	[p15l1183t2656r1282b2735],
5	EGFR	NN	O	egfr	nn	6	SENT_320	[p15l1284t2663r1494b2736],
6	mutations	NNS	O	mutation	prep_of	3	SENT_320	[p15l1509t2657r1933b2736],
7	suggests	VBZ	O	suggest	_	0	SENT_320	[p15l1958t2683r2134b2757, p15l10t2801r219b2885],
8	that	IN	O	that	complm	10	SENT_320	[p15l251t2785r420b2863],
9	they	PRP	O	they	nsubj	10	SENT_320	[p15l451t2785r627b2885],
10	exert	VBP	O	exert	ccomp	7	SENT_320	[p15l655t2801r862b2863],
11	a	DT	O	a	det	14	SENT_320	[p15l888t2811r933b2863],
12	dominant	JJ	O	dominant	amod	14	SENT_320	[p15l963t2784r1381b2863],
13	oncogenic	JJ	O	oncogenic	amod	14	SENT_320	[p15l1409t2785r1846b2885],
14	effect	NN	O	effect	dobj	10	SENT_320	[p15l1878t2784r2130b2880],
15	,	,	O	,	_	0	SENT_320	[p15l1878t2784r2130b2880],
16	Which	WDT	O	which	nsubj	18	SENT_320	[p15l6t2912r267b2992],
17	is	VBZ	O	be	cop	18	SENT_320	[p15l290t2913r355b2991],
18	evident	JJ	O	evident	rcmod	14	SENT_320	[p15l381t2912r687b2992],
19	despite	IN	O	despite	_	0	SENT_320	[p15l706t2913r1006b3013],
20	the	DT	O	the	det	21	SENT_320	[p15l1030t2913r1159b2991],
21	presence	NN	O	presence	prep_despite	18	SENT_320	[p15l1181t2938r1555b3013],
22	of	IN	O	of	_	0	SENT_320	[p15l1580t2912r1680b2991],
23	the	DT	O	the	det	28	SENT_320	[p15l1686t2912r1815b2991],
24	second	JJ	ORDINAL	second	amod	28	SENT_320	[p15l1840t2912r2135b2991],
25	Wild	NNP	O	Wild	nn	28	SENT_320	[p15l6t3040r396b3141],
26	—	CD	NUMBER	—	num	28	SENT_320	[p15l6t3040r396b3141],
27	type	NN	O	type	nn	28	SENT_320	[p15l6t3040r396b3141],
28	allele	NN	O	allele	prep_of	21	SENT_320	[p15l416t3041r655b3119],
29	.	.	O	.	_	0	SENT_320	[p15l416t3041r655b3119],

1	The	DT	O	the	det	2	SENT_321	[p15l678t3041r839b3119],
2	presence	NN	O	presence	nsubj	11	SENT_321	[p15l859t3066r1229b3141],
3	of	IN	O	of	_	0	SENT_321	[p15l1251t3040r1351b3119],
4	an	DT	O	a	det	7	SENT_321	[p15l1353t3066r1454b3119],
5	additive	JJ	O	additive	amod	7	SENT_321	[p15l1474t3040r1798b3120],
6	speciﬁc	NN	O	speciﬁc	nn	7	SENT_321	[p15l1822t3040r2136b3141],
7	gain	NN	O	gain	prep_of	2	SENT_321	[p15l10t3169r189b3269],
8	of	IN	O	of	_	0	SENT_321	[p15l212t3168r311b3247],
9	ﬁanction	NN	O	ﬁanction	prep_of	7	SENT_321	[p15l315t3168r664b3248],
10	is	VBZ	O	be	cop	11	SENT_321	[p15l685t3169r749b3247],
11	ﬁlrther	JJ	O	ﬁlrther	_	0	SENT_321	[p15l773t3168r1062b3248],
12	supported	VBN	O	support	dep	11	SENT_321	[p15l1083t3169r1503b3269],
13	by	IN	O	by	_	0	SENT_321	[p15l1525t3169r1621b3269],
14	the	DT	O	the	det	15	SENT_321	[p15l1639t3169r1766b3247],
15	observation	NN	O	observation	prep_by	12	SENT_321	[p15l1789t3168r2135b3248, p15l11t3297r177b3375],
16	of	IN	O	of	_	0	SENT_321	[p15l205t3296r306b3375],
17	identical	JJ	O	identical	amod	19	SENT_321	[p15l314t3296r676b3375],
18	somatic	JJ	O	somatic	amod	19	SENT_321	[p15l704t3297r1035b3375],
19	mutations	NNS	O	mutation	prep_of	15	SENT_321	[p15l1061t3297r1492b3376],
20	in	IN	O	in	_	0	SENT_321	[p15l1521t3297r1602b3374],
21	different	JJ	O	different	prep_in	12	SENT_321	[p15l1630t3296r1997b3375],
22	tu	FW	O	tu	nn	24	SENT_321	[p15l2020t3313r2134b3376],
23	—	FW	O	—	nn	24	SENT_321	[p15l2020t3313r2134b3376],
24	mors	NNS	O	mor	dep	21	SENT_321	[p15l11t3450r251b3503],
25	.	.	O	.	_	0	SENT_321	[p15l11t3450r251b3503],

1	These	DT	O	these	det	2	SENT_322	[p15l283t3425r535b3503],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_322	[p15l565t3425r996b3504],
3	are	VBP	O	be	auxpass	4	SENT_322	[p15l1026t3451r1152b3503],
4	clustered	VBN	O	cluster	_	0	SENT_322	[p15l1183t3424r1565b3504],
5	near	IN	O	near	_	0	SENT_322	[p15l1594t3450r1780b3503],
6	the	DT	O	the	det	8	SENT_322	[p15l1807t3425r1936b3503],
7	ATP	NN	O	atp	nn	8	SENT_322	[p15l1963t3430r2137b3502],
8	cleft	NN	O	cleft	prep_near	4	SENT_322	[p15l11t3552r191b3631],
9	of	IN	O	of	_	0	SENT_322	[p15l207t3552r307b3631],
10	the	DT	O	the	det	13	SENT_322	[p15l309t3553r436b3631],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_322	[p15l457t3553r787b3653],
12	kinase	NN	O	kinase	nn	13	SENT_322	[p15l807t3553r1073b3632],
13	domain	NN	O	domain	prep_of	8	SENT_322	[p15l1095t3553r1437b3648],
14	,	,	O	,	_	0	SENT_322	[p15l1095t3553r1437b3648],
15	Where	WRB	O	where	advmod	17	SENT_322	[p15l1459t3553r1714b3632],
16	they	PRP	O	they	nsubj	17	SENT_322	[p15l1736t3553r1909b3653],
17	ﬂank	VBP	O	ﬂank	rcmod	13	SENT_322	[p15l1926t3552r2140b3632],
18	amino	NN	O	amino	nn	19	SENT_322	[p15l10t3681r283b3759],
19	acids	NNS	O	acid	dobj	17	SENT_322	[p15l314t3681r531b3759],
20	shown	VBN	O	show	partmod	19	SENT_322	[p15l565t3680r849b3760],
21	in	IN	O	in	_	0	SENT_322	[p15l879t3681r961b3758],
22	crystallographic	JJ	O	crystallographic	amod	23	SENT_322	[p15l993t3680r1688b3781],
23	studies	NNS	O	study	prep_in	20	SENT_322	[p15l1719t3681r2019b3760],
24	to	TO	O	to	aux	25	SENT_322	[p15l2053t3697r2133b3759],
25	mediate	VB	O	mediate	xcomp	20	SENT_322	[p16l11t20r352b99],
26	binding	NN	O	binding	dobj	25	SENT_322	[p16l412t20r752b121],
27	of	IN	O	of	_	0	SENT_322	[p16l807t20r909b99],
28	4-anilinoquinazoline	JJ	O	4-anilinoquinazoline	amod	29	SENT_322	[p16l947t20r1856b121],
29	compounds	NNS	O	compound	prep_of	26	SENT_322	[p16l1915t46r2133b99, p16l9t149r351b250],
30	,	,	O	,	_	0	SENT_322	[p16l1915t46r2133b99, p16l9t149r351b250],
31	such	JJ	O	such	_	0	SENT_322	[p16l392t150r587b229],
32	as	IN	O	as	_	0	SENT_322	[p16l620t176r704b228],
33	geﬁtinibzz	NN	O	geﬁtinibzz	nn	35	SENT_322	[p16l739t145r1176b250],
34	(	CD	NUMBER	(	num	35	SENT_322	[p16l1216t150r1399b250],
35	Fig	NN	O	fig	prep_such_as	13	SENT_322	[p16l1216t150r1399b250],
36	.	.	O	.	_	0	SENT_322	[p16l1216t150r1399b250],

1	4	CD	NUMBER	4	_	0	SENT_323	[p16l1437t155r1544b241],
2	)	NN	O	)	dep	1	SENT_323	[p16l1437t155r1544b241],
3	.	.	O	.	_	0	SENT_323	[p16l1437t155r1544b241],

1	We	PRP	O	we	nsubj	2	SENT_324	[p16l1580t157r1713b228],
2	postulate	VBP	O	postulate	_	0	SENT_324	[p16l1746t150r2135b250],
3	that	IN	O	that	complm	6	SENT_324	[p16l11t278r178b356],
4	the	DT	O	the	det	5	SENT_324	[p16l203t278r333b356],
5	mutations	NNS	O	mutation	nsubj	6	SENT_324	[p16l363t278r793b357],
6	result	VBP	O	result	ccomp	2	SENT_324	[p16l825t278r1067b357],
7	in	IN	O	in	_	0	SENT_324	[p16l1091t278r1172b355],
8	repositioning	NN	O	repositioning	prep_in	6	SENT_324	[p16l1202t278r1776b378],
9	of	IN	O	of	_	0	SENT_324	[p16l1804t277r1904b356],
10	these	DT	O	these	det	12	SENT_324	[p16l1917t277r2135b356],
11	critical	JJ	O	critical	amod	12	SENT_324	[p16l11t405r295b484],
12	residues	NNS	O	residue	prep_of	8	SENT_324	[p16l331t405r703b501],
13	,	,	O	,	_	0	SENT_324	[p16l331t405r703b501],
14	stabilizing	VBG	O	stabilize	xcomp	6	SENT_324	[p16l746t406r1194b506],
15	their	PRP$	O	they	poss	16	SENT_324	[p16l1226t406r1424b484],
16	interaction	NN	O	interaction	dobj	14	SENT_324	[p16l1456t406r1915b484],
17	with	IN	O	with	_	0	SENT_324	[p16l1946t406r2135b485],
18	both	CC	O	both	preconj	19	SENT_324	[p16l11t533r205b612],
19	ATP	NN	ORGANIZATION	atp	prep_with	14	SENT_324	[p16l244t539r418b611],
20	and	CC	O	and	_	0	SENT_324	[p16l460t533r615b612],
21	its	PRP$	O	its	poss	24	SENT_324	[p16l659t534r755b612],
22	competitive	JJ	O	competitive	amod	24	SENT_324	[p16l801t534r1290b634],
23	inhibitor	NN	O	inhibitor	nn	24	SENT_324	[p16l1334t534r1709b612],
24	geﬁtinib	NN	O	geﬁtinib	prep_with	14	SENT_324	[p16l1750t533r2130b634],
25	.	.	O	.	_	0	SENT_324	[p16l1750t533r2130b634],

1	Such	PDT	O	such	predet	3	SENT_325	[p16l13t662r219b741],
2	a	DT	O	a	det	3	SENT_325	[p16l268t688r312b740],
3	mechanism	NN	O	mechanism	nsubj	5	SENT_325	[p16l361t661r863b740],
4	would	MD	O	would	aux	5	SENT_325	[p16l909t661r1178b741],
5	explain	VB	O	explain	_	0	SENT_325	[p16l1229t662r1539b762],
6	both	CC	O	both	advmod	5	SENT_325	[p16l1589t661r1785b740],
7	the	DT	O	the	det	10	SENT_325	[p16l1836t662r1967b740],
8	increased	VBN	O	increase	amod	10	SENT_325	[p16l2016t662r2133b739, p16l11t790r323b868],
9	receptor	NN	O	receptor	nn	10	SENT_325	[p16l345t806r693b890],
10	activation	NN	O	activation	dobj	5	SENT_325	[p16l712t790r1114b869],
11	after	IN	O	after	_	0	SENT_325	[p16l1136t789r1327b868],
12	ligand	NN	O	ligand	nn	13	SENT_325	[p16l1346t789r1609b890],
13	binding	NN	O	binding	prep_after	5	SENT_325	[p16l1633t790r1962b890],
14	and	CC	O	and	_	0	SENT_325	[p16l1981t789r2135b868],
15	the	DT	O	the	det	17	SENT_325	[p16l11t918r139b996],
16	enhanced	VBN	O	enhance	amod	17	SENT_325	[p16l161t918r564b996],
17	inhibition	NN	O	inhibition	conj_and	13	SENT_325	[p16l583t917r999b996],
18	induced	VBN	O	induce	partmod	17	SENT_325	[p16l1019t918r1353b997],
19	by	IN	O	by	_	0	SENT_325	[p16l1375t918r1471b1018],
20	geﬁtinib	NN	O	geﬁtinib	agent	18	SENT_325	[p16l1487t917r1862b1018],
21	.	.	O	.	_	0	SENT_325	[p16l1487t917r1862b1018],

1	Structural	JJ	MISC	structural	amod	2	SENT_326	[p16l1890t923r2134b997, p16l11t1046r204b1125],
2	analysis	NN	O	analysis	nsubj	7	SENT_326	[p16l225t1046r553b1146],
3	of	IN	O	of	_	0	SENT_326	[p16l579t1045r678b1124],
4	the	DT	O	the	det	6	SENT_326	[p16l683t1046r812b1124],
5	mutant	JJ	O	mutant	amod	6	SENT_326	[p16l834t1062r1146b1125],
6	receptors	NNS	O	receptor	prep_of	2	SENT_326	[p16l1163t1062r1553b1146],
7	will	MD	O	will	_	0	SENT_326	[p16l1573t1045r1730b1125],
8	therefore	RB	O	therefore	advmod	7	SENT_326	[p16l1752t1045r2135b1124],

1	N	NN	O	n	nn	3	SENT_327	[p16l516t1223r529b1238],
2	ENGLJ	NN	O	englj	nn	3	SENT_327	[p16l545t1222r629b1244],
3	MED35o	NN	O	med35o	_	0	SENT_327	[p16l644t1222r787b1244],
4	;	:	O	;	_	0	SENT_327	[p16l644t1222r787b1244],
5	21	CD	NUMBER	21	num	7	SENT_327	[p16l644t1222r787b1244],
6	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	7	SENT_327	[p16l824t1222r1036b1244],
7	MAY	NNP	DATE	MAY	dep	3	SENT_327	[p16l1075t1222r1127b1238],
8	20,2004	CD	DATE	20,2004	number	9	SENT_327	[p16l1138t1222r1258b1244],
9	2135	CD	DATE	2135	dep	7	SENT_327	[p16l1940t1221r2015b1243],

1	The	DT	O	the	det	4	SENT_328	[p16l702t1255r753b1279],
2	New	NNP	O	New	nn	4	SENT_328	[p16l762t1256r824b1279],
3	England	NNP	O	England	nn	4	SENT_328	[p16l833t1255r944b1286],
4	Journal	NNP	O	Journal	_	0	SENT_328	[p16l953t1255r1050b1279],
5	of	IN	O	of	_	0	SENT_328	[p16l1060t1255r1089b1279],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_328	[p16l1095t1255r1220b1279],

1	Copyright	NN	O	copyright	_	0	SENT_329	[p16l494t1337r629b1368],
2	©	CD	NUMBER	©	num	6	SENT_329	[p16l638t1337r661b1361],
3	2004	CD	DATE	2004	num	6	SENT_329	[p16l672t1337r737b1361],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_329	[p16l746t1337r937b1361],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_329	[p16l947t1337r1055b1361],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_329	[p16l1065t1337r1170b1368],
7	.	.	O	.	_	0	SENT_329	[p16l1065t1337r1170b1368],

1	All	DT	O	all	det	2	SENT_330	[p16l1181t1337r1223b1361],
2	rights	NNS	O	rights	nsubj	3	SENT_330	[p16l1232t1337r1307b1368],
3	reserved	VBN	O	reserve	_	0	SENT_330	[p16l1316t1337r1435b1361],
4	.	.	O	.	_	0	SENT_330	[p16l1316t1337r1435b1361],

1	The	DT	O	the	det	3	SENT_331	[p16l715t1379r752b1400],
2	NEW	NNP	O	NEW	nn	3	SENT_331	[p16l764t1381r844b1400],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_331	[p16l858t1381r1033b1400],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_331	[p16l1047t1381r1213b1407],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_331	[p16l1227t1379r1443b1406],

1	.	.	O	.	_	0	SENT_332	[p16l665t1586r668b1589],

1	.	.	O	.	_	0	SENT_333	[p16l952t1586r955b1589],

1	+	CC	O	+	cc	3	SENT_334	[p16l1606t1572r1627b1583],
2	L858R	NN	O	l858r	nn	3	SENT_334	[p16l1643t1566r1715b1587],
3	M	NN	O	m	_	0	SENT_334	[p16l640t1586r684b1606],
4	'	''	O	'	_	0	SENT_334	[p16l640t1586r684b1606],
5	"	``	O	"	punct	6	SENT_334	[p16l640t1586r684b1606],
6	M	NN	O	m	nsubj	12	SENT_334	[p16l927t1586r971b1606],
7	'	''	O	'	_	0	SENT_334	[p16l927t1586r971b1606],
8	"	``	O	"	punct	12	SENT_334	[p16l927t1586r971b1606],
9	+	CC	O	+	cc	12	SENT_334	[p16l1606t1609r1627b1617],
10	de	FW	O	de	nn	11	SENT_334	[p16l1642t1600r1861b1622],
11	|	FW	O	|	amod	12	SENT_334	[p16l1642t1600r1861b1622],
12	L747	NN	O	l747	rcmod	3	SENT_334	[p16l1642t1600r1861b1622],
13	.	.	O	.	_	0	SENT_334	[p16l1642t1600r1861b1622],

1	—	NN	O	—	_	0	SENT_335	[p16l1642t1600r1861b1622],
2	.	.	O	.	_	0	SENT_335	[p16l1642t1600r1861b1622],

1	P753insS	NN	O	p753inss	_	0	SENT_336	[p16l1642t1600r1861b1622],

1	o	NN	O	o	dep	8	SENT_337	[p16l543t1637r556b1658],
2	5	CD	NUMBER	5	number	3	SENT_337	[p16l596t1638r607b1658],
3	15	CD	NUMBER	15	dep	1	SENT_337	[p16l643t1638r667b1658],
4	30	CD	NUMBER	30	num	5	SENT_337	[p16l695t1637r722b1658],
5	180	CD	NUMBER	180	dep	3	SENT_337	[p16l742t1637r782b1658],
6	o	NN	O	o	dep	8	SENT_337	[p16l842t1637r855b1658],
7	5	CD	NUMBER	5	num	6	SENT_337	[p16l896t1638r906b1658],
8	15	CD	NUMBER	15	dep	11	SENT_337	[p16l943t1638r967b1658],
9	30180	CD	NUMBER	30180	dep	8	SENT_337	[p16l995t1637r1082b1658],
10	-	:	O	-	_	0	SENT_337	[p16l1606t1636r1752b1665],
11	r-Wildtype	NN	O	r-wildtype	_	0	SENT_337	[p16l1606t1636r1752b1665],

1	Wildtypegiééi	NNP	O	Wildtypegiééi	_	0	SENT_338	[p16l408t1679r787b1710],
2	—	CD	NUMBER	—	num	3	SENT_338	[p16l821t1679r1090b1715],
3	jQﬂﬂ	NN	O	jqﬂﬂ	dep	1	SENT_338	[p16l821t1679r1090b1715],
4	188	CD	NUMBER	188	dep	3	SENT_338	[p16l1406t1685r1446b1732],
5	Lsszre	NN	O	lsszre	dep	1	SENT_338	[p16l448t1750r519b1771],
6	'	''	O	'	_	0	SENT_338	[p16l533t1748r564b1760],
7	`	``	O	`	_	0	SENT_338	[p16l583t1742r792b1781],
8	s	NNS	O	s	dep	5	SENT_338	[p16l583t1742r792b1781],
9	!	.	O	!	_	0	SENT_338	[p16l583t1742r792b1781],

1	+	CC	O	+	nsubj	4	SENT_339	[p16l583t1742r792b1781],
2	W.	NNP	O	W.	nn	4	SENT_339	[p16l810t1738r907b1784],
3	I.	NNP	O	I.	nn	4	SENT_339	[p16l918t1744r1026b1784],
4	ﬁ	NNP	O	ﬁ	_	0	SENT_339	[p16l918t1744r1026b1784],
5	*	NN	O	*	dobj	4	SENT_339	[p16l918t1744r1026b1784],
6	!	.	O	!	_	0	SENT_339	[p16l1038t1748r1093b1784],

1	8	CD	NUMBER	8	num	2	SENT_340	[p16l1419t1738r1446b1759],
2	°	NN	O	°	_	0	SENT_340	[p16l1419t1738r1446b1759],

1	de	IN	O	de	amod	3	SENT_341	[p16l299t1818r518b1840],
2	|	CD	NUMBER	|	num	3	SENT_341	[p16l299t1818r518b1840],
3	L747	NN	O	l747	_	0	SENT_341	[p16l299t1818r518b1840],
4	.	.	O	.	_	0	SENT_341	[p16l299t1818r518b1840],

1	—	NN	O	—	_	0	SENT_342	[p16l299t1818r518b1840],
2	.	.	O	.	_	0	SENT_342	[p16l299t1818r518b1840],

1	P753insS	NN	O	p753inss	nsubj	3	SENT_343	[p16l299t1818r518b1840],
2	*	CD	NUMBER	*	num	1	SENT_343	[p16l541t1819r570b1825],
3	ii	LS	O	ii	_	0	SENT_343	[p16l591t1809r784b1834],
4	.	.	O	.	_	0	SENT_343	[p16l591t1809r784b1834],

1	‘	NN	O	‘	_	0	SENT_344	[p16l591t1809r784b1834],
2	.	.	O	.	_	0	SENT_344	[p16l819t1818r1034b1850],

1	--	:	O	--	_	0	SENT_345	[p16l819t1818r1034b1850],
2	I	PRP	O	I	nsubj	3	SENT_345	[p16l819t1818r1034b1850],
3	“	VBP	O	“	_	0	SENT_345	[p16l819t1818r1034b1850],
4	.	.	O	.	_	0	SENT_345	[p16l819t1818r1034b1850],

1	:	:	O	:	_	0	SENT_346	[p16l1048t1820r1090b1848, p16l591t1884r731b1907],
2	Anti-Y1068	NN	O	anti-y1068	_	0	SENT_346	[p16l1048t1820r1090b1848, p16l591t1884r731b1907],

1	Anti-EG	JJ	O	anti-eg	amod	2	SENT_347	[p16l885t1882r983b1905],
2	FR	NN	O	fr	_	0	SENT_347	[p16l988t1884r1019b1905],
3	(	NN	O	(	nn	4	SENT_347	[p16l900t1917r1005b1948],
4	control	NN	O	control	dep	2	SENT_347	[p16l900t1917r1005b1948],
5	)	CD	NUMBER	)	dep	2	SENT_347	[p16l900t1917r1005b1948],

1	Activation	NN	O	activation	_	0	SENT_348	[p16l1341t1781r1364b1909],
2	(	CD	PERCENT	(	num	3	SENT_348	[p16l1342t1727r1372b1769],
3	%	NN	PERCENT	%	dep	1	SENT_348	[p16l1342t1727r1372b1769],
4	)	CD	NUMBER	)	dep	1	SENT_348	[p16l1342t1727r1372b1769],

1	AI	NN	O	aus	nn	2	SENT_349	[p16l1450t1915r1776b1952],
2	O	NN	O	o	_	0	SENT_349	[p16l1491t1960r1504b1980],
3	5	CD	NUMBER	5	number	4	SENT_349	[p16l1561t1960r1572b1980],
4	15	CD	NUMBER	15	num	6	SENT_349	[p16l1624t1959r1648b1979],
5	30	CD	NUMBER	30	number	6	SENT_349	[p16l1693t1958r1720b1978],
6	180	CD	NUMBER	180	dep	2	SENT_349	[p16l1756t1961r1796b1982],
7	Time	NNP	O	Time	dep	2	SENT_349	[p16l1480t2011r1545b2034],
8	after	IN	O	after	_	0	SENT_349	[p16l1554t2011r1612b2034],
9	EGF	NN	O	egf	nn	12	SENT_349	[p16l1622t2013r1674b2034],
10	(	CD	NUMBER	(	num	12	SENT_349	[p16l1685t2012r1750b2042],
11	min	NN	DURATION	min	nn	12	SENT_349	[p16l1685t2012r1750b2042],
12	)	NN	O	)	prep_after	7	SENT_349	[p16l1685t2012r1750b2042],

1	-	:	O	-	_	0	SENT_350	[p16l1606t2125r1627b2137],
2	o	NN	O	o	_	0	SENT_350	[p16l1606t2125r1627b2137],
3	-	:	O	-	_	0	SENT_350	[p16l1606t2125r1627b2137],
4	L858R	NN	O	l858r	dep	2	SENT_350	[p16l1643t2120r1715b2141],
5	--	:	O	--	_	0	SENT_350	[p16l1606t2162r1627b2171],
6	de	IN	O	de	_	0	SENT_350	[p16l1642t2154r1861b2176],
7	|	CD	NUMBER	|	num	8	SENT_350	[p16l1642t2154r1861b2176],
8	L747	NN	O	l747	prep_de	2	SENT_350	[p16l1642t2154r1861b2176],
9	.	.	O	.	_	0	SENT_350	[p16l1642t2154r1861b2176],

1	—	NN	O	—	_	0	SENT_351	[p16l1642t2154r1861b2176],
2	.	.	O	.	_	0	SENT_351	[p16l1642t2154r1861b2176],

1	P753insS	NN	O	p753inss	_	0	SENT_352	[p16l1642t2154r1861b2176],
2	1	CD	NUMBER	1	num	1	SENT_352	[p16l1606t2196r1627b2208],
3	-	:	O	-	_	0	SENT_352	[p16l1606t2196r1627b2208],
4	Wild	NNP	O	Wild	nn	5	SENT_352	[p16l1641t2189r1693b2211],
5	type	NN	O	type	dep	1	SENT_352	[p16l1703t2193r1752b2218],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	2	SENT_353	[p16l612t2134r714b2157],
2	(	NN	O	(	_	0	SENT_353	[p16l726t2136r781b2163],
3	)	CD	NUMBER	)	num	4	SENT_353	[p16l726t2136r781b2163],
4	4M	NN	O	4m	dep	2	SENT_353	[p16l726t2136r781b2163],
5	)	CD	NUMBER	)	num	7	SENT_353	[p16l726t2136r781b2163],
6	Gefitinib	NNP	O	Gefitinib	nn	7	SENT_353	[p16l942t2134r1044b2157],
7	(	NN	O	(	dep	2	SENT_353	[p16l1056t2136r1111b2163],
8	;	:	O	;	_	0	SENT_353	[p16l1056t2136r1111b2163],
9	4M	NN	O	4m	nn	12	SENT_353	[p16l1056t2136r1111b2163],
10	)	CD	NUMBER	)	num	12	SENT_353	[p16l1056t2136r1111b2163],
11	L	NN	O	l	nn	12	SENT_353	[p16l584t2177r847b2197],
12	M	NN	O	m	dep	2	SENT_353	[p16l917t2179r1173b2199],
13	U	NN	O	u	prep	12	SENT_353	[p16l555t2219r570b2239],
14	0002	CD	DATE	0002	num	15	SENT_353	[p16l597t2218r660b2239],
15	0.02	CD	NUMBER	0.02	dep	13	SENT_353	[p16l671t2218r719b2239],
16	0.2	CD	NUMBER	0.2	number	17	SENT_353	[p16l744t2218r778b2239],
17	2.0	CD	NUMBER	2.0	num	18	SENT_353	[p16l811t2218r845b2239],
18	U	NNP	O	U	dep	12	SENT_353	[p16l885t2219r900b2239],
19	0.002	CD	NUMBER	0.002	number	20	SENT_353	[p16l927t2218r990b2239],
20	0.02	CD	NUMBER	0.02	dep	24	SENT_353	[p16l1000t2218r1049b2239],
21	0.2	CD	NUMBER	0.2	number	22	SENT_353	[p16l1074t2218r1108b2239],
22	2.0	CD	NUMBER	2.0	dep	24	SENT_353	[p16l1140t2218r1175b2239],
23	Wild	NNP	O	Wild	dep	24	SENT_353	[p16l408t2263r460b2285],
24	type	NN	O	type	amod	18	SENT_353	[p16l470t2268r519b2292],
25	i	LS	O	i	dep	18	SENT_353	[p16l533t2250r648b2302],
26	-	:	O	-	_	0	SENT_353	[p16l662t2269r772b2296],
27	_	NN	O	_	dep	2	SENT_353	[p16l662t2269r772b2296],
28	:	:	O	:	_	0	SENT_353	[p16l662t2269r772b2296],
29	i	LS	O	i	dep	27	SENT_353	[p16l662t2269r772b2296],
30	-	:	O	-	_	0	SENT_353	[p16l662t2269r772b2296],
31	Q	NNP	O	Q	nn	32	SENT_353	[p16l870t2260r925b2293],
32	U	NNP	O	U	dep	2	SENT_353	[p16l939t2262r986b2291],
33	SE	NN	O	se	dep	32	SENT_353	[p16l999t2262r1112b2292],
34	‘	CD	NUMBER	‘	num	33	SENT_353	[p16l999t2262r1112b2292],
35	I	PRP	O	I	nsubj	37	SENT_353	[p16l1130t2260r1178b2287],
36	'll	MD	O	'll	aux	37	SENT_353	[p16l1130t2260r1178b2287],
37	L858	VB	O	l858	rcmod	2	SENT_353	[p16l448t2337r519b2358],
38	“	CD	NUMBER	“	num	39	SENT_353	[p16l448t2337r519b2358],
39	delL747	NN	O	dell747	dobj	37	SENT_353	[p16l299t2407r518b2429],
40	.	.	O	.	_	0	SENT_353	[p16l299t2407r518b2429],

1	—	NN	O	—	_	0	SENT_354	[p16l299t2407r518b2429],
2	.	.	O	.	_	0	SENT_354	[p16l299t2407r518b2429],

1	P753insS	NN	O	p753inss	nn	2	SENT_355	[p16l299t2407r518b2429],
2	D	NN	O	d	_	0	SENT_355	[p16l532t2398r656b2441],
3	;	:	O	;	_	0	SENT_355	[p16l532t2398r656b2441],
4	an	DT	O	a	det	10	SENT_355	[p16l670t2412r718b2432],
5	-	:	O	-	_	0	SENT_355	[p16l754t2420r766b2424],
6	i	FW	O	i	dep	10	SENT_355	[p16l873t2404r922b2433],
7	Q	NNP	O	Q	dep	6	SENT_355	[p16l935t2408r984b2435],
8	3	CD	NUMBER	3	num	7	SENT_355	[p16l999t2406r1050b2433],
9	—	NN	O	—	nn	10	SENT_355	[p16l1064t2406r1114b2433],
10	t	NN	O	t	dep	2	SENT_355	[p16l1064t2406r1114b2433],
11	‘	CD	NUMBER	‘	dep	10	SENT_355	[p16l1128t2406r1174b2429],
12	it	PRP	O	it	dep	10	SENT_355	[p16l1128t2406r1174b2429],

1	Anti-Y1068	JJ	O	anti-y1068	amod	3	SENT_356	[p16l622t2472r763b2495],
2	Anti-EGFR	NN	O	anti-egfr	nn	3	SENT_356	[p16l959t2470r1093b2493],
3	o	NN	O	o	_	0	SENT_356	[p16l1433t2469r1446b2489],

1	(	NN	O	(	nn	2	SENT_357	[p16l974t2505r1079b2536],
2	comol	NN	O	comol	_	0	SENT_357	[p16l974t2505r1079b2536],
3	)	CD	NUMBER	)	num	5	SENT_357	[p16l974t2505r1079b2536],
4	o.	NN	O	o.	nn	5	SENT_357	[p16l1466t2500r1515b2521],
5	oo	NN	O	oo	dep	2	SENT_357	[p16l1466t2500r1515b2521],
6	0.002	CD	NUMBER	0.002	num	7	SENT_357	[p16l1526t2500r1590b2521],
7	0.02	CD	NUMBER	0.02	dep	2	SENT_357	[p16l1601t2500r1650b2521],
8	0.2	CD	NUMBER	0.2	number	9	SENT_357	[p16l1677t2500r1711b2521],
9	2.0	CD	NUMBER	2.0	dep	7	SENT_357	[p16l1744t2500r1779b2521],

1	Log	VB	MISC	log	_	0	SENT_358	[p16l1416t2545r1461b2574],
2	Geﬁtinib	NNP	MISC	Geﬁtinib	nn	3	SENT_358	[p16l1470t2543r1580b2567],
3	Concentration	NN	MISC	concentration	nsubj	8	SENT_358	[p16l1589t2544r1769b2567],
4	(	CD	NUMBER	(	num	3	SENT_358	[p16l1781t2545r1840b2574],
5	yM	NN	O	ym	nn	8	SENT_358	[p16l1781t2545r1840b2574],
6	)	CD	NUMBER	)	num	8	SENT_358	[p16l1781t2545r1840b2574],
7	1O	NN	O	1o	nn	8	SENT_358	[p16l1406t2205r1415b2225, p16l1418t2204r1431b2225],
8	(	NN	O	(	xcomp	1	SENT_358	[p16l1433t2204r1446b2225],
9	D	NN	O	d	nn	12	SENT_358	[p16l1433t2204r1446b2225],
10	oo	NN	O	oo	nn	12	SENT_358	[p16l1419t2257r1431b2278],
11	O	NN	O	o	nn	12	SENT_358	[p16l1433t2257r1446b2278],
12	O	NN	O	o	dep	8	SENT_358	[p16l1419t2310r1431b2331],
13	'	''	O	'	_	0	SENT_358	[p16l1419t2310r1431b2331],
14	\	CD	NUMBER	\	num	15	SENT_358	[p16l1419t2310r1431b2331],
15	O	NN	O	o	dep	8	SENT_358	[p16l1433t2310r1446b2331],
16	-	:	O	-	_	0	SENT_358	[p16l1418t2364r1431b2383],
17	J	NN	O	j	dep	1	SENT_358	[p16l1418t2364r1431b2383],
18	>	JJR	O	>	amod	19	SENT_358	[p16l1418t2364r1431b2383],
19	o	NN	O	o	dobj	17	SENT_358	[p16l1433t2363r1446b2384],

1	Activation	NN	O	activation	_	0	SENT_359	[p16l1341t2313r1364b2441],
2	(	CD	PERCENT	(	num	3	SENT_359	[p16l1342t2260r1372b2301],
3	%	NN	PERCENT	%	dep	1	SENT_359	[p16l1342t2260r1372b2301],
4	)	CD	NUMBER	)	dep	1	SENT_359	[p16l1342t2260r1372b2301],

1	l	NN	O	l	_	0	SENT_360	[p16l1419t2416r1431b2436],
2	\	SYM	O	\	dep	3	SENT_360	[p16l1419t2416r1431b2436],
3	)	CD	NUMBER	)	rcmod	1	SENT_360	[p16l1419t2416r1431b2436],
4	O	NN	O	o	dep	1	SENT_360	[p16l1433t2416r1446b2437],

1	Figure	NNP	O	Figure	_	0	SENT_361	[p16l264t2634r348b2666],
2	3	CD	NUMBER	3	dep	1	SENT_361	[p16l357t2635r380b2658],
3	.	.	O	.	_	0	SENT_361	[p16l357t2635r380b2658],

1	Enhanced	VBN	O	enhance	_	0	SENT_362	[p16l392t2633r523b2658],
2	EG	NN	O	eg	nn	3	SENT_362	[p16l536t2635r572b2658],
3	F	NN	O	f	dobj	1	SENT_362	[p16l577t2633r762b2665],
4	.	.	O	.	_	0	SENT_362	[p16l577t2633r762b2665],

1	—	NN	O	—	_	0	SENT_363	[p16l577t2633r762b2665],
2	.	.	O	.	_	0	SENT_363	[p16l577t2633r762b2665],

1	Dependent	JJ	O	dependent	amod	2	SENT_364	[p16l577t2633r762b2665],
2	Activation	NN	O	activation	_	0	SENT_364	[p16l769t2633r906b2658],
3	of	IN	O	of	_	0	SENT_364	[p16l916t2632r947b2658],
4	Mutant	JJ	O	mutant	amod	5	SENT_364	[p16l953t2635r1052b2658],
5	EGFR	NN	O	egfr	prep_of	2	SENT_364	[p16l1062t2635r1137b2658],
6	and	CC	O	and	_	0	SENT_364	[p16l1147t2633r1196b2658],
7	Increased	VBN	O	increase	amod	8	SENT_364	[p16l1208t2633r1337b2658],
8	Sensitivity	NN	O	sensitivity	conj_and	5	SENT_364	[p16l1348t2633r1489b2666],
9	of	IN	O	of	_	0	SENT_364	[p16l1497t2632r1528b2658],
10	Mutant	JJ	O	mutant	amod	11	SENT_364	[p16l1534t2635r1633b2658],
11	EGFR	NN	O	egfr	prep_of	8	SENT_364	[p16l1643t2635r1719b2658],
12	to	TO	O	to	_	0	SENT_364	[p16l1727t2637r1754b2658],
13	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	8	SENT_364	[p16l1763t2632r1888b2658],
14	.	.	O	.	_	0	SENT_364	[p16l1763t2632r1888b2658],

1	Panel	NN	O	panel	nn	2	SENT_365	[p16l264t2683r334b2708],
2	A	NN	O	a	nsubj	3	SENT_365	[p16l344t2685r363b2708],
3	shows	VBZ	O	show	_	0	SENT_365	[p16l373t2683r457b2708],
4	the	DT	O	the	det	6	SENT_365	[p16l466t2683r508b2708],
5	time	NN	O	time	nn	6	SENT_365	[p16l517t2685r578b2708],
6	course	NN	O	course	nsubj	10	SENT_365	[p16l587t2692r677b2708],
7	ofligand-induced	JJ	O	ofligand-induced	amod	10	SENT_365	[p16l686t2683r922b2716],
8	activation	NN	O	activation	nn	10	SENT_365	[p16l933t2685r1063b2708],
9	ofthe	NN	O	ofthe	nn	10	SENT_365	[p16l1074t2683r1150b2708],
10	delL747	NN	O	dell747	xcomp	3	SENT_365	[p16l1159t2683r1408b2708],
11	.	.	O	.	_	0	SENT_365	[p16l1159t2683r1408b2708],

1	—	NN	O	—	_	0	SENT_366	[p16l1159t2683r1408b2708],
2	.	.	O	.	_	0	SENT_366	[p16l1159t2683r1408b2708],

1	P753insS	NN	O	p753inss	nn	5	SENT_367	[p16l1159t2683r1408b2708],
2	and	CC	O	and	_	0	SENT_367	[p16l1419t2683r1467b2708],
3	L858R	NN	O	l858r	conj_and	1	SENT_367	[p16l1480t2684r1561b2708],
4	EGFR	NN	O	egfr	nn	5	SENT_367	[p16l1573t2685r1647b2708],
5	mutants	NNS	O	mutant	nsubj	8	SENT_367	[p16l1657t2688r1777b2713],
6	,	,	O	,	_	0	SENT_367	[p16l1657t2688r1777b2713],
7	as	IN	O	as	advmod	8	SENT_367	[p16l1788t2692r1815b2708],
8	compared	VBN	O	compare	_	0	SENT_367	[p16l1825t2692r1893b2708, p16l263t2725r337b2757],
9	with	IN	O	with	_	0	SENT_367	[p16l346t2725r402b2750],
10	wild-type	JJ	O	wild-type	amod	12	SENT_367	[p16l411t2725r533b2758],
11	EG	NN	O	eg	nn	12	SENT_367	[p16l543t2726r579b2750],
12	FR	NN	O	fr	prep_with	8	SENT_367	[p16l585t2727r624b2754],
13	,	,	O	,	_	0	SENT_367	[p16l585t2727r624b2754],
14	afterthe	JJ	O	afterthe	amod	15	SENT_367	[p16l635t2724r745b2750],
15	addition	NN	O	addition	appos	12	SENT_367	[p16l753t2725r864b2750],
16	of	IN	O	of	_	0	SENT_367	[p16l874t2724r903b2750],
17	EG	NN	O	eg	nn	18	SENT_367	[p16l909t2727r944b2750],
18	F	NN	O	f	prep_of	15	SENT_367	[p16l951t2727r964b2749],
19	to	TO	O	to	_	0	SENT_367	[p16l971t2729r998b2750],
20	serum-starved	JJ	O	serum-starved	amod	21	SENT_367	[p16l1007t2725r1201b2750],
21	cells	NNS	O	cell	prep_to	8	SENT_367	[p16l1211t2725r1277b2750],
22	.	.	O	.	_	0	SENT_367	[p16l1211t2725r1277b2750],

1	The	DT	O	the	det	4	SENT_368	[p16l1285t2725r1336b2750],
2	autophosphorylation	NN	O	autophosphorylation	nn	4	SENT_368	[p16l1345t2725r1628b2758],
3	ofEG	NN	O	ofeg	nn	4	SENT_368	[p16l1638t2724r1709b2750],
4	FR	NN	O	fr	nsubjpass	6	SENT_368	[p16l1715t2727r1747b2749],
5	is	VBZ	O	be	auxpass	6	SENT_368	[p16l1757t2727r1776b2750],
6	used	VBN	O	use	_	0	SENT_368	[p16l1786t2725r1848b2750],
7	as	IN	O	as	_	0	SENT_368	[p16l1858t2733r1886b2750],
8	a	DT	O	a	det	9	SENT_368	[p16l262t2775r275b2791],
9	marker	NN	O	marker	prep_as	6	SENT_368	[p16l287t2766r382b2791],
10	of	IN	O	of	_	0	SENT_368	[p16l391t2766r420b2791],
11	receptor	NN	O	receptor	nn	12	SENT_368	[p16l427t2771r539b2799],
12	activation	NN	O	activation	prep_of	9	SENT_368	[p16l548t2769r687b2796],
13	,	,	O	,	_	0	SENT_368	[p16l548t2769r687b2796],
14	with	IN	O	with	_	0	SENT_368	[p16l698t2766r754b2791],
15	the	DT	O	the	det	18	SENT_368	[p16l764t2766r807b2791],
16	use	NN	O	use	nn	18	SENT_368	[p16l818t2775r863b2791],
17	ofWestern	NN	O	ofwestern	nn	18	SENT_368	[p16l873t2766r1017b2791],
18	blotting	NN	O	blotting	prep_with	6	SENT_368	[p16l1029t2766r1134b2799],
19	with	IN	O	with	_	0	SENT_368	[p16l1142t2766r1198b2791],
20	an	DT	O	a	det	21	SENT_368	[p16l1210t2775r1240b2791],
21	antibody	NN	O	antibody	prep_with	18	SENT_368	[p16l1252t2766r1369b2799],
22	that	WDT	O	that	nsubj	24	SENT_368	[p16l1378t2766r1431b2791],
23	speciﬁcally	RB	O	speciﬁcally	advmod	24	SENT_368	[p16l1441t2766r1588b2799],
24	recognizes	VBZ	O	recognize	rcmod	21	SENT_368	[p16l1599t2769r1743b2799],
25	the	DT	O	the	dobj	24	SENT_368	[p16l1753t2766r1796b2791],
26	phosphorylated	VBN	O	phosphorylate	dep	25	SENT_368	[p16l1807t2766r1881b2799, p16l263t2808r405b2841],
27	tyrosine1	NN	O	tyrosine1	dobj	26	SENT_368	[p16l415t2810r575b2841],
28	°	CD	NUMBER	°	number	29	SENT_368	[p16l415t2810r575b2841],
29	53	CD	NUMBER	53	num	33	SENT_368	[p16l415t2810r575b2841],
30	(	NN	O	(	nn	33	SENT_368	[p16l588t2809r689b2841],
31	Y1068	NN	O	y1068	nn	33	SENT_368	[p16l588t2809r689b2841],
32	)	CD	NUMBER	)	num	33	SENT_368	[p16l588t2809r689b2841],
33	residue	NN	O	residue	nsubj	38	SENT_368	[p16l704t2808r802b2833],
34	of	IN	O	of	_	0	SENT_368	[p16l811t2808r841b2833],
35	EG	NN	O	eg	nn	36	SENT_368	[p16l849t2810r884b2833],
36	FR	NN	O	fr	prep_of	33	SENT_368	[p16l890t2810r922b2833],
37	(	CD	NUMBER	(	num	36	SENT_368	[p16l935t2808r986b2841],
38	left	VBD	O	leave	rcmod	27	SENT_368	[p16l935t2808r986b2841],
39	side	NN	O	side	nn	40	SENT_368	[p16l996t2808r1069b2841],
40	)	NN	O	)	dobj	38	SENT_368	[p16l996t2808r1069b2841],
41	,	,	O	,	_	0	SENT_368	[p16l996t2808r1069b2841],
42	and	CC	O	and	_	0	SENT_368	[p16l1081t2808r1129b2833],
43	compared	VBN	O	compare	dep	25	SENT_368	[p16l1140t2808r1276b2841],
44	with	IN	O	with	_	0	SENT_368	[p16l1287t2808r1343b2833],
45	the	DT	O	the	det	47	SENT_368	[p16l1353t2808r1396b2833],
46	total	JJ	O	total	amod	47	SENT_368	[p16l1405t2808r1464b2833],
47	concentrations	NNS	O	concentration	prep_with	43	SENT_368	[p16l1476t2810r1679b2833],
48	of	IN	O	of	_	0	SENT_368	[p16l1690t2808r1719b2833],
49	EGFR	NN	O	egfr	prep_of	47	SENT_368	[p16l1727t2810r1801b2833],
50	expressed	VBN	O	express	partmod	49	SENT_368	[p16l1811t2817r1847b2833, p16l263t2850r367b2882],
51	in	IN	O	in	_	0	SENT_368	[p16l378t2852r400b2874],
52	Cos-7	NN	O	cos-7	nn	53	SENT_368	[p16l410t2851r486b2875],
53	cells	NNS	O	cell	prep_in	50	SENT_368	[p16l495t2850r553b2875],
54	as	IN	O	as	_	0	SENT_368	[p16l563t2858r590b2875],
55	control	NN	O	control	nn	59	SENT_368	[p16l600t2850r695b2875],
56	(	RB	O	(	advmod	57	SENT_368	[p16l708t2850r780b2883],
57	right	JJ	O	right	amod	59	SENT_368	[p16l708t2850r780b2883],
58	side	NN	O	side	nn	59	SENT_368	[p16l789t2850r862b2883],
59	)	NN	O	)	prep_as	50	SENT_368	[p16l789t2850r862b2883],
60	.	.	O	.	_	0	SENT_368	[p16l789t2850r862b2883],

1	Autophosphorylation	NN	O	autophosphorylation	nsubjpass	6	SENT_369	[p16l871t2850r1160b2883],
2	of	IN	O	of	_	0	SENT_369	[p16l1170t2849r1200b2875],
3	EG	NN	O	eg	nn	4	SENT_369	[p16l1206t2852r1242b2875],
4	FR	NN	O	fr	prep_of	1	SENT_369	[p16l1248t2852r1280b2874],
5	is	VBZ	O	be	auxpass	6	SENT_369	[p16l1290t2852r1309b2875],
6	measured	VBN	O	measure	dep	9	SENT_369	[p16l1320t2850r1453b2875],
7	at	IN	O	at	_	0	SENT_369	[p16l1464t2854r1488b2875],
8	intervals	NNS	O	interval	prep_at	6	SENT_369	[p16l1497t2850r1610b2875],
9	afterthe	VBP	O	afterthe	_	0	SENT_369	[p16l1620t2849r1731b2875],
10	addition	NN	O	addition	dobj	9	SENT_369	[p16l1740t2850r1851b2875],
11	of	IN	O	of	_	0	SENT_369	[p16l1861t2849r1891b2875],
12	EGF	NN	O	egf	prep_of	10	SENT_369	[p16l264t2893r319b2916],
13	(	CD	NUMBER	(	number	14	SENT_369	[p16l332t2893r372b2924],
14	10	CD	NUMBER	10	num	15	SENT_369	[p16l332t2893r372b2924],
15	ng	NN	O	ng	nsubj	9	SENT_369	[p16l383t2900r415b2924],
16	per	IN	O	per	_	0	SENT_369	[p16l426t2900r469b2924],
17	milliliter	NN	O	milliliter	nn	18	SENT_369	[p16l479t2891r609b2924],
18	)	NN	O	)	prep_per	15	SENT_369	[p16l479t2891r609b2924],
19	.	.	O	.	_	0	SENT_369	[p16l479t2891r609b2924],

1	Panel	NN	O	panel	nn	2	SENT_370	[p16l622t2891r692b2916],
2	B	NN	O	b	nsubj	4	SENT_370	[p16l706t2894r720b2916],
3	also	RB	O	also	advmod	4	SENT_370	[p16l731t2891r785b2916],
4	shows	VBZ	O	show	_	0	SENT_370	[p16l796t2891r880b2916],
5	the	DT	O	the	dep	8	SENT_370	[p16l890t2891r932b2916],
6	EGF-induced	JJ	O	egf-induced	amod	8	SENT_370	[p16l944t2891r1118b2916],
7	phosphorylation	NN	O	phosphorylation	dep	8	SENT_370	[p16l1130t2891r1351b2924],
8	ofwild-type	JJ	O	ofwild-type	dobj	4	SENT_370	[p16l1362t2891r1518b2924],
9	and	CC	O	and	_	0	SENT_370	[p16l1528t2891r1576b2916],
10	mutant	JJ	O	mutant	amod	11	SENT_370	[p16l1589t2896r1687b2916],
11	EGFR	NN	O	egfr	dobj	4	SENT_370	[p16l1698t2893r1780b2916],
12	.	.	O	.	_	0	SENT_370	[p16l1698t2893r1780b2916],

1	Autoradiographs	NNS	O	autoradiograph	nsubjpass	7	SENT_371	[p16l1790t2893r1891b2916, p16l262t2933r398b2966],
2	from	IN	O	from	_	0	SENT_371	[p16l407t2933r471b2958],
3	three	CD	NUMBER	three	num	5	SENT_371	[p16l481t2933r550b2958],
4	independent	JJ	O	independent	amod	5	SENT_371	[p16l561t2933r732b2966],
5	experiments	NNS	O	experiment	prep_from	1	SENT_371	[p16l741t2935r907b2966],
6	were	VBD	O	be	auxpass	7	SENT_371	[p16l916t2942r980b2958],
7	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_371	[p16l989t2933r1125b2966],
8	with	IN	O	with	_	0	SENT_371	[p16l1134t2933r1190b2958],
9	the	DT	O	the	det	12	SENT_371	[p16l1200t2933r1243b2958],
10	use	NN	O	use	nn	12	SENT_371	[p16l1253t2942r1298b2958],
11	ofNational	NNP	O	ofNational	nn	12	SENT_371	[p16l1308t2933r1458b2958],
12	Institutes	NNPS	O	Institutes	prep_with	7	SENT_371	[p16l1471t2935r1596b2958],
13	ofHea	NNP	O	ofHea	tmod	7	SENT_371	[p16l1607t2933r1731b2958],
14	|	CD	NUMBER	|	num	13	SENT_371	[p16l1607t2933r1731b2958],
15	th	DT	O	th	det	17	SENT_371	[p16l1607t2933r1731b2958],
16	image	NN	O	image	nn	17	SENT_371	[p16l1742t2935r1824b2966],
17	software	NN	O	software	dep	13	SENT_371	[p16l1834t2933r1892b2958, p16l261t2983r332b3004],
18	;	:	O	;	_	0	SENT_371	[p16l1834t2933r1892b2958, p16l261t2983r332b3004],
19	the	DT	O	the	det	22	SENT_371	[p16l340t2975r383b3000],
20	intensity	NN	O	intensity	nn	22	SENT_371	[p16l393t2977r507b3007],
21	ofEGFR	NN	O	ofegfr	nn	22	SENT_371	[p16l515t2974r624b3000],
22	phosphorylation	NN	O	phosphorylation	nsubjpass	25	SENT_371	[p16l634t2975r854b3007],
23	has	VBZ	O	have	aux	25	SENT_371	[p16l865t2975r910b3000],
24	been	VBN	O	be	auxpass	25	SENT_371	[p16l920t2975r982b3000],
25	adjusted	VBN	O	adjust	parataxis	7	SENT_371	[p16l993t2975r1107b3008],
26	forthetotal	JJ	O	forthetotal	amod	28	SENT_371	[p16l1116t2974r1270b3000],
27	protein	NN	O	protein	nn	28	SENT_371	[p16l1281t2977r1376b3007],
28	expression	NN	O	expression	dobj	25	SENT_371	[p16l1385t2977r1530b3007],
29	and	CC	O	and	_	0	SENT_371	[p16l1540t2975r1588b3000],
30	is	VBZ	O	be	auxpass	31	SENT_371	[p16l1599t2977r1618b3000],
31	shown	VBN	O	show	parataxis	7	SENT_371	[p16l1628t2975r1714b3000],
32	as	IN	O	as	_	0	SENT_371	[p16l1724t2983r1752b3000],
33	the	DT	O	the	det	35	SENT_371	[p16l1760t2975r1802b3000],
34	mean	JJ	O	mean	amod	35	SENT_371	[p16l1812t2983r1885b3000],
35	(	NN	O	(	prep_as	31	SENT_371	[p16l265t3018r341b3049],
36	:	:	O	:	_	0	SENT_371	[p16l265t3018r341b3049],
37	SD	NN	O	sd	nn	40	SENT_371	[p16l265t3018r341b3049],
38	)	CD	PERCENT	)	num	40	SENT_371	[p16l265t3018r341b3049],
39	percent	NN	PERCENT	percent	nn	40	SENT_371	[p16l355t3021r456b3049],
40	activation	NN	O	activation	dep	35	SENT_371	[p16l466t3019r596b3041],
41	ofthe	NN	O	ofthe	nn	42	SENT_371	[p16l608t3016r684b3041],
42	receptor	NN	O	receptor	dep	40	SENT_371	[p16l695t3021r811b3049],
43	.	.	O	.	_	0	SENT_371	[p16l695t3021r811b3049],

1	Panel	NN	O	panel	nn	2	SENT_372	[p16l832t3016r902b3041],
2	C	NN	O	c	nsubj	3	SENT_372	[p16l914t3018r932b3041],
3	shows	VBZ	O	show	_	0	SENT_372	[p16l942t3016r1026b3041],
4	the	DT	O	the	det	8	SENT_372	[p16l1036t3016r1079b3041],
5	dose-dependent	JJ	O	dose-dependent	amod	8	SENT_372	[p16l1089t3016r1310b3049],
6	inhibition	NN	O	inhibition	nn	8	SENT_372	[p16l1321t3016r1449b3041],
7	ofthe	NN	O	ofthe	nn	8	SENT_372	[p16l1460t3016r1537b3041],
8	activation	NN	O	activation	dobj	3	SENT_372	[p16l1547t3019r1677b3041],
9	of	IN	O	of	_	0	SENT_372	[p16l1689t3016r1718b3041],
10	EGFR	NN	O	egfr	prep_of	8	SENT_372	[p16l1726t3018r1800b3041],
11	by	IN	O	by	_	0	SENT_372	[p16l1811t3016r1839b3049],
12	geﬁtinib	NN	O	geﬁtinib	prep_by	3	SENT_372	[p16l1849t3025r1888b3049, p16l261t3058r347b3083],
13	.	.	O	.	_	0	SENT_372	[p16l1849t3025r1888b3049, p16l261t3058r347b3083],

1	Autophosphorylation	NN	O	autophosphorylation	nsubjpass	8	SENT_373	[p16l357t3058r646b3091],
2	of	IN	O	of	_	0	SENT_373	[p16l657t3058r687b3083],
3	EGFR	NN	O	egfr	nn	4	SENT_373	[p16l694t3060r768b3083],
4	tyrosine1	NN	O	tyrosine1	prep_of	1	SENT_373	[p16l777t3060r938b3091],
5	°	CD	NUMBER	°	number	6	SENT_373	[p16l777t3060r938b3091],
6	53	CD	NUMBER	53	num	4	SENT_373	[p16l777t3060r938b3091],
7	is	VBZ	O	be	auxpass	8	SENT_373	[p16l949t3060r968b3083],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_373	[p16l979t3058r1169b3083],
9	by	IN	O	by	_	0	SENT_373	[p16l1182t3058r1210b3091],
10	Western	NN	MISC	western	nn	14	SENT_373	[p16l1218t3060r1328b3083],
11	blot	NN	O	blot	nn	14	SENT_373	[p16l1341t3058r1392b3083],
12	analysis	NN	O	analysis	nn	14	SENT_373	[p16l1401t3058r1508b3091],
13	ofCos-7	NN	O	ofcos-7	nn	14	SENT_373	[p16l1518t3058r1629b3083],
14	cells	NNS	O	cell	agent	8	SENT_373	[p16l1639t3058r1697b3083],
15	expressing	VBG	O	express	xcomp	8	SENT_373	[p16l1708t3060r1853b3091],
16	wild-type	JJ	O	wild-type	amod	19	SENT_373	[p16l261t3100r383b3133],
17	or	CC	O	or	_	0	SENT_373	[p16l393t3108r421b3125],
18	mutant	JJ	O	mutant	conj_or	16	SENT_373	[p16l431t3104r529b3125],
19	receptors	NNS	O	receptor	dobj	15	SENT_373	[p16l540t3104r665b3132],
20	and	CC	O	and	_	0	SENT_373	[p16l676t3100r724b3125],
21	stimulated	VBN	O	stimulate	conj_and	8	SENT_373	[p16l736t3100r879b3125],
22	with	IN	O	with	_	0	SENT_373	[p16l890t3100r946b3125],
23	100	CD	NUMBER	100	num	24	SENT_373	[p16l959t3101r1005b3125],
24	ng	NN	O	ng	prep_with	21	SENT_373	[p16l1016t3108r1048b3133],
25	of	IN	O	of	_	0	SENT_373	[p16l1058t3099r1087b3125],
26	EGF	NN	ORGANIZATION	egf	prep_of	24	SENT_373	[p16l1095t3102r1149b3125],
27	per	IN	O	per	_	0	SENT_373	[p16l1160t3108r1203b3132],
28	milliliter	NN	O	milliliter	prep_per	26	SENT_373	[p16l1213t3100r1325b3125],
29	for	IN	O	for	_	0	SENT_373	[p16l1333t3099r1371b3125],
30	30	CD	DURATION	30	num	31	SENT_373	[p16l1380t3101r1411b3125],
31	minutes	NNS	NUMBER	minute	prep_for	28	SENT_373	[p16l1422t3102r1539b3125],
32	.	.	O	.	_	0	SENT_373	[p16l1422t3102r1539b3125],

1	Cells	NNS	O	cell	nsubjpass	8	SENT_374	[p16l1551t3100r1613b3125],
2	were	VBD	O	be	auxpass	3	SENT_374	[p16l1623t3108r1687b3125],
3	untreated	JJ	O	untreated	_	0	SENT_374	[p16l1698t3100r1826b3125],
4	(	NN	O	(	nn	5	SENT_374	[p16l1840t3102r1880b3133],
5	U	NN	O	u	dobj	3	SENT_374	[p16l1840t3102r1880b3133],
6	)	CD	NUMBER	)	num	5	SENT_374	[p16l1840t3102r1880b3133],
7	or	CC	O	or	_	0	SENT_374	[p16l262t3150r290b3166],
8	pretreated	VBN	O	pretreat	conj_or	3	SENT_374	[p16l299t3141r436b3174],
9	for	IN	O	for	_	0	SENT_374	[p16l445t3141r483b3166],
10	three	CD	DURATION	three	num	11	SENT_374	[p16l490t3141r559b3166],
11	hours	NNS	NUMBER	hour	prep_for	8	SENT_374	[p16l569t3141r645b3166],
12	with	IN	O	with	_	0	SENT_374	[p16l654t3141r710b3166],
13	increasing	VBG	O	increase	amod	14	SENT_374	[p16l721t3144r860b3174],
14	concentrations	NNS	O	concentration	prep_with	11	SENT_374	[p16l869t3144r1072b3166],
15	ofgeﬁtinib	NN	O	ofgeﬁtinib	dobj	3	SENT_374	[p16l1081t3141r1225b3174],
16	(	CD	NUMBER	(	num	15	SENT_374	[p16l1237t3141r1288b3174],
17	left	VBD	O	leave	rcmod	15	SENT_374	[p16l1237t3141r1288b3174],
18	side	NN	O	side	nn	19	SENT_374	[p16l1297t3141r1370b3174],
19	)	NN	O	)	dobj	17	SENT_374	[p16l1297t3141r1370b3174],
20	.	.	O	.	_	0	SENT_374	[p16l1297t3141r1370b3174],

1	Total	JJ	O	total	amod	2	SENT_375	[p16l1379t3141r1443b3166],
2	amounts	NNS	O	amount	nsubjpass	7	SENT_375	[p16l1453t3146r1573b3166],
3	of	IN	O	of	_	0	SENT_375	[p16l1583t3141r1613b3166],
4	EGFR	NN	O	egfr	prep_of	2	SENT_375	[p16l1619t3143r1693b3166],
5	expressed	VBN	O	express	partmod	4	SENT_375	[p16l1702t3141r1835b3174],
6	are	VBP	O	be	auxpass	7	SENT_375	[p16l1846t3150r1886b3166],
7	shown	VBN	O	show	_	0	SENT_375	[p16l263t3183r349b3208],
8	on	IN	O	on	_	0	SENT_375	[p16l361t3192r393b3208],
9	the	DT	O	the	det	13	SENT_375	[p16l403t3183r446b3208],
10	right	JJ	O	right	amod	13	SENT_375	[p16l457t3183r519b3216],
11	side	NN	O	side	nn	13	SENT_375	[p16l529t3183r583b3208],
12	(	NN	O	(	nn	13	SENT_375	[p16l596t3183r720b3216],
13	control	NN	O	control	prep_on	7	SENT_375	[p16l596t3183r720b3216],
14	)	CD	NUMBER	)	dep	13	SENT_375	[p16l596t3183r720b3216],
15	.	.	O	.	_	0	SENT_375	[p16l596t3183r720b3216],

1	Panel	NN	O	panel	nn	2	SENT_376	[p16l741t3183r811b3208],
2	D	NN	O	d	nsubj	4	SENT_376	[p16l825t3185r844b3208],
3	also	RB	O	also	advmod	4	SENT_376	[p16l855t3183r908b3208],
4	shows	VBZ	O	show	_	0	SENT_376	[p16l919t3183r1003b3208],
5	the	DT	O	the	det	7	SENT_376	[p16l1013t3183r1055b3208],
6	mean	JJ	O	mean	amod	7	SENT_376	[p16l1067t3192r1140b3208],
7	(	NN	O	(	dobj	4	SENT_376	[p16l1154t3185r1230b3216],
8	:	:	O	:	_	0	SENT_376	[p16l1154t3185r1230b3216],
9	l	NN	O	l	dep	7	SENT_376	[p16l1154t3185r1230b3216],
10	:	:	O	:	_	0	SENT_376	[p16l1154t3185r1230b3216],
11	SD	NN	O	sd	nn	13	SENT_376	[p16l1154t3185r1230b3216],
12	)	NN	O	)	nn	13	SENT_376	[p16l1154t3185r1230b3216],
13	inhibition	NN	O	inhibition	dep	7	SENT_376	[p16l1244t3183r1372b3208],
14	of	IN	O	of	_	0	SENT_376	[p16l1383t3183r1413b3208],
15	EGFR	NN	O	egfr	prep_of	13	SENT_376	[p16l1420t3185r1494b3208],
16	by	IN	O	by	_	0	SENT_376	[p16l1506t3183r1534b3216],
17	gefitinib	NN	O	gefitinib	prep_by	4	SENT_376	[p16l1543t3183r1661b3216],
18	.	.	O	.	_	0	SENT_376	[p16l1543t3183r1661b3216],

1	Concentrations	NNS	O	concentration	nsubjpass	5	SENT_377	[p16l1672t3185r1880b3208],
2	ofphosphorylated	VBN	O	ofphosphorylate	partmod	1	SENT_377	[p16l262t3224r508b3257],
3	EGFR	NN	ORGANIZATION	egfr	dobj	2	SENT_377	[p16l522t3226r596b3250],
4	were	VBD	O	be	auxpass	5	SENT_377	[p16l605t3233r668b3250],
5	adjusted	VBN	O	adjust	_	0	SENT_377	[p16l679t3225r793b3258],
6	for	IN	O	for	_	0	SENT_377	[p16l804t3224r842b3250],
7	total	JJ	O	total	amod	9	SENT_377	[p16l850t3225r909b3250],
8	protein	NN	O	protein	nn	9	SENT_377	[p16l922t3227r1017b3257],
9	expression	NN	O	expression	prep_for	5	SENT_377	[p16l1028t3227r1181b3257],
10	.	.	O	.	_	0	SENT_377	[p16l1028t3227r1181b3257],

1	provide	VB	O	provide	_	0	SENT_378	[p16l6t3502r317b3602],
2	important	JJ	O	important	amod	3	SENT_378	[p16l338t3502r765b3602],
3	insight	NN	O	insight	dobj	1	SENT_378	[p16l780t3502r1076b3602],
4	into	IN	O	into	_	0	SENT_378	[p16l1091t3502r1254b3580],
5	the	DT	O	the	det	6	SENT_378	[p16l1277t3502r1404b3580],
6	mechanisms	NNS	O	mechanism	prep_into	1	SENT_378	[p16l1425t3502r1953b3580],
7	that	WDT	O	that	nsubj	8	SENT_378	[p16l1977t3502r2141b3580],
8	regulate	VBP	O	regulate	rcmod	6	SENT_378	[p16l7t3630r347b3730],
9	the	DT	O	the	det	10	SENT_378	[p16l382t3630r511b3708],
10	activation	NN	O	activation	dobj	8	SENT_378	[p16l545t3630r953b3709],
11	of	IN	O	of	_	0	SENT_378	[p16l988t3629r1089b3708],
12	EGFR	NN	O	egfr	prep_of	10	SENT_378	[p16l1103t3635r1362b3713],
13	and	CC	O	and	_	0	SENT_378	[p16l1384t3630r1541b3708],
14	the	DT	O	the	det	15	SENT_378	[p16l1575t3630r1704b3708],
15	design	NN	O	design	conj_and	10	SENT_378	[p16l1739t3630r2018b3730],
16	of	IN	O	of	_	0	SENT_378	[p16l2053t3629r2153b3708],
17	more	JJR	O	more	amod	19	SENT_378	[p17l8t45r231b98],
18	potent	JJ	O	potent	amod	19	SENT_378	[p17l271t37r555b120],
19	inhibitors	NNS	O	inhibitor	prep_of	15	SENT_378	[p17l590t21r1014b98],
20	targeting	VBG	O	target	partmod	19	SENT_378	[p17l1058t21r1454b120],
21	the	DT	O	the	det	23	SENT_378	[p17l1493t21r1624b98],
22	mutant	JJ	O	mutant	amod	23	SENT_378	[p17l1665t36r1983b99],
23	receptors	NNS	O	receptor	dobj	20	SENT_378	[p17l2019t46r2132b98, p17l8t165r347b249],
24	.	.	O	.	_	0	SENT_378	[p17l2019t46r2132b98, p17l8t165r347b249],

1	Our	PRP$	O	we	poss	2	SENT_379	[p17l137t282r302b356],
2	observations	NNS	O	observation	nsubj	3	SENT_379	[p17l324t277r847b355],
3	have	VBP	O	have	_	0	SENT_379	[p17l874t277r1059b356],
4	implications	NNS	O	implication	dobj	3	SENT_379	[p17l1083t277r1601b377],
5	for	IN	O	for	_	0	SENT_379	[p17l1627t276r1749b355],
6	the	DT	O	the	det	7	SENT_379	[p17l1771t277r1898b355],
7	identiﬁcation	NN	O	identiﬁcation	prep_for	4	SENT_379	[p17l1922t277r2134b355, p17l8t404r392b483],
8	of	IN	O	of	_	0	SENT_379	[p17l428t404r529b483],
9	molecular	JJ	O	molecular	amod	10	SENT_379	[p17l546t405r981b484],
10	targets	NNS	O	target	prep_of	7	SENT_379	[p17l1013t421r1306b505],
11	for	IN	O	for	_	0	SENT_379	[p17l1343t404r1468b483],
12	cancer	NN	O	cancer	nn	13	SENT_379	[p17l1501t430r1782b483],
13	therapy	NN	O	therapy	prep_for	3	SENT_379	[p17l1814t404r2138b505],
14	using	VBG	O	use	partmod	13	SENT_379	[p17l7t533r249b633],
15	small	JJ	O	small	amod	19	SENT_379	[p17l274t533r926b612],
16	—	NN	O	—	nn	19	SENT_379	[p17l274t533r926b612],
17	molecule	NN	O	molecule	nn	19	SENT_379	[p17l274t533r926b612],
18	kinase	NN	O	kinase	nn	19	SENT_379	[p17l952t533r1222b612],
19	inhibitors	NNS	O	inhibitor	dobj	14	SENT_379	[p17l1247t533r1687b611],
20	.	.	O	.	_	0	SENT_379	[p17l1247t533r1687b611],

1	The	DT	O	the	det	2	SENT_380	[p17l1715t533r1876b611],
2	effectiveness	NN	O	effectiveness	nsubjpass	8	SENT_380	[p17l1902t532r2134b611, p17l8t661r339b740],
3	of	IN	O	of	_	0	SENT_380	[p17l364t660r465b739],
4	imatinib	NN	O	imatinib	prep_of	2	SENT_380	[p17l468t661r825b739],
5	in	IN	O	in	_	0	SENT_380	[p17l848t661r929b738],
6	CML	NN	ORGANIZATION	cml	prep_in	4	SENT_380	[p17l951t666r1154b739],
7	is	VBZ	O	be	auxpass	8	SENT_380	[p17l1173t661r1238b739],
8	based	VBN	O	base	_	0	SENT_380	[p17l1263t660r1505b739],
9	on	IN	O	on	_	0	SENT_380	[p17l1528t686r1635b739],
10	its	PRP$	O	its	poss	11	SENT_380	[p17l1657t661r1753b739],
11	ability	NN	O	ability	prep_on	8	SENT_380	[p17l1776t661r2037b761],
12	to	TO	O	to	aux	13	SENT_380	[p17l2055t677r2134b739],
13	target	VB	O	target	infmod	11	SENT_380	[p17l8t804r258b888],
14	the	DT	O	the	det	17	SENT_380	[p17l289t789r418b866],
15	ABL	NNP	ORGANIZATION	ABL	nn	17	SENT_380	[p17l451t795r630b866],
16	tyrosine	NN	O	tyrosine	nn	17	SENT_380	[p17l665t789r1000b888],
17	kinase	NN	O	kinase	dobj	13	SENT_380	[p17l1035t789r1330b883],
18	,	,	O	,	_	0	SENT_380	[p17l1035t789r1330b883],
19	which	WDT	O	which	nsubjpass	21	SENT_380	[p17l1367t789r1628b867],
20	is	VBZ	O	be	auxpass	21	SENT_380	[p17l1663t789r1728b866],
21	activated	VBN	O	activate	rcmod	17	SENT_380	[p17l1765t789r2135b867],
22	by	IN	O	by	_	0	SENT_380	[p17l8t917r106b1017],
23	the	DT	O	the	det	24	SENT_380	[p17l126t917r256b995],
24	BCR	NN	O	bcr	agent	21	SENT_380	[p17l280t922r631b996],
25	.	.	O	.	_	0	SENT_380	[p17l280t922r631b996],

1	—	NN	O	—	_	0	SENT_381	[p17l280t922r631b996],
2	.	.	O	.	_	0	SENT_381	[p17l280t922r631b996],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_382	[p17l280t922r631b996],
2	translocation	NN	O	translocation	nsubj	4	SENT_382	[p17l653t917r1210b995],
3	(	CD	NUMBER	(	dep	2	SENT_382	[p17l1241t917r1421b1012],
4	i.e.	FW	O	i.e.	_	0	SENT_382	[p17l1241t917r1421b1012],
5	,	,	O	,	_	0	SENT_382	[p17l1241t917r1421b1012],
6	the	DT	O	the	det	9	SENT_382	[p17l1453t917r1582b995],
7	Philadelphia	NNP	LOCATION	Philadelphia	nn	9	SENT_382	[p17l1606t917r2136b1017],
8	chromosome	NN	O	chromosome	nn	9	SENT_382	[p17l8t1045r600b1136],
9	)	NN	O	)	appos	4	SENT_382	[p17l8t1045r600b1136],
10	in	IN	O	in	_	0	SENT_382	[p17l635t1045r717b1122],
11	all	DT	O	all	det	12	SENT_382	[p17l746t1045r846b1123],
12	patients	NNS	O	patient	prep_in	9	SENT_382	[p17l875t1045r1210b1145],
13	with	IN	O	with	_	0	SENT_382	[p17l1238t1045r1427b1124],
14	this	DT	O	this	det	15	SENT_382	[p17l1459t1045r1612b1123],
15	disease	NN	O	disease	prep_with	4	SENT_382	[p17l1645t1044r1949b1123],
16	and	CC	O	and	_	0	SENT_382	[p17l1980t1045r2135b1123],
17	can	MD	O	can	aux	18	SENT_382	[p17l8t1199r152b1252],
18	transform	VB	O	transform	conj_and	4	SENT_382	[p17l181t1173r605b1252],
19	hematopoietic	JJ	O	hematopoietic	amod	21	SENT_382	[p17l634t1174r1242b1274],
20	cells	NNS	O	cell	nn	21	SENT_382	[p17l1270t1169r1626b1252],
21	.2	NN	NUMBER	.2	dobj	18	SENT_382	[p17l1270t1169r1626b1252],
22	’23	CD	NUMBER	’23	num	24	SENT_382	[p17l1270t1169r1626b1252],
23	Similar	JJ	O	similar	amod	24	SENT_382	[p17l1659t1174r1963b1252],
24	evidence	NN	O	evidence	nsubj	35	SENT_382	[p17l1989t1174r2133b1253, p17l8t1301r256b1380],
25	designating	VBG	O	designate	partmod	24	SENT_382	[p17l291t1302r802b1402],
26	a	DT	O	a	det	27	SENT_382	[p17l833t1328r877b1380],
27	protein	NN	O	protein	dobj	25	SENT_382	[p17l908t1302r1222b1402],
28	as	IN	O	as	_	0	SENT_382	[p17l1255t1328r1341b1380],
29	an	DT	O	a	det	32	SENT_382	[p17l1376t1327r1478b1380],
30	optimal	JJ	O	optimal	amod	32	SENT_382	[p17l1512t1302r1846b1402],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_382	[p17l1880t1302r2133b1380, p17l6t1430r270b1530],
32	target	NN	O	target	prep_as	25	SENT_382	[p17l320t1446r569b1530],
33	is	VBZ	O	be	cop	35	SENT_382	[p17l610t1430r675b1508],
34	not	RB	O	not	neg	35	SENT_382	[p17l723t1446r867b1508],
35	available	JJ	O	available	rcmod	21	SENT_382	[p17l908t1430r1272b1509],
36	for	IN	O	for	_	0	SENT_382	[p17l1319t1429r1443b1508],
37	most	JJS	O	most	amod	39	SENT_382	[p17l1486t1446r1702b1508],
38	epithelial	JJ	O	epithelial	amod	39	SENT_382	[p17l1745t1430r2135b1530],
39	cancers	NNS	O	cancer	prep_for	35	SENT_382	[p17l8t1583r342b1636],
40	.	.	O	.	_	0	SENT_382	[p17l8t1583r342b1636],

1	Our	PRP$	O	we	poss	2	SENT_383	[p17l368t1563r530b1637],
2	data	NNS	O	datum	nsubj	3	SENT_383	[p17l548t1557r724b1636],
3	suggest	VBP	O	suggest	_	0	SENT_383	[p17l745t1574r1064b1658],
4	that	IN	O	that	complm	12	SENT_383	[p17l1080t1558r1243b1636],
5	EGF	NN	O	egf	nn	9	SENT_383	[p17l1258t1563r1436b1636],
6	R	NN	O	r	nn	9	SENT_383	[p17l1441t1564r1513b1641],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_383	[p17l1524t1558r1851b1658],
8	kinase	NN	O	kinase	nn	9	SENT_383	[p17l1871t1558r2136b1637],
9	mutations	NNS	O	mutation	nsubjpass	12	SENT_383	[p17l7t1686r430b1765],
10	can	MD	O	can	aux	12	SENT_383	[p17l464t1711r608b1764],
11	be	VB	O	be	auxpass	12	SENT_383	[p17l640t1686r736b1764],
12	used	VBN	O	use	ccomp	3	SENT_383	[p17l767t1686r962b1765],
13	to	TO	O	to	aux	14	SENT_383	[p17l994t1702r1073b1764],
14	identify	VB	O	identify	xcomp	12	SENT_383	[p17l1105t1685r1427b1786],
15	the	DT	O	the	det	16	SENT_383	[p17l1454t1686r1583b1764],
16	subgroup	NN	O	subgroup	dobj	14	SENT_383	[p17l1616t1685r2019b1786],
17	of	IN	O	of	_	0	SENT_383	[p17l2053t1685r2153b1764],
18	patients	NNS	O	patient	prep_of	16	SENT_383	[p17l6t1814r341b1914],
19	with	IN	O	with	_	0	SENT_383	[p17l366t1814r555b1893],
20	non	JJ	O	non	amod	26	SENT_383	[p17l582t1814r1215b1892],
21	—	JJ	O	—	amod	26	SENT_383	[p17l582t1814r1215b1892],
22	small	JJ	O	small	amod	26	SENT_383	[p17l582t1814r1215b1892],
23	—	NN	O	—	nn	26	SENT_383	[p17l582t1814r1215b1892],
24	cell	NN	O	cell	nn	26	SENT_383	[p17l582t1814r1215b1892],
25	lung	NN	O	lung	nn	26	SENT_383	[p17l1241t1814r1435b1914],
26	cancer	NN	O	cancer	prep_with	14	SENT_383	[p17l1460t1839r1735b1892],
27	in	IN	O	in	_	0	SENT_383	[p17l1759t1814r1840b1891],
28	whom	WP	O	whom	rel	35	SENT_383	[p17l1863t1814r2135b1893],
29	this	DT	O	this	det	32	SENT_383	[p17l8t1941r161b2020],
30	growth	NN	O	growth	nn	32	SENT_383	[p17l193t1942r497b2042],
31	factor	NN	O	factor	nn	32	SENT_383	[p17l528t1941r774b2020],
32	receptor	NN	O	receptor	nsubj	35	SENT_383	[p17l802t1958r1153b2042],
33	may	MD	O	may	aux	35	SENT_383	[p17l1181t1968r1358b2042],
34	be	VB	O	be	cop	35	SENT_383	[p17l1385t1942r1480b2020],
35	essential	JJ	O	essential	rcmod	26	SENT_383	[p17l1512t1942r1878b2020],
36	to	TO	O	to	_	0	SENT_383	[p17l1909t1958r1988b2020],
37	tumor	NN	O	tumor	nn	38	SENT_383	[p17l2020t1958r2134b2021, p17l7t2095r185b2148],
38	growth	NN	O	growth	prep_to	35	SENT_383	[p17l211t2070r538b2170],
39	,	,	O	,	_	0	SENT_383	[p17l211t2070r538b2170],
40	whereas	IN	O	whereas	mark	51	SENT_383	[p17l569t2070r918b2149],
41	the	DT	O	the	det	42	SENT_383	[p17l950t2070r1079b2148],
42	overexpression	NN	O	overexpression	nsubj	51	SENT_383	[p17l1110t2070r1745b2170],
43	of	IN	O	of	_	0	SENT_383	[p17l1776t2069r1876b2148],
44	EGFR	NN	O	egfr	prep_of	42	SENT_383	[p17l1886t2075r2145b2153],
45	in	IN	O	in	_	0	SENT_383	[p17l7t2198r89b2275],
46	the	DT	O	the	det	47	SENT_383	[p17l132t2198r261b2276],
47	absence	NN	O	absence	prep_in	44	SENT_383	[p17l304t2198r639b2276],
48	of	IN	O	of	_	0	SENT_383	[p17l684t2197r785b2276],
49	mutations	NNS	O	mutation	prep_of	47	SENT_383	[p17l809t2198r1240b2277],
50	may	MD	O	may	aux	51	SENT_383	[p17l1285t2224r1462b2298],
51	reﬂect	VB	O	reﬂect	advcl	35	SENT_383	[p17l1501t2197r1768b2276],
52	the	DT	O	the	det	55	SENT_383	[p17l1806t2198r1935b2276],
53	less	RBR	O	less	advmod	54	SENT_383	[p17l1977t2198r2133b2276],
54	critical	JJ	O	critical	amod	55	SENT_383	[p17l8t2325r293b2404],
55	role	NN	O	role	dobj	51	SENT_383	[p17l323t2326r484b2404],
56	played	VBN	O	play	partmod	55	SENT_383	[p17l514t2326r785b2426],
57	by	IN	O	by	_	0	SENT_383	[p17l817t2326r914b2426],
58	this	DT	O	this	det	59	SENT_383	[p17l941t2326r1094b2404],
59	factor	NN	O	factor	agent	56	SENT_383	[p17l1127t2325r1373b2404],
60	in	IN	O	in	_	0	SENT_383	[p17l1401t2326r1482b2403],
61	the	DT	O	the	det	62	SENT_383	[p17l1513t2325r1643b2404],
62	majority	NN	O	majority	prep_in	59	SENT_383	[p17l1674t2326r2026b2426],
63	of	IN	O	of	_	0	SENT_383	[p17l2053t2325r2153b2404],
64	cases	NNS	O	case	prep_of	62	SENT_383	[p17l8t2479r252b2531],
65	.	.	O	.	_	0	SENT_383	[p17l8t2479r252b2531],

1	This	DT	O	this	det	2	SENT_384	[p17l280t2454r465b2531],
2	emphasis	NN	O	emphasis	nsubj	7	SENT_384	[p17l493t2454r894b2553],
3	on	IN	O	on	_	0	SENT_384	[p17l923t2478r1029b2531],
4	genetic	JJ	O	genetic	amod	5	SENT_384	[p17l1055t2454r1359b2553],
5	alterations	NNS	O	alteration	prep_on	2	SENT_384	[p17l1383t2454r1829b2531],
6	is	VBZ	O	be	cop	7	SENT_384	[p17l1856t2454r1921b2531],
7	consistent	JJ	O	consistent	_	0	SENT_384	[p17l1949t2478r2134b2531, p17l10t2582r289b2660],
8	with	IN	O	with	_	0	SENT_384	[p17l307t2582r496b2661],
9	the	DT	O	the	det	10	SENT_384	[p17l524t2582r652b2660],
10	observation	NN	O	observation	prep_with	7	SENT_384	[p17l681t2582r1173b2660],
11	that	IN	O	that	complm	22	SENT_384	[p17l1201t2582r1368b2660],
12	the	DT	O	the	det	13	SENT_384	[p17l1391t2582r1519b2660],
13	ampliﬁcation	NN	O	ampliﬁcation	nsubj	22	SENT_384	[p17l1569t2581r2135b2682],
14	of	IN	O	of	_	0	SENT_384	[p17l8t2709r109b2788],
15	the	DT	O	the	det	17	SENT_384	[p17l129t2710r258b2788],
16	HER2/neu	NN	O	her2/neu	nn	17	SENT_384	[p17l295t2716r681b2807],
17	gene	NN	O	gene	prep_of	13	SENT_384	[p17l718t2735r917b2810],
18	is	VBZ	O	be	cop	22	SENT_384	[p17l955t2710r1020b2788],
19	a	DT	O	a	det	22	SENT_384	[p17l1060t2736r1104b2788],
20	more	RBR	O	more	advmod	21	SENT_384	[p17l1141t2735r1361b2788],
21	reliable	JJ	O	reliable	amod	22	SENT_384	[p17l1400t2710r1710b2788],
22	predictor	NN	O	predictor	ccomp	7	SENT_384	[p17l1747t2710r2138b2810],
23	than	IN	O	than	_	0	SENT_384	[p17l8t2837r196b2916],
24	protein	NN	O	protein	nn	25	SENT_384	[p17l224t2838r531b2938],
25	overexpression	NN	O	overexpression	prep_than	22	SENT_384	[p17l560t2838r1195b2938],
26	of	IN	O	of	_	0	SENT_384	[p17l1224t2837r1325b2916],
27	the	DT	O	the	det	28	SENT_384	[p17l1336t2838r1465b2916],
28	responsiveness	NN	O	responsiveness	prep_of	25	SENT_384	[p17l1494t2838r2133b2938],
29	of	IN	O	of	_	0	SENT_384	[p17l8t2965r109b3044],
30	breast	NN	O	breast	nn	31	SENT_384	[p17l126t2966r391b3044],
31	cancer	NN	O	cancer	prep_of	28	SENT_384	[p17l421t2991r701b3044],
32	to	TO	O	to	_	0	SENT_384	[p17l734t2982r814b3044],
33	the	DT	O	the	det	37	SENT_384	[p17l850t2966r981b3044],
34	targeting	VBG	O	target	amod	37	SENT_384	[p17l1016t2966r1413b3066],
35	antibody	NN	O	antibody	nn	37	SENT_384	[p17l1443t2966r1822b3066],
36	trastu	NN	O	trastu	nn	37	SENT_384	[p17l1853t2982r2133b3045],
37	—	NN	O	—	prep_to	22	SENT_384	[p17l1853t2982r2133b3045],

1	2136	CD	DATE	2136	num	3	SENT_385	[p17l149t3141r226b3164],
2	N	NN	O	n	nn	3	SENT_385	[p17l908t3144r922b3159],
3	ENGLJ	NN	O	englj	_	0	SENT_385	[p17l937t3143r1021b3165],
4	MED	VBD	O	med	partmod	3	SENT_385	[p17l1036t3144r1089b3159],
5	35o	CD	NUMBER	35o	dobj	4	SENT_385	[p17l1101t3143r1180b3165],
6	;	:	O	;	_	0	SENT_385	[p17l1101t3143r1180b3165],
7	21	CD	NUMBER	21	dep	3	SENT_385	[p17l1101t3143r1180b3165],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_385	[p17l1217t3143r1429b3165],
9	MAY	NNP	DATE	MAY	dep	7	SENT_385	[p17l1468t3143r1519b3159],
10	20	CD	DATE	20	num	9	SENT_385	[p17l1531t3143r1570b3163],
11	,	,	DATE	,	_	0	SENT_385	[p17l1531t3143r1570b3163],
12	2004	CD	DATE	2004	num	9	SENT_385	[p17l1583t3143r1651b3165],

1	The	DT	O	the	det	4	SENT_386	[p17l936t3176r987b3200],
2	New	NNP	O	New	nn	4	SENT_386	[p17l996t3177r1058b3200],
3	England	NNP	O	England	nn	4	SENT_386	[p17l1067t3176r1178b3207],
4	Journal	NNP	O	Journal	_	0	SENT_386	[p17l1187t3176r1284b3200],
5	of	IN	O	of	_	0	SENT_386	[p17l1294t3176r1323b3200],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_386	[p17l1330t3176r1455b3200],

1	MUTATIONS	NNS	O	mutation	_	0	SENT_387	[p17l443t3302r643b3321],
2	IN	IN	O	in	_	0	SENT_387	[p17l658t3302r696b3321],
3	EGFR	NN	O	egfr	prep_in	1	SENT_387	[p17l712t3302r798b3321],
4	IN	IN	O	in	_	0	SENT_387	[p17l812t3302r850b3321],
5	NON	NNP	O	NON	prep_in	1	SENT_387	[p17l865t3302r1170b3321],
6	.	.	O	.	_	0	SENT_387	[p17l865t3302r1170b3321],

1	—	NN	O	—	_	0	SENT_388	[p17l865t3302r1170b3321],
2	.	.	O	.	_	0	SENT_388	[p17l865t3302r1170b3321],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_389	[p17l865t3302r1170b3321],
2	LUNG	NN	O	lung	_	0	SENT_389	[p17l1184t3302r1278b3321],
3	CANCER	NNP	O	CANCER	dep	2	SENT_389	[p17l1291t3302r1427b3321],

1	A	DT	O	a	_	0	SENT_390	[p18l115t76r137b101],

1	EGFRprotein739KIPVAIKELREATSPKAN	NN	O	egfrprotein739kipvaikelreatspkan	_	0	SENT_391	[p18l128t169r1299b196],
2	756856	CD	NUMBER	756856	number	3	SENT_391	[p18l1361t169r1484b190],
3	FGLAKLLG863	CD	NUMBER	fglakllg863	num	5	SENT_391	[p18l1547t169r2027b190],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_391	[p18l127t219r193b240],
5	gene	NN	O	gene	dep	1	SENT_391	[p18l202t225r258b247],
6	2215	CD	DATE	2215	dep	1	SENT_391	[p18l323t220r378b240],
7	AAAA	NNP	ORGANIZATION	AAAA	poss	11	SENT_391	[p18l397t219r1340b240],
8	'	POS	O	'	_	0	SENT_391	[p18l397t219r1340b240],
9	|	JJ	O	|	amod	11	SENT_391	[p18l397t219r1340b240],
10	"	``	O	"	punct	11	SENT_391	[p18l397t219r1340b240],
11	CCCGTCGCTATCAAGGAATFAAGAGAAGCAACATCTCCGAAAGCCAAC	NNP	O	CCCGTCGCTATCAAGGAATFAAGAGAAGCAACATCTCCGAAAGCCAAC	dep	6	SENT_391	[p18l397t219r1340b240],
12	2268	CD	DATE	2268	number	13	SENT_391	[p18l1359t219r1415b240],
13	2566	CD	DATE	2566	dep	6	SENT_391	[p18l1443t219r1499b240],
14	TITGGGCTGGCCAAACTGCTGGGT	NNP	DATE	TITGGGCTGGCCAAACTGCTGGGT	dep	13	SENT_391	[p18l1531t219r1958b240],
15	2589	CD	DATE	2589	num	14	SENT_391	[p18l1987t219r2043b240],

1	Patient	NN	O	patient	_	0	SENT_392	[p18l128t320r209b340],
2	1	CD	NUMBER	1	num	1	SENT_392	[p18l220t320r229b339],
3	AAAAT	NN	O	aaaat	dep	1	SENT_392	[p18l397t319r743b340],
4	'	''	O	'	_	0	SENT_392	[p18l397t319r743b340],
5	CCCGTCGCTATCAA	SYM	ORGANIZATION	cccgtcgctatcaa	amod	3	SENT_392	[p18l397t319r743b340],
6	-	:	O	-	_	0	SENT_392	[p18l397t319r743b340],
7	-	:	O	-	_	0	SENT_392	[p18l751t327r760b332],
8	-	:	O	-	_	0	SENT_392	[p18l768t327r776b332],
9	-	:	O	-	_	0	SENT_392	[p18l784t327r793b332],
10	-	:	O	-	_	0	SENT_392	[p18l801t327r810b332],
11	-	:	O	-	_	0	SENT_392	[p18l818t327r826b332],
12	-	:	O	-	_	0	SENT_392	[p18l834t327r843b332],
13	-	:	O	-	_	0	SENT_392	[p18l851t327r860b332],
14	-	:	O	-	_	0	SENT_392	[p18l868t327r876b332],
15	-	:	O	-	_	0	SENT_392	[p18l884t327r893b332],
16	-	:	O	-	_	0	SENT_392	[p18l901t327r910b332],
17	-	:	O	-	_	0	SENT_392	[p18l918t327r926b332],
18	-	:	O	-	_	0	SENT_392	[p18l934t327r943b332],
19	-	:	O	-	_	0	SENT_392	[p18l951t327r960b332],
20	-	:	O	-	_	0	SENT_392	[p18l968t327r976b332],
21	-	:	O	-	_	0	SENT_392	[p18l984t327r993b332],
22	AACATCTCCGAAAGCCAAC	NN	O	aacatctccgaaagccaac	nn	23	SENT_392	[p18l1008t319r1341b340],
23	TITGGGCTGGCCAAACTGCTGGGT	NN	O	titgggctggccaaactgctgggt	dep	3	SENT_392	[p18l1531t319r1958b340],

1	Patient	NN	O	patient	nsubj	2	SENT_393	[p18l128t420r209b440],
2	2	CD	NUMBER	2	_	0	SENT_393	[p18l218t420r230b439],
3	AAAA	NN	ORGANIZATION	aaaa	dep	2	SENT_393	[p18l397t419r828b440],
4	'	''	O	'	_	0	SENT_393	[p18l397t419r828b440],
5	|	SYM	O	|	dep	9	SENT_393	[p18l397t419r828b440],
6	"	``	O	"	punct	9	SENT_393	[p18l397t419r828b440],
7	CCCGTCGCTATCAAGGAA	NNP	O	CCCGTCGCTATCAAGGAA	nsubj	9	SENT_393	[p18l397t419r828b440],
8	"	``	O	"	punct	9	SENT_393	[p18l397t419r828b440],
9	-	:	O	-	_	0	SENT_393	[p18l828t429r837b433],
10	-	:	O	-	_	0	SENT_393	[p18l845t429r854b433],
11	-	:	O	-	_	0	SENT_393	[p18l862t429r870b433],
12	-	:	O	-	_	0	SENT_393	[p18l878t429r887b433],
13	-	:	O	-	_	0	SENT_393	[p18l895t429r904b433],
14	-	:	O	-	_	0	SENT_393	[p18l912t429r920b433],
15	-	:	O	-	_	0	SENT_393	[p18l928t429r937b433],
16	-	:	O	-	_	0	SENT_393	[p18l945t429r954b433],
17	-	:	O	-	_	0	SENT_393	[p18l962t429r970b433],
18	-	:	O	-	_	0	SENT_393	[p18l978t429r987b433],
19	-	:	O	-	_	0	SENT_393	[p18l995t429r1004b433],
20	-	:	O	-	_	0	SENT_393	[p18l1012t429r1020b433],
21	CATCTCCGAAAGCCAAC	NN	O	catctccgaaagccaac	dep	2	SENT_393	[p18l1041t419r1337b440],
22	TITGGGCTGGCCAAACTGCTGGGT	NN	O	titgggctggccaaactgctgggt	dep	21	SENT_393	[p18l1522t419r1958b440],

1	Patients	NNS	O	patient	_	0	SENT_394	[p18l128t520r221b540],
2	3	CD	NUMBER	3	num	1	SENT_394	[p18l231t520r242b540],
3	and	CC	O	and	_	0	SENT_394	[p18l253t518r295b540],
4	4	CD	NUMBER	4	conj_and	1	SENT_394	[p18l305t520r318b540],
5	AAAA	NN	ORGANIZATION	aaaa	dep	1	SENT_394	[p18l397t519r819b540],
6	'	''	O	'	_	0	SENT_394	[p18l397t519r819b540],
7	lTCCCGTCGCTATCAAGGAA	NN	O	ltcccgtcgctatcaaggaa	dep	5	SENT_394	[p18l397t519r819b540],
8	'	''	O	'	_	0	SENT_394	[p18l397t519r819b540],
9	CGAAAGCCAAC	NNP	O	CGAAAGCCAAC	nn	10	SENT_394	[p18l1143t519r1339b540],
10	TITGGGCTGGCCAAACTGCTGGGT	NNP	O	TITGGGCTGGCCAAACTGCTGGGT	dep	1	SENT_394	[p18l1531t519r1958b540],

1	Patients	NNS	O	patient	_	0	SENT_395	[p18l128t620r221b640],
2	5	CD	NUMBER	5	num	1	SENT_395	[p18l232t620r242b640],
3	and	CC	O	and	_	0	SENT_395	[p18l253t618r295b640],
4	6	CD	NUMBER	6	conj_and	1	SENT_395	[p18l306t620r318b640],
5	AAAATFCCCGTCGCTATCAAGGAA	NN	ORGANIZATION	aaaatfcccgtcgctatcaaggaa	dep	1	SENT_395	[p18l397t619r1340b640],
6	'	''	O	'	_	0	SENT_395	[p18l397t619r1340b640],
7	"	``	O	"	punct	8	SENT_395	[p18l397t619r1340b640],
8	|	NN	O	|	dep	5	SENT_395	[p18l397t619r1340b640],
9	'	''	O	'	_	0	SENT_395	[p18l397t619r1340b640],
10	AAGAGAAGCAACATCTCCGAAAGCCAAC	NNP	O	AAGAGAAGCAACATCTCCGAAAGCCAAC	nn	11	SENT_395	[p18l397t619r1340b640],
11	TITGGGCQGGCCAAACTGCTGGGT	NNP	O	TITGGGCQGGCCAAACTGCTGGGT	dep	1	SENT_395	[p18l1531t619r1963b646],

1	AAAATTCCCGTCG	NNP	MISC	AAAATTCCCGTCG	nn	3	SENT_396	[p18l397t719r621b740],
2	CTATCAAGGAKTAAGAGAAG	NNP	MISC	CTATCAAGGAKTAAGAGAAG	nn	3	SENT_396	[p18l625t719r988b740],
3	CAACATCTCCGAAAG	NNP	MISC	CAACATCTCCGAAAG	_	0	SENT_396	[p18l992t719r1251b740],
4	CCAAC	NN	MISC	ccaac	nn	5	SENT_396	[p18l1255t719r1340b740],
5	TITGGGCTGGCCAAACAGCTGGGT	NN	MISC	titgggctggccaaacagctgggt	dep	3	SENT_396	[p18l1531t719r1960b746],

1	Exon	NN	O	exon	_	0	SENT_397	[p18l1707t817r1768b840],
2	21	CD	NUMBER	21	num	1	SENT_397	[p18l1780t817r1810b839],

1	delL747	NN	O	dell747	_	0	SENT_398	[p18l171t1004r420b1029],
2	.	.	O	.	_	0	SENT_398	[p18l171t1004r420b1029],

1	—	NN	O	—	_	0	SENT_399	[p18l171t1004r420b1029],
2	.	.	O	.	_	0	SENT_399	[p18l171t1004r420b1029],

1	P753insS	NN	O	p753inss	_	0	SENT_400	[p18l171t1004r420b1029],
2	.	.	O	.	_	0	SENT_400	[p18l625t1023r627b1025],

1	delE746	NN	O	dele746	_	0	SENT_401	[p18l171t1044r365b1069],
2	.	.	O	.	_	0	SENT_401	[p18l171t1044r365b1069],

1	—	NN	O	—	_	0	SENT_402	[p18l171t1044r365b1069],
2	.	.	O	.	_	0	SENT_402	[p18l171t1044r365b1069],

1	A750	NN	O	a750	_	0	SENT_403	[p18l171t1044r365b1069],
2	V	NN	O	v	nn	3	SENT_403	[p18l597t1074r607b1078],
3	_	NN	O	_	dep	1	SENT_403	[p18l597t1074r607b1078],
4	.	.	O	.	_	0	SENT_403	[p18l617t1060r623b1067, p18l171t1083r419b1108],

1	delL747	NN	O	dell747	_	0	SENT_404	[p18l617t1060r623b1067, p18l171t1083r419b1108],
2	.	.	O	.	_	0	SENT_404	[p18l617t1060r623b1067, p18l171t1083r419b1108],

1	—	NN	O	—	_	0	SENT_405	[p18l617t1060r623b1067, p18l171t1083r419b1108],
2	.	.	O	.	_	0	SENT_405	[p18l617t1060r623b1067, p18l171t1083r419b1108],

1	T751insS	NN	O	t751inss	nsubj	2	SENT_406	[p18l617t1060r623b1067, p18l171t1083r419b1108],
2	,	,	O	,	_	0	SENT_406	[p18l607t1088r619b1113],
3	.	.	O	.	_	0	SENT_406	[p18l607t1088r619b1113],

1	‘	SYM	O	‘	dep	7	SENT_407	[p18l311t1556r511b1587],
2	-	:	O	-	_	0	SENT_407	[p18l311t1556r511b1587],
3	‘	NN	O	‘	dobj	7	SENT_407	[p18l311t1556r511b1587],
4	C-terminal	JJ	O	c-terminal	amod	3	SENT_407	[p18l311t1556r511b1587],
5	)	CD	NUMBER	)	num	6	SENT_407	[p18l311t1556r511b1587],
6	”	NN	O	”	dep	4	SENT_407	[p18l311t1556r511b1587],
7	C	NN	O	c	_	0	SENT_407	[p18l566t1560r589b1584],
8	’	CD	NUMBER	’	num	9	SENT_407	[p18l566t1560r589b1584],
9	‘	NN	O	‘	nsubj	10	SENT_407	[p18l260t1590r345b1636],
10	had	VBD	O	have	ccomp	7	SENT_407	[p18l260t1590r345b1636],
11	,	,	O	,	_	0	SENT_407	[p18l260t1590r345b1636],
12	lobe	NN	O	lobe	dep	10	SENT_407	[p18l380t1598r436b1623],

1	Figure	NNP	O	Figure	_	0	SENT_408	[p18l122t1817r206b1849],
2	4	CD	NUMBER	4	dep	1	SENT_408	[p18l215t1819r238b1841],
3	.	.	O	.	_	0	SENT_408	[p18l215t1819r238b1841],

1	Clustering	NN	O	clustering	_	0	SENT_409	[p18l248t1816r389b1849],
2	of	IN	O	of	_	0	SENT_409	[p18l397t1816r428b1842],
3	Mutations	NNS	O	mutation	prep_of	1	SENT_409	[p18l434t1817r572b1842],
4	in	IN	O	in	_	0	SENT_409	[p18l583t1817r606b1841],
5	the	DT	O	the	det	7	SENT_409	[p18l615t1816r659b1842],
6	EGFR	NN	O	egfr	nn	7	SENT_409	[p18l669t1818r747b1842],
7	Gene	NN	O	gene	prep_in	3	SENT_409	[p18l755t1818r827b1842],
8	at	IN	O	at	_	0	SENT_409	[p18l836t1821r861b1842],
9	Critical	JJ	O	critical	amod	10	SENT_409	[p18l869t1816r962b1842],
10	Sites	NNS	O	site	prep_at	1	SENT_409	[p18l972t1817r1038b1842],
11	within	IN	O	within	_	0	SENT_409	[p18l1047t1816r1131b1842],
12	the	DT	O	the	det	14	SENT_409	[p18l1140t1816r1185b1842],
13	ATP-Binding	NN	O	atp-binding	nn	14	SENT_409	[p18l1192t1816r1363b1849],
14	Pocket	NN	O	pocket	prep_within	1	SENT_409	[p18l1373t1816r1470b1842],
15	.	.	O	.	_	0	SENT_409	[p18l1373t1816r1470b1842],

1	Panel	NN	O	panel	nn	2	SENT_410	[p18l130t1866r201b1892],
2	A	NN	O	a	nsubj	3	SENT_410	[p18l211t1868r230b1891],
3	shows	VBZ	O	show	_	0	SENT_410	[p18l240t1866r324b1892],
4	the	DT	O	the	det	5	SENT_410	[p18l334t1866r377b1892],
5	position	NN	O	position	dobj	3	SENT_410	[p18l388t1869r496b1899],
6	ofoverlapping	VBG	O	ofoverlapp	partmod	5	SENT_410	[p18l508t1866r704b1900],
7	in-frame	RB	O	in-frame	advmod	6	SENT_410	[p18l714t1866r827b1892],
8	deletions	NNS	O	deletion	dobj	6	SENT_410	[p18l837t1866r961b1892],
9	in	IN	O	in	_	0	SENT_410	[p18l972t1869r994b1891],
10	exon	NN	O	exon	prep_in	8	SENT_410	[p18l1006t1875r1067b1892],
11	19	CD	NUMBER	19	num	10	SENT_410	[p18l1080t1869r1109b1892],
12	and	CC	O	and	_	0	SENT_410	[p18l1120t1866r1168b1892],
13	missense	NN	O	missense	nn	14	SENT_410	[p18l1181t1869r1308b1892],
14	mutations	NNS	O	mutation	conj_and	8	SENT_410	[p18l1319t1869r1457b1892],
15	in	IN	O	in	_	0	SENT_410	[p18l1468t1869r1490b1891],
16	exon	NN	O	exon	nn	20	SENT_410	[p18l1501t1875r1563b1892],
17	21	CD	NUMBER	21	num	20	SENT_410	[p18l1574t1869r1604b1891],
18	ofthe	NN	O	ofthe	nn	20	SENT_410	[p18l1615t1866r1692b1892],
19	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_410	[p18l1704t1868r1780b1892],
20	gene	NN	O	gene	prep_in	14	SENT_410	[p18l1789t1875r1853b1900],
21	in	IN	O	in	_	0	SENT_410	[p18l1864t1869r1886b1891],
22	seven	CD	NUMBER	seven	num	23	SENT_410	[p18l1898t1875r1973b1892],
23	patients	NNS	O	patient	prep_in	6	SENT_410	[p18l1986t1875r2025b1899, p18l119t1910r195b1933],
24	with	IN	O	with	_	0	SENT_410	[p18l205t1908r261b1933],
25	non	JJ	O	non	amod	29	SENT_410	[p18l273t1908r470b1933],
26	—	JJ	O	—	amod	29	SENT_410	[p18l273t1908r470b1933],
27	small-cell	NN	O	small-cell	nn	29	SENT_410	[p18l273t1908r470b1933],
28	lung	NN	O	lung	nn	29	SENT_410	[p18l482t1908r541b1941],
29	cancer	NN	O	cancer	prep_with	23	SENT_410	[p18l550t1917r643b1933],
30	.	.	O	.	_	0	SENT_410	[p18l550t1917r643b1933],

1	The	DT	O	the	det	6	SENT_411	[p18l653t1908r703b1933],
2	partial	JJ	O	partial	amod	6	SENT_411	[p18l714t1908r797b1941],
3	nucleotide	NN	O	nucleotide	nn	6	SENT_411	[p18l810t1908r951b1933],
4	sequence	NN	O	sequence	nn	6	SENT_411	[p18l961t1917r1089b1941],
5	ofeach	NN	O	ofeach	nn	6	SENT_411	[p18l1099t1908r1194b1933],
6	exon	NN	O	exon	nsubjpass	24	SENT_411	[p18l1206t1917r1267b1933],
7	is	VBZ	O	be	auxpass	8	SENT_411	[p18l1279t1910r1298b1933],
8	shown	VBN	O	show	_	0	SENT_411	[p18l1310t1908r1405b1938],
9	,	,	O	,	_	0	SENT_411	[p18l1310t1908r1405b1938],
10	with	IN	O	with	_	0	SENT_411	[p18l1415t1908r1471b1933],
11	deletions	NNS	O	deletion	prep_with	8	SENT_411	[p18l1483t1908r1606b1933],
12	indicated	VBN	O	indicate	partmod	11	SENT_411	[p18l1618t1908r1741b1933],
13	by	IN	O	by	_	0	SENT_411	[p18l1753t1908r1782b1941],
14	red	JJ	O	red	agent	12	SENT_411	[p18l1792t1908r1832b1933],
15	dashed	VBN	O	dash	partmod	14	SENT_411	[p18l1843t1908r1940b1933],
16	lines	NNS	O	line	dobj	15	SENT_411	[p18l1953t1908r2013b1933],
17	and	CC	O	and	_	0	SENT_411	[p18l121t1950r168b1975],
18	missense	NN	O	missense	nn	19	SENT_411	[p18l180t1952r304b1975],
19	mutations	NNS	O	mutation	conj_and	16	SENT_411	[p18l314t1952r447b1975],
20	shown	VBN	O	show	partmod	16	SENT_411	[p18l458t1950r542b1975],
21	in	IN	O	in	_	0	SENT_411	[p18l554t1952r575b1975],
22	red	JJ	O	red	prep_in	20	SENT_411	[p18l587t1950r626b1975],
23	and	CC	O	and	_	0	SENT_411	[p18l636t1950r683b1975],
24	underlined	VBD	O	underline	conj_and	8	SENT_411	[p18l695t1950r843b1979],
25	;	:	O	;	_	0	SENT_411	[p18l695t1950r843b1979],
26	the	DT	O	the	det	29	SENT_411	[p18l852t1950r894b1975],
27	wild-type	JJ	O	wild-type	amod	29	SENT_411	[p18l902t1950r1020b1983],
28	EGFR	NN	O	egfr	nn	29	SENT_411	[p18l1031t1952r1105b1975],
29	nucleotide	NN	O	nucleotide	nsubjpass	35	SENT_411	[p18l1115t1950r1251b1975],
30	and	CC	O	and	_	0	SENT_411	[p18l1260t1950r1308b1975],
31	amino	NN	O	amino	nn	33	SENT_411	[p18l1318t1952r1402b1975],
32	acid	NN	O	acid	nn	33	SENT_411	[p18l1411t1950r1463b1975],
33	sequences	NNS	O	sequence	nsubjpass	35	SENT_411	[p18l1474t1959r1611b1983],
34	are	VBP	O	be	auxpass	35	SENT_411	[p18l1621t1959r1661b1975],
35	shown	VBN	O	show	parataxis	8	SENT_411	[p18l1670t1950r1755b1975],
36	at	IN	O	at	_	0	SENT_411	[p18l1766t1955r1789b1975],
37	the	DT	O	the	det	38	SENT_411	[p18l1797t1950r1838b1975],
38	top	NN	O	top	prep_at	35	SENT_411	[p18l1846t1955r1897b1983],
39	.	.	O	.	_	0	SENT_411	[p18l1846t1955r1897b1983],

1	Panel	NN	O	panel	nn	2	SENT_412	[p18l1909t1950r1978b1975],
2	B	NN	O	b	nsubj	3	SENT_412	[p18l1990t1952r2005b1975],
3	shows	VBZ	O	show	dep	24	SENT_412	[p18l121t1991r204b2017],
4	the	DT	O	the	det	10	SENT_412	[p18l214t1991r256b2017],
5	tridimensional	JJ	O	tridimensional	amod	10	SENT_412	[p18l265t1991r464b2017],
6	structure	NN	O	structure	nn	10	SENT_412	[p18l475t1996r597b2017],
7	ofthe	JJ	O	ofthe	amod	10	SENT_412	[p18l607t1991r684b2017],
8	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_412	[p18l696t1993r770b2017],
9	ATP	NN	ORGANIZATION	atp	nn	10	SENT_412	[p18l779t1993r832b2016],
10	cleft	NN	O	cleft	nsubj	11	SENT_412	[p18l841t1991r898b2017],
11	ﬂanked	VBN	O	ﬂanked	dep	3	SENT_412	[p18l907t1991r1004b2017],
12	by	IN	O	by	_	0	SENT_412	[p18l1016t1991r1045b2024],
13	the	DT	O	the	det	15	SENT_412	[p18l1053t1991r1096b2017],
14	N-terminal	JJ	MISC	n-terminal	amod	15	SENT_412	[p18l1108t1991r1252b2017],
15	lobe	NN	O	lobe	prep_by	11	SENT_412	[p18l1265t1991r1320b2017],
16	and	CC	O	and	_	0	SENT_412	[p18l1330t1991r1379b2017],
17	the	DT	O	the	det	21	SENT_412	[p18l1389t1991r1432b2017],
18	C-terminal	JJ	MISC	c-terminal	amod	21	SENT_412	[p18l1442t1991r1583b2017],
19	lobe	NN	O	lobe	nn	21	SENT_412	[p18l1595t1991r1651b2017],
20	ofthe	NN	O	ofthe	nn	21	SENT_412	[p18l1661t1991r1737b2017],
21	kinase	NN	O	kinase	prep_by	11	SENT_412	[p18l1749t1991r1833b2017],
22	domain	NN	O	domain	nsubj	24	SENT_412	[p18l1843t1991r1945b2017],
23	(	CD	NUMBER	(	num	22	SENT_412	[p18l1960t1994r2037b2025, p18l120t2033r218b2058],
24	coordinates	VBZ	O	coordinate	_	0	SENT_412	[p18l1960t1994r2037b2025, p18l120t2033r218b2058],
25	derived	VBN	O	derive	dep	24	SENT_412	[p18l228t2033r326b2058],
26	from	IN	O	from	_	0	SENT_412	[p18l336t2033r400b2058],
27	Protein	NN	ORGANIZATION	protein	nn	29	SENT_412	[p18l412t2035r506b2058],
28	Data	NNP	ORGANIZATION	Data	nn	29	SENT_412	[p18l519t2035r580b2058],
29	Bank	NNP	ORGANIZATION	Bank	prep_from	25	SENT_412	[p18l591t2033r657b2058],
30	1M14	NN	O	1m14	dep	29	SENT_412	[p18l667t2035r742b2058],
31	and	CC	O	and	_	0	SENT_412	[p18l751t2033r799b2058],
32	displayed	VBD	O	display	conj_and	24	SENT_412	[p18l810t2033r936b2066],
33	with	IN	O	with	_	0	SENT_412	[p18l946t2033r1002b2058],
34	the	DT	O	the	det	38	SENT_412	[p18l1011t2033r1054b2058],
35	use	NN	O	use	nn	38	SENT_412	[p18l1064t2042r1109b2058],
36	ofCn3D	NN	O	ofcn3d	nn	38	SENT_412	[p18l1118t2033r1228b2058],
37	software	NN	O	software	nn	38	SENT_412	[p18l1239t2033r1372b2066],
38	)	NN	O	)	prep_with	32	SENT_412	[p18l1239t2033r1372b2066],
39	.	.	O	.	_	0	SENT_412	[p18l1239t2033r1372b2066],

1	The	DT	O	the	det	3	SENT_413	[p18l1381t2033r1432b2058],
2	inhibitor	NN	O	inhibitor	nn	3	SENT_413	[p18l1442t2033r1557b2058],
3	(	NN	O	(	nsubj	11	SENT_413	[p18l1568t2033r1636b2066],
4	dark	JJ	O	dark	amod	6	SENT_413	[p18l1568t2033r1636b2066],
5	blue	JJ	O	blue	amod	6	SENT_413	[p18l1646t2033r1721b2066],
6	)	NN	O	)	dep	3	SENT_413	[p18l1646t2033r1721b2066],
7	,	,	O	,	_	0	SENT_413	[p18l1646t2033r1721b2066],
8	representing	VBG	O	represent	partmod	11	SENT_413	[p18l1732t2036r1904b2066],
9	geﬁtinib	NN	O	geﬁtinib	dobj	8	SENT_413	[p18l1912t2033r2030b2066],
10	,	,	O	,	_	0	SENT_413	[p18l1912t2033r2030b2066],
11	occupies	VBZ	O	occupy	_	0	SENT_413	[p18l120t2077r240b2108],
12	the	DT	O	the	det	14	SENT_413	[p18l249t2075r292b2100],
13	ATP	NN	O	atp	nn	14	SENT_413	[p18l301t2076r354b2100],
14	cleft	NN	O	cleft	dobj	11	SENT_413	[p18l364t2074r427b2100],
15	.	.	O	.	_	0	SENT_413	[p18l364t2074r427b2100],

1	The	DT	O	the	det	2	SENT_414	[p18l437t2075r487b2100],
2	locations	NNS	O	location	nsubj	3	SENT_414	[p18l498t2075r620b2100],
3	ofthe	VBP	O	ofthe	_	0	SENT_414	[p18l631t2074r707b2100],
4	two	CD	NUMBER	two	num	6	SENT_414	[p18l716t2080r765b2100],
5	missense	NN	O	missense	nn	6	SENT_414	[p18l777t2077r904b2100],
6	mutations	NNS	O	mutation	nsubjpass	8	SENT_414	[p18l915t2077r1052b2100],
7	are	VBP	O	be	auxpass	8	SENT_414	[p18l1064t2084r1104b2100],
8	shown	VBN	O	show	ccomp	3	SENT_414	[p18l1114t2075r1201b2100],
9	within	IN	O	within	_	0	SENT_414	[p18l1211t2075r1294b2100],
10	the	DT	O	the	det	16	SENT_414	[p18l1304t2075r1347b2100],
11	activating	VBG	O	activate	amod	16	SENT_414	[p18l1357t2077r1489b2108],
12	loop	NN	O	loop	nn	16	SENT_414	[p18l1499t2075r1557b2108],
13	ofthe	NN	O	ofthe	nn	16	SENT_414	[p18l1567t2074r1644b2100],
14	tyrosine	NN	O	tyrosine	nn	16	SENT_414	[p18l1653t2077r1762b2108],
15	kinase	NN	O	kinase	nn	16	SENT_414	[p18l1773t2075r1857b2100],
16	(	NN	O	(	prep_within	8	SENT_414	[p18l1870t2075r1939b2108],
17	light	NN	O	light	prep	16	SENT_414	[p18l1870t2075r1939b2108],
18	blue	JJ	O	blue	amod	19	SENT_414	[p18l1950t2075r2025b2108],
19	)	NN	O	)	dep	17	SENT_414	[p18l1950t2075r2025b2108],
20	;	:	O	;	_	0	SENT_414	[p18l1950t2075r2025b2108],
21	the	DT	O	the	det	22	SENT_414	[p18l119t2116r162b2142],
22	three	CD	NUMBER	three	dep	24	SENT_414	[p18l171t2116r240b2142],
23	in-frame	RB	O	in-frame	dep	22	SENT_414	[p18l251t2116r364b2142],
24	deletions	NNS	O	deletion	nsubj	31	SENT_414	[p18l374t2116r498b2142],
25	are	VBP	O	be	cop	31	SENT_414	[p18l509t2125r549b2142],
26	all	DT	O	all	det	31	SENT_414	[p18l559t2116r587b2142],
27	present	JJ	DATE	present	amod	31	SENT_414	[p18l600t2121r701b2149],
28	within	IN	O	within	_	0	SENT_414	[p18l709t2116r792b2142],
29	another	DT	O	another	det	30	SENT_414	[p18l803t2116r909b2142],
30	loop	NN	O	loop	prep_within	27	SENT_414	[p18l919t2116r977b2149],
31	(	NN	O	(	parataxis	3	SENT_414	[p18l990t2116r1086b2150],
32	shown	VBN	O	show	partmod	31	SENT_414	[p18l990t2116r1086b2150],
33	in	IN	O	in	_	0	SENT_414	[p18l1099t2119r1121b2141],
34	red	JJ	O	red	amod	35	SENT_414	[p18l1133t2116r1194b2150],
35	)	NN	O	)	prep_in	32	SENT_414	[p18l1133t2116r1194b2150],
36	,	,	O	,	_	0	SENT_414	[p18l1133t2116r1194b2150],
37	which	WDT	O	which	nsubj	38	SENT_414	[p18l1204t2116r1283b2142],
38	ﬂanks	VBZ	O	ﬂanks	rcmod	35	SENT_414	[p18l1293t2116r1372b2142],
39	the	DT	O	the	det	41	SENT_414	[p18l1382t2116r1425b2142],
40	ATP	NN	O	atp	nn	41	SENT_414	[p18l1434t2118r1487b2141],
41	cleft	NN	O	cleft	dobj	38	SENT_414	[p18l1496t2116r1560b2142],
42	.	.	O	.	_	0	SENT_414	[p18l1496t2116r1560b2142],

1	Panel	NN	O	panel	nn	2	SENT_415	[p18l1581t2116r1651b2142],
2	C	NN	O	c	nsubj	3	SENT_415	[p18l1663t2118r1680b2142],
3	shows	VBZ	O	show	_	0	SENT_415	[p18l1691t2116r1775b2142],
4	a	DT	O	a	det	6	SENT_415	[p18l1786t2125r1799b2142],
5	close-up	NN	O	close-up	nn	6	SENT_415	[p18l1809t2116r1923b2149],
6	view	NN	O	view	dobj	3	SENT_415	[p18l1933t2119r1993b2142],
7	of	IN	O	of	_	0	SENT_415	[p18l2002t2116r2032b2142],
8	the	DT	O	the	det	13	SENT_415	[p18l119t2158r162b2183],
9	EG	NN	O	eg	nn	13	SENT_415	[p18l173t2160r208b2183],
10	FR	NN	O	fr	nn	13	SENT_415	[p18l215t2160r247b2183],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_415	[p18l255t2161r364b2191],
12	kinase	NN	O	kinase	nn	13	SENT_415	[p18l374t2158r459b2183],
13	domain	NN	O	domain	prep_of	6	SENT_415	[p18l467t2158r579b2188],
14	,	,	O	,	_	0	SENT_415	[p18l467t2158r579b2188],
15	with	IN	O	with	_	0	SENT_415	[p18l588t2158r644b2183],
16	the	DT	O	the	det	19	SENT_415	[p18l654t2158r696b2183],
17	critical	JJ	O	critical	amod	19	SENT_415	[p18l705t2158r793b2183],
18	amino	NN	O	amino	nn	19	SENT_415	[p18l804t2161r889b2183],
19	acids	NNS	O	acid	prep_with	3	SENT_415	[p18l899t2158r967b2183],
20	implicated	VBN	O	implicate	partmod	19	SENT_415	[p18l978t2158r1119b2191],
21	in	IN	O	in	_	0	SENT_415	[p18l1130t2161r1152b2183],
22	binding	VBG	O	bind	prep_in	20	SENT_415	[p18l1164t2158r1266b2191],
23	to	TO	O	to	_	0	SENT_415	[p18l1274t2163r1300b2183],
24	ATP	NN	O	atp	prep_to	22	SENT_415	[p18l1309t2160r1362b2183],
25	or	CC	O	or	_	0	SENT_415	[p18l1370t2167r1398b2183],
26	the	DT	O	the	det	27	SENT_415	[p18l1405t2158r1448b2183],
27	inhibitor	NN	O	inhibitor	prep_to	22	SENT_415	[p18l1458t2158r1577b2183],
28	.	.	O	.	_	0	SENT_415	[p18l1458t2158r1577b2183],

1	Speciﬁcally	RB	O	speciﬁcally	advmod	8	SENT_416	[p18l1587t2158r1742b2191],
2	,	,	O	,	_	0	SENT_416	[p18l1587t2158r1742b2191],
3	4-anilinoquinazoline	JJ	O	4-anilinoquinazoline	amod	4	SENT_416	[p18l1751t2158r2031b2191],
4	compounds	NNS	O	compound	nsubj	8	SENT_416	[p18l120t2200r283b2233],
5	such	JJ	O	such	_	0	SENT_416	[p18l294t2200r356b2225],
6	as	IN	O	as	_	0	SENT_416	[p18l367t2209r395b2225],
7	gefitinib	NN	O	gefitinib	prep_such_as	4	SENT_416	[p18l406t2199r516b2233],
8	inhibit	VBP	O	inhibit	_	0	SENT_416	[p18l527t2200r613b2225],
9	catalysis	NN	O	catalysis	dobj	8	SENT_416	[p18l622t2200r736b2233],
10	by	IN	O	by	_	0	SENT_416	[p18l748t2200r776b2233],
11	occupying	VBG	O	occupy	prepc_by	8	SENT_416	[p18l785t2202r924b2233],
12	the	DT	O	the	det	14	SENT_416	[p18l932t2200r975b2225],
13	ATP-binding	JJ	O	atp-binding	amod	14	SENT_416	[p18l984t2200r1152b2233],
14	site	NN	O	site	dobj	11	SENT_416	[p18l1162t2202r1215b2229],
15	,	,	O	,	_	0	SENT_416	[p18l1162t2202r1215b2229],
16	where	WRB	O	where	advmod	18	SENT_416	[p18l1225t2200r1307b2225],
17	they	PRP	O	they	nsubj	18	SENT_416	[p18l1316t2200r1373b2233],
18	form	VBP	O	form	rcmod	14	SENT_416	[p18l1381t2199r1445b2225],
19	hydrogen	NN	O	hydrogen	nn	20	SENT_416	[p18l1457t2200r1582b2233],
20	bonds	NNS	O	bond	dobj	18	SENT_416	[p18l1594t2200r1677b2225],
21	with	IN	O	with	_	0	SENT_416	[p18l1686t2200r1742b2225],
22	methionine759	NN	O	methionine759	nn	25	SENT_416	[p18l1763t2200r1957b2225],
23	(	CD	NUMBER	(	num	25	SENT_416	[p18l123t2244r219b2275],
24	M769	NN	O	m769	nn	25	SENT_416	[p18l123t2244r219b2275],
25	)	NN	O	)	prep_with	20	SENT_416	[p18l123t2244r219b2275],
26	and	CC	O	and	_	0	SENT_416	[p18l231t2241r279b2267],
27	cysteine751	NN	O	cysteine751	conj_and	20	SENT_416	[p18l290t2244r437b2274],
28	(	CD	NUMBER	(	num	31	SENT_416	[p18l451t2243r537b2275],
29	C751	NN	O	c751	nn	31	SENT_416	[p18l451t2243r537b2275],
30	)	NN	O	)	nn	31	SENT_416	[p18l451t2243r537b2275],
31	residues	NNS	O	residue	dep	27	SENT_416	[p18l551t2241r671b2271],
32	,	,	O	,	_	0	SENT_416	[p18l551t2241r671b2271],
33	whereas	IN	O	whereas	mark	38	SENT_416	[p18l681t2241r792b2267],
34	their	PRP$	O	they	poss	36	SENT_416	[p18l801t2241r865b2267],
35	anilino	NN	O	anilino	nn	36	SENT_416	[p18l873t2241r965b2267],
36	ring	NN	O	ring	nsubj	38	SENT_416	[p18l976t2244r1028b2275],
37	is	VBZ	O	be	cop	38	SENT_416	[p18l1038t2244r1057b2267],
38	close	JJ	O	close	advcl	18	SENT_416	[p18l1067t2241r1136b2267],
39	to	TO	O	to	_	0	SENT_416	[p18l1145t2246r1171b2267],
40	methionine742	NN	O	methionine742	nn	42	SENT_416	[p18l1182t2241r1377b2267],
41	(	CD	NUMBER	(	num	42	SENT_416	[p18l1389t2244r1495b2275],
42	M742	NN	O	m742	prep_to	38	SENT_416	[p18l1389t2244r1495b2275],
43	)	CD	NUMBER	)	num	42	SENT_416	[p18l1389t2244r1495b2275],
44	,	,	O	,	_	0	SENT_416	[p18l1389t2244r1495b2275],
45	|	CD	NUMBER	|	num	46	SENT_416	[p18l1507t2241r1620b2274],
46	ysine721	NN	O	ysine721	dobj	11	SENT_416	[p18l1507t2241r1620b2274],
47	(	CD	NUMBER	(	num	49	SENT_416	[p18l1633t2244r1728b2275],
48	K721	NN	O	k721	nn	49	SENT_416	[p18l1633t2244r1728b2275],
49	)	NN	O	)	dep	46	SENT_416	[p18l1633t2244r1728b2275],
50	,	,	O	,	_	0	SENT_416	[p18l1633t2244r1728b2275],
51	and	CC	O	and	_	0	SENT_416	[p18l1739t2241r1787b2267],
52	leucine754	NN	O	leucine754	conj_and	14	SENT_416	[p18l1800t2241r1934b2267],
53	(	CD	NUMBER	(	num	56	SENT_416	[p18l1946t2244r2029b2275],
54	L764	NN	O	l764	nn	56	SENT_416	[p18l1946t2244r2029b2275],
55	)	NN	O	)	nn	56	SENT_416	[p18l1946t2244r2029b2275],
56	residues	NNS	O	residue	nsubj	57	SENT_416	[p18l122t2283r234b2308],
57	(	VBP	O	(	rcmod	52	SENT_416	[p18l247t2283r285b2316],
58	all	DT	O	all	nsubjpass	80	SENT_416	[p18l247t2283r285b2316],
59	shown	VBN	O	show	partmod	58	SENT_416	[p18l297t2283r383b2308],
60	in	IN	O	in	_	0	SENT_416	[p18l396t2286r418b2308],
61	green	JJ	O	green	amod	65	SENT_416	[p18l429t2285r551b2316],
62	)	NN	O	)	nn	65	SENT_416	[p18l429t2285r551b2316],
63	.22	CD	NUMBER	.22	num	65	SENT_416	[p18l429t2285r551b2316],
64	In-frame	JJ	O	in-frame	amod	65	SENT_416	[p18l563t2283r677b2308],
65	deletions	NNS	O	deletion	prep_in	59	SENT_416	[p18l686t2283r810b2308],
66	within	IN	O	within	_	0	SENT_416	[p18l820t2283r902b2308],
67	the	DT	O	the	det	68	SENT_416	[p18l913t2283r955b2308],
68	loop	NN	O	loop	prep_within	59	SENT_416	[p18l966t2283r1024b2316],
69	that	WDT	O	that	nsubjpass	71	SENT_416	[p18l1034t2283r1087b2308],
70	is	VBZ	O	be	auxpass	71	SENT_416	[p18l1098t2286r1117b2308],
71	targeted	VBN	O	target	rcmod	68	SENT_416	[p18l1127t2283r1238b2316],
72	by	IN	O	by	_	0	SENT_416	[p18l1250t2283r1279b2316],
73	mutations	NNS	O	mutation	agent	71	SENT_416	[p18l1289t2286r1427b2308],
74	(	CD	NUMBER	(	num	73	SENT_416	[p18l1441t2283r1537b2316],
75	shown	VBN	O	show	partmod	73	SENT_416	[p18l1441t2283r1537b2316],
76	in	IN	O	in	_	0	SENT_416	[p18l1550t2286r1571b2308],
77	red	JJ	O	red	amod	78	SENT_416	[p18l1584t2283r1635b2316],
78	)	NN	O	)	prep_in	75	SENT_416	[p18l1584t2283r1635b2316],
79	are	VBP	O	be	auxpass	80	SENT_416	[p18l1648t2292r1688b2308],
80	predicted	VBN	O	predict	ccomp	57	SENT_416	[p18l1699t2283r1824b2316],
81	to	TO	O	to	aux	82	SENT_416	[p18l1834t2288r1861b2308],
82	alter	VB	O	alter	xcomp	80	SENT_416	[p18l1872t2283r1931b2308],
83	the	DT	O	the	det	87	SENT_416	[p18l1939t2283r1982b2308],
84	position	NN	O	position	nn	87	SENT_416	[p18l1993t2292r2034b2316, p18l121t2327r194b2350],
85	ofthese	NN	O	ofthese	nn	87	SENT_416	[p18l205t2324r312b2350],
86	amino	NN	O	amino	nn	87	SENT_416	[p18l321t2327r407b2350],
87	acids	NNS	O	acid	dobj	82	SENT_416	[p18l417t2325r485b2350],
88	relative	JJ	O	relative	advmod	82	SENT_416	[p18l497t2325r593b2350],
89	to	TO	O	to	_	0	SENT_416	[p18l601t2330r628b2350],
90	that	DT	O	that	det	92	SENT_416	[p18l637t2325r691b2350],
91	ofthe	NN	O	ofthe	nn	92	SENT_416	[p18l699t2325r776b2350],
92	inhibitor	NN	O	inhibitor	prep_to	88	SENT_416	[p18l786t2325r905b2350],
93	.	.	O	.	_	0	SENT_416	[p18l786t2325r905b2350],

1	Mutated	VBN	O	mutate	_	0	SENT_417	[p18l917t2325r1029b2350],
2	residues	NNS	O	residue	nsubj	3	SENT_417	[p18l1041t2325r1154b2350],
3	(	VBP	O	(	ccomp	1	SENT_417	[p18l1167t2325r1228b2358],
4	red	JJ	O	red	amod	5	SENT_417	[p18l1167t2325r1228b2358],
5	)	NN	O	)	dobj	3	SENT_417	[p18l1167t2325r1228b2358],
6	are	VBP	O	be	auxpass	7	SENT_417	[p18l1240t2334r1281b2350],
7	shown	VBN	O	show	auxpass	1	SENT_417	[p18l1291t2325r1378b2350],
8	within	IN	O	within	_	0	SENT_417	[p18l1387t2325r1470b2350],
9	the	DT	O	the	det	12	SENT_417	[p18l1480t2325r1522b2350],
10	activation	NN	O	activation	nn	12	SENT_417	[p18l1532t2327r1663b2350],
11	loop	NN	O	loop	nn	12	SENT_417	[p18l1675t2325r1733b2358],
12	ofthe	NN	O	ofthe	prep_within	7	SENT_417	[p18l1742t2325r1818b2350],
13	tyrosine	NN	O	tyrosine	nn	15	SENT_417	[p18l1827t2327r1935b2358],
14	kinase	NN	O	kinase	nn	15	SENT_417	[p18l1946t2325r2030b2350],
15	(	NN	O	(	nsubjpass	1	SENT_417	[p18l123t2366r192b2400],
16	light	NN	O	light	prep	15	SENT_417	[p18l123t2366r192b2400],
17	blue	JJ	O	blue	amod	18	SENT_417	[p18l203t2366r278b2400],
18	)	NN	O	)	dep	16	SENT_417	[p18l203t2366r278b2400],
19	.	.	O	.	_	0	SENT_417	[p18l203t2366r278b2400],

1	N	NN	O	n	_	0	SENT_418	[p18l565t2526r579b2541],
2	ENGL	NN	ORGANIZATION	engl	nn	5	SENT_418	[p18l594t2525r678b2547],
3	)	CD	NUMBER	)	num	5	SENT_418	[p18l594t2525r678b2547],
4	MED	NN	O	med	nn	5	SENT_418	[p18l693t2526r746b2541],
5	35o	NN	O	35o	dep	1	SENT_418	[p18l758t2525r837b2547],
6	;	:	O	;	_	0	SENT_418	[p18l758t2525r837b2547],
7	21	CD	NUMBER	21	num	9	SENT_418	[p18l758t2525r837b2547],
8	WWW.NEjM.oRG	NNP	O	WWW.NEjM.oRG	nn	9	SENT_418	[p18l874t2525r1086b2547],
9	MAY	NNP	DATE	MAY	dep	5	SENT_418	[p18l1125t2525r1176b2541],
10	20,2004	CD	DATE	20,2004	number	11	SENT_418	[p18l1188t2525r1308b2547],
11	2137	CD	DATE	2137	dep	9	SENT_418	[p18l1990t2524r2066b2546],

1	The	DT	O	the	det	4	SENT_419	[p18l752t2558r802b2582],
2	New	NNP	O	New	nn	4	SENT_419	[p18l812t2559r874b2582],
3	England	NNP	O	England	nn	4	SENT_419	[p18l883t2558r994b2589],
4	Journal	NNP	O	Journal	_	0	SENT_419	[p18l1002t2558r1100b2582],
5	of	IN	O	of	_	0	SENT_419	[p18l1110t2558r1138b2582],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_419	[p18l1145t2558r1270b2582],

1	The	DT	O	the	det	4	SENT_420	[p18l715t2746r752b2767],
2	NEW	NNP	O	NEW	nn	4	SENT_420	[p18l764t2748r845b2767],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_420	[p18l859t2748r1034b2767],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_420	[p18l1048t2748r1214b2774],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_420	[p18l1228t2746r1444b2773],

1	zumab	NN	O	zumab	_	0	SENT_421	[p18l8t2969r299b3048],
2	and	CC	O	and	_	0	SENT_421	[p18l326t2968r483b3047],
3	that	IN	O	that	conj_and	1	SENT_421	[p18l507t2969r674b3047],
4	C	NN	O	c	pobj	3	SENT_421	[p18l692t2974r922b3047],
5	.	.	O	.	_	0	SENT_421	[p18l692t2974r922b3047],

1	—	NN	O	—	_	0	SENT_422	[p18l692t2974r922b3047],
2	.	.	O	.	_	0	SENT_422	[p18l692t2974r922b3047],

1	KIT	NN	O	kit	nn	2	SENT_423	[p18l692t2974r922b3047],
2	mutations	NNS	O	mutation	nsubjpass	5	SENT_423	[p18l936t2969r1368b3048],
3	can	MD	O	can	aux	5	SENT_423	[p18l1394t2994r1538b3047],
4	be	VB	O	be	auxpass	5	SENT_423	[p18l1562t2969r1658b3047],
5	used	VBN	O	use	_	0	SENT_423	[p18l1681t2968r1877b3048],
6	to	TO	O	to	aux	7	SENT_423	[p18l1901t2985r1980b3047],
7	determine	VB	O	determine	xcomp	5	SENT_423	[p18l2006t2968r2135b3047, p18l10t3097r341b3175],
8	the	DT	O	the	det	9	SENT_423	[p18l377t3097r509b3175],
9	response	NN	O	response	dobj	7	SENT_423	[p18l546t3122r932b3197],
10	of	IN	O	of	_	0	SENT_423	[p18l971t3096r1072b3175],
11	gastrointestinal	JJ	O	gastrointestinal	amod	13	SENT_423	[p18l1090t3096r1768b3197],
12	stromal	JJ	O	stromal	amod	13	SENT_423	[p18l1806t3097r2135b3175],
13	tumors	NNS	O	tumor	prep_of	9	SENT_423	[p18l10t3242r316b3305],
14	to	TO	O	to	aux	15	SENT_423	[p18l350t3242r430b3304],
15	imatinib	VB	O	imatinib	xcomp	7	SENT_423	[p18l461t3221r1044b3304],
16	.24	CD	NUMBER	.24	num	24	SENT_423	[p18l461t3221r1044b3304],
17	’25	CD	NUMBER	’25	num	24	SENT_423	[p18l461t3221r1044b3304],
18	Ongoing	NNP	O	Ongoing	nn	24	SENT_423	[p18l1077t3226r1484b3326],
19	,	,	O	,	_	0	SENT_423	[p18l1077t3226r1484b3326],
20	large	JJ	O	large	amod	24	SENT_423	[p18l1519t3225r1983b3326],
21	—	NN	O	—	nn	24	SENT_423	[p18l1519t3225r1983b3326],
22	scale	NN	O	scale	nn	24	SENT_423	[p18l1519t3225r1983b3326],
23	sequencing	NN	O	sequencing	nn	24	SENT_423	[p18l2015t3252r2134b3304, p18l10t3354r414b3454],
24	efforts	NNS	O	effort	dobj	15	SENT_423	[p18l447t3353r718b3432],
25	may	MD	O	may	aux	26	SENT_423	[p18l755t3380r933b3454],
26	reveal	VB	O	reveal	rcmod	24	SENT_423	[p18l963t3353r1206b3433],
27	additional	JJ	O	additional	amod	28	SENT_423	[p18l1240t3353r1669b3432],
28	mutations	NNS	O	mutation	dobj	26	SENT_423	[p18l1703t3354r2134b3433],
29	in	IN	O	in	_	0	SENT_423	[p18l8t3482r90b3559],
30	other	JJ	O	other	amod	31	SENT_423	[p18l130t3482r354b3560],
31	kinases	NNS	O	kinase	prep_in	26	SENT_423	[p18l391t3481r729b3577],
32	,	,	O	,	_	0	SENT_423	[p18l391t3481r729b3577],
33	linking	VBG	O	link	partmod	26	SENT_423	[p18l773t3481r1080b3582],
34	different	JJ	O	different	amod	35	SENT_423	[p18l1117t3481r1484b3560],
35	cancers	NNS	O	cancer	dobj	33	SENT_423	[p18l1520t3507r1833b3560],
36	to	TO	O	to	_	0	SENT_423	[p18l1875t3498r1954b3560],
37	potential	JJ	O	potential	amod	39	SENT_423	[p18l1995t3507r2135b3582, p18l10t3609r274b3687],
38	therapeutic	JJ	O	therapeutic	amod	39	SENT_423	[p18l299t3609r775b3709],
39	targets	NNS	O	target	prep_to	33	SENT_423	[p18l799t3602r1302b3709],
40	.26	CD	NUMBER	.26	num	41	SENT_423	[p18l799t3602r1302b3709],
41	>	JJR	O	>	tmod	33	SENT_423	[p18l799t3602r1302b3709],
42	27	CD	NUMBER	27	dep	41	SENT_423	[p18l799t3602r1302b3709],

1	Geﬁtinib	NNP	O	Geﬁtinib	nsubj	4	SENT_424	[p19l138t21r515b100],
2	has	VBZ	O	have	aux	4	SENT_424	[p19l555t22r696b100],
3	not	RB	O	not	neg	4	SENT_424	[p19l737t38r880b100],
4	elicited	VBN	O	elicit	ccomp	48	SENT_424	[p19l914t22r1216b100],
5	clinical	JJ	O	clinical	amod	6	SENT_424	[p19l1255t21r1556b100],
6	responses	NNS	O	response	dobj	4	SENT_424	[p19l1594t47r2015b122],
7	in	IN	O	in	_	0	SENT_424	[p19l2055t22r2136b99],
8	patients	NNS	O	patient	prep_in	4	SENT_424	[p19l7t150r342b250],
9	with	IN	O	with	_	0	SENT_424	[p19l374t150r563b229],
10	gliomas	NNS	O	glioma	prep_with	4	SENT_424	[p19l597t149r958b250],
11	,	,	O	,	_	0	SENT_424	[p19l597t149r958b250],
12	despite	IN	O	despite	_	0	SENT_424	[p19l998t150r1299b250],
13	the	DT	O	the	det	15	SENT_424	[p19l1334t150r1462b228],
14	high	JJ	O	high	amod	15	SENT_424	[p19l1497t150r1689b250],
15	frequency	NN	O	frequency	prep_despite	4	SENT_424	[p19l1723t149r2140b250],
16	of	IN	O	of	_	0	SENT_424	[p19l10t277r111b356],
17	ampliﬁcation	NN	O	ampliﬁcation	prep_of	15	SENT_424	[p19l130t277r697b378],
18	and	CC	O	and	_	0	SENT_424	[p19l735t277r891b356],
19	rearrangements	NNS	O	rearrangement	npadvmod	4	SENT_424	[p19l930t294r1599b378],
20	of	IN	O	of	_	0	SENT_424	[p19l1641t277r1742b356],
21	the	DT	O	the	det	23	SENT_424	[p19l1763t278r1892b356],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_424	[p19l1929t284r2142b357],
23	gene	NN	O	gene	prep_of	19	SENT_424	[p19l9t430r208b505],
24	in	IN	O	in	_	0	SENT_424	[p19l239t406r320b482],
25	such	JJ	O	such	amod	26	SENT_424	[p19l354t405r548b484],
26	patients	NNS	O	patient	prep_in	4	SENT_424	[p19l578t398r1130b505],
27	.15	CD	NUMBER	.15	number	28	SENT_424	[p19l578t398r1130b505],
28	’16	CD	NUMBER	’16	num	26	SENT_424	[p19l578t398r1130b505],
29	However	RB	O	however	advmod	4	SENT_424	[p19l1162t412r1554b500],
30	,	,	O	,	_	0	SENT_424	[p19l1162t412r1554b500],
31	the	DT	O	the	det	35	SENT_424	[p19l1592t405r1721b483],
32	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_424	[p19l1751t411r2011b488],
33	tyrosine	NN	O	tyrosine	nn	35	SENT_424	[p19l2033t421r2134b505, p19l9t534r266b612],
34	kinase	NN	O	kinase	nn	35	SENT_424	[p19l286t534r550b613],
35	mutations	NNS	O	mutation	nsubj	48	SENT_424	[p19l571t534r992b613],
36	in	IN	O	in	_	0	SENT_424	[p19l1014t534r1094b611],
37	patients	NNS	O	patient	prep_in	35	SENT_424	[p19l1113t534r1439b634],
38	with	IN	O	with	_	0	SENT_424	[p19l1458t534r1643b613],
39	non	JJ	O	non	amod	45	SENT_424	[p19l1663t534r2136b612],
40	—	JJ	O	—	amod	45	SENT_424	[p19l1663t534r2136b612],
41	small	JJ	O	small	amod	45	SENT_424	[p19l1663t534r2136b612],
42	—	NN	O	—	nn	45	SENT_424	[p19l1663t534r2136b612],
43	cell	NN	O	cell	nn	45	SENT_424	[p19l10t662r151b740],
44	lung	NN	O	lung	nn	45	SENT_424	[p19l185t661r380b762],
45	cancer	NN	O	cancer	prep_with	37	SENT_424	[p19l412t687r687b740],
46	are	VBP	O	be	cop	48	SENT_424	[p19l719t688r846b740],
47	fundamentally	RB	O	fundamentally	advmod	48	SENT_424	[p19l881t661r1500b762],
48	different	JJ	O	different	_	0	SENT_424	[p19l1531t661r1899b740],
49	from	IN	O	from	_	0	SENT_424	[p19l1928t661r2136b740],
50	the	DT	O	the	det	52	SENT_424	[p19l10t789r140b868],
51	glioma	NN	O	glioma	nn	52	SENT_424	[p19l172t789r960b890],
52	—	NN	O	—	prep_from	48	SENT_424	[p19l172t789r960b890],
53	associated	VBN	O	associate	partmod	52	SENT_424	[p19l172t789r960b890],
54	deletions	NNS	O	deletion	dobj	53	SENT_424	[p19l993t789r1384b868],
55	within	IN	O	within	_	0	SENT_424	[p19l1414t790r1695b869],
56	the	DT	O	the	det	58	SENT_424	[p19l1727t790r1859b868],
57	extracellular	JJ	O	extracellular	amod	58	SENT_424	[p19l1892t806r2134b868, p19l10t917r329b997],
58	domain	NN	O	domain	prep_within	53	SENT_424	[p19l367t918r692b996],
59	of	IN	O	of	_	0	SENT_424	[p19l731t917r831b996],
60	EGFR	NN	O	egfr	prep_of	58	SENT_424	[p19l848t923r1121b1001],
61	.	.	O	.	_	0	SENT_424	[p19l848t923r1121b1001],

1	These	DT	O	these	nsubj	2	SENT_425	[p19l1161t918r1412b996],
2	truncated	VBN	O	truncate	_	0	SENT_425	[p19l1450t917r1851b997],
3	EGFR	NN	O	egfr	dobj	2	SENT_425	[p19l1887t923r2147b1001],

1	proteins	NNS	O	protein	nsubj	7	SENT_426	[p19l7t1046r364b1146],
2	resemble	VBP	O	resemble	cop	7	SENT_426	[p19l396t1045r787b1124],
3	the	DT	O	the	det	7	SENT_426	[p19l817t1046r949b1124],
4	avian	JJ	O	avian	amod	7	SENT_426	[p19l978t1046r1201b1125],
5	erythroblastosis	NN	O	erythroblastosis	nn	7	SENT_426	[p19l1232t1045r1921b1146],
6	viral	JJ	O	viral	amod	7	SENT_426	[p19l1949t1046r2135b1125],
7	oncogene	NN	O	oncogene	_	0	SENT_426	[p19l10t1199r413b1274],
8	v	LS	O	v	prep	7	SENT_426	[p19l446t1173r682b1253],
9	—	CD	NUMBER	—	num	10	SENT_426	[p19l446t1173r682b1253],
10	erbB	NN	O	erbb	dep	8	SENT_426	[p19l446t1173r682b1253],
11	in	IN	O	in	_	0	SENT_426	[p19l719t1174r799b1251],
12	mediating	VBG	O	mediate	prepc_in	7	SENT_426	[p19l835t1173r1262b1274],
13	constitutive	JJ	O	constitutive	amod	16	SENT_426	[p19l1296t1174r1798b1269],
14	,	,	O	,	_	0	SENT_426	[p19l1296t1174r1798b1269],
15	ligandindependent	JJ	O	ligandindependent	amod	16	SENT_426	[p19l1839t1174r2134b1274, p19l8t1301r553b1402],
16	activation	NN	O	activation	dobj	12	SENT_426	[p19l573t1302r980b1381],
17	of	IN	O	of	_	0	SENT_426	[p19l1007t1301r1108b1380],
18	the	DT	O	the	det	19	SENT_426	[p19l1116t1302r1245b1380],
19	receptor	NN	O	receptor	prep_of	16	SENT_426	[p19l1271t1318r1639b1402],
20	,	,	O	,	_	0	SENT_426	[p19l1271t1318r1639b1402],
21	but	CC	O	but	_	0	SENT_426	[p19l1671t1302r1812b1381],
22	they	PRP	O	they	nsubj	25	SENT_426	[p19l1833t1302r2010b1402],
23	do	VBP	O	do	aux	25	SENT_426	[p19l2032t1302r2135b1380],
24	not	RB	O	not	neg	25	SENT_426	[p19l9t1446r152b1508],
25	alter	VB	O	alter	conj_but	7	SENT_426	[p19l175t1430r363b1508],
26	the	DT	O	the	det	28	SENT_426	[p19l388t1430r518b1508],
27	ATP	NN	O	atp	nn	28	SENT_426	[p19l542t1435r716b1507],
28	cleft	NN	O	cleft	dobj	25	SENT_426	[p19l743t1429r926b1508],
29	of	IN	O	of	_	0	SENT_426	[p19l949t1429r1050b1508],
30	the	DT	O	the	det	32	SENT_426	[p19l1060t1430r1189b1508],
31	tyrosine	NN	O	tyrosine	nn	32	SENT_426	[p19l1218t1430r1553b1530],
32	kinase	NN	O	kinase	prep_of	28	SENT_426	[p19l1581t1429r1852b1509],
33	that	WDT	O	that	nsubjpass	35	SENT_426	[p19l1880t1429r2047b1508],
34	is	VBZ	O	be	auxpass	35	SENT_426	[p19l2069t1430r2134b1508],
35	bound	VBN	O	bind	rcmod	28	SENT_426	[p19l10t1557r282b1637],
36	by	IN	O	by	_	0	SENT_426	[p19l308t1558r405b1658],
37	geﬁtinib	NN	O	geﬁtinib	agent	35	SENT_426	[p19l427t1557r807b1658],
38	.	.	O	.	_	0	SENT_426	[p19l427t1557r807b1658],

1	The	DT	O	the	det	3	SENT_427	[p19l835t1557r997b1636],
2	enhanced	VBN	O	enhance	amod	3	SENT_427	[p19l1024t1557r1431b1636],
3	sensitivity	NN	O	sensitivity	nsubj	13	SENT_427	[p19l1458t1558r1878b1658],
4	to	TO	O	to	_	0	SENT_427	[p19l1900t1574r1979b1636],
5	geﬁtinib	NN	O	geﬁtinib	prep_to	3	SENT_427	[p19l2006t1584r2135b1658, p19l9t1685r263b1764],
6	associated	VBN	O	associate	partmod	5	SENT_427	[p19l307t1686r744b1764],
7	with	IN	O	with	_	0	SENT_427	[p19l781t1686r970b1765],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_427	[p19l1013t1686r1348b1786],
9	kinase	NN	O	kinase	nn	10	SENT_427	[p19l1390t1685r1661b1765],
10	mutations	NNS	O	mutation	prep_with	6	SENT_427	[p19l1703t1686r2134b1765],
11	may	MD	O	may	aux	13	SENT_427	[p19l9t1840r186b1914],
12	therefore	RB	O	therefore	advmod	13	SENT_427	[p19l210t1813r594b1892],
13	contribute	VB	O	contribute	_	0	SENT_427	[p19l623t1814r1059b1893],
14	substantially	RB	O	substantially	advmod	13	SENT_427	[p19l1090t1813r1628b1914],
15	to	TO	O	to	_	0	SENT_427	[p19l1653t1830r1732b1892],
16	the	DT	O	the	det	18	SENT_427	[p19l1763t1813r1891b1892],
17	clinical	JJ	O	clinical	amod	18	SENT_427	[p19l1921t1813r2135b1892, p19l10t1941r125b2020],
18	responses	NNS	O	response	prep_to	13	SENT_427	[p19l159t1967r580b2042],
19	of	IN	O	of	_	0	SENT_427	[p19l618t1941r719b2020],
20	certain	JJ	O	certain	amod	21	SENT_427	[p19l736t1942r1025b2020],
21	patients	NNS	O	patient	prep_of	18	SENT_427	[p19l1059t1942r1394b2042],
22	with	IN	O	with	_	0	SENT_427	[p19l1427t1941r1616b2021],
23	non	JJ	O	non	amod	29	SENT_427	[p19l1650t1942r2135b2020],
24	—	JJ	O	—	amod	29	SENT_427	[p19l1650t1942r2135b2020],
25	small	JJ	O	small	amod	29	SENT_427	[p19l1650t1942r2135b2020],
26	—	NN	O	—	nn	29	SENT_427	[p19l1650t1942r2135b2020],
27	cell	NN	O	cell	nn	29	SENT_427	[p19l10t2070r151b2148],
28	lung	NN	O	lung	nn	29	SENT_427	[p19l175t2069r369b2170],
29	cancer	NN	O	cancer	prep_with	13	SENT_427	[p19l392t2095r683b2148],
30	.	.	O	.	_	0	SENT_427	[p19l392t2095r683b2148],

1	The	DT	O	the	det	3	SENT_428	[p19l135t2197r297b2276],
2	plasma	NN	O	plasma	nn	3	SENT_428	[p19l350t2198r662b2298],
3	concentrations	NNS	O	concentration	nsubj	17	SENT_428	[p19l715t2198r1357b2276],
4	of	IN	O	of	_	0	SENT_428	[p19l1414t2197r1516b2276],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_428	[p19l1551t2197r1914b2298],
6	that	WDT	O	that	nsubjpass	9	SENT_428	[p19l1970t2198r2140b2276],
7	can	MD	O	can	aux	9	SENT_428	[p19l10t2351r156b2404],
8	be	VB	O	be	auxpass	9	SENT_428	[p19l201t2326r297b2404],
9	achieved	VBN	O	achieve	rcmod	5	SENT_428	[p19l341t2326r713b2405],
10	with	IN	O	with	_	0	SENT_428	[p19l752t2326r944b2405],
11	the	DT	O	the	det	12	SENT_428	[p19l989t2325r1120b2404],
12	use	NN	O	use	prep_with	9	SENT_428	[p19l1165t2352r1306b2405],
13	of	IN	O	of	_	0	SENT_428	[p19l1351t2325r1453b2404],
14	current	JJ	DATE	current	amod	16	SENT_428	[p19l1479t2342r1795b2405],
15	dosage	JJ	O	dosage	amod	16	SENT_428	[p19l1834t2326r2135b2426],
16	recommendations	NNS	O	recommendation	prep_of	12	SENT_428	[p19l9t2448r852b2532],
17	”	VBP	O	”	_	0	SENT_428	[p19l9t2448r852b2532],
18	exceed	VB	O	exceed	xcomp	17	SENT_428	[p19l880t2453r1156b2532],
19	the	DT	O	the	det	21	SENT_428	[p19l1183t2454r1311b2532],
20	drug	NN	O	drug	nn	21	SENT_428	[p19l1339t2454r1536b2554],
21	concentration	NN	O	concentration	dobj	18	SENT_428	[p19l1560t2454r2136b2532],
22	that	WDT	O	that	nsubj	35	SENT_428	[p19l10t2581r174b2660],
23	suppressed	VBD	O	suppress	rcmod	21	SENT_428	[p19l214t2581r691b2682],
24	autophosphorylation	NN	O	autophosphorylation	dobj	23	SENT_428	[p19l732t2581r1622b2682],
25	of	IN	O	of	_	0	SENT_428	[p19l1666t2581r1767b2660],
26	the	DT	O	the	det	30	SENT_428	[p19l1791t2582r1921b2660],
27	mutant	JJ	O	mutant	amod	30	SENT_428	[p19l1964t2608r2135b2661, p19l10t2726r179b2788],
28	EGFR	NN	O	egfr	nn	30	SENT_428	[p19l201t2715r458b2793],
29	tyrosine	NN	O	tyrosine	nn	30	SENT_428	[p19l476t2710r806b2810],
30	kinase	NN	O	kinase	prep_of	24	SENT_428	[p19l834t2710r1100b2789],
31	in	IN	O	in	_	0	SENT_428	[p19l1128t2710r1209b2787],
32	our	PRP$	O	we	poss	33	SENT_428	[p19l1238t2735r1380b2789],
33	assays	NNS	O	assay	prep_in	30	SENT_428	[p19l1405t2736r1662b2810],
34	but	CC	O	but	_	0	SENT_428	[p19l1693t2709r1832b2789],
35	are	VBP	O	be	conj_but	23	SENT_428	[p19l1855t2736r1979b2788],
36	below	IN	O	below	_	0	SENT_428	[p19l2008t2710r2135b2788, p19l8t2838r164b2917],
37	those	DT	O	those	prep_below	35	SENT_428	[p19l198t2838r430b2916],
38	required	VBN	O	require	partmod	37	SENT_428	[p19l469t2837r832b2938],
39	to	TO	O	to	aux	40	SENT_428	[p19l871t2854r951b2916],
40	suppress	VB	O	suppress	xcomp	38	SENT_428	[p19l992t2864r1372b2938],
41	the	DT	O	the	det	45	SENT_428	[p19l1413t2838r1545b2916],
42	wild	JJ	O	wild	amod	45	SENT_428	[p19l1579t2837r1981b2938],
43	—	NN	O	—	nn	45	SENT_428	[p19l1579t2837r1981b2938],
44	type	NN	O	type	nn	45	SENT_428	[p19l1579t2837r1981b2938],
45	receptor	NN	O	receptor	dobj	40	SENT_428	[p19l2020t2864r2134b2916, p19l10t2982r300b3066],
46	.	.	O	.	_	0	SENT_428	[p19l2020t2864r2134b2916, p19l10t2982r300b3066],

1	In	FW	O	in	nn	3	SENT_429	[p19l334t2973r422b3043],
2	vitro	FW	O	vitro	nn	3	SENT_429	[p19l446t2966r635b3045],
3	analysis	NN	O	analysis	nsubj	11	SENT_429	[p19l662t2966r987b3066],
4	of	IN	O	of	_	0	SENT_429	[p19l1016t2965r1116b3044],
5	wild	JJ	O	wild	amod	8	SENT_429	[p19l1119t2965r1506b3066],
6	—	NN	O	—	nn	8	SENT_429	[p19l1119t2965r1506b3066],
7	type	NN	O	type	nn	8	SENT_429	[p19l1119t2965r1506b3066],
8	EGFR	NN	O	egfr	prep_of	3	SENT_429	[p19l1531t2971r1788b3049],
9	has	VBZ	O	have	aux	11	SENT_429	[p19l1804t2966r1943b3044],
10	also	RB	O	also	advmod	11	SENT_429	[p19l1971t2966r2135b3044],
11	suggested	VBN	O	suggest	_	0	SENT_429	[p19l11t3093r430b3194],
12	that	IN	O	that	complm	19	SENT_429	[p19l454t3094r621b3172],
13	low	JJ	O	low	amod	14	SENT_429	[p19l640t3093r795b3173],
14	concentrations	NNS	O	concentration	nsubj	19	SENT_429	[p19l818t3094r1446b3172],
15	of	IN	O	of	_	0	SENT_429	[p19l1475t3093r1575b3172],
16	geﬁtinib	NN	O	geﬁtinib	prep_of	14	SENT_429	[p19l1582t3093r1937b3194],
17	may	MD	O	may	aux	19	SENT_429	[p19l1964t3120r2140b3194],
18	be	VB	O	be	cop	19	SENT_429	[p19l10t3221r106b3300],
19	sufficient	JJ	O	sufficient	ccomp	11	SENT_429	[p19l143t3221r551b3301],
20	to	TO	O	to	aux	21	SENT_429	[p19l582t3238r662b3300],
21	suppress	VB	O	suppress	xcomp	19	SENT_429	[p19l700t3248r1080b3322],
22	autophosphorylation	NN	O	autophosphorylation	dobj	21	SENT_429	[p19l1117t3221r2026b3322],
23	at	IN	O	at	_	0	SENT_429	[p19l2060t3238r2140b3300],
24	some	DT	O	some	det	26	SENT_429	[p19l11t3375r239b3428],
25	tyrosine	NN	O	tyrosine	nn	26	SENT_429	[p19l290t3350r633b3450],
26	residues	NNS	O	residue	prep_at	21	SENT_429	[p19l684t3349r1066b3445],
27	,	,	O	,	_	0	SENT_429	[p19l684t3349r1066b3445],
28	but	CC	O	but	_	0	SENT_429	[p19l1123t3350r1266b3429],
29	that	IN	O	that	complm	34	SENT_429	[p19l1312t3350r1483b3428],
30	abrogation	NN	O	abrogation	nsubj	34	SENT_429	[p19l1528t3350r2000b3450],
31	of	IN	O	of	_	0	SENT_429	[p19l2052t3349r2153b3428],
32	downstream	JJ	O	downstream	amod	33	SENT_429	[p19l10t3478r547b3558],
33	signaling	NN	O	signaling	prep_of	30	SENT_429	[p19l588t3479r992b3579],
34	requires	VBZ	O	require	conj_but	19	SENT_429	[p19l1029t3479r1378b3579],
35	a	DT	O	a	det	37	SENT_429	[p19l1419t3505r1464b3557],
36	higher	JJR	O	higher	amod	37	SENT_429	[p19l1502t3479r1786b3579],
37	dose	NN	O	dose	dobj	34	SENT_429	[p19l1825t3474r2134b3557],
38	.	.	O	.	_	0	SENT_429	[p19l1825t3474r2134b3557],

1	”	NN	O	”	nsubj	34	SENT_430	[p19l1825t3474r2134b3557],
2	Thus	RB	O	thus	advmod	1	SENT_430	[p19l6t3606r248b3702],
3	,	,	O	,	_	0	SENT_430	[p19l6t3606r248b3702],
4	in	IN	O	in	_	0	SENT_430	[p19l280t3607r363b3684],
5	patients	NNS	O	patient	prep_in	34	SENT_430	[p19l388t3607r731b3707],
6	with	IN	O	with	_	0	SENT_430	[p19l756t3607r949b3686],
7	gliomas	NNS	O	glioma	prep_with	5	SENT_430	[p19l976t3606r1345b3707],
8	,	,	O	,	_	0	SENT_430	[p19l976t3606r1345b3707],
9	in	IN	O	in	_	0	SENT_430	[p19l1377t3607r1459b3684],
10	whom	WP	O	whom	rel	17	SENT_430	[p19l1482t3607r1758b3686],
11	biologic	JJ	O	biologic	amod	12	SENT_430	[p19l1786t3606r2136b3707],
12	dependence	NN	O	dependence	nsubjpass	17	SENT_430	[p20l10t20r522b121],
13	on	IN	O	on	_	0	SENT_430	[p20l547t46r653b99],
14	EGFR	NN	O	egfr	nn	15	SENT_430	[p20l677t26r936b104],
15	signaling	NN	O	signaling	prep_on	12	SENT_430	[p20l953t20r1347b121],
16	is	VBZ	O	be	auxpass	17	SENT_430	[p20l1368t21r1433b99],
17	identiﬁed	VBN	O	identiﬁed	rcmod	7	SENT_430	[p20l1459t20r1864b99],
18	by	IN	O	by	_	0	SENT_430	[p20l1889t21r1986b121],
19	the	DT	O	the	det	20	SENT_430	[p20l2007t21r2136b99],
20	presence	NN	O	presence	agent	17	SENT_430	[p20l7t174r381b249],
21	of	IN	O	of	_	0	SENT_430	[p20l410t148r510b227],
22	gene	NN	O	gene	nn	23	SENT_430	[p20l519t174r718b249],
23	ampliﬁcation	NN	O	ampliﬁcation	prep_of	20	SENT_430	[p20l745t148r1311b249],
24	or	CC	O	or	_	0	SENT_430	[p20l1339t174r1429b227],
25	deletions	NNS	O	deletion	rcmod	7	SENT_430	[p20l1454t148r1836b227],
26	Within	IN	O	within	dep	25	SENT_430	[p20l1861t149r2136b228],
27	the	DT	O	the	det	29	SENT_430	[p20l10t276r138b355],
28	extracellular	JJ	O	extracellular	amod	29	SENT_430	[p20l171t277r704b356],
29	domain	NN	O	domain	pobj	26	SENT_430	[p20l734t276r1088b372],
30	,	,	O	,	_	0	SENT_430	[p20l734t276r1088b372],
31	a	DT	O	a	det	33	SENT_430	[p20l1126t303r1170b355],
32	clinical	JJ	O	clinical	amod	33	SENT_430	[p20l1201t276r1510b355],
33	response	NN	O	response	nsubj	34	SENT_430	[p20l1541t302r1928b377],
34	may	MD	O	may	_	0	SENT_430	[p20l1960t303r2140b377],

1	REFERENCES	NNS	O	reference	_	0	SENT_431	[p20l13t571r483b612],

1	1	LS	NUMBER	1	_	0	SENT_432	[p20l14t733r88b811],
2	.	.	O	.	_	0	SENT_432	[p20l14t733r88b811],

1	Schiller	NNP	PERSON	Schiller	nn	2	SENT_433	[p20l211t721r580b813],
2	JH	NNP	O	JH	_	0	SENT_433	[p20l600t729r758b831],
3	,	,	O	,	_	0	SENT_433	[p20l600t729r758b831],
4	Harrington	NNP	PERSON	Harrington	nn	5	SENT_433	[p20l799t723r1354b837],
5	D	NNP	O	D	appos	2	SENT_433	[p20l1387t729r1491b831],
6	,	,	O	,	_	0	SENT_433	[p20l1387t729r1491b831],
7	Belani	NNP	PERSON	Belani	nn	8	SENT_433	[p20l1531t721r1838b811],
8	CP	NNP	O	CP	appos	2	SENT_433	[p20l1874t727r2020b831],
9	,	,	O	,	_	0	SENT_433	[p20l1874t727r2020b831],
10	et	FW	O	et	nn	11	SENT_433	[p20l2063t741r2153b811],
11	al.	FW	O	al.	appos	2	SENT_433	[p20l8t871r118b961],
12	.	.	O	.	_	0	SENT_433	[p20l8t871r118b961],

1	Comparison	NN	O	comparison	_	0	SENT_434	[p20l163t873r772b987],
2	of	IN	O	of	_	0	SENT_434	[p20l811t869r927b963],
3	four	CD	NUMBER	four	num	5	SENT_434	[p20l943t869r1150b963],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_434	[p20l1186t871r1890b987],
5	regimens	NNS	O	regimen	prep_of	1	SENT_434	[p20l1922t873r2147b987, p20l10t1051r273b1111],
6	for	IN	O	for	_	0	SENT_434	[p20l299t1019r443b1111],
7	advanced	JJ	O	advanced	amod	9	SENT_434	[p20l462t1021r917b1113],
8	non	JJ	O	non	amod	9	SENT_434	[p20l941t1021r1673b1111],
9	—	NN	O	—	prep_for	1	SENT_434	[p20l941t1021r1673b1111],
10	small	JJ	O	small	amod	14	SENT_434	[p20l941t1021r1673b1111],
11	—	NN	O	—	nn	14	SENT_434	[p20l941t1021r1673b1111],
12	cell	NN	O	cell	nn	14	SENT_434	[p20l941t1021r1673b1111],
13	lung	NN	O	lung	nn	14	SENT_434	[p20l1695t1021r1920b1137],
14	cancer	NN	O	cancer	dep	9	SENT_434	[p20l1942t1051r2147b1111, p20l10t1201r174b1261],
15	.	.	O	.	_	0	SENT_434	[p20l1942t1051r2147b1111, p20l10t1201r174b1261],

1	N	NN	O	n	nn	2	SENT_435	[p20l207t1179r295b1263],
2	EnglJ	NN	O	englj	nsubj	3	SENT_435	[p20l319t1171r604b1287],
3	Med	VBD	O	med	_	0	SENT_435	[p20l628t1171r845b1261],
4	2002	CD	DATE	2002	dobj	3	SENT_435	[p20l873t1177r1617b1281],
5	;	:	O	;	_	0	SENT_435	[p20l873t1177r1617b1281],
6	346:92	CD	NUMBER	346:92	number	7	SENT_435	[p20l873t1177r1617b1281],
7	—	CD	NUMBER	—	dep	4	SENT_435	[p20l873t1177r1617b1281],
8	8	CD	NUMBER	8	dep	7	SENT_435	[p20l873t1177r1617b1281],
9	.	.	O	.	_	0	SENT_435	[p20l873t1177r1617b1281],

1	2	LS	NUMBER	2	_	0	SENT_436	[p20l8t1331r88b1411],
2	.	.	O	.	_	0	SENT_436	[p20l8t1331r88b1411],

1	Druker	NN	PERSON	druker	nn	3	SENT_437	[p20l207t1321r550b1413],
2	B	NN	O	b	nn	3	SENT_437	[p20l574t1329r700b1431],
3	]	NN	O	]	_	0	SENT_437	[p20l574t1329r700b1431],
4	,	,	O	,	_	0	SENT_437	[p20l574t1329r700b1431],
5	Talpaz	NNP	O	Talpaz	nn	6	SENT_437	[p20l730t1321r1045b1437],
6	M	NNP	O	M	appos	3	SENT_437	[p20l1070t1329r1196b1431],
7	,	,	O	,	_	0	SENT_437	[p20l1070t1329r1196b1431],
8	Resta	NNP	ORGANIZATION	Resta	nn	9	SENT_437	[p20l1228t1329r1493b1417],
9	DJ	NNP	ORGANIZATION	DJ	appos	3	SENT_437	[p20l1519t1329r1657b1431],
10	,	,	O	,	_	0	SENT_437	[p20l1519t1329r1657b1431],
11	et	FW	O	et	nn	12	SENT_437	[p20l1694t1339r1782b1411],
12	al.	FW	O	al.	appos	3	SENT_437	[p20l1804t1321r1910b1411],
13	.	.	O	.	_	0	SENT_437	[p20l1804t1321r1910b1411],

1	Efficacy	NN	O	efficacy	_	0	SENT_438	[p20l1943t1319r2147b1411, p20l10t1501r213b1587],
2	and	CC	O	and	_	0	SENT_438	[p20l241t1471r419b1561],
3	safety	NN	O	safety	conj_and	1	SENT_438	[p20l455t1469r734b1587],
4	of	IN	O	of	_	0	SENT_438	[p20l767t1469r885b1561],
5	a	DT	O	a	det	7	SENT_438	[p20l901t1501r951b1561],
6	speciﬁc	NN	O	speciﬁc	nn	7	SENT_438	[p20l989t1469r1360b1587],
7	inhibitor	NN	O	inhibitor	prep_of	1	SENT_438	[p20l1395t1471r1830b1561],
8	of	IN	O	of	_	0	SENT_438	[p20l1866t1469r1984b1561],
9	the	DT	O	the	det	10	SENT_438	[p20l2000t1471r2147b1561],
10	BCR	NN	O	bcr	prep_of	1	SENT_438	[p20l8t1627r461b1717],
11	.	.	O	.	_	0	SENT_438	[p20l8t1627r461b1717],

1	—	NN	O	—	_	0	SENT_439	[p20l8t1627r461b1717],
2	.	.	O	.	_	0	SENT_439	[p20l8t1627r461b1717],

1	ABL	NN	ORGANIZATION	abl	nn	3	SENT_440	[p20l8t1627r461b1717],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_440	[p20l490t1623r871b1737],
3	kinase	NN	O	kinase	_	0	SENT_440	[p20l903t1621r1212b1713],
4	in	IN	O	in	_	0	SENT_440	[p20l1242t1621r1336b1711],
5	chronic	JJ	O	chronic	amod	7	SENT_440	[p20l1369t1621r1733b1711],
6	myeloid	JJ	O	myeloid	amod	7	SENT_440	[p20l1764t1621r2147b1737],
7	leukemia	NN	O	leukemia	prep_in	3	SENT_440	[p20l8t1771r483b1863],
8	.	.	O	.	_	0	SENT_440	[p20l8t1771r483b1863],

1	N	NN	O	n	nn	2	SENT_441	[p20l516t1779r604b1863],
2	EnglJ	NN	O	englj	nsubj	3	SENT_441	[p20l628t1771r913b1887],
3	Med	VBD	O	med	_	0	SENT_441	[p20l937t1771r1154b1861],
4	2001	CD	DATE	2001	dobj	3	SENT_441	[p20l1182t1777r2048b1881],
5	;	:	O	;	_	0	SENT_441	[p20l1182t1777r2048b1881],
6	344:1031	CD	NUMBER	344:1031	num	7	SENT_441	[p20l1182t1777r2048b1881],
7	—	NN	O	—	dep	4	SENT_441	[p20l1182t1777r2048b1881],
8	7	CD	NUMBER	7	dep	7	SENT_441	[p20l1182t1777r2048b1881],
9	.	.	O	.	_	0	SENT_441	[p20l1182t1777r2048b1881],

1	3	LS	NUMBER	3	_	0	SENT_442	[p20l10t1931r88b2011],
2	.	.	O	.	_	0	SENT_442	[p20l10t1931r88b2011],

1	Wakeling	VBG	PERSON	wakele	_	0	SENT_443	[p20l205t1921r674b2037],
2	AE	NN	O	ae	dobj	1	SENT_443	[p20l703t1929r871b2031],
3	,	,	O	,	_	0	SENT_443	[p20l703t1929r871b2031],
4	Guy	NNP	O	Guy	nn	5	SENT_443	[p20l915t1927r1115b2037],
5	SP	NN	O	sp	appos	2	SENT_443	[p20l1150t1927r1280b2031],
6	,	,	O	,	_	0	SENT_443	[p20l1150t1927r1280b2031],
7	Woodburn	NNP	ORGANIZATION	Woodburn	nn	8	SENT_443	[p20l1320t1921r1850b2013],
8	JR	NNP	ORGANIZATION	JR	appos	2	SENT_443	[p20l1876t1929r2020b2031],
9	,	,	O	,	_	0	SENT_443	[p20l1876t1929r2020b2031],
10	et	FW	O	et	nn	11	SENT_443	[p20l2065t1941r2153b2011],
11	al.	FW	O	al.	appos	2	SENT_443	[p20l8t2071r118b2161],
12	.	.	O	.	_	0	SENT_443	[p20l8t2071r118b2161],

1	ZD	NNP	O	ZD	nn	5	SENT_444	[p20l146t2079r291b2161],
2	1839	CD	DATE	1839	num	5	SENT_444	[p20l303t2077r537b2163],
3	(	NNP	O	(	nn	5	SENT_444	[p20l568t2079r957b2177],
4	Iressa	NNP	O	Iressa	nn	5	SENT_444	[p20l568t2079r957b2177],
5	)	NNP	O	)	_	0	SENT_444	[p20l568t2079r957b2177],
6	:	:	O	:	_	0	SENT_444	[p20l568t2079r957b2177],
7	an	DT	O	a	det	10	SENT_444	[p20l985t2101r1102b2161],
8	orally	RB	O	orally	advmod	9	SENT_444	[p20l1126t2071r1402b2187],
9	active	JJ	O	active	amod	10	SENT_444	[p20l1419t2071r1693b2163],
10	inhibitor	NN	O	inhibitor	dep	5	SENT_444	[p20l1716t2071r2151b2163],
11	of	IN	O	of	_	0	SENT_444	[p20l10t2219r126b2311],
12	epidermal	JJ	O	epidermal	amod	15	SENT_444	[p20l147t2221r652b2337],
13	growth	NN	O	growth	nn	15	SENT_444	[p20l692t2221r1051b2337],
14	factor	NN	O	factor	nn	15	SENT_444	[p20l1092t2219r1384b2311],
15	signaling	NN	O	signaling	prep_of	10	SENT_444	[p20l1423t2221r1892b2337],
16	with	IN	O	with	_	0	SENT_444	[p20l1924t2221r2147b2313],
17	potential	JJ	O	potential	prep_with	15	SENT_444	[p20l8t2371r454b2487],
18	for	IN	O	for	_	0	SENT_444	[p20l515t2369r660b2461],
19	cancer	NN	O	cancer	nn	20	SENT_444	[p20l720t2401r1045b2461],
20	therapy	NN	O	therapy	prep_for	17	SENT_444	[p20l1104t2371r1493b2487],
21	.	.	O	.	_	0	SENT_444	[p20l1104t2371r1493b2487],

1	Cancer	NNP	O	Cancer	nn	3	SENT_445	[p20l1561t2377r1910b2461],
2	Res	NNP	O	Res	nn	3	SENT_445	[p20l1967t2379r2143b2467],
3	20O2	NN	O	20o2	_	0	SENT_445	[p20l10t2527r887b2631],
4	;	:	O	;	_	0	SENT_445	[p20l10t2527r887b2631],
5	62:5749	CD	NUMBER	62:5749	number	6	SENT_445	[p20l10t2527r887b2631],
6	—	CD	NUMBER	—	dep	3	SENT_445	[p20l10t2527r887b2631],
7	54	CD	NUMBER	54	dep	6	SENT_445	[p20l10t2527r887b2631],
8	.	.	O	.	_	0	SENT_445	[p20l10t2527r887b2631],

1	4	LS	NUMBER	4	_	0	SENT_446	[p20l6t2683r88b2761],
2	.	.	O	.	_	0	SENT_446	[p20l6t2683r88b2761],

1	Arteaga	NNP	O	Arteaga	_	0	SENT_447	[p20l205t2679r584b2787],
2	CL	NN	O	cl	dep	1	SENT_447	[p20l638t2677r796b2761],
3	.	.	O	.	_	0	SENT_447	[p20l638t2677r796b2761],

1	ErbB	NN	O	erbb	nsubj	5	SENT_448	[p20l855t2671r1541b2787],
2	—	CD	NUMBER	—	num	1	SENT_448	[p20l855t2671r1541b2787],
3	targeted	VBN	O	target	partmod	1	SENT_448	[p20l855t2671r1541b2787],
4	therapeutic	JJ	O	therapeutic	dobj	3	SENT_448	[p20l1597t2671r2149b2787],
5	require	VBP	O	require	_	0	SENT_448	[p20l10t2981r309b3081],
6	plasma	NN	O	plasma	nn	7	SENT_448	[p20l332t2981r636b3081],
7	concentrations	NNS	O	concentration	dobj	5	SENT_448	[p20l659t2981r1280b3059],
8	of	IN	O	of	_	0	SENT_448	[p20l1306t2980r1406b3059],
9	an	DT	O	a	det	13	SENT_448	[p20l1411t3006r1510b3059],
10	EGFR	NN	O	egfr	nn	13	SENT_448	[p20l1533t2986r1790b3064],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_448	[p20l1804t2981r2135b3081],
12	kinase	NN	O	kinase	nn	13	SENT_448	[p20l10t3103r281b3183],
13	inhibitor	NN	O	inhibitor	prep_of	7	SENT_448	[p20l333t3104r717b3182],
14	that	WDT	O	that	nsubj	16	SENT_448	[p20l768t3104r938b3182],
15	are	VBP	O	be	cop	16	SENT_448	[p20l985t3130r1113b3182],
16	sufﬁcient	JJ	O	sufﬁcient	rcmod	7	SENT_448	[p20l1167t3103r1576b3183],
17	to	TO	O	to	aux	18	SENT_448	[p20l1624t3120r1704b3182],
18	abrogate	VB	O	abrogate	xcomp	16	SENT_448	[p20l1758t3103r2133b3204],
19	downstream	JJ	O	downstream	amod	20	SENT_448	[p20l11t3227r544b3306],
20	signaling	NN	O	signaling	dobj	18	SENT_448	[p20l571t3227r985b3327],
21	.	.	O	.	_	0	SENT_448	[p20l571t3227r985b3327],

1	Understanding	VBG	O	understand	csubj	9	SENT_449	[p20l139t3350r782b3450],
2	the	DT	O	the	det	4	SENT_449	[p20l816t3350r945b3428],
3	molecular	JJ	O	molecular	amod	4	SENT_449	[p20l982t3349r1408b3429],
4	basis	NN	O	basis	dobj	1	SENT_449	[p20l1443t3350r1652b3428],
5	of	IN	O	of	_	0	SENT_449	[p20l1692t3349r1792b3428],
6	responsiveness	NN	O	responsiveness	prep_of	4	SENT_449	[p20l1810t3375r2133b3450, p20l12t3473r350b3552],
7	to	TO	O	to	_	0	SENT_449	[p20l372t3489r451b3551],
8	geﬁtinib	NN	O	geﬁtinib	prep_to	1	SENT_449	[p20l473t3472r823b3573],
9	has	VBZ	O	have	_	0	SENT_449	[p20l844t3473r984b3551],
10	immediate	JJ	O	immediate	amod	12	SENT_449	[p20l1006t3472r1453b3551],
11	clinical	JJ	O	clinical	amod	12	SENT_449	[p20l1474t3472r1771b3551],
12	implications	NNS	O	implication	dobj	9	SENT_449	[p20l1790t3472r2134b3573, p20l11t3596r222b3674],
13	With	IN	O	with	_	0	SENT_449	[p20l246t3595r438b3675],
14	respect	NN	O	respect	prep_with	12	SENT_449	[p20l464t3612r776b3696],
15	to	TO	O	to	_	0	SENT_449	[p20l798t3612r877b3674],
16	patients	NNS	O	patient	prep_to	9	SENT_449	[p20l904t3596r1246b3696],
17	with	IN	O	with	_	0	SENT_449	[p20l1270t3596r1462b3675],
18	non	JJ	O	non	amod	24	SENT_449	[p20l1488t3595r2135b3674],
19	—	JJ	O	—	amod	24	SENT_449	[p20l1488t3595r2135b3674],
20	small	JJ	O	small	amod	24	SENT_449	[p20l1488t3595r2135b3674],
21	—	NN	O	—	nn	24	SENT_449	[p20l1488t3595r2135b3674],
22	cell	NN	O	cell	nn	24	SENT_449	[p20l1488t3595r2135b3674],
23	lung	NN	O	lung	nn	24	SENT_449	[p21l9t19r206b119],
24	cancer	NN	O	cancer	prep_with	16	SENT_449	[p21l243t44r540b97],
25	.	.	O	.	_	0	SENT_449	[p21l243t44r540b97],

1	The	DT	O	the	det	2	SENT_450	[p21l582t19r746b97],
2	clustering	NN	O	clustering	nsubj	15	SENT_450	[p21l786t18r1219b119],
3	of	IN	O	of	_	0	SENT_450	[p21l1255t18r1357b97],
4	mutations	NNS	O	mutation	prep_of	2	SENT_450	[p21l1377t19r1816b98],
5	Within	IN	O	within	_	0	SENT_450	[p21l1853t19r2134b98],
6	speciﬁc	NN	O	speciﬁc	nn	7	SENT_450	[p21l12t141r322b242],
7	regions	NNS	O	region	prep_within	15	SENT_450	[p21l342t142r649b242],
8	of	IN	O	of	_	0	SENT_450	[p21l672t141r771b220],
9	the	DT	O	the	det	10	SENT_450	[p21l773t142r900b220],
10	EGFRtY1	NN	O	egfrty1	poss	14	SENT_450	[p21l919t142r1512b242],
11	'	POS	O	'	_	0	SENT_450	[p21l919t142r1512b242],
12	osine	NN	O	osine	nn	14	SENT_450	[p21l919t142r1512b242],
13	kinase	NN	O	kinase	nn	14	SENT_450	[p21l1531t142r1797b221],
14	domain	NN	O	domain	prep_of	7	SENT_450	[p21l1817t142r2136b220],
15	makes	VBZ	O	make	_	0	SENT_450	[p21l10t265r280b344],
16	possible	JJ	O	possible	amod	19	SENT_450	[p21l306t264r657b365],
17	the	DT	O	the	det	19	SENT_450	[p21l683t265r812b343],
18	potential	JJ	O	potential	amod	19	SENT_450	[p21l837t265r1212b365],
19	development	NN	O	development	nsubj	27	SENT_450	[p21l1238t264r1788b365],
20	of	IN	O	of	_	0	SENT_450	[p21l1809t264r1909b343],
21	rapid	JJ	O	rapid	amod	25	SENT_450	[p21l1916t264r2135b365],
22	and	CC	O	and	_	0	SENT_450	[p21l10t387r165b466],
23	reliable	JJ	O	reliable	amod	25	SENT_450	[p21l192t387r502b466],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_450	[p21l530t388r969b488],
25	testing	NN	O	testing	prep_of	19	SENT_450	[p21l996t388r1285b488],
26	to	TO	O	to	aux	27	SENT_450	[p21l1309t404r1388b466],
27	guide	VB	O	guide	xcomp	15	SENT_450	[p21l1416t388r1650b488],
28	the	DT	O	the	det	30	SENT_450	[p21l1678t387r1806b466],
29	clinical	JJ	O	clinical	amod	30	SENT_450	[p21l1834t388r2135b466],
30	use	NN	O	use	dobj	27	SENT_450	[p21l10t537r148b590],
31	of	IN	O	of	_	0	SENT_450	[p21l171t510r272b589],
32	geﬁtinib	NN	O	geﬁtinib	prep_of	30	SENT_450	[p21l275t510r650b611],
33	.	.	O	.	_	0	SENT_450	[p21l275t510r650b611],

1	For	IN	O	for	_	0	SENT_451	[p21l677t518r820b589],
2	patients	NNS	O	patient	prep_for	27	SENT_451	[p21l838t511r1168b611],
3	Whose	WP$	O	whose	poss	4	SENT_451	[p21l1189t511r1460b590],
4	tumors	NNS	O	tumor	nsubj	5	SENT_451	[p21l1483t527r1781b590],
5	have	VBP	O	have	rcmod	2	SENT_451	[p21l1806t511r1992b590],
6	activating	VBG	O	activate	amod	7	SENT_451	[p21l2014t537r2134b589, p21l11t634r328b734],
7	mutations	NNS	O	mutation	dobj	5	SENT_451	[p21l348t634r778b713],
8	of	IN	O	of	_	0	SENT_451	[p21l803t633r904b712],
9	EGFR	NN	O	egfr	prep_of	7	SENT_451	[p21l906t640r1136b729],
10	,	,	O	,	_	0	SENT_451	[p21l906t640r1136b729],
11	the	DT	O	the	det	13	SENT_451	[p21l1164t633r1293b712],
12	dramatic	JJ	O	dramatic	amod	13	SENT_451	[p21l1317t633r1690b712],
13	responses	NNS	O	response	nsubj	27	SENT_451	[p21l1711t659r2132b734],
14	to	TO	O	to	_	0	SENT_451	[p21l11t773r90b835],
15	gefitinib	NN	O	gefitinib	prep_to	13	SENT_451	[p21l121t756r476b857],
16	of	IN	O	of	_	0	SENT_451	[p21l508t756r608b835],
17	patients	NNS	O	patient	prep_of	15	SENT_451	[p21l618t757r953b857],
18	Whose	WP$	O	whose	poss	19	SENT_451	[p21l980t756r1254b836],
19	disease	NN	O	disease	nsubj	22	SENT_451	[p21l1286t756r1588b835],
20	has	VBZ	O	have	aux	22	SENT_451	[p21l1619t757r1759b835],
21	been	VBN	O	be	cop	22	SENT_451	[p21l1793t757r1992b835],
22	refractory	JJ	O	refractory	rcmod	17	SENT_451	[p21l2022t783r2133b835, p21l10t879r334b980],
23	to	TO	O	to	_	0	SENT_451	[p21l350t896r429b958],
24	all	DT	O	all	det	26	SENT_451	[p21l450t879r548b958],
25	other	JJ	O	other	amod	26	SENT_451	[p21l569t879r791b958],
26	therapies	NNS	O	therapy	prep_to	22	SENT_451	[p21l808t879r1189b980],
27	suggest	VBP	O	suggest	_	0	SENT_451	[p21l1213t896r1536b980],
28	that	IN	O	that	complm	34	SENT_451	[p21l1552t880r1717b958],
29	this	DT	O	this	det	30	SENT_451	[p21l1733t880r1884b958],
30	agent	NN	O	agent	nsubj	34	SENT_451	[p21l1906t896r2140b980],
31	may	MD	O	may	aux	34	SENT_451	[p21l10t1029r186b1103],
32	be	VB	O	be	cop	34	SENT_451	[p21l204t1003r299b1081],
33	more	RBR	O	more	advmod	34	SENT_451	[p21l322t1028r540b1081],
34	effective	JJ	O	effective	ccomp	27	SENT_451	[p21l563t1002r904b1082],
35	if	IN	O	if	mark	36	SENT_451	[p21l926t1002r1001b1080],
36	used	VBN	O	use	ccomp	34	SENT_451	[p21l1004t1002r1198b1082],
37	earlier	RBR	O	earlier	advmod	36	SENT_451	[p21l1221t1003r1485b1081],
38	in	IN	O	in	_	0	SENT_451	[p21l1503t1003r1584b1080],
39	the	DT	O	the	det	40	SENT_451	[p21l1607t1003r1735b1081],
40	course	NN	O	course	prep_in	36	SENT_451	[p21l1758t1028r2030b1082],
41	of	IN	O	of	_	0	SENT_451	[p21l2054t1002r2154b1081],
42	treatment	NN	O	treatment	prep_of	40	SENT_451	[p21l11t1142r443b1204],
43	.	.	O	.	_	0	SENT_451	[p21l11t1142r443b1204],

1	Prospective	JJ	O	prospective	amod	2	SENT_452	[p21l473t1126r953b1226],
2	validation	NN	O	validation	nsubjpass	16	SENT_452	[p21l975t1126r1393b1205],
3	of	IN	O	of	_	0	SENT_452	[p21l1419t1125r1519b1204],
4	EGFR	NN	O	egfr	nn	7	SENT_452	[p21l1525t1131r1784b1209],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_452	[p21l1799t1126r2135b1226],
6	kinase	NN	O	kinase	nn	7	SENT_452	[p21l10t1248r280b1328],
7	mutations	NNS	O	mutation	prep_of	2	SENT_452	[p21l315t1249r746b1328],
8	as	IN	O	as	_	0	SENT_452	[p21l783t1275r867b1327],
9	predictors	NNS	O	predictor	prep_as	7	SENT_452	[p21l902t1249r1331b1349],
10	of	IN	O	of	_	0	SENT_452	[p21l1368t1248r1469b1327],
11	the	DT	O	the	det	12	SENT_452	[p21l1486t1249r1615b1327],
12	responsiveness	NN	O	responsiveness	prep_of	9	SENT_452	[p21l1651t1249r2133b1349, p21l10t1397r193b1450],
13	to	TO	O	to	_	0	SENT_452	[p21l218t1388r297b1450],
14	gefitinib	NN	O	gefitinib	prep_to	12	SENT_452	[p21l319t1371r674b1472],
15	is	VBZ	O	be	auxpass	16	SENT_452	[p21l697t1372r762b1450],
16	warranted	VBN	O	warrant	_	0	SENT_452	[p21l781t1372r1236b1467],
17	,	,	O	,	_	0	SENT_452	[p21l781t1372r1236b1467],
18	and	CC	O	and	_	0	SENT_452	[p21l1263t1372r1419b1450],
19	genotype	NN	O	genotype	nsubjpass	58	SENT_452	[p21l1439t1371r2133b1472],
20	—	CD	NUMBER	—	num	22	SENT_452	[p21l1439t1371r2133b1472],
21	direct	JJ	O	direct	amod	22	SENT_452	[p21l1439t1371r2133b1472],
22	—	NN	O	—	nsubj	23	SENT_452	[p21l1439t1371r2133b1472],
23	ed	VBD	O	ed	rcmod	19	SENT_452	[p21l11t1494r108b1573],
24	clinical	JJ	O	clinical	amod	25	SENT_452	[p21l146t1494r454b1573],
25	trials	NNS	O	trial	dobj	23	SENT_452	[p21l491t1495r704b1573],
26	of	IN	O	of	_	0	SENT_452	[p21l744t1494r846b1573],
27	this	DT	O	this	det	30	SENT_452	[p21l865t1495r1020b1573],
28	tyrosine	NN	O	tyrosine	nn	30	SENT_452	[p21l1060t1495r1402b1595],
29	kinase	NN	O	kinase	nn	30	SENT_452	[p21l1439t1495r1716b1574],
30	inhibitor	NN	O	inhibitor	prep_of	25	SENT_452	[p21l1753t1495r2136b1573],
31	in	IN	O	in	_	0	SENT_452	[p21l10t1618r92b1695],
32	the	DT	O	the	det	34	SENT_452	[p21l120t1618r249b1696],
33	initial	JJ	O	initial	amod	34	SENT_452	[p21l274t1618r518b1696],
34	treatment	NN	O	treatment	prep_in	30	SENT_452	[p21l544t1634r958b1696],
35	of	IN	O	of	_	0	SENT_452	[p21l979t1617r1080b1696],
36	advanced	JJ	O	advanced	amod	38	SENT_452	[p21l1086t1617r1478b1697],
37	non	JJ	O	non	amod	38	SENT_452	[p21l1503t1617r2135b1696],
38	—	NN	O	—	prep_of	34	SENT_452	[p21l1503t1617r2135b1696],
39	small	JJ	O	small	amod	44	SENT_452	[p21l1503t1617r2135b1696],
40	—	NN	O	—	nn	44	SENT_452	[p21l1503t1617r2135b1696],
41	cell	NN	O	cell	nn	44	SENT_452	[p21l1503t1617r2135b1696],
42	lung	NN	O	lung	nn	44	SENT_452	[p21l9t1741r201b1841],
43	cancer	NN	O	cancer	nn	44	SENT_452	[p21l221t1766r494b1819],
44	—	NN	O	—	tmod	23	SENT_452	[p21l509t1786r616b1793],
45	and	CC	O	and	_	0	SENT_452	[p21l633t1740r788b1819],
46	even	RB	O	even	advmod	44	SENT_452	[p21l810t1766r995b1820],
47	in	IN	O	in	_	0	SENT_452	[p21l1016t1741r1097b1818],
48	the	DT	O	the	det	50	SENT_452	[p21l1119t1741r1247b1819],
49	adjuvant	JJ	O	adjuvant	amod	50	SENT_452	[p21l1269t1740r1625b1841],
50	setting	NN	O	setting	prep_in	46	SENT_452	[p21l1644t1741r1929b1841],
51	after	IN	O	after	_	0	SENT_452	[p21l1947t1740r2138b1819],
52	surgical	JJ	O	surgical	amod	53	SENT_452	[p21l12t1864r343b1964],
53	resection	NN	O	resection	prep_after	50	SENT_452	[p21l368t1864r752b1942],
54	—	NN	O	—	conj_and	44	SENT_452	[p21l773t1908r881b1916],
55	should	MD	O	should	aux	58	SENT_452	[p21l903t1864r1190b1943],
56	now	RB	DATE	now	advmod	58	SENT_452	[p21l1215t1889r1399b1943],
57	be	VB	O	be	auxpass	58	SENT_452	[p21l1421t1864r1517b1942],
58	considered	VBN	O	consider	conj_and	16	SENT_452	[p21l1542t1863r2029b1942],
59	.	.	O	.	_	0	SENT_452	[p21l1542t1863r2029b1942],

1	Similar	JJ	O	similar	amod	2	SENT_453	[p21l141t1986r445b2065],
2	results	NNS	O	result	nsubjpass	5	SENT_453	[p21l479t1987r757b2066],
3	are	VBP	O	be	aux	5	SENT_453	[p21l796t2013r922b2065],
4	being	VBG	O	be	auxpass	5	SENT_453	[p21l960t1987r1199b2087],
5	reported	VBN	O	report	_	0	SENT_453	[p21l1233t1986r1592b2087],
6	by	IN	O	by	_	0	SENT_453	[p21l1630t1986r1727b2087],
7	other	JJ	O	other	amod	8	SENT_453	[p21l1761t1986r1985b2065],
8	investigators	NNS	O	investigator	agent	5	SENT_453	[p21l2019t1987r2133b2064, p21l6t2109r574b2208],
9	.29	CD	NUMBER	.29	tmod	5	SENT_453	[p21l2019t1987r2133b2064, p21l6t2109r574b2208],

1	Funded	VBN	O	fund	dep	54	SENT_454	[p21l94t2257r336b2317],
2	by	IN	O	by	_	0	SENT_454	[p21l373t2257r447b2332],
3	grants	NNS	O	grant	prep_by	1	SENT_454	[p21l481t2270r682b2332],
4	(	VBP	O	(	dep	1	SENT_454	[p21l724t2261r881b2325],
5	P01	NN	O	p01	dobj	4	SENT_454	[p21l724t2261r881b2325],
6	95281	CD	NUMBER	95281	nsubj	1	SENT_454	[p21l918t2261r1135b2328],
7	,	,	O	,	_	0	SENT_454	[p21l918t2261r1135b2328],
8	to	TO	O	to	_	0	SENT_454	[p21l1177t2269r1237b2316],
9	Drs.	NNP	O	Drs.	nn	10	SENT_454	[p21l1274t2262r1406b2316],
10	Bell	NNP	PERSON	Bell	prep_to	6	SENT_454	[p21l1447t2257r1569b2315],
11	and	CC	O	and	_	0	SENT_454	[p21l1605t2257r1724b2316],
12	Haber	NNP	O	Haber	conj_and	10	SENT_454	[p21l1760t2257r1977b2328],
13	;	:	O	;	_	0	SENT_454	[p21l1760t2257r1977b2328],
14	P30	NN	O	p30	nn	15	SENT_454	[p21l2016t2261r2135b2316],
15	CA0516	NN	O	ca0516	conj_and	10	SENT_454	[p21l10t2357r285b2424],
16	,	,	O	,	_	0	SENT_454	[p21l10t2357r285b2424],
17	to	TO	O	to	_	0	SENT_454	[p21l307t2365r367b2412],
18	Dr.	NNP	O	Dr.	nn	19	SENT_454	[p21l385t2358r481b2412],
19	Supko	NNP	PERSON	Supko	prep_to	15	SENT_454	[p21l504t2353r726b2428],
20	;	:	O	;	_	0	SENT_454	[p21l504t2353r726b2428],
21	and	CC	O	and	_	0	SENT_454	[p21l746t2353r864b2412],
22	R01	NN	O	r01	conj_and	10	SENT_454	[p21l882t2357r1021b2415],
23	CA	NNP	O	CA	dep	22	SENT_454	[p21l1039t2357r1136b2412],
24	092824	CD	NUMBER	092824	num	23	SENT_454	[p21l1152t2357r1391b2412],
25	and	CC	O	and	_	0	SENT_454	[p21l1408t2353r1527b2412],
26	P50	NN	O	p50	conj_and	10	SENT_454	[p21l1544t2357r1662b2412],
27	CA	NNP	O	CA	dep	26	SENT_454	[p21l1681t2357r1778b2412],
28	090578	CD	NUMBER	090578	num	27	SENT_454	[p21l1794t2357r2051b2424],
29	,	,	O	,	_	0	SENT_454	[p21l1794t2357r2051b2424],
30	to	TO	O	to	_	0	SENT_454	[p21l2074t2365r2134b2412],
31	Dr.	NNP	O	Dr.	nn	32	SENT_454	[p21l8t2436r104b2490],
32	Christiani	NNP	PERSON	Christiani	prep_to	1	SENT_454	[p21l128t2431r471b2500],
33	)	CD	NUMBER	)	num	32	SENT_454	[p21l128t2431r471b2500],
34	from	IN	O	from	_	0	SENT_454	[p21l495t2430r653b2490],
35	the	DT	O	the	det	37	SENT_454	[p21l673t2431r771b2489],
36	National	NNP	ORGANIZATION	National	nn	37	SENT_454	[p21l790t2431r1071b2491],
37	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	1	SENT_454	[p21l1089t2432r1392b2491],
38	of	IN	ORGANIZATION	of	_	0	SENT_454	[p21l1414t2430r1490b2490],
39	Health	NNP	ORGANIZATION	Health	prep_of	37	SENT_454	[p21l1496t2431r1731b2502],
40	;	:	O	;	_	0	SENT_454	[p21l1496t2431r1731b2502],
41	grants	NNS	O	grant	parataxis	54	SENT_454	[p21l1754t2444r1956b2506],
42	from	IN	O	from	dep	41	SENT_454	[p21l1977t2430r2136b2490],
43	the	DT	O	the	det	45	SENT_454	[p21l10t2509r108b2567],
44	Doris	NNP	ORGANIZATION	Doris	nn	45	SENT_454	[p21l127t2510r303b2568],
45	Duke	NNP	ORGANIZATION	Duke	pobj	42	SENT_454	[p21l322t2509r493b2569],
46	Charitable	JJ	ORGANIZATION	charitable	amod	47	SENT_454	[p21l512t2509r849b2568],
47	Foundation	NNP	ORGANIZATION	Foundation	dep	49	SENT_454	[p21l867t2509r1242b2569],
48	(	CD	NUMBER	(	num	47	SENT_454	[p21l1265t2514r1349b2578],
49	to	TO	O	to	dep	41	SENT_454	[p21l1265t2514r1349b2578],
50	Dr.	NNP	O	Dr.	nn	52	SENT_454	[p21l1368t2514r1464b2568],
51	Haber	NNP	O	Haber	nn	52	SENT_454	[p21l1487t2509r1731b2580],
52	)	NNP	O	)	pobj	49	SENT_454	[p21l1487t2509r1731b2580],
53	;	:	O	;	_	0	SENT_454	[p21l1487t2509r1731b2580],
54	grants	NNS	O	grant	_	0	SENT_454	[p21l1753t2521r1955b2584],
55	from	IN	O	from	_	0	SENT_454	[p21l1976t2508r2135b2568],
56	the	DT	O	the	det	59	SENT_454	[p21l10t2587r108b2645],
57	Sandler	NNP	ORGANIZATION	Sandler	nn	59	SENT_454	[p21l141t2587r386b2646],
58	Family	NNP	ORGANIZATION	Family	nn	59	SENT_454	[p21l414t2587r633b2662],
59	Foundation	NNP	ORGANIZATION	Foundation	prep_from	54	SENT_454	[p21l660t2587r1035b2647],
60	(	CD	NUMBER	(	num	59	SENT_454	[p21l1070t2592r1153b2655],
61	to	TO	O	to	dep	54	SENT_454	[p21l1070t2592r1153b2655],
62	Drs.	NNP	O	Drs.	nn	63	SENT_454	[p21l1185t2592r1317b2646],
63	Bell	NNP	PERSON	Bell	pobj	61	SENT_454	[p21l1351t2587r1474b2645],
64	and	CC	O	and	_	0	SENT_454	[p21l1504t2587r1623b2646],
65	Haber	NNP	O	Haber	conj_and	63	SENT_454	[p21l1653t2587r1897b2658],
66	)	CD	NUMBER	)	num	65	SENT_454	[p21l1653t2587r1897b2658],
67	;	:	O	;	_	0	SENT_454	[p21l1653t2587r1897b2658],
68	grants	NNS	O	grant	dep	63	SENT_454	[p21l1932t2599r2134b2662],
69	from	IN	O	from	dep	54	SENT_454	[p21l10t2664r167b2724],
70	the	DT	O	the	det	71	SENT_454	[p21l193t2665r291b2723],
71	Cole	NNP	O	Cole	pobj	69	SENT_454	[p21l317t2665r751b2740],
72	.	.	O	.	_	0	SENT_454	[p21l317t2665r751b2740],

1	—	NN	O	—	_	0	SENT_455	[p21l317t2665r751b2740],
2	.	.	O	.	_	0	SENT_455	[p21l317t2665r751b2740],

1	Angelus	NNP	O	Angelus	nn	2	SENT_456	[p21l317t2665r751b2740],
2	Fund	NNP	O	Fund	_	0	SENT_456	[p21l776t2665r960b2736],
3	,	,	O	,	_	0	SENT_456	[p21l776t2665r960b2736],
4	Romaine	NNP	O	Romaine	nn	5	SENT_456	[p21l988t2666r1280b2727],
5	Fund	NNP	O	Fund	conj_and	2	SENT_456	[p21l1304t2665r1488b2736],
6	,	,	O	,	_	0	SENT_456	[p21l1304t2665r1488b2736],
7	and	CC	O	and	_	0	SENT_456	[p21l1517t2665r1635b2724],
8	Sue	VB	O	sue	dep	16	SENT_456	[p21l1662t2669r1827b2725],
9	’s	POS	O	’s	nsubj	10	SENT_456	[p21l1662t2669r1827b2725],
10	Fund	NN	O	fund	ccomp	8	SENT_456	[p21l1852t2665r2018b2725],
11	for	IN	O	for	_	0	SENT_456	[p21l2043t2664r2137b2724],
12	Lung	NN	O	lung	nn	14	SENT_456	[p21l8t2748r175b2818],
13	Cancer	NNP	O	Cancer	nn	14	SENT_456	[p21l194t2747r420b2802],
14	Research	NNP	O	Research	prep_for	10	SENT_456	[p21l438t2743r732b2805],
15	(	CD	NUMBER	(	num	14	SENT_456	[p21l757t2748r840b2811],
16	to	TO	O	to	conj_and	2	SENT_456	[p21l757t2748r840b2811],
17	Dr.	NNP	O	Dr.	nn	19	SENT_456	[p21l861t2748r956b2802],
18	Lynch	NNP	PERSON	Lynch	nn	19	SENT_456	[p21l980t2743r1219b2818],
19	)	NN	O	)	pobj	16	SENT_456	[p21l980t2743r1219b2818],
20	;	:	O	;	_	0	SENT_456	[p21l980t2743r1219b2818],
21	and	CC	O	and	_	0	SENT_456	[p21l1243t2743r1361b2802],
22	the	DT	O	the	det	24	SENT_456	[p21l1382t2743r1481b2801],
23	Saltonstall	NNP	O	Saltonstall	nn	24	SENT_456	[p21l1504t2743r1845b2802],
24	Scholarship	NN	O	scholarship	conj_and	2	SENT_456	[p21l1866t2743r2133b2802, p21l11t2821r146b2896],
25	(	CD	NUMBER	(	num	24	SENT_456	[p21l171t2826r254b2890],
26	to	TO	O	to	_	0	SENT_456	[p21l171t2826r254b2890],
27	Dr.	NNP	O	Dr.	nn	29	SENT_456	[p21l274t2826r370b2880],
28	Settleman	NNP	O	Settleman	nn	29	SENT_456	[p21l396t2821r762b2890],
29	)	NN	O	)	prep_to	24	SENT_456	[p21l396t2821r762b2890],
30	.	.	O	.	_	0	SENT_456	[p21l396t2821r762b2890],

1	Dr.	NNP	O	Dr.	nn	2	SENT_457	[p21l94t2915r188b2969],
2	Lynch	NNP	PERSON	Lynch	nsubj	3	SENT_457	[p21l216t2910r404b2986],
3	reports	VBZ	O	report	_	0	SENT_457	[p21l429t2923r651b2986],
4	having	VBG	O	have	aux	5	SENT_457	[p21l677t2911r890b2986],
5	received	VBN	O	receive	xcomp	3	SENT_457	[p21l912t2910r1166b2970],
6	lecture	NN	O	lecture	nn	7	SENT_457	[p21l1190t2911r1401b2970],
7	fees	NNS	O	fee	dobj	5	SENT_457	[p21l1426t2910r1546b2969],
8	from	IN	O	from	_	0	SENT_457	[p21l1573t2910r1727b2969],
9	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	prep_from	5	SENT_457	[p21l1750t2916r2137b2969],
10	and	CC	O	and	_	0	SENT_457	[p21l9t2986r125b3045],
11	grant	NN	O	grant	nn	12	SENT_457	[p21l140t2999r310b3062],
12	support	NN	O	support	prep_from	5	SENT_457	[p21l323t2999r570b3062],
13	from	IN	O	from	_	0	SENT_457	[p21l582t2986r736b3045],
14	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	5	SENT_457	[p21l749t2992r1153b3058],
15	,	,	O	,	_	0	SENT_457	[p21l749t2992r1153b3058],
16	Merck	NNP	PERSON	Merck	nn	26	SENT_457	[p21l1170t2986r1386b3058],
17	,	,	O	,	_	0	SENT_457	[p21l1170t2986r1386b3058],
18	Genentech	NNP	ORGANIZATION	Genentech	appos	26	SENT_457	[p21l1406t2986r1764b3058],
19	,	,	O	,	_	0	SENT_457	[p21l1406t2986r1764b3058],
20	Pharmacia	NNP	LOCATION	Pharmacia	appos	26	SENT_457	[p21l1782t2987r2132b3058],
21	,	,	O	,	_	0	SENT_457	[p21l1782t2987r2132b3058],
22	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	26	SENT_457	[p21l10t3064r587b3136],
23	,	,	O	,	_	0	SENT_457	[p21l10t3064r587b3136],
24	Chiron	NNP	ORGANIZATION	Chiron	appos	26	SENT_457	[p21l620t3065r863b3136],
25	,	,	O	,	_	0	SENT_457	[p21l620t3065r863b3136],
26	Bristol	NNP	LOCATION	Bristol	appos	14	SENT_457	[p21l895t3064r1331b3140],
27	.	.	O	.	_	0	SENT_457	[p21l895t3064r1331b3140],

1	—	NN	O	—	_	0	SENT_458	[p21l895t3064r1331b3140],
2	.	.	O	.	_	0	SENT_458	[p21l895t3064r1331b3140],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_459	[p21l895t3064r1331b3140],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_459	[p21l1362t3064r1606b3140],
3	,	,	O	,	_	0	SENT_459	[p21l1362t3064r1606b3140],
4	and	CC	O	and	_	0	SENT_459	[p21l1637t3064r1756b3123],
5	Kosan	NNP	O	Kosan	conj_and	2	SENT_459	[p21l1783t3070r2004b3125],
6	.	.	O	.	_	0	SENT_459	[p21l1783t3070r2004b3125],

1	Dr.	NNP	O	Dr.	nn	2	SENT_460	[p21l2035t3069r2130b3123],
2	Haluska	NNP	PERSON	Haluska	nsubj	3	SENT_460	[p21l9t3142r268b3202],
3	reports	VBZ	O	report	_	0	SENT_460	[p21l285t3155r507b3218],
4	having	VBG	O	have	aux	5	SENT_460	[p21l527t3143r739b3218],
5	received	VBN	O	receive	xcomp	3	SENT_460	[p21l754t3142r1008b3202],
6	consulting	NN	O	consulting	nn	7	SENT_460	[p21l1026t3143r1362b3218],
7	fees	NNS	O	fee	dobj	5	SENT_460	[p21l1377t3142r1498b3201],
8	from	IN	O	from	_	0	SENT_460	[p21l1518t3142r1672b3201],
9	Celgene	NNP	ORGANIZATION	Celgene	prep_from	5	SENT_460	[p21l1690t3142r1958b3218],
10	,	,	O	,	_	0	SENT_460	[p21l1690t3142r1958b3218],
11	Gentra	NNP	ORGANIZATION	Gentra	nn	17	SENT_460	[p21l1981t3147r2136b3201, p21l10t3231r109b3290],
12	,	,	O	,	_	0	SENT_460	[p21l1981t3147r2136b3201, p21l10t3231r109b3290],
13	Genzyme	NNP	ORGANIZATION	Genzyme	appos	17	SENT_460	[p21l136t3223r450b3294],
14	,	,	O	,	_	0	SENT_460	[p21l136t3223r450b3294],
15	Metaphore	NNP	O	Metaphore	appos	17	SENT_460	[p21l476t3218r837b3294],
16	,	,	O	,	_	0	SENT_460	[p21l476t3218r837b3294],
17	Schering	NNP	ORGANIZATION	Schering	appos	9	SENT_460	[p21l866t3218r1410b3294],
18	.	.	O	.	_	0	SENT_460	[p21l866t3218r1410b3294],

1	—	NN	O	—	_	0	SENT_461	[p21l866t3218r1410b3294],
2	.	.	O	.	_	0	SENT_461	[p21l866t3218r1410b3294],

1	Plough	NNP	O	Plough	nn	5	SENT_462	[p21l866t3218r1410b3294],
2	,	,	O	,	_	0	SENT_462	[p21l866t3218r1410b3294],
3	Teva	NNP	ORGANIZATION	Teva	appos	5	SENT_462	[p21l1435t3223r1591b3290],
4	,	,	O	,	_	0	SENT_462	[p21l1435t3223r1591b3290],
5	Xoma	NNP	ORGANIZATION	Xoma	_	0	SENT_462	[p21l1616t3224r1817b3290],
6	,	,	O	,	_	0	SENT_462	[p21l1616t3224r1817b3290],
7	and	CC	O	and	_	0	SENT_462	[p21l1845t3218r1961b3277],
8	CTLI	NNP	O	CTLI	nn	9	SENT_462	[p21l1985t3223r2134b3285],
9	MannKind	NNP	ORGANIZATION	MannKind	conj_and	5	SENT_462	[p21l7t3296r349b3357],
10	and	CC	O	and	_	0	SENT_462	[p21l368t3297r485b3355],
11	research	NN	O	research	conj_and	5	SENT_462	[p21l505t3296r771b3355],
12	support	NN	O	support	nn	15	SENT_462	[p21l792t3309r1041b3372],
13	and	CC	O	and	_	0	SENT_462	[p21l1056t3296r1174b3355],
14	stock	NN	O	stock	nn	15	SENT_462	[p21l1194t3297r1364b3356],
15	options	NNS	O	option	dep	5	SENT_462	[p21l1380t3297r1618b3372],
16	from	IN	O	from	_	0	SENT_462	[p21l1639t3296r1794b3355],
17	Genzyme	NNP	ORGANIZATION	Genzyme	prep_from	15	SENT_462	[p21l1814t3301r2131b3372],
18	.	.	O	.	_	0	SENT_462	[p21l1814t3301r2131b3372],

1	Dr.	NNP	O	Dr.	nn	2	SENT_463	[p21l8t3379r103b3433],
2	Christiani	NNP	PERSON	Christiani	nsubj	3	SENT_463	[p21l126t3374r440b3433],
3	reports	VBZ	O	report	_	0	SENT_463	[p21l457t3387r682b3450],
4	having	VBG	O	have	aux	5	SENT_463	[p21l702t3374r916b3450],
5	received	VBN	O	receive	xcomp	3	SENT_463	[p21l932t3374r1188b3434],
6	consulting	NN	O	consulting	nn	7	SENT_463	[p21l1207t3374r1547b3450],
7	fees	NNS	O	fee	dobj	5	SENT_463	[p21l1563t3374r1684b3433],
8	from	IN	O	from	_	0	SENT_463	[p21l1704t3374r1860b3433],
9	Gentra	NNP	ORGANIZATION	Gentra	prep_from	5	SENT_463	[p21l1879t3379r2114b3433],
10	.	.	O	.	_	0	SENT_463	[p21l1879t3379r2114b3433],

1	We	PRP	O	we	nsubj	3	SENT_464	[p21l92t3480r193b3533],
2	are	VBP	O	be	cop	3	SENT_464	[p21l211t3494r307b3533],
3	indebted	JJ	O	indebted	_	0	SENT_464	[p21l325t3474r602b3534],
4	to	TO	O	to	_	0	SENT_464	[p21l622t3487r682b3534],
5	Dr.	NNP	O	Dr.	nn	7	SENT_464	[p21l700t3479r794b3534],
6	Anat	NNP	PERSON	Anat	nn	7	SENT_464	[p21l815t3480r967b3533],
7	Stemmer	NNP	PERSON	Stemmer	prep_to	3	SENT_464	[p21l985t3474r1728b3546],
8	.	.	O	.	_	0	SENT_464	[p21l985t3474r1728b3546],

1	—	NN	O	—	_	0	SENT_465	[p21l985t3474r1728b3546],
2	.	.	O	.	_	0	SENT_465	[p21l985t3474r1728b3546],

1	Rachamimov	NNP	PERSON	Rachamimov	_	0	SENT_466	[p21l985t3474r1728b3546],
2	,	,	O	,	_	0	SENT_466	[p21l985t3474r1728b3546],
3	Ms.	NNP	O	Ms.	nn	5	SENT_466	[p21l1749t3479r1864b3534],
4	Jennifer	NNP	PERSON	Jennifer	nn	5	SENT_466	[p21l1879t3474r2137b3543],
5	Roy	NNP	PERSON	Roy	conj_and	1	SENT_466	[p21l8t3557r140b3627],
6	,	,	O	,	_	0	SENT_466	[p21l8t3557r140b3627],
7	and	CC	O	and	_	0	SENT_466	[p21l166t3552r282b3611],
8	Ms.	NNP	O	Ms.	nn	10	SENT_466	[p21l303t3557r416b3611],
9	Li	NNP	PERSON	Li	nn	10	SENT_466	[p21l442t3553r500b3610],
10	Su	NNP	PERSON	Su	conj_and	1	SENT_466	[p21l524t3556r600b3612],
11	for	IN	O	for	_	0	SENT_466	[p21l621t3552r713b3611],
12	help	NN	O	help	prep_for	10	SENT_466	[p21l733t3552r869b3627],
13	With	IN	O	with	_	0	SENT_466	[p21l890t3552r1032b3612],
14	archival	JJ	O	archival	amod	15	SENT_466	[p21l1053t3552r1300b3612],
15	tissues	NNS	O	tissue	prep_with	12	SENT_466	[p21l1322t3553r1553b3624],
16	,	,	O	,	_	0	SENT_466	[p21l1322t3553r1553b3624],
17	and	CC	O	and	_	0	SENT_466	[p21l1580t3552r1696b3611],
18	to	TO	O	to	_	0	SENT_466	[p21l1719t3565r1778b3611],
19	Drs.	NNP	O	Drs.	nn	21	SENT_466	[p21l1800t3557r1930b3611],
20	Bruce	NNP	PERSON	Bruce	nn	21	SENT_466	[p21l1955t3557r2136b3612],
21	Chabner	NNP	PERSON	Chabner	prep_to	10	SENT_466	[p21l10t3630r282b3689],
22	and	CC	O	and	_	0	SENT_466	[p21l299t3630r415b3689],
23	Kurt	NNP	PERSON	Kurt	nn	24	SENT_466	[p21l433t3635r578b3691],
24	Isselbacher	NNP	PERSON	Isselbacher	conj_and	21	SENT_466	[p21l591t3630r953b3689],
25	for	IN	O	for	_	0	SENT_466	[p21l969t3630r1061b3689],
26	helpful	JJ	O	helpful	amod	27	SENT_466	[p21l1078t3629r1303b3705],
27	discussions	NNS	O	discussion	prep_for	21	SENT_466	[p21l1321t3630r1707b3690],
28	.	.	O	.	_	0	SENT_466	[p21l1321t3630r1707b3690],

1	approaches	NNS	O	approach	_	0	SENT_467	[p22l9t87r280b143],
2	in	IN	O	in	_	0	SENT_467	[p22l301t87r346b130],
3	human	JJ	O	human	amod	4	SENT_467	[p22l366t87r534b131],
4	cancer	NN	O	cancer	prep_in	1	SENT_467	[p22l555t101r717b131],
5	.	.	O	.	_	0	SENT_467	[p22l555t101r717b131],

1	Exp	NN	O	exp	nn	2	SENT_468	[p22l740t91r827b143],
2	Cell	NN	O	cell	_	0	SENT_468	[p22l848t87r939b131],
3	Res	NNP	O	Res	dep	2	SENT_468	[p22l958t91r1042b134],
4	2003	CD	DATE	2003	num	3	SENT_468	[p22l10t161r428b211],
5	;	:	O	;	_	0	SENT_468	[p22l10t161r428b211],
6	284:122	CD	NUMBER	284:122	number	7	SENT_468	[p22l10t161r428b211],
7	—	CD	NUMBER	—	dep	2	SENT_468	[p22l10t161r428b211],
8	30	CD	NUMBER	30	dep	7	SENT_468	[p22l10t161r428b211],
9	.	.	O	.	_	0	SENT_468	[p22l10t161r428b211],

1	5	CD	NUMBER	5	_	0	SENT_469	[p22l10t234r48b273],
2	.	.	O	.	_	0	SENT_469	[p22l10t234r48b273],

1	Jorissen	NNP	PERSON	Jorissen	nn	2	SENT_470	[p22l100t229r292b280],
2	RN	NNP	O	RN	_	0	SENT_470	[p22l303t233r391b282],
3	,	,	O	,	_	0	SENT_470	[p22l303t233r391b282],
4	Walker	NNP	PERSON	Walker	nn	5	SENT_470	[p22l404t229r572b274],
5	F	NN	O	f	appos	2	SENT_470	[p22l582t233r617b282],
6	,	,	O	,	_	0	SENT_470	[p22l582t233r617b282],
7	Pouliot	NNP	PERSON	Pouliot	nn	8	SENT_470	[p22l631t229r801b273],
8	N	NNP	O	N	appos	5	SENT_470	[p22l809t233r861b282],
9	,	,	O	,	_	0	SENT_470	[p22l809t233r861b282],
10	Garrett	NNP	PERSON	Garrett	nn	11	SENT_470	[p22l876t232r1045b273],
11	TP	NNP	O	TP	appos	5	SENT_470	[p22l8t303r77b353],
12	,	,	O	,	_	0	SENT_470	[p22l8t303r77b353],
13	Ward	NNP	ORGANIZATION	Ward	nn	14	SENT_470	[p22l89t300r214b344],
14	CW	NNP	ORGANIZATION	CW	appos	5	SENT_470	[p22l225t303r316b353],
15	,	,	O	,	_	0	SENT_470	[p22l225t303r316b353],
16	Burgess	NNP	PERSON	Burgess	nn	17	SENT_470	[p22l329t304r513b356],
17	AW	NNP	O	AW	appos	5	SENT_470	[p22l523t304r613b344],
18	.	.	O	.	_	0	SENT_470	[p22l523t304r613b344],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_471	[p22l626t300r867b356],
2	growth	NN	O	growth	nn	4	SENT_471	[p22l877t300r1044b356],
3	factor	NN	O	factor	nn	4	SENT_471	[p22l10t370r151b415],
4	receptor	NN	O	receptor	_	0	SENT_471	[p22l172t380r386b427],
5	:	:	O	:	_	0	SENT_471	[p22l172t380r386b427],
6	mechanisms	NNS	O	mechanism	dep	4	SENT_471	[p22l410t371r716b415],
7	of	IN	O	of	_	0	SENT_471	[p22l740t370r797b415],
8	activation	NN	O	activation	prep_of	6	SENT_471	[p22l809t371r1043b415],
9	and	CC	O	and	_	0	SENT_471	[p22l9t442r98b486],
10	signaling	NN	O	signaling	conj_and	8	SENT_471	[p22l113t442r344b498],
11	.	.	O	.	_	0	SENT_471	[p22l113t442r344b498],

1	Exp	NN	O	exp	nn	2	SENT_472	[p22l359t446r446b498],
2	Cell	NN	O	cell	_	0	SENT_472	[p22l459t442r549b486],
3	Res	NNP	O	Res	dep	2	SENT_472	[p22l561t446r643b489],
4	2003	CD	DATE	2003	num	3	SENT_472	[p22l657t445r1039b495],
5	;	:	O	;	_	0	SENT_472	[p22l657t445r1039b495],
6	284:31	CD	NUMBER	284:31	number	7	SENT_472	[p22l657t445r1039b495],
7	—	CD	NUMBER	—	dep	2	SENT_472	[p22l657t445r1039b495],
8	53	CD	NUMBER	53	dep	7	SENT_472	[p22l657t445r1039b495],
9	.	.	O	.	_	0	SENT_472	[p22l657t445r1039b495],

1	6	CD	NUMBER	6	_	0	SENT_473	[p22l10t518r48b557],
2	.	.	O	.	_	0	SENT_473	[p22l10t518r48b557],

1	Luetteke	NNP	ORGANIZATION	Luetteke	nn	2	SENT_474	[p22l105t513r306b558],
2	NC	NNP	ORGANIZATION	NC	_	0	SENT_474	[p22l319t516r410b566],
3	,	,	O	,	_	0	SENT_474	[p22l319t516r410b566],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_474	[p22l426t513r604b569],
5	HK	NNP	O	HK	appos	2	SENT_474	[p22l619t517r711b566],
6	,	,	O	,	_	0	SENT_474	[p22l619t517r711b566],
7	Qui	NNP	O	Qui	nn	8	SENT_474	[p22l728t513r814b568],
8	TH	NN	O	th	appos	2	SENT_474	[p22l826t516r915b566],
9	,	,	O	,	_	0	SENT_474	[p22l826t516r915b566],
10	et	FW	O	et	nn	11	SENT_474	[p22l933t522r976b557],
11	al.	FW	O	al.	appos	2	SENT_474	[p22l987t513r1040b557],
12	.	.	O	.	_	0	SENT_474	[p22l987t513r1040b557],

1	The	DT	O	the	det	2	SENT_475	[p22l8t584r98b628],
2	mouse	NN	O	mouse	nsubj	3	SENT_475	[p22l113t598r270b628],
3	waved	VBD	O	wave	dep	7	SENT_475	[p22l282t584r478b628],
4	—	CD	NUMBER	—	number	5	SENT_475	[p22l282t584r478b628],
5	2	CD	NUMBER	2	num	6	SENT_475	[p22l282t584r478b628],
6	phenotype	NN	O	phenotype	dobj	3	SENT_475	[p22l493t584r741b640],
7	results	VBZ	O	result	_	0	SENT_475	[p22l756t584r911b628],
8	from	IN	O	from	_	0	SENT_475	[p22l927t583r1043b628],
9	a	DT	O	a	det	11	SENT_475	[p22l9t669r34b699],
10	point	NN	O	point	nn	11	SENT_475	[p22l53t655r181b711],
11	mutation	NN	O	mutation	prep_from	7	SENT_475	[p22l199t655r416b699],
12	in	IN	O	in	_	0	SENT_475	[p22l437t655r482b698],
13	the	DT	O	the	det	16	SENT_475	[p22l503t655r575b699],
14	EGF	NN	ORGANIZATION	egf	nn	16	SENT_475	[p22l595t658r697b699],
15	receptor	NN	O	receptor	nn	16	SENT_475	[p22l718t664r915b711],
16	tyro	NN	O	tyro	prep_in	11	SENT_475	[p22l934t664r1042b711],
17	—	CD	NUMBER	—	num	19	SENT_475	[p22l934t664r1042b711],
18	sine	NN	O	sine	nn	19	SENT_475	[p22l11t726r105b770],
19	kinase	NN	O	kinase	nsubj	7	SENT_475	[p22l119t726r283b771],
20	.	.	O	.	_	0	SENT_475	[p22l119t726r283b771],

1	Genes	NNS	O	gene	_	0	SENT_476	[p22l301t729r447b770],
2	Dev	JJ	O	dev	amod	1	SENT_476	[p22l462t730r552b770],
3	1994	CD	DATE	1994	tmod	2	SENT_476	[p22l566t729r953b779],
4	;	:	O	;	_	0	SENT_476	[p22l566t729r953b779],
5	8:399	CD	NUMBER	8:399	num	6	SENT_476	[p22l566t729r953b779],
6	—	NN	O	—	dep	1	SENT_476	[p22l566t729r953b779],
7	413	CD	NUMBER	413	dep	6	SENT_476	[p22l566t729r953b779],
8	.	.	O	.	_	0	SENT_476	[p22l566t729r953b779],

1	7	CD	NUMBER	7	_	0	SENT_477	[p22l11t802r48b841],
2	.	.	O	.	_	0	SENT_477	[p22l11t802r48b841],

1	Threadgill	NNP	PERSON	Threadgill	nn	2	SENT_478	[p22l104t797r354b853],
2	DW	NNP	O	DW	_	0	SENT_478	[p22l382t801r480b850],
3	,	,	O	,	_	0	SENT_478	[p22l382t801r480b850],
4	Dlugosz	NNP	ORGANIZATION	Dlugosz	nn	5	SENT_478	[p22l512t797r712b853],
5	AA	NNP	ORGANIZATION	AA	appos	2	SENT_478	[p22l740t801r825b850],
6	,	,	O	,	_	0	SENT_478	[p22l740t801r825b850],
7	Hansen	NNP	ORGANIZATION	Hansen	nn	8	SENT_478	[p22l857t801r1042b841],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_478	[p22l9t872r84b921],
9	,	,	O	,	_	0	SENT_478	[p22l9t872r84b921],
10	et	FW	O	et	nn	11	SENT_478	[p22l105t877r147b912],
11	al.	FW	O	al.	appos	2	SENT_478	[p22l160t868r212b912],
12	.	.	O	.	_	0	SENT_478	[p22l160t868r212b912],

1	Targeted	VBN	O	target	_	0	SENT_479	[p22l229t868r433b924],
2	disruption	NN	O	disruption	dobj	1	SENT_479	[p22l449t868r692b924],
3	of	IN	O	of	_	0	SENT_479	[p22l709t867r764b912],
4	mouse	NN	O	mouse	nn	6	SENT_479	[p22l771t882r926b912],
5	EGF	NN	O	egf	nn	6	SENT_479	[p22l942t871r1043b912],
6	receptor	NN	O	receptor	prep_of	2	SENT_479	[p22l10t948r222b995],
7	:	:	O	:	_	0	SENT_479	[p22l10t948r222b995],
8	effect	NN	O	effect	dep	2	SENT_479	[p22l250t938r381b983],
9	of	IN	O	of	_	0	SENT_479	[p22l405t938r461b983],
10	genetic	JJ	O	genetic	amod	11	SENT_479	[p22l476t939r646b995],
11	background	NN	O	background	prep_of	8	SENT_479	[p22l672t939r957b995],
12	on	IN	O	on	_	0	SENT_479	[p22l983t953r1043b983],
13	mutant	JJ	O	mutant	amod	14	SENT_479	[p22l10t1019r182b1054],
14	phenotype	NN	O	phenotype	prep_on	1	SENT_479	[p22l191t1010r449b1066],
15	.	.	O	.	_	0	SENT_479	[p22l191t1010r449b1066],

1	Science	NNP	O	Science	_	0	SENT_480	[p22l466t1010r638b1054],
2	1995	CD	DATE	1995	num	1	SENT_480	[p22l653t1013r1034b1063],
3	;	:	O	;	_	0	SENT_480	[p22l653t1013r1034b1063],
4	269:230	CD	NUMBER	269:230	number	5	SENT_480	[p22l653t1013r1034b1063],
5	—	CD	NUMBER	—	dep	1	SENT_480	[p22l653t1013r1034b1063],
6	4	CD	NUMBER	4	dep	5	SENT_480	[p22l653t1013r1034b1063],
7	.	.	O	.	_	0	SENT_480	[p22l653t1013r1034b1063],

1	8	CD	NUMBER	8	_	0	SENT_481	[p22l1117t91r1155b131],
2	.	.	O	.	_	0	SENT_481	[p22l1117t91r1155b131],

1	Ranson	NNP	PERSON	Ranson	nn	2	SENT_482	[p22l1213t91r1393b134],
2	M	NNP	O	M	_	0	SENT_482	[p22l1405t91r1465b140],
3	,	,	O	,	_	0	SENT_482	[p22l1405t91r1465b140],
4	Hammond	NNP	ORGANIZATION	Hammond	nn	5	SENT_482	[p22l1481t87r1740b131],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_482	[p22l1752t91r1829b140],
6	,	,	O	,	_	0	SENT_482	[p22l1752t91r1829b140],
7	Ferry	NN	O	ferry	nn	8	SENT_482	[p22l1844t91r1966b143],
8	D	NN	O	d	appos	2	SENT_482	[p22l1976t91r2025b140],
9	,	,	O	,	_	0	SENT_482	[p22l1976t91r2025b140],
10	et	FW	O	et	nn	11	SENT_482	[p22l2041t96r2085b131],
11	al.	FW	O	al.	appos	2	SENT_482	[p22l2094t87r2147b131],
12	.	.	O	.	_	0	SENT_482	[p22l2094t87r2147b131],

1	ZD1839	NN	O	zd1839	nsubj	15	SENT_483	[p22l1116t161r1322b211],
2	,	,	O	,	_	0	SENT_483	[p22l1116t161r1322b211],
3	a	DT	O	a	det	13	SENT_483	[p22l1343t172r1368b202],
4	selective	JJ	O	selective	amod	13	SENT_483	[p22l1386t158r1587b202],
5	oral	JJ	O	oral	amod	13	SENT_483	[p22l1605t158r1698b202],
6	epidermal	JJ	O	epidermal	amod	13	SENT_483	[p22l1716t158r1959b214],
7	growth	NN	O	growth	nn	13	SENT_483	[p22l1977t158r2150b214],
8	factor	NN	O	factor	nn	13	SENT_483	[p22l1117t228r1258b273],
9	receptor	NN	O	receptor	nn	13	SENT_483	[p22l1276t229r1683b285],
10	—	NN	O	—	nn	13	SENT_483	[p22l1276t229r1683b285],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_483	[p22l1276t229r1683b285],
12	kinase	NN	O	kinase	nn	13	SENT_483	[p22l1702t229r1854b274],
13	inhibitor	NN	O	inhibitor	appos	1	SENT_483	[p22l1872t229r2091b282],
14	,	,	O	,	_	0	SENT_483	[p22l1872t229r2091b282],
15	is	VBZ	O	be	_	0	SENT_483	[p22l2112t229r2149b273],
16	well	RB	O	well	advmod	17	SENT_483	[p22l1115t300r1214b344],
17	tolerated	VBN	O	tolerate	dep	15	SENT_483	[p22l1240t300r1453b344],
18	and	CC	O	and	_	0	SENT_483	[p22l1479t300r1567b344],
19	active	JJ	O	active	conj_and	17	SENT_483	[p22l1593t300r1728b344],
20	in	IN	O	in	_	0	SENT_483	[p22l1754t300r1800b343],
21	patients	NNS	O	patient	nn	33	SENT_483	[p22l1825t300r2017b356],
22	with	IN	O	with	_	0	SENT_483	[p22l2042t300r2150b344],
23	solid	JJ	O	solid	amod	26	SENT_483	[p22l1118t371r1248b424],
24	,	,	O	,	_	0	SENT_483	[p22l1118t371r1248b424],
25	malignant	JJ	O	malignant	amod	26	SENT_483	[p22l1265t371r1512b427],
26	tumors	NNS	O	tumor	prep_with	21	SENT_483	[p22l1522t380r1706b415],
27	:	:	O	:	_	0	SENT_483	[p22l1522t380r1706b415],
28	results	NNS	O	result	dep	21	SENT_483	[p22l1721t371r1876b415],
29	of	IN	O	of	_	0	SENT_483	[p22l1890t370r1947b415],
30	a	DT	O	a	det	31	SENT_483	[p22l1948t385r1973b415],
31	phase	NN	O	phase	prep_of	28	SENT_483	[p22l1984t371r2122b427],
32	I	PRP	O	I	dep	31	SENT_483	[p22l2134t375r2151b414],
33	trial	NN	O	trial	prep_in	19	SENT_483	[p22l1117t442r1224b486],
34	.	.	O	.	_	0	SENT_483	[p22l1117t442r1224b486],

1	J	NNP	O	J	nn	3	SENT_484	[p22l1235t446r1256b493],
2	Clin	NNP	O	Clin	nn	3	SENT_484	[p22l1269t442r1366b486],
3	Oncol	NNP	O	Oncol	_	0	SENT_484	[p22l1380t442r1522b486],
4	2002	CD	DATE	2002	num	3	SENT_484	[p22l1536t445r1955b495],
5	;	:	O	;	_	0	SENT_484	[p22l1536t445r1955b495],
6	20:2240	CD	NUMBER	20:2240	number	7	SENT_484	[p22l1536t445r1955b495],
7	-50	CD	NUMBER	-50	dep	3	SENT_484	[p22l1536t445r1955b495],
8	.	.	O	.	_	0	SENT_484	[p22l1536t445r1955b495],

1	9	CD	NUMBER	9	_	0	SENT_485	[p22l1117t518r1155b557],
2	.	.	O	.	_	0	SENT_485	[p22l1117t518r1155b557],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_486	[p22l1213t513r1379b557],
2	RS	NN	ORGANIZATION	r	_	0	SENT_486	[p22l1399t516r1478b566],
3	,	,	O	,	_	0	SENT_486	[p22l1399t516r1478b566],
4	Maddox	NNP	PERSON	Maddox	nn	5	SENT_486	[p22l1503t513r1700b557],
5	A-M	NNP	O	A-M	appos	2	SENT_486	[p22l1720t517r1837b566],
6	,	,	O	,	_	0	SENT_486	[p22l1720t517r1837b566],
7	Rothenberg	NNP	PERSON	Rothenberg	nn	8	SENT_486	[p22l1863t513r2152b569],
8	ML	NNP	O	ML	appos	2	SENT_486	[p22l1116t588r1206b637],
9	,	,	O	,	_	0	SENT_486	[p22l1116t588r1206b637],
10	et	FW	O	et	nn	11	SENT_486	[p22l1231t593r1275b628],
11	al.	FW	O	al.	appos	2	SENT_486	[p22l1293t584r1347b628],
12	.	.	O	.	_	0	SENT_486	[p22l1293t584r1347b628],

1	Selective	JJ	O	selective	amod	10	SENT_487	[p22l1372t584r1577b628],
2	oral	JJ	O	oral	amod	10	SENT_487	[p22l1599t584r1692b628],
3	epidermal	JJ	O	epidermal	amod	10	SENT_487	[p22l1713t584r1956b640],
4	growth	NN	O	growth	nn	10	SENT_487	[p22l1977t584r2150b640],
5	factor	NN	O	factor	nn	10	SENT_487	[p22l1117t654r1258b699],
6	receptor	NN	O	receptor	nn	10	SENT_487	[p22l1290t664r1491b711],
7	tyrosine	NN	O	tyrosine	nn	10	SENT_487	[p22l1523t655r1715b711],
8	kinase	NN	O	kinase	nn	10	SENT_487	[p22l1749t655r1903b700],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_487	[p22l1937t655r2152b699],
10	ZD1839	NN	O	zd1839	nsubj	13	SENT_487	[p22l1116t729r1307b770],
11	is	VBZ	O	be	cop	13	SENT_487	[p22l1328t726r1364b770],
12	generally	RB	O	generally	advmod	13	SENT_487	[p22l1385t726r1601b782],
13	well-tolerated	JJ	O	well-tolerated	_	0	SENT_487	[p22l1616t726r1944b770],
14	and	CC	O	and	_	0	SENT_487	[p22l1963t726r2051b770],
15	has	VBZ	O	have	conj_and	13	SENT_487	[p22l2070t726r2149b770],
16	activity	NN	O	activity	nn	33	SENT_487	[p22l1117t797r1286b853],
17	in	IN	O	in	_	0	SENT_487	[p22l1307t797r1353b840],
18	non	JJ	O	non	amod	22	SENT_487	[p22l1376t797r1728b841],
19	—	JJ	O	—	amod	22	SENT_487	[p22l1376t797r1728b841],
20	small-cell	NN	O	small-cell	nn	22	SENT_487	[p22l1376t797r1728b841],
21	lung	NN	O	lung	nn	22	SENT_487	[p22l1751t797r1861b853],
22	cancer	NN	O	cancer	prep_in	16	SENT_487	[p22l1883t811r2040b841],
23	and	CC	O	and	_	0	SENT_487	[p22l2062t797r2150b841],
24	other	JJ	O	other	amod	26	SENT_487	[p22l1118t868r1245b912],
25	solid	JJ	O	solid	amod	26	SENT_487	[p22l1260t868r1375b912],
26	tumors	NNS	O	tumor	prep_in	16	SENT_487	[p22l1389t877r1573b912],
27	:	:	O	:	_	0	SENT_487	[p22l1389t877r1573b912],
28	results	NNS	O	result	dep	16	SENT_487	[p22l1590t868r1745b912],
29	of	IN	O	of	_	0	SENT_487	[p22l1761t867r1817b912],
30	a	DT	O	a	det	31	SENT_487	[p22l1821t882r1846b912],
31	phase	NN	O	phase	prep_of	28	SENT_487	[p22l1858t868r1997b924],
32	I	PRP	O	I	dep	31	SENT_487	[p22l2010t872r2027b911],
33	trial	NN	O	trial	dobj	15	SENT_487	[p22l2041t868r2147b912],
34	.	.	O	.	_	0	SENT_487	[p22l2041t868r2147b912],

1	IClin	NN	O	iclin	nn	2	SENT_488	[p22l1112t939r1243b990],
2	Oncol	NN	O	oncol	_	0	SENT_488	[p22l1256t939r1399b983],
3	2002	CD	DATE	2002	dep	2	SENT_488	[p22l1413t942r1831b992],
4	;	:	O	;	_	0	SENT_488	[p22l1413t942r1831b992],
5	20:3815	CD	NUMBER	20:3815	number	6	SENT_488	[p22l1413t942r1831b992],
6	—	CD	NUMBER	—	dep	2	SENT_488	[p22l1413t942r1831b992],
7	25	CD	NUMBER	25	dep	6	SENT_488	[p22l1413t942r1831b992],
8	.	.	O	.	_	0	SENT_488	[p22l1413t942r1831b992],

1	10	CD	NUMBER	10	_	0	SENT_489	[p22l1119t1014r1183b1054],
2	.	.	O	.	_	0	SENT_489	[p22l1119t1014r1183b1054],

1	Baselga	NNP	PERSON	Baselga	nn	2	SENT_490	[p22l1213t1010r1398b1066],
2	J	NNP	PERSON	J	_	0	SENT_490	[p22l1412t1014r1445b1063],
3	,	,	O	,	_	0	SENT_490	[p22l1412t1014r1445b1063],
4	Rischin	NNP	PERSON	Rischin	nn	5	SENT_490	[p22l1468t1010r1651b1057],
5	D	NNP	O	D	appos	2	SENT_490	[p22l1671t1014r1722b1063],
6	,	,	O	,	_	0	SENT_490	[p22l1671t1014r1722b1063],
7	Ranson	NNP	PERSON	Ranson	nn	8	SENT_490	[p22l1744t1014r1928b1057],
8	M	NNP	O	M	appos	2	SENT_490	[p22l1947t1014r2008b1063],
9	,	,	O	,	_	0	SENT_490	[p22l1947t1014r2008b1063],
10	et	FW	O	et	nn	11	SENT_490	[p22l2032t1019r2075b1054],
11	al.	FW	O	al.	appos	2	SENT_490	[p22l2093t1010r2146b1054],
12	.	.	O	.	_	0	SENT_490	[p22l2093t1010r2146b1054],

1	N	NN	O	n	nn	2	SENT_491	[p22l908t1143r922b1158],
2	ENGLJ	NN	O	englj	_	0	SENT_491	[p22l937t1142r1021b1164],
3	MED	VBD	O	med	partmod	2	SENT_491	[p22l1036t1143r1089b1158],
4	35o	CD	NUMBER	35o	dobj	3	SENT_491	[p22l1101t1142r1180b1164],
5	;	:	O	;	_	0	SENT_491	[p22l1101t1142r1180b1164],
6	21	CD	NUMBER	21	dep	2	SENT_491	[p22l1101t1142r1180b1164],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_491	[p22l1217t1142r1429b1164],
8	MAY	NNP	DATE	MAY	dep	6	SENT_491	[p22l1468t1142r1519b1158],
9	20	CD	DATE	20	num	8	SENT_491	[p22l1531t1142r1570b1162],
10	,	,	DATE	,	_	0	SENT_491	[p22l1531t1142r1570b1162],
11	2004	CD	DATE	2004	num	8	SENT_491	[p22l1583t1142r1651b1164],
12	The	DT	O	the	det	15	SENT_491	[p22l936t1175r987b1199],
13	New	NNP	O	New	nn	15	SENT_491	[p22l996t1176r1058b1199],
14	England	NNP	O	England	nn	15	SENT_491	[p22l1067t1175r1178b1206],
15	Journal	NNP	O	Journal	dep	6	SENT_491	[p22l1187t1175r1284b1199],
16	of	IN	O	of	_	0	SENT_491	[p22l1294t1175r1323b1199],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_491	[p22l1330t1175r1455b1199],

1	MUTATIONS	NNS	O	mutation	_	0	SENT_492	[p22l588t1363r788b1382],
2	IN	IN	O	in	_	0	SENT_492	[p22l803t1363r841b1382],
3	EGFR	NN	O	egfr	prep_in	1	SENT_492	[p22l857t1363r943b1382],
4	IN	IN	O	in	_	0	SENT_492	[p22l956t1363r994b1382],
5	NON	NNP	O	NON	prep_in	1	SENT_492	[p22l1010t1363r1314b1382],
6	.	.	O	.	_	0	SENT_492	[p22l1010t1363r1314b1382],

1	—	NN	O	—	_	0	SENT_493	[p22l1010t1363r1314b1382],
2	.	.	O	.	_	0	SENT_493	[p22l1010t1363r1314b1382],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_494	[p22l1010t1363r1314b1382],
2	LUNG	NN	O	lung	_	0	SENT_494	[p22l1328t1363r1423b1382],
3	CANCER	NNP	O	CANCER	dep	2	SENT_494	[p22l1436t1363r1572b1382],

1	Phase	NN	O	phase	_	0	SENT_495	[p22l12t1526r150b1570],
2	I	CD	NUMBER	i	num	3	SENT_495	[p22l170t1530r188b1570],
3	safety	NN	O	safety	dep	1	SENT_495	[p22l209t1526r353b1582],
4	,	,	O	,	_	0	SENT_495	[p22l209t1526r353b1582],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_495	[p22l374t1526r789b1582],
6	,	,	O	,	_	0	SENT_495	[p22l374t1526r789b1582],
7	and	CC	O	and	_	0	SENT_495	[p22l811t1526r898b1570],
8	pharmacodynamic	JJ	O	pharmacodynamic	amod	9	SENT_495	[p22l916t1526r1044b1582, p22l13t1597r338b1654],
9	trial	NN	O	trial	conj_and	3	SENT_495	[p22l349t1597r439b1641],
10	of	IN	O	of	_	0	SENT_495	[p22l451t1597r506b1642],
11	ZD1839	NN	O	zd1839	prep_of	1	SENT_495	[p22l507t1601r704b1651],
12	,	,	O	,	_	0	SENT_495	[p22l507t1601r704b1651],
13	a	DT	O	a	det	22	SENT_495	[p22l719t1612r744b1641],
14	selective	JJ	O	selective	amod	22	SENT_495	[p22l755t1597r945b1642],
15	oral	JJ	O	oral	amod	22	SENT_495	[p22l957t1598r1045b1642],
16	epidermal	JJ	O	epidermal	amod	22	SENT_495	[p22l13t1668r255b1725],
17	growth	NN	O	growth	nn	22	SENT_495	[p22l276t1668r448b1725],
18	factor	NN	O	factor	nn	22	SENT_495	[p22l470t1668r611b1713],
19	receptor	NN	O	receptor	nn	22	SENT_495	[p22l631t1678r832b1725],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_495	[p22l852t1669r1044b1725],
21	kinase	NN	O	kinase	nn	22	SENT_495	[p22l13t1739r163b1784],
22	inhibitor	NN	O	inhibitor	appos	11	SENT_495	[p22l175t1739r389b1793],
23	,	,	O	,	_	0	SENT_495	[p22l175t1739r389b1793],
24	in	IN	O	in	_	0	SENT_495	[p22l404t1740r448b1783],
25	patients	NNS	O	patient	prep_in	1	SENT_495	[p22l460t1740r643b1796],
26	with	IN	O	with	_	0	SENT_495	[p22l654t1740r758b1784],
27	ﬁve	NN	O	ﬁve	prep_with	25	SENT_495	[p22l770t1739r849b1784],
28	selected	VBN	O	select	partmod	27	SENT_495	[p22l862t1739r1045b1784],
29	solid	JJ	O	solid	amod	31	SENT_495	[p22l13t1810r130b1855],
30	tumor	NN	O	tumor	nn	31	SENT_495	[p22l156t1820r306b1855],
31	types	NNS	O	type	dobj	28	SENT_495	[p22l330t1820r467b1867],
32	.	.	O	.	_	0	SENT_495	[p22l330t1820r467b1867],

1	J	NNP	O	J	nn	3	SENT_496	[p22l490t1815r511b1861],
2	Clin	NNP	O	Clin	nn	3	SENT_496	[p22l535t1811r634b1855],
3	Oncol	NNP	O	Oncol	_	0	SENT_496	[p22l659t1811r805b1855],
4	2002	CD	DATE	2002	num	3	SENT_496	[p22l830t1814r1041b1864],
5	;	:	O	;	_	0	SENT_496	[p22l830t1814r1041b1864],
6	20	CD	NUMBER	20	num	8	SENT_496	[p22l830t1814r1041b1864],
7	:	:	O	:	_	0	SENT_496	[p22l830t1814r1041b1864],
8	4292-302	CD	NUMBER	4292-302	dep	3	SENT_496	[p22l12t1886r254b1927],
9	.	.	O	.	_	0	SENT_496	[p22l12t1886r254b1927],

1	11	CD	NUMBER	11	_	0	SENT_497	[p22l15t1959r79b1997],
2	.	.	O	.	_	0	SENT_497	[p22l15t1959r79b1997],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_498	[p22l109t1954r204b1998],
2	MG	NN	PERSON	mg	_	0	SENT_498	[p22l225t1957r329b2007],
3	,	,	O	,	_	0	SENT_498	[p22l225t1957r329b2007],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_498	[p22l352t1953r509b1997],
5	RB	NN	O	rb	appos	2	SENT_498	[p22l530t1957r613b2007],
6	,	,	O	,	_	0	SENT_498	[p22l530t1957r613b2007],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_498	[p22l637t1953r803b1997],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_498	[p22l821t1957r899b2007],
9	,	,	O	,	_	0	SENT_498	[p22l821t1957r899b2007],
10	et	FW	O	et	nn	11	SENT_498	[p22l924t1962r968b1997],
11	al.	FW	O	al.	appos	2	SENT_498	[p22l987t1953r1041b1997],
12	.	.	O	.	_	0	SENT_498	[p22l987t1953r1041b1997],

1	Efficacy	NN	O	efficacy	_	0	SENT_499	[p22l12t2023r202b2080],
2	of	IN	O	of	_	0	SENT_499	[p22l214t2023r270b2068],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_499	[p22l274t2023r491b2080],
4	,	,	O	,	_	0	SENT_499	[p22l274t2023r491b2080],
5	an	DT	O	a	det	6	SENT_499	[p22l508t2038r565b2067],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_499	[p22l578t2024r793b2068],
7	of	IN	O	of	_	0	SENT_499	[p22l805t2023r862b2068],
8	the	DT	O	the	det	14	SENT_499	[p22l866t2024r939b2068],
9	epidermal	JJ	O	epidermal	amod	14	SENT_499	[p22l953t2024r1043b2080, p22l13t2094r182b2139],
10	growth	NN	O	growth	nn	14	SENT_499	[p22l221t2094r394b2151],
11	factor	NN	O	factor	nn	14	SENT_499	[p22l434t2094r574b2139],
12	receptor	NN	O	receptor	nn	14	SENT_499	[p22l613t2104r814b2151],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_499	[p22l852t2095r1044b2151],
14	kinase	NN	O	kinase	prep_of	6	SENT_499	[p22l13t2165r180b2219],
15	,	,	O	,	_	0	SENT_499	[p22l13t2165r180b2219],
16	in	IN	O	in	_	0	SENT_499	[p22l202t2166r247b2209],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_499	[p22l270t2166r577b2222],
18	patients	NNS	O	patient	prep_in	3	SENT_499	[p22l597t2166r785b2222],
19	with	IN	O	with	_	0	SENT_499	[p22l805t2166r911b2210],
20	nonsmall	JJ	O	nonsmall	amod	23	SENT_499	[p22l933t2180r1044b2210, p22l13t2237r141b2280],
21	cell	NN	O	cell	nn	23	SENT_499	[p22l163t2236r242b2281],
22	lung	NN	O	lung	nn	23	SENT_499	[p22l263t2236r372b2293],
23	cancer	NN	O	cancer	prep_with	18	SENT_499	[p22l392t2251r558b2281],
24	:	:	O	:	_	0	SENT_499	[p22l392t2251r558b2281],
25	a	DT	O	a	det	27	SENT_499	[p22l582t2251r606b2280],
26	randomized	JJ	O	randomized	amod	27	SENT_499	[p22l628t2236r913b2281],
27	trial	NN	O	trial	dep	1	SENT_499	[p22l935t2236r1041b2281],
28	.	.	O	.	_	0	SENT_499	[p22l935t2236r1041b2281],

1	JAMA	NNP	O	JAMA	_	0	SENT_500	[p22l7t2313r149b2359],
2	2003	CD	DATE	2003	num	1	SENT_500	[p22l161t2312r609b2362],
3	;	:	O	;	_	0	SENT_500	[p22l161t2312r609b2362],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_500	[p22l161t2312r609b2362],
5	—	CD	NUMBER	—	dep	1	SENT_500	[p22l161t2312r609b2362],
6	58	CD	NUMBER	58	dep	5	SENT_500	[p22l161t2312r609b2362],
7	.	.	O	.	_	0	SENT_500	[p22l161t2312r609b2362],

1	12	CD	NUMBER	12	_	0	SENT_501	[p22l15t2385r79b2423],
2	.	.	O	.	_	0	SENT_501	[p22l15t2385r79b2423],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_502	[p22l108t2379r317b2424],
2	M	NNP	O	M	_	0	SENT_502	[p22l333t2383r394b2433],
3	,	,	O	,	_	0	SENT_502	[p22l333t2383r394b2433],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_502	[p22l413t2383r530b2423],
5	S	NNP	O	S	appos	2	SENT_502	[p22l550t2383r589b2433],
6	,	,	O	,	_	0	SENT_502	[p22l550t2383r589b2433],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_502	[p22l610t2380r835b2423],
8	G	NNP	O	G	appos	2	SENT_502	[p22l853t2383r906b2433],
9	,	,	O	,	_	0	SENT_502	[p22l853t2383r906b2433],
10	et	FW	O	et	nn	11	SENT_502	[p22l928t2388r972b2423],
11	al.	FW	O	al.	appos	2	SENT_502	[p22l987t2379r1041b2423],
12	.	.	O	.	_	0	SENT_502	[p22l987t2379r1041b2423],

1	Multi	JJ	O	multi	amod	2	SENT_503	[p22l11t2449r441b2494],
2	—	NN	O	—	nsubj	12	SENT_503	[p22l11t2449r441b2494],
3	institutional	JJ	O	institutional	amod	5	SENT_503	[p22l11t2449r441b2494],
4	randomized	JJ	O	randomized	amod	5	SENT_503	[p22l456t2449r738b2494],
5	phase	NN	O	phase	dep	2	SENT_503	[p22l752t2449r888b2506],
6	H	NN	O	h	nn	7	SENT_503	[p22l904t2454r939b2493],
7	trial	NN	O	trial	dep	2	SENT_503	[p22l954t2450r1045b2493],
8	of	IN	O	of	_	0	SENT_503	[p22l13t2520r69b2565],
9	gefitinib	NN	O	gefitinib	prep_of	7	SENT_503	[p22l81t2520r284b2577],
10	for	IN	O	for	prep	9	SENT_503	[p22l307t2520r377b2565],
11	previously	RB	DATE	previously	pcomp	10	SENT_503	[p22l396t2520r645b2577],
12	treated	VBN	O	treat	_	0	SENT_503	[p22l665t2520r830b2565],
13	patients	NNS	O	patient	dobj	12	SENT_503	[p22l851t2521r1043b2577],
14	with	IN	O	with	_	0	SENT_503	[p22l10t2592r118b2636],
15	advanced	JJ	O	advanced	amod	20	SENT_503	[p22l141t2591r362b2636],
16	non	JJ	O	non	amod	20	SENT_503	[p22l384t2591r727b2636],
17	—	NN	O	—	nn	20	SENT_503	[p22l384t2591r727b2636],
18	small-cell	NN	O	small-cell	nn	20	SENT_503	[p22l384t2591r727b2636],
19	lung	NN	O	lung	nn	20	SENT_503	[p22l749t2591r857b2648],
20	cancer	NN	O	cancer	prep_with	12	SENT_503	[p22l878t2606r1041b2636],
21	.	.	O	.	_	0	SENT_503	[p22l878t2606r1041b2636],

1	J	NNP	O	J	nn	3	SENT_504	[p22l7t2667r28b2713],
2	Clin	NNP	O	Clin	nn	3	SENT_504	[p22l41t2663r138b2707],
3	Oncol	NNP	O	Oncol	_	0	SENT_504	[p22l152t2663r295b2707],
4	2003	CD	DATE	2003	num	3	SENT_504	[p22l308t2666r726b2716],
5	;	:	O	;	_	0	SENT_504	[p22l308t2666r726b2716],
6	21:2237	CD	NUMBER	21:2237	number	7	SENT_504	[p22l308t2666r726b2716],
7	—	CD	NUMBER	—	dep	3	SENT_504	[p22l308t2666r726b2716],
8	46	CD	NUMBER	46	dep	7	SENT_504	[p22l308t2666r726b2716],
9	.	.	O	.	_	0	SENT_504	[p22l308t2666r726b2716],

1	13	CD	NUMBER	13	_	0	SENT_505	[p22l15t2739r79b2777],
2	.	.	O	.	_	0	SENT_505	[p22l15t2739r79b2777],

1	Giaccone	NNP	PERSON	Giaccone	nn	2	SENT_506	[p22l109t2734r329b2778],
2	G	NNP	PERSON	G	_	0	SENT_506	[p22l344t2737r398b2787],
3	,	,	O	,	_	0	SENT_506	[p22l344t2737r398b2787],
4	Herbst	NNP	ORGANIZATION	Herbst	nn	5	SENT_506	[p22l416t2733r579b2777],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_506	[p22l590t2737r668b2787],
6	,	,	O	,	_	0	SENT_506	[p22l590t2737r668b2787],
7	Manegold	NNP	ORGANIZATION	Manegold	nn	8	SENT_506	[p22l684t2733r924b2790],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_506	[p22l939t2737r986b2787],
9	,	,	O	,	_	0	SENT_506	[p22l939t2737r986b2787],
10	et	FW	O	et	nn	11	SENT_506	[p22l1004t2743r1047b2777],
11	al.	FW	O	al.	appos	2	SENT_506	[p22l12t2804r65b2849],
12	.	.	O	.	_	0	SENT_506	[p22l12t2804r65b2849],

1	Gefltinib	NNP	O	Gefltinib	_	0	SENT_507	[p22l90t2804r300b2849],
2	in	IN	O	in	_	0	SENT_507	[p22l322t2805r368b2848],
3	combination	NN	O	combination	prep_in	1	SENT_507	[p22l389t2804r691b2849],
4	with	IN	O	with	_	0	SENT_507	[p22l710t2804r816b2849],
5	gemcita	NN	O	gemcita	nn	7	SENT_507	[p22l837t2805r1043b2861],
6	—	CD	NUMBER	—	num	7	SENT_507	[p22l837t2805r1043b2861],
7	bine	NN	O	bine	prep_with	3	SENT_507	[p22l13t2876r114b2920],
8	and	CC	O	and	_	0	SENT_507	[p22l138t2875r225b2920],
9	cisplatin	NN	O	cisplatin	conj_and	3	SENT_507	[p22l249t2875r449b2932],
10	in	IN	O	in	_	0	SENT_507	[p22l472t2876r518b2919],
11	advanced	JJ	O	advanced	amod	16	SENT_507	[p22l541t2875r760b2920],
12	non	JJ	O	non	amod	16	SENT_507	[p22l783t2875r1044b2920, p22l13t2946r92b2991],
13	—	NN	O	—	nn	16	SENT_507	[p22l783t2875r1044b2920, p22l13t2946r92b2991],
14	smallcell	NN	O	smallcell	nn	16	SENT_507	[p22l783t2875r1044b2920, p22l13t2946r92b2991],
15	lung	NN	O	lung	nn	16	SENT_507	[p22l107t2947r215b3003],
16	cancer	NN	O	cancer	prep_in	9	SENT_507	[p22l229t2961r395b2991],
17	:	:	O	:	_	0	SENT_507	[p22l229t2961r395b2991],
18	a	DT	O	a	det	21	SENT_507	[p22l412t2961r437b2990],
19	phase	NN	O	phase	nn	21	SENT_507	[p22l450t2947r588b3003],
20	III	CD	NUMBER	iii	num	21	SENT_507	[p22l603t2951r657b2990],
21	trial	NN	O	trial	dep	1	SENT_507	[p22l671t2947r765b2990],
22	—	CD	NUMBER	—	num	23	SENT_507	[p22l777t2972r838b2976],
23	INTACT	NN	O	intact	dep	21	SENT_507	[p22l850t2950r1045b2991],
24	1	CD	NUMBER	1	dep	23	SENT_507	[p22l15t3021r53b3062],
25	.	.	O	.	_	0	SENT_507	[p22l15t3021r53b3062],

1	J	NNP	O	J	nn	3	SENT_508	[p22l64t3022r85b3068],
2	Clin	NNP	O	Clin	nn	3	SENT_508	[p22l98t3018r195b3062],
3	Oncol	NNP	O	Oncol	_	0	SENT_508	[p22l209t3018r351b3062],
4	2004	CD	DATE	2004	num	3	SENT_508	[p22l365t3021r753b3071],
5	;	:	O	;	_	0	SENT_508	[p22l365t3021r753b3071],
6	22:777	CD	NUMBER	22:777	number	7	SENT_508	[p22l365t3021r753b3071],
7	—	CD	NUMBER	—	dep	3	SENT_508	[p22l365t3021r753b3071],
8	84	CD	NUMBER	84	dep	7	SENT_508	[p22l365t3021r753b3071],
9	.	.	O	.	_	0	SENT_508	[p22l365t3021r753b3071],

1	14	CD	NUMBER	14	_	0	SENT_509	[p22l15t3094r79b3132],
2	.	.	O	.	_	0	SENT_509	[p22l15t3094r79b3132],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_510	[p22l109t3088r272b3133],
2	RS	NN	ORGANIZATION	r	_	0	SENT_510	[p22l289t3092r367b3142],
3	,	,	O	,	_	0	SENT_510	[p22l289t3092r367b3142],
4	Giaccone	NNP	PERSON	Giaccone	nn	5	SENT_510	[p22l391t3089r611b3133],
5	G	NNP	PERSON	G	appos	2	SENT_510	[p22l633t3092r686b3142],
6	,	,	O	,	_	0	SENT_510	[p22l633t3092r686b3142],
7	Schiller	NNP	PERSON	Schiller	nn	8	SENT_510	[p22l712t3088r889b3133],
8	JH	NNP	O	JH	appos	2	SENT_510	[p22l903t3092r979b3142],
9	,	,	O	,	_	0	SENT_510	[p22l903t3092r979b3142],
10	et	FW	O	et	nn	11	SENT_510	[p22l1004t3098r1047b3132],
11	al.	FW	O	al.	appos	2	SENT_510	[p22l12t3160r65b3204],
12	.	.	O	.	_	0	SENT_510	[p22l12t3160r65b3204],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_511	[p22l86t3159r297b3204],
2	in	IN	O	in	_	0	SENT_511	[p22l315t3160r361b3203],
3	combination	NN	O	combination	prep_in	1	SENT_511	[p22l379t3160r681b3204],
4	with	IN	O	with	_	0	SENT_511	[p22l696t3159r802b3204],
5	paclitaxel	NN	O	paclitaxel	prep_with	3	SENT_511	[p22l819t3159r1044b3216],
6	and	CC	O	and	_	0	SENT_511	[p22l12t3230r100b3275],
7	carboplatin	NN	O	carboplatin	conj_and	5	SENT_511	[p22l117t3230r386b3287],
8	in	IN	O	in	_	0	SENT_511	[p22l403t3231r448b3274],
9	advanced	JJ	O	advanced	amod	14	SENT_511	[p22l465t3230r684b3275],
10	non	JJ	O	non	amod	14	SENT_511	[p22l701t3230r1045b3275],
11	—	NN	O	—	nn	14	SENT_511	[p22l701t3230r1045b3275],
12	small-cell	NN	O	small-cell	nn	14	SENT_511	[p22l701t3230r1045b3275],
13	lung	NN	O	lung	nn	14	SENT_511	[p22l12t3302r121b3358],
14	cancer	NN	O	cancer	prep_in	1	SENT_511	[p22l139t3316r305b3346],
15	:	:	O	:	_	0	SENT_511	[p22l139t3316r305b3346],
16	a	DT	O	a	det	19	SENT_511	[p22l327t3316r352b3345],
17	phase	NN	O	phase	nn	19	SENT_511	[p22l369t3301r507b3358],
18	III	CD	NUMBER	iii	num	19	SENT_511	[p22l526t3306r580b3345],
19	trial	NN	O	trial	dep	1	SENT_511	[p22l600t3302r693b3345],
20	—	CD	NUMBER	—	num	21	SENT_511	[p22l710t3327r771b3331],
21	INTACT	NN	O	intact	dep	19	SENT_511	[p22l787t3305r983b3346],
22	2	CD	NUMBER	2	dep	21	SENT_511	[p22l1001t3305r1041b3346],
23	.	.	O	.	_	0	SENT_511	[p22l1001t3305r1041b3346],

1	J	NNP	O	J	nn	3	SENT_512	[p22l7t3377r28b3423],
2	Clin	NNP	O	Clin	nn	3	SENT_512	[p22l41t3373r138b3417],
3	Oncol	NNP	O	Oncol	_	0	SENT_512	[p22l152t3373r295b3417],
4	2004	CD	DATE	2004	num	3	SENT_512	[p22l308t3376r696b3426],
5	;	:	O	;	_	0	SENT_512	[p22l308t3376r696b3426],
6	22:785	CD	NUMBER	22:785	number	7	SENT_512	[p22l308t3376r696b3426],
7	—	CD	NUMBER	—	dep	3	SENT_512	[p22l308t3376r696b3426],
8	94	CD	NUMBER	94	dep	7	SENT_512	[p22l308t3376r696b3426],
9	.	.	O	.	_	0	SENT_512	[p22l308t3376r696b3426],

1	15	CD	NUMBER	15	_	0	SENT_513	[p22l15t3449r79b3487],
2	.	.	O	.	_	0	SENT_513	[p22l15t3449r79b3487],

1	Frederick	NNP	PERSON	Frederick	nn	2	SENT_514	[p22l108t3443r330b3488],
2	L	NNP	PERSON	L	_	0	SENT_514	[p22l338t3447r378b3497],
3	,	,	O	,	_	0	SENT_514	[p22l338t3447r378b3497],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_514	[p22l391t3447r529b3500],
5	X	NNP	O	X	appos	2	SENT_514	[p22l537t3447r622b3497],
6	.	.	O	.	_	0	SENT_514	[p22l537t3447r622b3497],

1	—	NN	O	—	_	0	SENT_515	[p22l537t3447r622b3497],
2	.	.	O	.	_	0	SENT_515	[p22l537t3447r622b3497],

1	Y	NN	O	y	_	0	SENT_516	[p22l537t3447r622b3497],
2	,	,	O	,	_	0	SENT_516	[p22l537t3447r622b3497],
3	Eley	NNP	PERSON	Eley	nn	4	SENT_516	[p22l636t3443r732b3499],
4	G	NNP	O	G	appos	1	SENT_516	[p22l741t3447r794b3497],
5	,	,	O	,	_	0	SENT_516	[p22l741t3447r794b3497],
6	James	NNP	PERSON	James	nn	7	SENT_516	[p22l803t3447r944b3494],
7	CD	NNP	O	CD	appos	4	SENT_516	[p22l957t3447r1041b3488],
8	.	.	O	.	_	0	SENT_516	[p22l957t3447r1041b3488],

1	Diversity	NN	O	diversity	_	0	SENT_517	[p22l12t3515r217b3571],
2	and	CC	O	and	_	0	SENT_517	[p22l226t3514r312b3559],
3	frequency	NN	O	frequency	conj_and	1	SENT_517	[p22l323t3514r557b3571],
4	of	IN	O	of	_	0	SENT_517	[p22l567t3514r623b3559],
5	epidermal	JJ	O	epidermal	amod	9	SENT_517	[p22l625t3514r863b3571],
6	growth	NN	O	growth	nn	9	SENT_517	[p22l874t3514r1044b3571],
7	factor	NN	O	factor	nn	9	SENT_517	[p22l13t3585r152b3630],
8	receptor	NN	O	receptor	nn	9	SENT_517	[p22l175t3595r375b3642],
9	mutations	NNS	O	mutation	prep_of	1	SENT_517	[p22l398t3586r644b3630],
10	in	IN	O	in	_	0	SENT_517	[p22l668t3586r715b3629],
11	human	JJ	O	human	amod	12	SENT_517	[p22l739t3586r908b3630],
12	glioblastomas	NNS	O	glioblastoma	prep_in	9	SENT_517	[p22l933t3585r1043b3642, p22l13t3657r272b3702],
13	.	.	O	.	_	0	SENT_517	[p22l933t3585r1043b3642, p22l13t3657r272b3702],

1	Cancer	NNP	O	Cancer	nn	2	SENT_518	[p22l289t3661r455b3702],
2	Res	NNP	O	Res	_	0	SENT_518	[p22l466t3661r550b3704],
3	2000	CD	DATE	2000	num	2	SENT_518	[p22l565t3661r953b3711],
4	;	:	O	;	_	0	SENT_518	[p22l565t3661r953b3711],
5	60:1383	CD	NUMBER	60:1383	number	6	SENT_518	[p22l565t3661r953b3711],
6	-7	CD	NUMBER	-7	dep	2	SENT_518	[p22l565t3661r953b3711],
7	.	.	O	.	_	0	SENT_518	[p22l565t3661r953b3711],

1	16	CD	NUMBER	16	_	0	SENT_519	[p22l15t3733r79b3771],
2	.	.	O	.	_	0	SENT_519	[p22l15t3733r79b3771],

1	RichJN	NNP	O	RichJN	_	0	SENT_520	[p22l108t3727r292b3781],
2	,	,	O	,	_	0	SENT_520	[p22l108t3727r292b3781],
3	Reardon	NNP	ORGANIZATION	Reardon	nn	4	SENT_520	[p22l306t3727r502b3774],
4	DA	NNP	ORGANIZATION	DA	appos	1	SENT_520	[p22l513t3731r598b3781],
5	,	,	O	,	_	0	SENT_520	[p22l513t3731r598b3781],
6	Peery	NNP	PERSON	Peery	nn	7	SENT_520	[p22l611t3731r735b3783],
7	T	NN	O	t	appos	1	SENT_520	[p22l741t3731r782b3781],
8	,	,	O	,	_	0	SENT_520	[p22l741t3731r782b3781],
9	etal	NN	O	etal	appos	1	SENT_520	[p22l796t3727r897b3771],
10	.	.	O	.	_	0	SENT_520	[p22l796t3727r897b3771],

1	Phase	NN	O	phase	_	0	SENT_521	[p22l911t3727r1045b3771],
2	II	CD	NUMBER	ii	dep	1	SENT_521	[p22l1117t1530r1154b1570],
3	trial	NN	O	trial	dep	2	SENT_521	[p22l1165t1526r1258b1570],
4	of	IN	O	of	prep	3	SENT_521	[p22l1270t1526r1327b1570],
5	geﬁtinib	NN	O	geﬁtinib	dep	4	SENT_521	[p22l1328t1526r1526b1583],
6	in	IN	O	in	_	0	SENT_521	[p22l1539t1527r1584b1570],
7	recurrent	JJ	O	recurrent	amod	8	SENT_521	[p22l1596t1535r1816b1571],
8	glioblastoma	NN	O	glioblastoma	prep_in	5	SENT_521	[p22l1824t1526r2147b1583],
9	.	.	O	.	_	0	SENT_521	[p22l1824t1526r2147b1583],
10	]	SYM	O	]	dep	3	SENT_521	[p22l1113t1598r1245b1648],

1	Clin	NNP	O	Clin	nn	2	SENT_522	[p22l1113t1598r1245b1648],
2	Oncol	NNP	O	Oncol	_	0	SENT_522	[p22l1260t1598r1402b1642],
3	2004	CD	DATE	2004	num	2	SENT_522	[p22l1416t1601r1804b1651],
4	;	:	O	;	_	0	SENT_522	[p22l1416t1601r1804b1651],
5	22:133	CD	NUMBER	22:133	number	6	SENT_522	[p22l1416t1601r1804b1651],
6	—	CD	NUMBER	—	dep	2	SENT_522	[p22l1416t1601r1804b1651],
7	42	CD	NUMBER	42	dep	6	SENT_522	[p22l1416t1601r1804b1651],
8	.	.	O	.	_	0	SENT_522	[p22l1416t1601r1804b1651],

1	17	CD	NUMBER	17	_	0	SENT_523	[p22l1120t1674r1184b1712],
2	.	.	O	.	_	0	SENT_523	[p22l1120t1674r1184b1712],

1	Cohen	NNP	PERSON	Cohen	nn	2	SENT_524	[p22l1214t1668r1369b1713],
2	MH	NNP	O	MH	_	0	SENT_524	[p22l1381t1672r1485b1722],
3	,	,	O	,	_	0	SENT_524	[p22l1381t1672r1485b1722],
4	Williams	NNP	PERSON	Williams	nn	5	SENT_524	[p22l1499t1668r1712b1712],
5	GA	NNP	O	GA	appos	2	SENT_524	[p22l1727t1672r1816b1722],
6	,	,	O	,	_	0	SENT_524	[p22l1727t1672r1816b1722],
7	Sridhara	NNP	O	Sridhara	nn	8	SENT_524	[p22l1834t1668r2033b1713],
8	R	NNP	O	R	appos	2	SENT_524	[p22l2045t1672r2093b1722],
9	,	,	O	,	_	0	SENT_524	[p22l2045t1672r2093b1722],
10	et	FW	O	et	nn	11	SENT_524	[p22l2110t1677r2153b1712],
11	al.	FW	O	al.	appos	2	SENT_524	[p22l1118t1739r1172b1784],
12	.	.	O	.	_	0	SENT_524	[p22l1118t1739r1172b1784],

1	United	NNP	ORGANIZATION	United	nn	3	SENT_525	[p22l1194t1739r1357b1784],
2	States	NNPS	ORGANIZATION	States	nn	3	SENT_525	[p22l1377t1743r1517b1784],
3	Food	NNP	ORGANIZATION	Food	_	0	SENT_525	[p22l1537t1739r1658b1784],
4	and	CC	ORGANIZATION	and	_	0	SENT_525	[p22l1677t1739r1765b1784],
5	Drug	NNP	ORGANIZATION	Drug	nn	6	SENT_525	[p22l1784t1743r1908b1796],
6	Administration	NNP	ORGANIZATION	Administration	conj_and	3	SENT_525	[p22l1923t1739r2148b1784, p22l1119t1811r1280b1855],
7	drug	NN	O	drug	nn	9	SENT_525	[p22l1306t1810r1420b1867],
8	approval	NN	O	approval	nn	9	SENT_525	[p22l1444t1810r1652b1867],
9	summary	NN	O	summary	dep	3	SENT_525	[p22l1679t1825r1917b1867],
10	:	:	O	:	_	0	SENT_525	[p22l1679t1825r1917b1867],
11	gefitinib	NN	O	gefitinib	dep	3	SENT_525	[p22l1945t1810r2149b1867],
12	(	CD	NUMBER	(	num	13	SENT_525	[p22l1121t1886r1343b1933],
13	ZD1839	NN	O	zd1839	dep	11	SENT_525	[p22l1121t1886r1343b1933],
14	:	:	O	:	_	0	SENT_525	[p22l1121t1886r1343b1933],
15	Iressa	NNP	O	Iressa	nn	16	SENT_525	[p22l1367t1886r1539b1933],
16	)	NNP	O	)	dep	3	SENT_525	[p22l1367t1886r1539b1933],
17	:	:	O	:	_	0	SENT_525	[p22l1367t1886r1539b1933],
18	tablets	NNS	O	tablet	dep	16	SENT_525	[p22l1564t1882r1733b1926],
19	.	.	O	.	_	0	SENT_525	[p22l1564t1882r1733b1926],

1	Clin	NNP	O	Clin	nn	3	SENT_526	[p22l1759t1882r1856b1926],
2	Cancer	NNP	O	Cancer	nn	3	SENT_526	[p22l1879t1886r2045b1926],
3	Res	NNP	O	Res	_	0	SENT_526	[p22l2065t1886r2149b1929],
4	2004	CD	DATE	2004	num	3	SENT_526	[p22l1118t1957r1507b2007],
5	;	:	O	;	_	0	SENT_526	[p22l1118t1957r1507b2007],
6	10:1212	CD	NUMBER	10:1212	number	7	SENT_526	[p22l1118t1957r1507b2007],
7	—	CD	NUMBER	—	dep	3	SENT_526	[p22l1118t1957r1507b2007],
8	8	CD	NUMBER	8	dep	7	SENT_526	[p22l1118t1957r1507b2007],
9	.	.	O	.	_	0	SENT_526	[p22l1118t1957r1507b2007],

1	18	CD	NUMBER	18	_	0	SENT_527	[p22l1120t2028r1184b2068],
2	.	.	O	.	_	0	SENT_527	[p22l1120t2028r1184b2068],

1	Therasse	NN	O	therasse	nn	2	SENT_528	[p22l1213t2023r1424b2067],
2	P	NN	O	p	_	0	SENT_528	[p22l1441t2027r1477b2077],
3	,	,	O	,	_	0	SENT_528	[p22l1441t2027r1477b2077],
4	Arbuck	NNP	O	Arbuck	nn	5	SENT_528	[p22l1495t2023r1671b2068],
5	SG	NNP	O	SG	appos	2	SENT_528	[p22l1686t2027r1768b2077],
6	,	,	O	,	_	0	SENT_528	[p22l1686t2027r1768b2077],
7	Eisenhauer	NNP	PERSON	Eisenhauer	nn	8	SENT_528	[p22l1787t2023r2052b2068],
8	EA	NN	PERSON	ea	appos	2	SENT_528	[p22l2067t2027r2147b2077],
9	,	,	O	,	_	0	SENT_528	[p22l2067t2027r2147b2077],
10	et	FW	O	et	nn	11	SENT_528	[p22l1119t2104r1161b2139],
11	al.	FW	O	al.	appos	2	SENT_528	[p22l1170t2094r1221b2139],
12	.	.	O	.	_	0	SENT_528	[p22l1170t2094r1221b2139],

1	New	NNP	O	New	nn	2	SENT_529	[p22l1235t2099r1344b2139],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_529	[p22l1353t2094r1592b2151],
3	to	TO	O	to	aux	4	SENT_529	[p22l1605t2104r1649b2139],
4	evaluate	VB	O	evaluate	_	0	SENT_529	[p22l1661t2094r1847b2139],
5	the	DT	O	the	det	6	SENT_529	[p22l1859t2095r1930b2138],
6	response	NN	O	response	dobj	4	SENT_529	[p22l1942t2109r2150b2151],
7	to	TO	O	to	_	0	SENT_529	[p22l1119t2175r1163b2210],
8	treatment	NN	O	treatment	prep_to	4	SENT_529	[p22l1182t2174r1414b2210],
9	in	IN	O	in	_	0	SENT_529	[p22l1430t2166r1476b2209],
10	solid	JJ	O	solid	amod	11	SENT_529	[p22l1496t2165r1609b2210],
11	tumors	NNS	O	tumor	prep_in	8	SENT_529	[p22l1629t2175r1812b2210],
12	.	.	O	.	_	0	SENT_529	[p22l1629t2175r1812b2210],

1	J	NNP	O	J	nn	4	SENT_530	[p22l1829t2170r1850b2217],
2	Natl	NNP	O	Natl	nn	4	SENT_530	[p22l1866t2166r1967b2210],
3	Cancer	NNP	O	Cancer	nn	4	SENT_530	[p22l1986t2169r2152b2210],
4	Inst	NNP	O	Inst	_	0	SENT_530	[p22l1117t2241r1211b2280],
5	2000	CD	DATE	2000	num	4	SENT_530	[p22l1222t2240r1610b2290],
6	;	:	O	;	_	0	SENT_530	[p22l1222t2240r1610b2290],
7	92:205	CD	NUMBER	92:205	number	8	SENT_530	[p22l1222t2240r1610b2290],
8	—	CD	NUMBER	—	dep	4	SENT_530	[p22l1222t2240r1610b2290],
9	16	CD	NUMBER	16	dep	8	SENT_530	[p22l1222t2240r1610b2290],
10	.	.	O	.	_	0	SENT_530	[p22l1222t2240r1610b2290],

1	19	CD	NUMBER	19	_	0	SENT_531	[p22l1120t2313r1184b2352],
2	.	.	O	.	_	0	SENT_531	[p22l1120t2313r1184b2352],

1	Fitch	NNP	ORGANIZATION	Fitch	nn	2	SENT_532	[p22l1214t2308r1332b2352],
2	KR	NNP	ORGANIZATION	KR	_	0	SENT_532	[p22l1357t2312r1444b2362],
3	,	,	O	,	_	0	SENT_532	[p22l1357t2312r1444b2362],
4	McGowan	NNP	PERSON	McGowan	nn	5	SENT_532	[p22l1471t2312r1720b2353],
5	KA	NN	O	ka	appos	2	SENT_532	[p22l1746t2312r1831b2362],
6	,	,	O	,	_	0	SENT_532	[p22l1746t2312r1831b2362],
7	van	NN	O	van	nn	8	SENT_532	[p22l1858t2322r1942b2353],
8	Raams	NN	O	raam	appos	2	SENT_532	[p22l1966t2312r2148b2355],
9	—	CD	NUMBER	—	num	11	SENT_532	[p22l1966t2312r2148b2355],
10	donk	NN	O	donk	nn	11	SENT_532	[p22l1119t2379r1242b2424],
11	CD	NN	O	cd	dep	8	SENT_532	[p22l1251t2383r1335b2433],
12	,	,	O	,	_	0	SENT_532	[p22l1251t2383r1335b2433],
13	et	FW	O	et	nn	14	SENT_532	[p22l1351t2388r1393b2423],
14	al.	FW	O	al.	appos	2	SENT_532	[p22l1402t2379r1454b2424],
15	.	.	O	.	_	0	SENT_532	[p22l1402t2379r1454b2424],

1	Genetics	NNP	O	Genetics	_	0	SENT_533	[p22l1469t2380r1670b2424],
2	of	IN	O	of	_	0	SENT_533	[p22l1684t2379r1740b2424],
3	dark	JJ	O	dark	amod	4	SENT_533	[p22l1742t2379r1848b2424],
4	skin	NN	O	skin	prep_of	1	SENT_533	[p22l1858t2380r1955b2424],
5	in	IN	O	in	_	0	SENT_533	[p22l1967t2380r2012b2423],
6	mice	NNS	O	mouse	prep_in	1	SENT_533	[p22l2024t2380r2147b2423],
7	.	.	O	.	_	0	SENT_533	[p22l2024t2380r2147b2423],

1	Genes	NNS	O	gene	_	0	SENT_534	[p22l1118t2453r1264b2494],
2	Dev	JJ	O	dev	amod	1	SENT_534	[p22l1278t2453r1368b2494],
3	2003	CD	DATE	2003	tmod	2	SENT_534	[p22l1380t2453r1768b2503],
4	;	:	O	;	_	0	SENT_534	[p22l1380t2453r1768b2503],
5	17:214	CD	NUMBER	17:214	number	6	SENT_534	[p22l1380t2453r1768b2503],
6	—	CD	NUMBER	—	dep	1	SENT_534	[p22l1380t2453r1768b2503],
7	28	CD	NUMBER	28	dep	6	SENT_534	[p22l1380t2453r1768b2503],
8	.	.	O	.	_	0	SENT_534	[p22l1380t2453r1768b2503],

1	20	CD	NUMBER	20	_	0	SENT_535	[p22l1117t2525r1184b2564],
2	.	.	O	.	_	0	SENT_535	[p22l1117t2525r1184b2564],

1	Nielsen	NNP	ORGANIZATION	Nielsen	nn	2	SENT_536	[p22l1213t2520r1394b2564],
2	UB	NNP	ORGANIZATION	UB	_	0	SENT_536	[p22l1417t2524r1502b2574],
3	,	,	O	,	_	0	SENT_536	[p22l1417t2524r1502b2574],
4	Cardone	NNP	PERSON	Cardone	nn	5	SENT_536	[p22l1529t2520r1729b2565],
5	MH	NNP	O	MH	appos	2	SENT_536	[p22l1751t2524r1855b2574],
6	,	,	O	,	_	0	SENT_536	[p22l1751t2524r1855b2574],
7	Sinskey	NNP	PERSON	Sinskey	nn	9	SENT_536	[p22l1883t2520r2063b2576],
8	A	NNP	O	A	nn	9	SENT_536	[p22l2082t2524r2147b2574],
9	]	NN	O	]	appos	2	SENT_536	[p22l2082t2524r2147b2574],
10	,	,	O	,	_	0	SENT_536	[p22l2082t2524r2147b2574],
11	MacBeath	NNP	O	MacBeath	nn	12	SENT_536	[p22l1117t2591r1357b2636],
12	G	NNP	O	G	appos	2	SENT_536	[p22l1373t2595r1427b2645],
13	,	,	O	,	_	0	SENT_536	[p22l1373t2595r1427b2645],
14	Sorger	NNP	O	Sorger	nn	15	SENT_536	[p22l1446t2595r1606b2648],
15	PK	NNP	O	PK	appos	2	SENT_536	[p22l1619t2595r1700b2637],
16	.	.	O	.	_	0	SENT_536	[p22l1619t2595r1700b2637],

1	Profiling	VBG	O	profile	_	0	SENT_537	[p22l1718t2591r1934b2648],
2	receptor	NN	O	receptor	nn	5	SENT_537	[p22l1948t2601r2151b2648],
3	tyrosine	NN	O	tyrosine	nn	5	SENT_537	[p22l1119t2663r1310b2719],
4	kinase	NN	O	kinase	nn	5	SENT_537	[p22l1350t2662r1505b2707],
5	activation	NN	O	activation	dobj	1	SENT_537	[p22l1545t2663r1778b2707],
6	by	IN	O	by	_	0	SENT_537	[p22l1819t2662r1874b2719],
7	using	VBG	O	use	prepc_by	1	SENT_537	[p22l1912t2663r2046b2719],
8	Ab	NN	O	ab	nn	9	SENT_537	[p22l2083t2662r2149b2707],
9	microarrays	NNS	O	microarray	dobj	7	SENT_537	[p22l1118t2734r1416b2790],
10	.	.	O	.	_	0	SENT_537	[p22l1118t2734r1416b2790],

1	Proc	NNP	O	Proc	nn	7	SENT_538	[p22l1433t2737r1538b2778],
2	Natl	NNP	O	Natl	nn	7	SENT_538	[p22l1550t2734r1651b2778],
3	Acad	NNP	O	Acad	nn	7	SENT_538	[p22l1663t2733r1781b2778],
4	Sci	NNP	O	Sci	nn	7	SENT_538	[p22l1797t2734r1863b2778],
5	U	NNP	O	U	nn	7	SENT_538	[p22l1877t2738r1916b2778],
6	S	NNP	O	S	nn	7	SENT_538	[p22l1930t2737r1954b2778],
7	A	NNP	O	A	_	0	SENT_538	[p22l1968t2738r2005b2777],
8	2003	CD	DATE	2003	num	7	SENT_538	[p22l2018t2737r2148b2787],
9	;	:	O	;	_	0	SENT_538	[p22l2018t2737r2148b2787],
10	100:9330	CD	NUMBER	100:9330	number	11	SENT_538	[p22l1120t2808r1401b2849],
11	—	CD	NUMBER	—	dep	7	SENT_538	[p22l1120t2808r1401b2849],
12	5	CD	NUMBER	5	dep	11	SENT_538	[p22l1120t2808r1401b2849],
13	.	.	O	.	_	0	SENT_538	[p22l1120t2808r1401b2849],

1	21	CD	NUMBER	21	_	0	SENT_539	[p22l1117t2881r1184b2919],
2	.	.	O	.	_	0	SENT_539	[p22l1117t2881r1184b2919],

1	Albanell	NNP	PERSON	Albanell	nn	2	SENT_540	[p22l1212t2875r1413b2919],
2	J	NNP	PERSON	J	_	0	SENT_540	[p22l1434t2879r1468b2929],
3	,	,	O	,	_	0	SENT_540	[p22l1434t2879r1468b2929],
4	Rojo	NNP	PERSON	Rojo	nn	5	SENT_540	[p22l1497t2876r1607b2931],
5	F	NN	O	f	appos	2	SENT_540	[p22l1634t2879r1670b2929],
6	,	,	O	,	_	0	SENT_540	[p22l1634t2879r1670b2929],
7	Averbuch	NNP	PERSON	Averbuch	nn	8	SENT_540	[p22l1698t2875r1927b2920],
8	S	NNP	O	S	appos	2	SENT_540	[p22l1955t2879r1994b2929],
9	,	,	O	,	_	0	SENT_540	[p22l1955t2879r1994b2929],
10	et	FW	O	et	nn	11	SENT_540	[p22l2025t2884r2068b2919],
11	al.	FW	O	al.	appos	2	SENT_540	[p22l2092t2875r2146b2919],
12	.	.	O	.	_	0	SENT_540	[p22l2092t2875r2146b2919],

1	Pharmacodynamic	JJ	O	pharmacodynamic	amod	2	SENT_541	[p22l1117t2946r1556b3003],
2	studies	NNS	O	study	_	0	SENT_541	[p22l1575t2946r1738b2991],
3	of	IN	O	of	_	0	SENT_541	[p22l1759t2946r1815b2991],
4	the	DT	O	the	det	10	SENT_541	[p22l1824t2946r1895b2991],
5	epidermal	JJ	O	epidermal	amod	10	SENT_541	[p22l1915t2946r2151b3003],
6	growth	NN	O	growth	nn	10	SENT_541	[p22l1118t3018r1288b3074],
7	factor	NN	O	factor	nn	10	SENT_541	[p22l1307t3017r1446b3062],
8	receptor	NN	O	receptor	nn	10	SENT_541	[p22l1462t3027r1658b3074],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_541	[p22l1673t3017r1884b3062],
10	ZD1839	NN	O	zd1839	prep_of	2	SENT_541	[p22l1898t3021r2087b3062],
11	in	IN	O	in	_	0	SENT_541	[p22l2105t3018r2150b3061],
12	skin	NN	O	skin	prep_in	10	SENT_541	[p22l1119t3088r1220b3133],
13	from	IN	O	from	_	0	SENT_541	[p22l1236t3088r1354b3133],
14	cancer	NN	O	cancer	nn	15	SENT_541	[p22l1371t3103r1528b3133],
15	patients	NNS	O	patient	prep_from	12	SENT_541	[p22l1542t3089r1750b3145],
16	:	:	O	:	_	0	SENT_541	[p22l1542t3089r1750b3145],
17	histopathologic	JJ	O	histopathologic	amod	20	SENT_541	[p22l1769t3088r2150b3145],
18	and	CC	O	and	_	0	SENT_541	[p22l1118t3159r1204b3204],
19	molecular	JJ	O	molecular	conj_and	17	SENT_541	[p22l1241t3159r1477b3204],
20	consequences	NNS	O	consequence	dep	2	SENT_541	[p22l1512t3174r1837b3216],
21	of	IN	O	of	_	0	SENT_541	[p22l1875t3159r1931b3204],
22	receptor	NN	O	receptor	nn	23	SENT_541	[p22l1958t3169r2152b3216],
23	inhibition	NN	O	inhibition	prep_of	20	SENT_541	[p22l1118t3230r1364b3275],
24	.	.	O	.	_	0	SENT_541	[p22l1118t3230r1364b3275],

1	J	NNP	O	J	nn	3	SENT_542	[p22l1375t3235r1397b3281],
2	Clin	NNP	O	Clin	nn	3	SENT_542	[p22l1409t3230r1506b3275],
3	Oncol	NNP	O	Oncol	_	0	SENT_542	[p22l1519t3230r1662b3275],
4	2002	CD	DATE	2002	num	3	SENT_542	[p22l1676t3234r2064b3284],
5	;	:	O	;	_	0	SENT_542	[p22l1676t3234r2064b3284],
6	20:110	CD	NUMBER	20:110	number	7	SENT_542	[p22l1676t3234r2064b3284],
7	-24	CD	NUMBER	-24	dep	3	SENT_542	[p22l1676t3234r2064b3284],
8	.	.	O	.	_	0	SENT_542	[p22l1676t3234r2064b3284],

1	22	CD	NUMBER	22	_	0	SENT_543	[p22l1117t3307r1184b3345],
2	.	.	O	.	_	0	SENT_543	[p22l1117t3307r1184b3345],

1	Stamos	NNP	PERSON	Stamos	nn	2	SENT_544	[p22l1216t3305r1389b3346],
2	J	NNP	PERSON	J	_	0	SENT_544	[p22l1401t3305r1434b3355],
3	,	,	O	,	_	0	SENT_544	[p22l1401t3305r1434b3355],
4	Sliwkowski	NNP	O	Sliwkowski	nn	5	SENT_544	[p22l1454t3301r1723b3346],
5	MX	NNP	O	MX	appos	2	SENT_544	[p22l1737t3305r1831b3355],
6	,	,	O	,	_	0	SENT_544	[p22l1737t3305r1831b3355],
7	Eigenbrot	NNP	O	Eigenbrot	nn	9	SENT_544	[p22l1850t3301r2087b3358],
8	C.	NNP	O	C.	nn	9	SENT_544	[p22l2100t3305r2147b3346],
9	Structure	NN	O	structure	appos	2	SENT_544	[p22l1119t3376r1338b3417],
10	of	IN	O	of	_	0	SENT_544	[p22l1366t3372r1422b3417],
11	the	DT	O	the	det	17	SENT_544	[p22l1440t3373r1513b3417],
12	epidermal	JJ	O	epidermal	amod	17	SENT_544	[p22l1541t3372r1784b3429],
13	growth	NN	O	growth	nn	17	SENT_544	[p22l1810t3373r1983b3429],
14	factor	NN	O	factor	nn	17	SENT_544	[p22l2010t3372r2151b3417],
15	receptor	NN	O	receptor	nn	17	SENT_544	[p22l1118t3452r1319b3500],
16	kinase	NN	O	kinase	nn	17	SENT_544	[p22l1335t3444r1490b3488],
17	domain	NN	O	domain	prep_of	9	SENT_544	[p22l1508t3443r1692b3488],
18	alone	RB	O	alone	dep	17	SENT_544	[p22l1710t3444r1840b3488],
19	and	CC	O	and	_	0	SENT_544	[p22l1857t3443r1946b3488],
20	in	IN	O	in	dep	17	SENT_544	[p22l1963t3444r2009b3487],
21	complex	NN	O	complex	pobj	20	SENT_544	[p22l2027t3458r2149b3488, p22l1117t3514r1218b3571],
22	with	IN	O	with	_	0	SENT_544	[p22l1236t3514r1344b3559],
23	a	DT	O	a	det	27	SENT_544	[p22l1365t3529r1390b3558],
24	4	CD	NUMBER	4	num	27	SENT_544	[p22l1410t3514r1907b3571],
25	—	NN	O	—	nn	27	SENT_544	[p22l1410t3514r1907b3571],
26	anilinoquinazoline	NN	O	anilinoquinazoline	nn	27	SENT_544	[p22l1410t3514r1907b3571],
27	inhibitor	NN	O	inhibitor	prep_with	21	SENT_544	[p22l1928t3514r2146b3559],
28	.	.	O	.	_	0	SENT_544	[p22l1928t3514r2146b3559],

1	J	NNP	O	J	nn	3	SENT_545	[p22l1113t3590r1134b3636],
2	Biol	NNP	O	Biol	nn	3	SENT_545	[p22l1146t3586r1241b3630],
3	Chem	NNP	O	Chem	_	0	SENT_545	[p22l1254t3586r1395b3630],
4	2002	CD	DATE	2002	num	3	SENT_545	[p22l1408t3589r1885b3639],
5	;	:	O	;	_	0	SENT_545	[p22l1408t3589r1885b3639],
6	277:46265	CD	NUMBER	277:46265	number	7	SENT_545	[p22l1408t3589r1885b3639],
7	—	CD	NUMBER	—	dep	3	SENT_545	[p22l1408t3589r1885b3639],
8	72	CD	NUMBER	72	dep	7	SENT_545	[p22l1408t3589r1885b3639],
9	.	.	O	.	_	0	SENT_545	[p22l1408t3589r1885b3639],

1	23	CD	NUMBER	23	_	0	SENT_546	[p22l1117t3663r1184b3701],
2	.	.	O	.	_	0	SENT_546	[p22l1117t3663r1184b3701],

1	Daley	NNP	PERSON	Daley	nn	2	SENT_547	[p22l1214t3657r1346b3713],
2	GQ	NNP	PERSON	GQ	_	0	SENT_547	[p22l1366t3661r1458b3712],
3	,	,	O	,	_	0	SENT_547	[p22l1366t3661r1458b3712],
4	Van	NNP	PERSON	Van	nn	6	SENT_547	[p22l1481t3661r1569b3701],
5	Etten	NNP	PERSON	Etten	nn	6	SENT_547	[p22l1590t3661r1714b3701],
6	RA	NN	O	ra	appos	2	SENT_547	[p22l1735t3661r1818b3711],
7	,	,	O	,	_	0	SENT_547	[p22l1735t3661r1818b3711],
8	Baltimore	NNP	LOCATION	Baltimore	nn	10	SENT_547	[p22l1843t3657r2076b3701],
9	D.	NNP	O	D.	nn	10	SENT_547	[p22l2097t3661r2146b3701],
10	Induction	NN	O	induction	appos	2	SENT_547	[p22l1117t3727r1352b3772],
11	of	IN	O	of	_	0	SENT_547	[p22l1377t3727r1434b3772],
12	chronic	JJ	O	chronic	amod	14	SENT_547	[p22l1449t3728r1632b3772],
13	myelogenous	JJ	O	myelogenous	amod	14	SENT_547	[p22l1656t3728r1976b3784],
14	leukemia	NN	O	leukemia	prep_of	10	SENT_547	[p22l2002t3727r2149b3772, p23l10t282r197b372],

1	in	IN	O	in	_	0	SENT_548	[p23l231t282r327b370],
2	mice	NNS	O	mouse	pobj	1	SENT_548	[p23l364t282r601b372],
3	by	IN	O	by	_	0	SENT_548	[p23l639t282r753b396],
4	the	DT	O	the	det	6	SENT_548	[p23l786t280r938b372],
5	P210bcrlabl	NN	O	p210bcrlabl	nn	6	SENT_548	[p23l974t282r1566b384],
6	gene	NN	O	gene	prep_by	2	SENT_548	[p23l1599t310r1830b398],
7	of	IN	O	of	_	0	SENT_548	[p23l1866t280r1982b372],
8	the	DT	O	the	det	10	SENT_548	[p23l1996t280r2145b372],
9	Philadelphia	NNP	LOCATION	Philadelphia	nn	10	SENT_548	[p23l8t432r622b548],
10	chromosome	NN	O	chromosome	prep_of	6	SENT_548	[p23l689t432r1366b522],
11	.	.	O	.	_	0	SENT_548	[p23l689t432r1366b522],

1	Science	NN	O	science	_	0	SENT_549	[p23l1444t432r1805b522],
2	1990	CD	DATE	1990	num	1	SENT_549	[p23l1878t438r2143b542],
3	;	:	O	;	_	0	SENT_549	[p23l1878t438r2143b542],
4	247:824	CD	NUMBER	247:824	number	5	SENT_549	[p23l10t588r596b672],
5	—	CD	NUMBER	—	dep	1	SENT_549	[p23l10t588r596b672],
6	30	CD	NUMBER	30	dep	5	SENT_549	[p23l10t588r596b672],
7	.	.	O	.	_	0	SENT_549	[p23l10t588r596b672],

1	24	CD	NUMBER	24	_	0	SENT_550	[p23l8t742r146b822],
2	.	.	O	.	_	0	SENT_550	[p23l8t742r146b822],

1	Pegram	NNP	PERSON	Pegram	nn	2	SENT_551	[p23l207t738r576b848],
2	MD	NNP	O	MD	_	0	SENT_551	[p23l596t738r799b842],
3	,	,	O	,	_	0	SENT_551	[p23l596t738r799b842],
4	Konecny	NNP	PERSON	Konecny	nn	5	SENT_551	[p23l828t740r1253b846],
5	G	NNP	PERSON	G	appos	2	SENT_551	[p23l1270t738r1378b842],
6	,	,	O	,	_	0	SENT_551	[p23l1270t738r1378b842],
7	Slamon	NNP	PERSON	Slamon	nn	8	SENT_551	[p23l1410t730r1776b822],
8	DJ	NNP	O	DJ	appos	5	SENT_551	[p23l1796t738r1936b836],
9	.	.	O	.	_	0	SENT_551	[p23l1796t738r1936b836],

1	The	DT	O	the	det	5	SENT_552	[p23l1962t730r2147b822],
2	molecular	JJ	O	molecular	amod	5	SENT_552	[p23l10t880r514b972],
3	and	CC	O	and	_	0	SENT_552	[p23l567t880r751b972],
4	cellular	JJ	O	cellular	amod	5	SENT_552	[p23l810t882r1179b972],
5	biology	NN	O	biology	_	0	SENT_552	[p23l1235t880r1609b998],
6	of	IN	O	of	_	0	SENT_552	[p23l1663t880r1781b972],
7	HERZI	NNP	O	HERZI	prep_of	5	SENT_552	[p23l1816t888r2143b984],
8	neu	NN	O	neu	nn	10	SENT_552	[p23l10t1060r191b1122],
9	gene	NN	O	gene	nn	10	SENT_552	[p23l229t1060r462b1148],
10	amplification	NN	O	amplification	dep	7	SENT_552	[p23l500t1030r1932b1148],
11	!	.	O	!	_	0	SENT_552	[p23l500t1030r1932b1148],

1	overexpression	NN	O	overexpression	_	0	SENT_553	[p23l500t1030r1932b1148],
2	and	CC	O	and	_	0	SENT_553	[p23l1966t1030r2147b1122],
3	the	DT	O	the	det	5	SENT_553	[p23l10t1182r160b1272],
4	clinical	JJ	O	clinical	amod	5	SENT_553	[p23l199t1182r548b1272],
5	development	NN	O	development	conj_and	1	SENT_553	[p23l585t1180r1223b1298],
6	of	IN	O	of	_	0	SENT_553	[p23l1255t1180r1372b1272],
7	herceptin	NN	O	herceptin	nn	11	SENT_553	[p23l1388t1182r1851b1298],
8	(	CD	NUMBER	(	num	11	SENT_553	[p23l1894t1190r2145b1286, p23l10t1332r476b1436],
9	trastuzumab	NN	O	trastuzumab	nn	11	SENT_553	[p23l1894t1190r2145b1286, p23l10t1332r476b1436],
10	)	NN	O	)	nn	11	SENT_553	[p23l1894t1190r2145b1286, p23l10t1332r476b1436],
11	therapy	NN	O	therapy	prep_of	1	SENT_553	[p23l520t1332r887b1448],
12	for	IN	O	for	_	0	SENT_553	[p23l918t1330r1060b1422],
13	breast	NN	O	breast	nn	14	SENT_553	[p23l1095t1330r1396b1422],
14	cancer	NN	O	cancer	prep_for	1	SENT_553	[p23l1428t1360r1763b1422],
15	.	.	O	.	_	0	SENT_553	[p23l1428t1360r1763b1422],

1	Cancer	NNP	O	Cancer	nn	3	SENT_554	[p23l1806t1338r2149b1422],
2	Treat	NNP	O	Treat	nn	3	SENT_554	[p23l6t1488r261b1572],
3	Res	NNP	O	Res	_	0	SENT_554	[p23l283t1488r456b1578],
4	2000	CD	DATE	2000	num	3	SENT_554	[p23l488t1488r1293b1592],
5	;	:	O	;	_	0	SENT_554	[p23l488t1488r1293b1592],
6	103:57	CD	NUMBER	103:57	number	7	SENT_554	[p23l488t1488r1293b1592],
7	—	CD	NUMBER	—	dep	3	SENT_554	[p23l488t1488r1293b1592],
8	75	CD	NUMBER	75	dep	7	SENT_554	[p23l488t1488r1293b1592],
9	.	.	O	.	_	0	SENT_554	[p23l488t1488r1293b1592],

1	25	CD	NUMBER	25	_	0	SENT_555	[p23l8t1642r146b1722],
2	.	.	O	.	_	0	SENT_555	[p23l8t1642r146b1722],

1	Heinrich	NNP	PERSON	Heinrich	nn	2	SENT_556	[p23l209t1630r647b1722],
2	MC	NNP	PERSON	MC	_	0	SENT_556	[p23l673t1638r878b1742],
3	,	,	O	,	_	0	SENT_556	[p23l673t1638r878b1742],
4	Corless	NNP	ORGANIZATION	Corless	nn	5	SENT_556	[p23l914t1630r1281b1722],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_556	[p23l1314t1638r1476b1742],
6	,	,	O	,	_	0	SENT_556	[p23l1314t1638r1476b1742],
7	Demetri	NNP	PERSON	Demetri	nn	8	SENT_556	[p23l1510t1632r1918b1722],
8	GD	NN	MISC	gd	appos	2	SENT_556	[p23l1948t1638r2137b1742],
9	,	,	O	,	_	0	SENT_556	[p23l1948t1638r2137b1742],
10	et	FW	O	et	nn	11	SENT_556	[p23l10t1800r98b1872],
11	al.	FW	O	al.	appos	2	SENT_556	[p23l113t1780r219b1872],
12	.	.	O	.	_	0	SENT_556	[p23l113t1780r219b1872],

1	Kinase	NN	O	kinase	nn	2	SENT_557	[p23l247t1782r568b1874],
2	mutations	NNS	O	mutation	_	0	SENT_557	[p23l590t1782r1075b1872],
3	and	CC	O	and	_	0	SENT_557	[p23l1097t1780r1275b1872],
4	imatinib	NN	O	imatinib	conj_and	2	SENT_557	[p23l1296t1782r1697b1872],
5	response	NN	O	response	dep	2	SENT_557	[p23l1721t1810r2147b1898],
6	in	IN	O	in	_	0	SENT_557	[p23l10t1932r104b2020],
7	patients	NNS	O	patient	prep_in	5	SENT_557	[p23l147t1932r534b2048],
8	with	IN	O	with	_	0	SENT_557	[p23l573t1932r793b2022],
9	metastatic	JJ	O	metastatic	amod	12	SENT_557	[p23l834t1932r1341b2022],
10	gastrointestinal	JJ	O	gastrointestinal	amod	12	SENT_557	[p23l1380t1932r2147b2048],
11	stromal	JJ	O	stromal	amod	12	SENT_557	[p23l12t2080r381b2172],
12	tumor	NN	O	tumor	prep_with	7	SENT_557	[p23l406t2100r723b2172],
13	.	.	O	.	_	0	SENT_557	[p23l406t2100r723b2172],

1	J	NNP	O	J	nn	3	SENT_558	[p23l745t2090r789b2186],
2	Clin	NNP	O	Clin	nn	3	SENT_558	[p23l812t2082r1010b2172],
3	Oncol	NNP	O	Oncol	_	0	SENT_558	[p23l1035t2082r1326b2172],
4	2003	CD	DATE	2003	num	3	SENT_558	[p23l1350t2088r2141b2192],
5	;	:	O	;	_	0	SENT_558	[p23l1350t2088r2141b2192],
6	21:4342	CD	NUMBER	21:4342	number	7	SENT_558	[p23l1350t2088r2141b2192],
7	—	CD	NUMBER	—	dep	3	SENT_558	[p23l1350t2088r2141b2192],
8	9	CD	NUMBER	9	dep	7	SENT_558	[p23l1350t2088r2141b2192],
9	.	.	O	.	_	0	SENT_558	[p23l1350t2088r2141b2192],

1	26	CD	NUMBER	26	_	0	SENT_559	[p23l8t2242r146b2322],
2	.	.	O	.	_	0	SENT_559	[p23l8t2242r146b2322],

1	Davies	NNP	PERSON	Davies	nn	2	SENT_560	[p23l207t2232r520b2322],
2	H	NNP	PERSON	H	_	0	SENT_560	[p23l548t2240r659b2342],
3	,	,	O	,	_	0	SENT_560	[p23l548t2240r659b2342],
4	Bignell	NNP	PERSON	Bignell	nn	5	SENT_560	[p23l691t2230r1032b2348],
5	GR	NN	O	gr	appos	2	SENT_560	[p23l1057t2238r1239b2342],
6	,	,	O	,	_	0	SENT_560	[p23l1057t2238r1239b2342],
7	Cox	NN	ORGANIZATION	cox	nn	8	SENT_560	[p23l1273t2238r1462b2322],
8	C	NN	ORGANIZATION	c	appos	2	SENT_560	[p23l1484t2238r1580b2342],
9	,	,	O	,	_	0	SENT_560	[p23l1484t2238r1580b2342],
10	et	FW	O	et	nn	11	SENT_560	[p23l1613t2250r1701b2322],
11	al.	FW	O	al.	appos	2	SENT_560	[p23l1720t2230r1827b2322],
12	.	.	O	.	_	0	SENT_560	[p23l1720t2230r1827b2322],

1	Mutations	NNS	O	mutation	_	0	SENT_561	[p23l1856t2238r2145b2322, p23l10t2382r253b2472],
2	of	IN	O	of	_	0	SENT_561	[p23l303t2380r420b2472],
3	the	DT	O	the	det	5	SENT_561	[p23l446t2382r598b2472],
4	BRAF	NN	O	braf	nn	5	SENT_561	[p23l643t2388r924b2478],
5	gene	NN	O	gene	prep_of	1	SENT_561	[p23l972t2410r1207b2498],
6	in	IN	O	in	_	0	SENT_561	[p23l1253t2382r1349b2470],
7	human	JJ	O	human	amod	8	SENT_561	[p23l1394t2380r1747b2472],
8	cancer	NN	O	cancer	prep_in	1	SENT_561	[p23l1794t2410r2137b2472],
9	.	.	O	.	_	0	SENT_561	[p23l1794t2410r2137b2472],

1	Nature	NNP	O	Nature	_	0	SENT_562	[p23l8t2540r349b2622],
2	2002	CD	DATE	2002	num	1	SENT_562	[p23l380t2538r1247b2640],
3	;	:	O	;	_	0	SENT_562	[p23l380t2538r1247b2640],
4	417:949	CD	NUMBER	417:949	number	5	SENT_562	[p23l380t2538r1247b2640],
5	—	CD	NUMBER	—	dep	1	SENT_562	[p23l380t2538r1247b2640],
6	54	CD	NUMBER	54	dep	5	SENT_562	[p23l380t2538r1247b2640],
7	.	.	O	.	_	0	SENT_562	[p23l380t2538r1247b2640],

1	27	CD	NUMBER	27	_	0	SENT_563	[p23l8t2692r146b2772],
2	.	.	O	.	_	0	SENT_563	[p23l8t2692r146b2772],

1	Bardelli	NNP	PERSON	Bardelli	nn	2	SENT_564	[p23l207t2680r583b2772],
2	A	NNP	O	A	_	0	SENT_564	[p23l601t2690r701b2792],
3	,	,	O	,	_	0	SENT_564	[p23l601t2690r701b2792],
4	Parsons	NNP	PERSON	Parsons	nn	5	SENT_564	[p23l729t2688r1110b2772],
5	DW	NNP	O	DW	appos	2	SENT_564	[p23l1135t2688r1334b2792],
6	,	,	O	,	_	0	SENT_564	[p23l1135t2688r1334b2792],
7	Silliman	NNP	PERSON	Silliman	nn	8	SENT_564	[p23l1366t2680r1767b2772],
8	N	NNP	O	N	appos	2	SENT_564	[p23l1788t2688r1894b2792],
9	,	,	O	,	_	0	SENT_564	[p23l1788t2688r1894b2792],
10	et	FW	O	et	nn	11	SENT_564	[p23l1926t2700r2015b2772],
11	al.	FW	O	al.	appos	2	SENT_564	[p23l2031t2680r2139b2772],
12	.	.	O	.	_	0	SENT_564	[p23l2031t2680r2139b2772],

1	Mutational	JJ	O	mutational	amod	2	SENT_565	[p23l6t2830r548b2922],
2	analysis	NN	O	analysis	_	0	SENT_565	[p23l588t2832r970b2946],
3	of	IN	O	of	_	0	SENT_565	[p23l1016t2830r1132b2922],
4	the	DT	O	the	det	6	SENT_565	[p23l1153t2832r1303b2922],
5	tyrosine	NN	O	tyrosine	nn	6	SENT_565	[p23l1344t2832r1733b2946],
6	kinome	NN	O	kinome	prep_of	2	SENT_565	[p23l1774t2830r2147b2922],
7	in	IN	O	in	_	0	SENT_565	[p23l10t2982r104b3070],
8	colorectal	JJ	O	colorectal	amod	9	SENT_565	[p23l173t2982r663b3072],
9	cancers	NNS	O	cancer	prep_in	2	SENT_565	[p23l729t3010r1131b3072],
10	.	.	O	.	_	0	SENT_565	[p23l729t3010r1131b3072],

1	Science	NNP	O	Science	_	0	SENT_566	[p23l1207t2982r1576b3072],
2	2003	CD	DATE	2003	num	1	SENT_566	[p23l1643t2988r2141b3092],
3	;	:	O	;	_	0	SENT_566	[p23l1643t2988r2141b3092],
4	300	CD	NUMBER	300	num	6	SENT_566	[p23l1643t2988r2141b3092],
5	:	:	O	:	_	0	SENT_566	[p23l1643t2988r2141b3092],
6	949	CD	NUMBER	949	dep	1	SENT_566	[p23l10t3138r219b3222],
7	.	.	O	.	_	0	SENT_566	[p23l10t3138r219b3222],

1	28	CD	NUMBER	28	_	0	SENT_567	[p23l8t3290r146b3372],
2	.	.	O	.	_	0	SENT_567	[p23l8t3290r146b3372],

1	Li	NNP	PERSON	Li	nn	2	SENT_568	[p23l207t3282r297b3370],
2	B	NNP	PERSON	B	_	0	SENT_568	[p23l319t3288r414b3392],
3	,	,	O	,	_	0	SENT_568	[p23l319t3288r414b3392],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_568	[p23l444t3280r769b3398],
5	CM	NN	O	cm	appos	2	SENT_568	[p23l789t3288r986b3392],
6	,	,	O	,	_	0	SENT_568	[p23l789t3288r986b3392],
7	Yuan	NN	O	yuan	nn	8	SENT_568	[p23l1013t3288r1255b3372],
8	M	NN	O	m	appos	2	SENT_568	[p23l1275t3290r1402b3392],
9	,	,	O	,	_	0	SENT_568	[p23l1275t3290r1402b3392],
10	McKenna	NNP	PERSON	McKenna	nn	11	SENT_568	[p23l1428t3288r1900b3374],
11	WG	NNP	O	WG	appos	2	SENT_568	[p23l1918t3288r2139b3392],
12	,	,	O	,	_	0	SENT_568	[p23l1918t3288r2139b3392],
13	Shu	NNP	PERSON	Shu	nn	14	SENT_568	[p23l12t3430r195b3522],
14	HK	NNP	O	HK	appos	2	SENT_568	[p23l221t3440r409b3524],
15	.	.	O	.	_	0	SENT_568	[p23l221t3440r409b3524],

1	Resistance	NN	O	resistance	_	0	SENT_569	[p23l440t3432r956b3528],
2	to	TO	O	to	_	0	SENT_569	[p23l984t3450r1074b3522],
3	small	JJ	O	small	amod	5	SENT_569	[p23l1105t3430r1364b3522],
4	molecule	NN	O	molecule	nn	5	SENT_569	[p23l1390t3432r1829b3522],
5	inhibitors	NNS	O	inhibitor	prep_to	1	SENT_569	[p23l1856t3432r2145b3522, p23l10t3582r225b3672],
6	of	IN	O	of	_	0	SENT_569	[p23l277t3580r396b3672],
7	epidermal	JJ	O	epidermal	amod	10	SENT_569	[p23l424t3580r932b3698],
8	growth	NN	O	growth	nn	10	SENT_569	[p23l980t3582r1340b3698],
9	factor	NN	O	factor	nn	10	SENT_569	[p23l1388t3580r1683b3672],
10	receptor	NN	O	receptor	prep_of	1	SENT_569	[p23l1729t3600r2149b3698],
11	in	IN	O	in	_	0	SENT_569	[p24l8t25r106b113],
12	malignant	JJ	O	malignant	amod	13	SENT_569	[p24l163t25r685b141],
13	gliomas	NNS	O	glioma	prep_in	1	SENT_569	[p24l737t25r1165b141],
14	.	.	O	.	_	0	SENT_569	[p24l737t25r1165b141],

1	Cancer	NN	O	cancer	_	0	SENT_570	[p24l1229t31r1578b115],
2	Res	NNP	O	Res	dep	1	SENT_570	[p24l1631t31r1807b121],
3	2003	CD	DATE	2003	num	2	SENT_570	[p24l1866t31r2141b133],
4	;	:	O	;	_	0	SENT_570	[p24l1866t31r2141b133],
5	63:7443	CD	NUMBER	63:7443	number	6	SENT_570	[p24l10t179r607b263],
6	—	CD	NUMBER	—	dep	1	SENT_570	[p24l10t179r607b263],
7	50	CD	NUMBER	50	dep	6	SENT_570	[p24l10t179r607b263],
8	.	.	O	.	_	0	SENT_570	[p24l10t179r607b263],

1	29	CD	NUMBER	29	_	0	SENT_571	[p24l8t333r146b415],
2	.	.	O	.	_	0	SENT_571	[p24l8t333r146b415],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_572	[p24l207t331r428b415],
2	JG	NNP	O	JG	_	0	SENT_572	[p24l468t331r624b435],
3	,	,	O	,	_	0	SENT_572	[p24l468t331r624b435],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_572	[p24l669t331r950b429],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_572	[p24l1000t331r1153b435],
6	,	,	O	,	_	0	SENT_572	[p24l1000t331r1153b435],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_572	[p24l1209t331r1372b415],
8	IC	NN	O	ic	appos	2	SENT_572	[p24l1410t331r1554b435],
9	,	,	O	,	_	0	SENT_572	[p24l1410t331r1554b435],
10	et	FW	O	et	nn	11	SENT_572	[p24l1611t343r1701b415],
11	al.	FW	O	al.	appos	2	SENT_572	[p24l1744t323r1852b415],
12	.	.	O	.	_	0	SENT_572	[p24l1744t323r1852b415],

1	EGFR	NN	O	egfr	nn	2	SENT_573	[p24l1906t331r2153b415],
2	mutations	NNS	O	mutation	_	0	SENT_573	[p24l10t475r508b565],
3	in	IN	O	in	_	0	SENT_573	[p24l555t475r650b563],
4	lung	NN	O	lung	nn	5	SENT_573	[p24l693t475r918b591],
5	cancer	NN	O	cancer	prep_in	2	SENT_573	[p24l960t503r1304b565],
6	:	:	O	:	_	0	SENT_573	[p24l960t503r1304b565],
7	correlation	NN	O	correlation	dep	2	SENT_573	[p24l1354t475r1888b565],
8	with	IN	O	with	_	0	SENT_573	[p24l1928t473r2147b565],
9	clinical	JJ	O	clinical	amod	10	SENT_573	[p24l10t625r359b715],
10	response	NN	O	response	prep_with	7	SENT_573	[p24l414t653r853b741],
11	to	TO	O	to	_	0	SENT_573	[p24l910t643r1000b715],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_573	[p24l1057t623r1468b741],
13	therapy	NN	O	therapy	prep_to	10	SENT_573	[p24l1525t625r1904b741],
14	.	.	O	.	_	0	SENT_573	[p24l1525t625r1904b741],

1	Science	NNP	O	Science	nn	3	SENT_574	[p24l1969t625r2143b715, p24l10t803r229b865],
2	10.1126	CD	NUMBER	10.1126	num	3	SENT_574	[p24l263t775r1514b877],
3	lscience	NN	O	lscience	_	0	SENT_574	[p24l263t775r1514b877],
4	.1099314	CD	NUMBER	.1099314	number	5	SENT_574	[p24l263t775r1514b877],
5	(	CD	NUMBER	(	dep	3	SENT_574	[p24l1547t781r1890b879],
6	2004	CD	DATE	2004	num	7	SENT_574	[p24l1547t781r1890b879],
7	)	NN	O	)	dep	5	SENT_574	[p24l1547t781r1890b879],
8	.	.	O	.	_	0	SENT_574	[p24l1547t781r1890b879],

1	Copyright	NN	O	copyright	_	0	SENT_575	[p24l12t909r382b1009],
2	©	CD	NUMBER	©	num	6	SENT_575	[p24l414t917r498b999],
3	2004	CD	DATE	2004	num	6	SENT_575	[p24l534t913r729b985],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_575	[p24l759t909r1318b985],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_575	[p24l1350t909r1657b985],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_575	[p24l1683t913r1966b1007],
7	.	.	O	.	_	0	SENT_575	[p24l1683t913r1966b1007],

1	ENGLJ	NNP	O	ENGLJ	nn	3	SENT_576	[p24l545t1085r629b1107],
2	MED	NNP	O	MED	nn	3	SENT_576	[p24l644t1086r696b1101],
3	35o	NN	O	35o	_	0	SENT_576	[p24l709t1085r787b1107],
4	;	:	O	;	_	0	SENT_576	[p24l709t1085r787b1107],
5	21	CD	NUMBER	21	num	6	SENT_576	[p24l709t1085r787b1107],
6	WWW	NNP	O	WWW	dep	3	SENT_576	[p24l824t1086r919b1101],
7	.	.	O	.	_	0	SENT_576	[p24l824t1086r919b1101],

1	N	NN	O	n	nn	3	SENT_577	[p24l824t1086r919b1101],
2	EJ	NN	O	ej	nn	3	SENT_577	[p24l927t1086r945b1107],
3	M.ORG	NN	O	m.org	_	0	SENT_577	[p24l953t1085r1036b1101],
4	MAY	NNP	DATE	MAY	dep	3	SENT_577	[p24l1075t1085r1127b1101],
5	20,200	CD	NUMBER	20,200	num	4	SENT_577	[p24l1138t1085r1241b1105],
6	The	DT	O	the	det	9	SENT_577	[p24l702t1118r753b1142],
7	New	NNP	O	New	nn	9	SENT_577	[p24l762t1119r824b1142],
8	England	NNP	O	England	nn	9	SENT_577	[p24l833t1118r944b1149],
9	Journal	NNP	O	Journal	dep	3	SENT_577	[p24l953t1118r1050b1142],
10	of	IN	O	of	_	0	SENT_577	[p24l1060t1118r1089b1142],
11	Medicine	NNP	O	Medicine	prep_of	9	SENT_577	[p24l1095t1118r1220b1142],

1	Downloaded	VBN	O	download	_	0	SENT_578	[p24l144t1159r314b1182],
2	from	IN	O	from	_	0	SENT_578	[p24l323t1159r387b1182],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_578	[p24l396t1159r514b1189],
4	at	IN	O	at	_	0	SENT_578	[p24l524t1163r548b1182],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_578	[p24l556t1159r739b1182],
6	on	IN	O	on	_	0	SENT_578	[p24l748t1166r780b1182],
7	January	NNP	DATE	January	prep_on	1	SENT_578	[p24l789t1159r892b1189],
8	5	CD	DATE	5	num	7	SENT_578	[p24l902t1159r924b1187],
9	,	,	DATE	,	_	0	SENT_578	[p24l902t1159r924b1187],
10	2014	CD	DATE	2014	num	7	SENT_578	[p24l935t1159r1007b1182],
11	.	.	O	.	_	0	SENT_578	[p24l935t1159r1007b1182],

1	or	CC	O	or	dep	4	SENT_579	[p24l1037t1166r1064b1182],
2	ersonal	JJ	O	ersonal	amod	3	SENT_579	[p24l1090t1159r1185b1182],
3	use	NN	O	use	npadvmod	4	SENT_579	[p24l1194t1166r1237b1182],
4	only	RB	O	only	_	0	SENT_579	[p24l1247t1159r1312b1189],
5	.	.	O	.	_	0	SENT_579	[p24l1247t1159r1312b1189],

1	No	DT	O	no	det	3	SENT_580	[p24l1322t1159r1362b1182],
2	other	JJ	O	other	amod	3	SENT_580	[p24l1372t1159r1440b1182],
3	uses	NNS	O	use	_	0	SENT_580	[p24l1449t1166r1504b1182],
4	without	IN	O	without	_	0	SENT_580	[p24l1515t1159r1616b1182],
5	permission	NN	O	permission	prep_without	3	SENT_580	[p24l1624t1159r1777b1189],
6	.	.	O	.	_	0	SENT_580	[p24l1624t1159r1777b1189],

1	Copyright	NN	O	copyright	nn	5	SENT_581	[p24l494t1200r629b1231],
2	©	CD	NUMBER	©	num	5	SENT_581	[p24l638t1200r661b1224],
3	2004	CD	DATE	2004	num	5	SENT_581	[p24l672t1200r737b1224],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_581	[p24l746t1200r937b1224],
5	Medica	NNP	ORGANIZATION	Medica	_	0	SENT_581	[p24l947t1200r1047b1224],
6	ociety	NN	O	ociety	dep	5	SENT_581	[p24l1084t1200r1170b1231],
7	.	.	O	.	_	0	SENT_581	[p24l1084t1200r1170b1231],

1	All	DT	O	all	det	2	SENT_582	[p24l1181t1200r1223b1224],
2	rights	NNS	O	rights	nsubj	3	SENT_582	[p24l1232t1200r1307b1231],
3	reserved	VBN	O	reserve	_	0	SENT_582	[p24l1316t1200r1435b1224],
4	.	.	O	.	_	0	SENT_582	[p24l1316t1200r1435b1224],

